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Abstract 
Progress towards the total synthesis of the marine natural product diazonamide A is 
described. The synthesis was conceived around an iminium-catalyzed 
alkylation/cyclization cascade that stereoselectively installs the central C(10) quaternary 
carbon stereocenter and the complete furanoindoline core of the natural product in an 
asymmetric, organocatalytic manner. The manner in which this idea was brought to bear is 
illustrated, with the remainder of the work focused on devising and executing strategies 
toward the synthesis of the two twelve-membered macrocycles of the target structure. 
Considerable efforts were made in this regard, and highlights include execution of a 
Witkop photo-annulation, development of a novel and highly selective magnesium-
mediated macroaldolization reaction to close a thirteen-membered ring, a Suzuki biaryl 
macrocyclization, an unusual oxidative ring contraction, and the development of a new 
DAST-mediated method for the synthesis of 4-acyl oxazoles. Five distinct approaches 
towards the endgame of the synthesis are described. In all cases these approaches came 
only a single synthetic operation from the assured completion of the natural product, but 
none proved ultimately viable.  
Also described is work focused on replacing a late-stage auxiliary-based aldol 
reaction in a previously completed MacMillan group synthesis of the macrolide antibiotic 
erythronolide B, with a substrate-controlled, diastereoselective variant. The overarching 
synthetic strategy and forward synthesis will be described along with a detailed discussion 
of the aforementioned, late stage aldol reaction to install the C(1)-C(2) portion of the seco 
acid. 
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Chapter 1 
 
 
Isolation, Structural Elucidation, and Biological Activity of the Diazonamides 
 
 
I. Isolation  
 The diazonamides are a structurally unique class of secondary metabolites 
produced by colonial marine ascidians of the genus Diazona. The first members of the 
class were reported in 1991 when Fenical and coworkers isolated diazonamides A (1) and 
B (2) from the methanol extracts a colony of Diazona angulata harvested in the waters 
off Siquijor Island in the Philippines.1 Subsequently, in early 2008, Reyes and coworkers 
reported the isolation of diazonamides C, D, and E (3–5) from an unspecified Diazona 
species found in Indonesian waters near Manado and Raja Ampat, roughly 500 miles 
south and 775 miles southeast, respectively, of the original isolation site (Figure 1).2  
Figure 1: Isolation sites of the diazonamides in the south seas
Legend:         Sijiquor Island, Phillipines.        Manado, Indonesia.         Raja Ampat, Indonesia.
1
2
3
1 2
*reproduced, with permission, from Google Maps*
3  
                                                
1 Lindquist, N.; Fenical, W.; Van Duyne, G. D.; Clardy, J. J. Am. Chem. Soc. 1991, 113, 2303–2304. 
2 Fernandez, R.; Martin, M. J.; Rodriguez-Acebes, R.; Reyes, F.; Francesch, A.; Cuevas, C. Tetrahedron 
Lett. 2008, 49, 2282–2285. 
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 The compact, polycyclic structures of the diazonamides are wholly unprecedented 
in the natural product literature and the relationships between their dominant structural 
features are distinctive and complex (Figure 2). All of the diazonamides consist of two 
conjoined twelve-membered macrocycles, effectively dividing the molecule into two 
discrete hemispheres. In each member, the right-hand macrocycle contains only a single 
sp3 carbon and all of its four constituent aromatic ring systems (A-B-CD-E) lie out of 
conjugation with one another, creating an impressive cyclophane-type substructure. 
Moreover, within the cyclophane, the B-ring oxazole exists as a single atropisomer along 
the A-B-C axis. The left-hand ring is a highly strained twelve-membered lactam 
containing two ansa-bridged aromatic rings and three stereogenic centers. These two 
large ring systems are fused together through a central triaryl-substituted quaternary 
carbon stereocenter at C(10) imbedded in a highly unusual tetracyclic furanoindoline core 
(E-F-G-H). Taken together, these features result in an extraordinarily compact, rigid, and 
exotic topography whose inner atoms possess almost no rotational degrees of freedom. 
These molecules differ from one another only in the pattern of halogenation on the 
3  
periphery of the aromatic rings, the presence and identity of the C(36)–C(40) side chain, 
and the inclusion of either a valine or isoleucine side chain appended to C(32). 
 These impressive structural attributes, together with potent anti-cancer activity 
(vide supra) and the lack of an abundant and renewable natural source, make the 
diazonamides exceptionally attractive targets for de novo synthesis. In fact, few 
molecules in recent history have generated such intense and sustained synthetic interest.3  
This thesis will endeavor to catalogue the fascinating history of the diazonamides from a 
synthetic chemist’s point of view, with an attendant emphasis on their structural features 
as they relate to both the biological function of these molecules and the ideas advanced in 
regard to their construction. 
 
II. Original Structural Proposal for Diazonamides A and B 
 Perhaps the most famous chapter in the diazonamide story revolves around the 
fact that the structures of diazonamide A and B were notoriously misassigned as 6 and 7, 
respectively, in Fenical and Clardy’s original report (Figure 3). Even though 54 mg of 
diazonamide A and 132 mg of diazonamide B were collected in the original 1991 
isolation, the large proportion of heteroatoms and unprotonated carbons precluded a 
complete and unambiguous NMR structural determination. Even though all of the 
constituent spin systems could be unambiguously identified, the way in which they were 
bonded together could not be determined with certainty. However, this difficulty was 
                                                
3 For a recent, comprehensive review of the synthetic efforts toward 1, see: Lachia, M.; Moody, C. J. Nat. 
Prod. Rep. 2008, 25, 227–253. 
 
4  
overcome when the isolation chemists were successful in solving an X-ray crystal 
structure of a p-bromobenzoate derivative of diazonamide B (Figure 3).4,5  
Proposed diazonamide A (6) Proposed diazonamide B (7)X-ray crystal structure of p-bromobenzoatederivative of diazonamide B
Figure 3: Originally proposed structures and accepted labeling for nominal diazonamide A
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 The X-ray data exhibits many of the features of 1–5 discussed above, with one 
crucial and notable exception. The diffraction pattern was unable to resolve the positions 
of the protons associated with the heteroatoms attached to C(11), leading Fenical and 
Clardy to assign both atoms as oxygen. However, this assignment was inconsistent with 
the observation of an exchangeable proton resonance at δ 7.36 possessing a 3.5 Hz 
coupling to the C(11) proton at δ 6.46 in the 1H NMR. To account for this, the isolation 
chemists proposed that the crystal structure connectivity corresponds to a dehydrated and 
cyclized form of diazonamide B, and that E-F-G ring system actually existed as an open 
hemiacetal form in the natural product, as shown in 7. Loss of water was proposed to 
occur during mass spectrometry to reconcile the observed molecular ions with the 
proposed molecular formulas. Based on this rationale, and the assumption that the 
diazonamide A side chain was valine, Fenical put forward structures 6 and 7 as being the 
natural forms of diazonamide A and diazonamide B, respectively (Figure 3). 
                                                
4 Diazonamide A was assigned by analogy to the crystal structure of diazonamide B, based on the similarity 
of the NMR data. The differentiating side chain was assumed to be L-valine. 
5 The X-ray structure in Figure 3 was reproduced with permission from the ACS. Originally published in 
Lindquist, N.; Fenical, W.; Van Duyne, G. D.; Clardy, J. J. Am. Chem. Soc. 1991, 113, 2303–2304. 
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III. A Revised Structural Proposal 
 Spurred by this initial report, more than a dozen synthetic research groups began 
to investigate and report synthetic routes to 6 in the early and mid 1990s. Yet, it took 
nearly a full decade until Harran and coworkers at University of Texas–Southwestern 
Medical Center finally succeeded in reporting a completed synthesis of 6 in late 2001.6 
However, the excitement around this impressive synthetic achievement was quickly 
tempered by the fact that the NMR spectral data for synthetic 6 did not match that 
reported for the natural product in the isolation paper. Moreover, synthetic 6 proved to be 
unstable to routine handling and purification protocols. In light of these findings, Harran 
proposed that structure 6 originally put forward by Fenical and Clardy was incorrectly 
assigned, and on the basis of the following propositions, put forward a new proposal for 
the true structure of diazonamide A. 
 It was known that an acid digest of the natural product produces no valine.7 
Moreover, the C(36)-methine  resonance is observed at δ 76.9 ppm in the 13C NMR, an 
anomalously high shift for a valine freebase. These facts taken together argue strongly 
against the proposal that valine constitutes the C(36)–C(40) side chain. Rather, Harran 
postulated that that this fragment was much more likely to be the corresponding α-
hydroxy acid.  
 Yet, to reconcile the molecular formula with this NH2 to OH substitution, a 
compensatory O to NH transposition in 6 was required. Realizing this meant that 
Fenical’s crystal structure had been misassigned, Harran exhaustively re-analyzed the 
original crystal data set, as well as a series of 1H/13C and 1H/15N HSQC NMR 
                                                
6 Li, J.; Jeong, S.; Esser, L.; Harran, P. G. Angew. Chem. Int. Ed. 2001, 40, 4765–4769. 
7 Lindquist, N. Ph.D. Thesis, University of California, San Diego, 1989. 
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experiments on a natural sample of diazonamide A. Harran convincingly demonstrated 
that one of the heteroatoms attached to C(11) was nitrogen, and that the true structure of 
the diazonamide A possessed a closed form of the tetracyclic aminal. This prompted him 
to put forth 1 as the likely structure of diazonamide A (Figure 4). 8   
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Figure 4: Originally proposed and revised structures of diazonamide A
 
 If correct, this structural hypothesis would possess one particularly pleasing and 
intuitive feature that was notably absent in its predecessor, 6. Specifically, this revision 
suggests a very clear and compelling hypothesis for the biosynthetic origin of the 
diazonamides (Figure 4). While the majority of the structure of 6 is clearly derived from 
naturally occurring amino acid residues, the biosynthetic origin of the central 
dihydrobenzofuran was far from obvious. Yet, the indoline moiety of 1 is almost 
certainly derived from an oxidized congener of the amino acid tryptophan. As such, 
Harran proposed the biosynthetic origins of diazonamide A to be based on the oxidative 
cyclizations of a hydroxy acid conjugated-tertrapeptide, as shown in Figure 5. 
Confirmation of this hypothesis came in 2002–2003 through a series of completed 
total syntheses of 6, all of which will be discussed in detail in the following chapter. 
                                                
8 Li, J.; Burgett, A. W. G.; Esser, L.; Amecuza, C.; Harran, P. G. Angew. Chem. Int. Ed. 2001, 40, 4769–
4772. 
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Figure 5: Harran's proposed biosynthesis of diazonamide A
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However, the collateral damage from this structural revision incurred by the synthetic 
community was unprecedented. With the structure of 6 now shown to be demonstrably 
incorrect, and substantially different from the true structure 1, nearly all of the groups 
who had been so heavily invested in the synthesis of these incredibly popular targets over 
the past decade now found themselves with obsolete synthetic strategies. Yet, as with any 
such rapid change in perspective, this new structure provided attendant opportunities to 
develop interesting synthetic strategies toward the newer structure. Both the theme and 
topic for the subsequent chapters of this thesis are the numerous creative ways in which 
these opportunities have been made manifest. 
 
IV. Biological Activity and Therapeutic Potential 
 In the original isolation paper, diazonamide A was reported to exhibit low 
nanomolar in vitro activity against HCT-116 human colon carcinoma and B-16 murine 
melanoma cell lines. Subsequent investigations showed that this nanomolar inhibition 
also extended to many other human cancers, including multiple cell lines of ovarian, 
breast, colon, pancreatic, melanoma, and lung cancer (Figure 6).  
8  
 
1AB-5 is deschloro-diazonamide A
2 Reproduced from Wang, G.; Shang, L.; Burgett, A. W. G.; Harran, P. G.; Wang, X. Proc. Nat. Acad. Sci. 
USA 2007, 104, 2068–2073
Figure 6: GI50 values for diazonamide A analog against a range of cancer cell lines 
1,2
 
  Initial investigations into the specific biological mode of action showed that 
diazonamide A was an antimitotic agent, arresting division at the G2/M interface of the 
cell cycle. Specifically, cells treated with diazonamide A and closely related synthetic 
analogues lacked a viable mitotic spindle (Figure 7).  
 Reproduced from Williams, N. S.; Burgett, A. W.; Atkins, A. S.; Wang, X.; Harran, P.; McKnight, S. L. 
Proc. Nat. Acad. Sci. USA 2007, 104, 2074–2079.
Figure 7:  Diazonamide-treated HeLa cells
control
in
te
rp
h
a
s
e
m
e
ta
p
h
a
s
e
diazonamide A (30 nM)
 
9  
 The qualitative similarity of these observations to the effects of other classical 
small molecule antimitotic agents, such as Taxol and the vinca alkaloids, led to an initial 
assumption that diazonamide acted as a tubulin-binding agent. Armed with this belief, 
researchers endeavored to identify the binding site for 1 on the protein. The 
Taxol-binding site was discounted by Nicolaou, who showed that 1 exhibited 2–5 nM 
IC50 values against 1A9/PTX10 cells, a strain of ovarian cancer that is resistant to 
treatment with Taxol due to an acquired mutation in the Taxol-binding site on β-tubulin.9 
Moreover, Cruz-Monserrate showed that 1 did not competitively inhibit the binding of 
vinblastine, dolastatin 10, or GTP to tubulin.10 This led these workers to initially 
postulate that 1 must occupy a new and unique binding site on tubulin; one that it does 
not share with any other known tubulin-binding molecules. Yet, no positive evidence for 
such an interaction could be found.  
 Harran and coworkers later attempted to test the tubulin-binding hypothesis 
directly by carrying out binding affinity studies between purified tubulin and radio-
labeled or biotinylated analogues of 1. Surprisingly these analogues of 1 did not bind 
with either monomeric tubulin or microtubules in vitro.11 Rather, affinity screening using 
biotinylated 1 revealed that ornithine acyl transferase (OAT), a well-characterized 
mitochondrial matrix protein, was the cellular target of diazonamide A. This was a highly 
unexpected finding. OAT was known to regulate flux in the urea cycle and to couple 
                                                
9 Nicolaou, K. C.; Hao, J.; Reddy, M. V.; Rao, P. B.; Rassias, G.; Snyder, S. A.; Huang, X.; Chen, D. 
Y.-K.; Brenzovich, W. E.; Giuseppone, N.; Giannakakou, P.; O’Brate, A. J. Am. Chem. Soc. 2004, 126, 
12897–12906. 
10 Cruz-Monserrate, Z.; Vervoort, H. C.; Bai, R.; Newman, D. J.; Howell, S. B.; Los, G.; Mullaney, J. T.; 
Williams, M. D.; Pettit, G. R.; Fenical, W.; Hamel, E. Mol. Pharm. 2003, 63, 1273–1280. 
11 Wang, G.; Shang, L.; Burgett, A. W. G.; Harran, P. G.; Wang, X. Proc. Nat. Acad. Sci. USA 2007, 104, 
2068–2073. 
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proline biosynthesis to consumption of fumarate in the citric acid cycle, but it had never 
been implicated in cell division.12 To address the possibility that OAT may play some 
hitherto unappreciated role in mitosis, siRNA strands were synthesized to block OAT 
synthesis in HeLa cells by selectively inactivating OAT mRNA.11 After 48 hours the 
HeLa cells treated with the designer siRNAs exhibited mitotic spindle defects similar to 
those observed upon exposure to diazonamide A, with cells accumulating at the G2/M 
interface. After 72 hours, cell death was observed in the majority of the treated cells, 
substantiating the hypothesis that OAT is the cellular target of diazonamide A and is 
essential to proper mitotic function and propagation in HeLa cells. 
 This was a puzzling result, as it is well established that OAT-null mice and 
OAT-deficient humans are viable, implying that OAT is not essential in development.13 
This is hardly likely if the enzyme is a key regulator in essential cellular processes such 
as division. As such, Harran and coworkers boldly hypothesized that OAT may be 
selectively utilized as a regulatory factor in mitosis by the cancer cells that exhibit 
diazonamide sensitivity, but not in healthy human cells. 
 If true, diazonamide A would represent a novel class of antimitotic small-
molecule inhibitor that has an intrinsically cancer-selective enzyme target. A corollary of 
this would be that if diazonamide was viable as an in vivo therapy, it should not exhibit 
any of the systemic toxicity characteristics of the classical tubulin binding antimitotics, 
which discriminate poorly between cancerous and healthy cells.  
                                                
12 Seller, N. Current Drug Targets 2000, 1, 119–153. 
13 (a) Wang, T.; Lawler, A. M.; Steel, G.; Sipila, I.; Milam, A.H.; Valle, D. Nat. Genet. 1995, 11, 185–190. 
(b) Brody, L. C.; Mitchell, G. A.; Obie, C.; Michaud, J.; Steel, G.; Fontaine, G.; Robert, M. F.; Sipila, I.; 
Kaiser-Kupfer, M.; Valle, D. J. Biol. Chem. 1992, 267, 3302–3307. 
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 To address this hypothesis, Harran and McKnight tested the hypothesis in nude 
mice.14 Tumors were xenografted onto nude mice, which were then subjected to a 
regimen of both 1 and Taxol. 1 was shown to be just as effective in vivo as it was in vitro, 
causing rapid regression of tumor growth, with 44% of mice being tumor free after 100 
days. Moreover, the mice treated with 1 exhibited no weight loss or loss of appetite, 
while Taxol-treated mice lost on average 20% of their body weight. Also, mice treated 
with 1 exhibited no signs of neutropenia, a major dose-limiting side effect in Taxol and 
vinblastine based therapies. This lack of overt toxicity, coupled with low nanomolar, 
broad-spectrum anti-tumor activity make 1 a truly unique and promising cancer therapy.15  
 
V. Known Structure-Activity Relationships 
 Toward this end, structure-activity relationships for a number of diazonamide 
derivatives have been established, illustrating which features are crucial for biological 
activity. Some of the most illuminating data comes from comparing the activities of the 
natural isolates themselves. 1 and 3 differ only in that 1 possesses the α-hydroxy side 
chain at C(38) while 3 possesses an α-amino group. Yet 1 is more than 300 times more 
active than 3 against lung (A549), colon (HT29), and breast (MDA-MB-231) cancer cell 
lines.2 Notably, all of the diazonamides lacking the C(36) side chain are much less active 
than 1.2 Thus, it is presumed that the α-hydroxy side chain is essential for potency.  
 Harran found that the when the α-hydroxy C(36) side chain is appended to the 
tetracyclic acetal derived from nominal diazonamide A (6), it is equipotent to 1.8 Thus the 
                                                
14 Williams, N. S.; Burgett, A. W.; Atkins, A. S.; Wang, X.; Harran, P.; McKnight, S. L. Proc. Nat. Acad. 
Sci. USA 2007, 104, 2074–2079. 
15 Joyant Pharmaceuticals has licensed the rights to develop diazonamide A as commercial anti-cancer 
therapy. 
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identity of the left-hand heteroatom attached to C(11) is unimportant. Also, Harran found 
that des-chloro diazonamide A is equipotent to 1, illustrating that the aryl chlorides are 
unnecessary for high levels of biological activity.11 Lastly, he found that structures 
lacking the D-E biaryl bond were more than a 100-fold less potent than 1.  
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Figure 8: Known structure-activity relationships in the diazonamide series
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 Taken together this knowledge can be compiled to give a fairly representative 
view of the structural aspects of 1 that are necessary for potent biological activity (Figure 
8). Unfortunately, such an analysis does little to suggest structurally less complex 
analogues that have a reasonable chance of remaining highly active. But, in time, all the 
work invested in the diazonamides is likely to bear significant fruit. Even if the molecules 
themselves are never developed as viable therapeutics, the elucidation of the OAT-
dependence of cell division in certain cancer cell lines is of fundamental importance. It is 
highly likely that a traditional small-molecule drug discovery program aimed at 
discovering OAT antagonists could be successfully undertaken, with the hope of 
developing an entire class of promising new antineoplastic therapies. In the meantime, 
discovering ever-better routes to 1 will facilitate the basic biological investigations of this 
pathway. 
 In closing, it should be noted that this work is a particularly striking example of 
the way in which synthetic chemistry, and complex target synthesis in particular, can still 
13  
be an engine for scientific discovery. The true structure of diazonamide A was arrived at 
on the basis of two completed total syntheses, one revealing the original structural 
misassignment and the other confirming the true structure. Moreover, the amount of 1 
isolated from natural sources would never satisfy the demand needed to fully elucidate 
the mode of biological action. Despite the great difficulty associated with its synthesis, 
synthetic 1 and its derivatives played the crucial role in elucidating the OAT-dependent 
mitotic pathway, which opened up exciting new avenues for both drug discovery and 
fundamental oncology. Though it may be vocally and frequently disparaged for being 
increasingly irrelevant, this story is testament to the central role of chemical synthesis 
still plays in the advancement of human medicine and its associated biological sciences. 
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Chapter 2 
 
Prior Efforts Toward the Synthesis of Diazonamide A 
I. Introduction 
 Prior to the outset of the MacMillan group’s synthetic investigations of 
diazonamide A, many approaches to the molecule and several completed syntheses had 
been described in the literature.1 The successes and failures of these earlier studies 
provided much of the context for our own work and will frame the discussion in 
subsequent chapters about the unique advantages and liabilities that our asymmetric 
organocatalytic strategy imposes in addressing the most challenging structural features of 
the target. Due to the fact that this area has been often and extensively reviewed in recent 
years, this chapter will only discuss highlights from the one completed synthesis of the 
nominal structure of diazonamide A (1), the three completed total syntheses of true 
diazonamide A (2), and one formal synthesis of 2 that have appeared in the literature. 
Specifically, these brief descriptions will focus on the strategies and methods used to 
assemble the E-F-H-G tetracyclic core, the two twelve-membered macrocycles, and the 
central C(10) quaternary carbon stereocenter (Figure 1).  
Figure 1: Structures, accepted carbon numbering, and ring labeling
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1 For reviews on the synthetic efforts towards both the original and revised diazonamide structures, see: (a) 
Lachia, M.; Moody, C. J. Nat. Prod. Rep. 2008, 25, 227–253. (b) Ritter, T.; Carriera, E. M. Angew. Chem. 
Int. Ed. 2002, 41, 2489–2495. (c) Fuerst, D. E. Ph.D. Thesis, Yale University, 2004. 
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II. Harran’s Synthesis of Nominal Diazonamide A 
 As described in Chapter 1, in late 2001 Harran and coworkers completed a 
synthesis of nominal diazonamide A (1) only to discover that the structure of the natural 
product had been misassigned in the isolation paper.2,3 Yet, due to this work being the 
only successful total synthesis of 1 and in light of the large degree of structural homology 
between 2 and 1, this work was highly influential in all future syntheses of 2. Selected 
highlights from this work are described herein. 
Scheme 1: Key steps from Harran's synthesis of nominal diazonamide A
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2 For a report of the synthesis of 1, see: Li, J.; Jeong, S.; Esser, L.; Harran, P. G. Angew. Chem. Int. Ed. 
2001, 40, 4765–4769. 
3 For a report of the structural revision of 1 to 2, see: Li, J.; Burgett, A. W. G.; Esser, L.; Amecuza, C.; 
Harran, P. G. Angew. Chem. Int. Ed. 2001, 4, 4770–4775. 
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 In the first key transformation, Harran employed a phenol-directed intramolecular 
Heck reaction to close the left-hand macrocycle, inducing the aryl palladium(II) species 
derived from 3 to insert the pendant olefin, furnishing thirteen-membered ring 4 after 
β-hydride elimination (eq 1). Following protection of the phenol, the resulting olefin 5 
was diastereoselectively dihydroxylated using a stoichiometric amount of chiral osmium 
complex 6 (eq 2).4 Notably, dihydroxylation with an analogous achiral osmium complex 
predominantly provided the undesired diastereomer. The resulting diol 7 then underwent 
a stereospecific acid-catalyzed pinacol rearrangement to yield triaryl-substituted aldehyde 
and the desired ring-contracted twelve-membered macrocycle 8 (eq 3). 
Scheme 2: Witkop annulation from Harran's synthesis of nominal diazonamide A
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4 (a) Hanessian, S.; Meffre, P.; Girard, M.; Beuadoin, S.; Sanceau, J.-Y.; Bennani, Y. J. Org. Chem. 1993, 
58, 1991–1993. (b) On the augmented reactivity of similar, formally 20-electron osmium complexes, see: 
Corey, E. J.; Sarshar, S.; Azimioara, M. D.; Newbold, R. C.; Noe, M. C. J. Am. Chem. Soc. 1996, 118, 
7851–7852. 
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 Aldehyde 8 was then converted to bisoxazole 9 through a conventional 10-step 
sequence (Scheme 2). Upon irradiation with UV light, it was proposed that bisoxazole 9 
would undergo a Witkop-type cyclization to yield to the desired aryl-aryl bond and the 
intact right-hand macrocycle.5 This Witkop-type ring closure is an unorthodox and 
elegant solution to the formation of the D-E biaryl bond. Mechanistically, it is proposed 
that absorption of a photon by the pendant indole moiety promotes a π electron to a high-
energy excited state. This new electronic state has a sufficiently high oxidation potential 
to transfer an electron to the adjacent aryl bromide, yielding a pair of aryl radical ions 
(10). Mesolytic cleavage of the carbon-bromine bond in the radical anion then creates a 
neutral radical, which combines with the pendant indolyl radical cation to form the 
desired biaryl bond.6 Accordingly, treatment of bisoxazole with 300 nm light in a 
buffered solution of aqueous acetonitrile and lithium acetate produced the desired product 
11 in a modest 32–40% yield, with most of the remaining mass recovered as unreacted 
starting material. Remarkably, the B-ring oxazole is created as a single atropisomer with 
the correct configuration for the natural product. This fact taken together with the relative 
mildness of the reaction conditions make this a truly innovative and well-conceived 
solution to an otherwise very difficult bond construction. 
 Following cyclization, Harran demonstrates that selective, late-stage installation 
of the aryl chlorides is possible on the intact diazonamide framework of 11, despite the 
large number of potentially reactive sites (Scheme 3).  This finding was substantial, as it 
allows all future retrosynthetic analyses to install this functionality to the 
                                                
5 (a)Yonemitsu, O.; Cerutti, P.; Witkop, B. J. Am. Chem. Soc. 1966, 88, 3941–3945. (b) Masnovi, J. M.; 
Kochi, J. K.; Hilinski, E. F.; Rentzepis, P. M. J. Am. Chem. Soc. 1986, 108, 1126–1135. 
6 Maslak, P.; Narvaez, J. N. Angew. Chem. Int. Ed. 1989, 29, 283–285. 
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Scheme 3: Chlorination and endgame in Harran's synthesis of nominal diazonamide A
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final stages of the synthesis. Lastly, removal of protecting groups and appendage of the 
valine side chain furnished nominal diazonamide A (1), prompting Harran to recognize 
the necessity of a structural revision.  
 This synthesis proceeded in 26 steps in the longest linear sequence and in 0.51 % 
overall yield. Importantly, even though the final target was not truly diazonamide A (2), 
this work established viable strategies toward several of the most daunting features of 2 
and many of its key innovations were appropriated and applied to the true natural product 
in later synthetic campaigns. 
 
III. First-Generation Nicolaou Synthesis 
 In late 2002, Nicolaou and coworkers at the Scripps Research Institute reported 
the first total synthesis of the revised structure of diazonamide A.7,8 In this work, the 
Nicolaou group chose to construct the C(10) stereocenter via nucleophilic attack of a 
lithiated oxazole 13 onto the functionalized bromoisatin 14 (Scheme 4). The adduct 15 
was then ionized upon subjection to p-TSA to form highly stabilized benzylic tertiary 
carbocation 16 that was subsequently captured by tyrosine derivative 17, according to the 
                                                
7 For the initial communication describing this work, see: Nicolaou, K. C.; Bella, M.; Chen, D. Y.-K.; 
Huang, X.; Ling, T.; Snyder, S. A. Angew. Chem. Int. Ed. 2002, 41, 3495–3499. 
8 For a full paper describing this work, see: Nicolaou, K. C.; Chen, D. Y.-K.; Huang, X.; Ling, T.; Bella, 
M.;  Snyder, S. A. J. Am. Chem. Soc. 2004, 126, 12888–12896. 
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method described by Olah.9 Thus, in remarkably short order Nicolaou and coworkers 
were able to access much of the carbon framework of diazonamide A. However, the 
product of this reaction sequence (18) was formed as a 1:1 mixture of diastereomers at 
the C(10) quaternary center with relatively poor reaction efficiency (Scheme 4). 
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Scheme 4: Original Nicolaou synthesis of C(10) center and heterocyclic core
 
 The two diastereomers of 18 were separated chromatographically and each was 
carried on independently, as the spectral data offered no insight into which diastereomer 
possessed the correct C(10) stereochemistry corresponding to that of the natural product. 
After several straightforward synthetic manipulations, lactamization of 19a was 
accomplished under the action of HATU and collidine in a dilute solution of DMF and 
CH2Cl2 to provide the left hand macrocycle, albeit in low yield (eq 4). Notably, only the 
S-configured C(10) diastereomer 19a underwent reaction while its R-antipode 19b 
oligomerized or decomposed under all conditions surveyed (eq 5).10 Fortunately for the 
                                                
9 Klumpp, D. A.; Yeung, K. Y.; Prakash, G. K. S.; Olah, G. A. J. Org. Chem. 1998, 63, 4481–4484. 
10 For a famous example of a macrocyclization dependence on seco acid stereochemistry, see: Woodward, 
R. B., et al. J. Am. Chem. Soc 1981, 103, 3213–3215. 
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Nicolaou group, the S-diastereomer was the properly configured C(10) diastereomer and 
they were able to carry on with the synthesis. 
 With the left-hand macrocycle in place, efforts turned to closing the right-hand 
ring. After a series of deprotections and oxidation state changes, carboxylic acid 21 was 
coupled to the oxidized tryptamine salt 22 (Scheme 5). The ketoamide 23 was then 
subjected to POCl3 in pyridine to affect a Robinson-Gabriel cyclodehydration, yielding 
the second oxazole 24 in 52% yield. This sequence installed the complete carbon skeleton 
of the molecule and provided the precursor for a Witkop-type photocyclization to form 
the right-hand macrocycle in 25. This approach to the D-E biaryl synthesis was 
conceptually appropriated from the Harran synthesis of nominal diazonamide A, but it 
also differs in certain key aspects. Notably, it demonstrated that this type of reactivity is 
compatible with the oxindole functionality present in the ring adjacent to the aryl 
bromide. Also, this cyclization required extremely high-energy 200 nm UV light, as 
opposed to the 300 nm light source that Harran had used, demonstrating that for these 
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Scheme 5: Oxazole cyclodehydration and Witkop photocyclization
reactions the excitation wavelength has a structural dependence independent from the 
indole-oxazole chromophore. 
Next, the B-ring oxazole and indole C-ring of 25 were selectively chlorinated and 
the tetracyclic furanoindoline core was closed by reductive cyclization of the H-ring 
phenol of 26 onto the F-ring oxindole under the action of excess DIBAL to yield 27 (eq 
6). After several further deprotection steps, Nicolaou completed the synthesis by coupling 
28 to both enantiomers (29 and 30) of the hydroxyvaleric acid side chain (eq 7). 
Diagnostic differences between the two diastereomers in the 1H NMR definitively 
established the configuration of the C(36) stereocenter in the natural product to be (S). 
Most importantly, the completion of this work demonstrably proved Harran’s hypothesis 
about the true molecular structure of diazonamide A.3  
In summary, this first completed synthesis consisted of 24 steps in the longest 
linear sequence, and proceeded in 0.015% overall yield. While this synthesis exhibits a 
number of interesting transformations, the steps creating the key architectural elements, 
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such as the C(10) quaternary stereocenter and the twelve-membered rings, are uniformly 
low yielding. Moreover, from a viewpoint of stereoselectivity, the central C(10) 
stereocenter was formed as a 1:1 mixture of diastereomers. While this synthesis firmly 
established the true structure of diazonamide A, it left a great deal of room for 
improvement with regards to the development of viably scalable and selective synthetic 
sequences. 
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IV. Second-Generation Nicolaou Synthesis of Diazonamide A  
While efforts toward the synthesis described above were underway, the Nicolaou 
group was simultaneously working on a second, distinct route toward the target molecule, 
which they published in mid-2003.11,12 This second route was strategically distinguished 
from the first in that the order of macrocycle closure was reversed, instead focusing on 
                                                
11 For the initial communication of this work, see: Nicolaou, K. C.; Rao, P. B.; Hao, J.; Reddy, M. V.; 
Rassias, G.; Huang, X.; Chen, D. Y.-K.; Snyder, S. A. Angew. Chem. Int. Ed. 2003, 42, 1753–1758. 
12 For a full paper describing this work, see: Nicolaou, K. C.; Hao, J.; Reddy, M. V.; Rao, P. B.; Rassias, 
G.; Snyder, S. A.; Huang, X.; Chen, D. Y.-K.; Brenzovich, W. E.; Giuseppone, N.; Giannakakou, P.; 
O’Brate, A. J. Am. Chem. Soc. 2004, 126, 12897–12906. 
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initial closure of the right-hand macrocycle. Selected highlights of this work are 
described below. 
This work commenced in a similar fashion to the first–generation Nicolaou 
synthesis with a Lewis acid-catalyzed addition of tyrosine derivative 32 into 
7-bromoisatin 33 to give 34 (Scheme 6). After a series of oxidation state adjustment and 
protecting group manipulations, siloxyoxindole 35 engages formaldehyde in an aldol 
coupling to yield 36 and the central C(10) quaternary center, albeit again as an equimolar 
mixture of diastereomers. The oxindole functionality is then reduced to its corresponding 
indoline form and the phenol protected to yield 37.  
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Scheme 6: Formation of C(10) center in second-generation Nicolaou synthesis
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Indoline 37 is next coupled to boronic ester 38 in a palladium-catalyzed Suzuki 
coupling, establishing the C(16)–C(18) biaryl bond of 39 (Scheme 7). The silyl ethers 
were then removed and the resulting alcohols were oxidized to their corresponding 
aldehydes. Treatment of the resulting dialdehyde with O-methyl hydroxylamine 
selectively generated the key oxime aldehyde intermediate 40. Treatment with SmI2 led 
to a hetero-pinacol coupling to form the right-hand macrocycle with concomitant 
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cleavage of the N-O bond. Coupling of the newly formed amine with a N-protected 
valine 41 using standard peptide coupling procedures gave hydroxy amide 42 in a 
combined yield of 45% over the two steps. 
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 Oxidation of the free hydroxyl group was followed by treatment with POCl3 in 
pyridine to give the A-ring oxazole of 43 in 32% yield over the two steps based on 
recovered starting material (eq 8). However, during this sequence the C(10) 
diastereomers were not chromatographically resolvable, and as such all of these 
intermediates were carried through the subsequent synthetic transformations as a mixture 
of diastereomers. 
Deprotection of the mixed acetal in 43, oxidation to the free carboxylic acid and 
liberation of the valine-derived primary amine set the stage for the second 
macrocyclization of 44. Unfortunately, this step proved much more difficult than it had in 
the previous synthesis. This was attributed by the authors to constraints resulting from the 
right-hand ring already being in place. In the end, treatment of 44 with HATU and 
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collidine in dilute DMF/CH2Cl2 produced the desired macrocycle 45 in only 10–15% 
yield (eq 9). Once again this step served to resolve the C(10) epimers, as only the 
correctly configured diastereomer of 44 underwent ring closure.  
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 At this juncture it became necessary to reinstall the oxindole moiety of the F-ring. 
Notably, this functionality had been present in prior intermediates in the synthesis, yet 
had been reductively excised to facilitate the success of other downstream 
transformations. The Nicolaou group was fortunate to find that the indoline 45 was 
unexpectedly oxidized to its corresponding oxindole under the nominally reducing 
hydrogenative conditions employed to remove the benzyl ether of 45, producing oxindole 
46 in 35% yield (Scheme 8). After a three-step sequence this oxindole was transformed 
into an intermediate from the first-generation synthesis, completing a late-stage formal 
synthesis of diazonamide A. Taking synthetic 43 on to the natural product 2 furnishes a 
32-step synthesis in the longest linear sequence proceeding in 0.017% overall yield.  
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Scheme 8: Second-generation endgame and completion of late-stage formal synthesis
43  
 In a critical sense, this synthesis was substantially longer than its predecessor, but 
proceeds with similarly low overall efficiency. With regard to addressing the key 
synthetic hurdles, the late stage amide coupling to close the left-hand macrocycle 
proceeds in only 10% yield, representing a severe hurdle to making meaningful quantities 
of diazonamide A in this manner. The fact that this lactamization step also serves to 
resolve the C(10) diastereomers shines an even harsher light on the strategic decision to 
synthesize this central structural feature as a 1:1 mixture. However, the reductive pinacol 
closure to form the right-hand macrocycle proved to be an interesting and more efficient 
strategic disconnect relative to the Witkop-type chemistry described previously. Yet it 
was still unlikely that either of these first two completed syntheses would be able to 
reasonably provide the material needed to establish the biological underpinnings of 
diazonamide A’s activity.  
 
V. Harran’s Synthesis of Diazonamide A 
 Having contributed so much to the early synthetic work in the diazonamide field 
and proposing the true structure of the natural product, it was only fitting that Harran and 
coworkers reported a third synthesis of the revised structure in late 2003.13 In a process 
                                                
13 Burgett, A. W. G.; Li, Q.; Wei, Q.; Harran, P. G. Angew. Chem. Int. Ed. 2003, 42, 4961–4966. 
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that may mimic the biosynthesis of the tetracyclic E-F-G-H core, the key disconnection in 
this synthesis is an intramolecular oxidative annulation of tyrosine across the enamine-
like π bond of a pendant indole to create the intact tetracyclic core, the central quaternary 
stereocenter, and the left-hand macrolactam of diazonamide A simultaneously. This idea 
was reduced to practice in the fifth linear step of the synthesis by subjecting phenol 46 to 
bis(acetoxy)iodosobenzene in cold trifluoroethanol to yield 47 as a 3:1 mixture of 
diastereomers in roughly 30% yield along with 15% of undesired product 48 (Scheme 9).  
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Scheme 9: Haran's synthesis of the E-F-G-H rings and the C(10) center
 
Mechanistically this process is believed to occur by coordination of the phenolic 
oxygen to the hypervalent iodine species, rendering the ortho-position of the aromatic 
ring electrophilic. The 3-position of the pendant indole then adds to this nascent 
electrophilic site. Following tautomerization, the phenol then closes down into the 
resulting indolium ion, yielding the desired product 47a. Despite the low yield and the 
modest diastereoselectivity, this step is able to address three of the most vexing features 
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of the diazonamides in a single well-conceived stroke, and represented by far the most 
rapid, diastereoselective, and efficient entry into the diazonamide A core to date.  
 After a number of straightforward synthetic manipulations, 47 was elaborated to 
the free carboxylic acid 48, which was successfully coupled to the HCl salt of 7-hydroxy 
tryptamine (Scheme 10). Subsequent acetylation of the free phenol was followed by 
benzylic oxidation of the 3’ position of the indole 49 by DDQ in aqueous THF.14 The 
resulting ketoamide was then cyclized to the desired oxazole 50 using the conditions 
reported by Wipf.15 This set the stage for a slightly modified and improved Witkop 
cyclization from the one encountered in the first-generation Nicolaou synthesis. Basic 
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Scheme 10: Haran's Witkop closure of the right-hand macrocycle
 
                                                
14 Oikawa, Y.; Yonemitsu, O. J. Org. Chem. 1977, 42, 1213–1216. 
15 Wipf, P.; Yokokawa, F. Tetrahedron Lett. 1998, 39, 2223–2226. 
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hydrolysis of the acetoxy group of 50 in situ followed by photo-irradiation of the 
resulting phenolate produced the right-hand macrocycle 52 in a yield of 72%. The greater 
electron density of the indole unit resulting from the anionic phenolate substituent results 
in a higher propensity for the indole to transfer an electron to the bromoindoline, as in 51, 
providing much higher yields than were realized in either Harran’s previous synthesis 
toward the proposed structure or the first Nicolaou synthesis. This augmented efficiency 
was considered to be ample justification for the inclusion of the otherwise extraneous 
phenol moiety on the indole. 
The phenolic oxygen was then excised via hydrogenolysis of its corresponding 
triflate. This was followed by the bischlorination and removal of the C(2) amine 
protecting group. Peptide coupling of the side chain 29 completed the shortest synthesis 
to date in a total of 21 steps in the longest linear sequence (19 distinct isolation steps) and 
an overall yield of 0.91%.  This synthesis sets a high bar for all forthcoming syntheses to 
reach. Harran’s synthesis is a result of years of work toward these molecules, but the final 
result is a remarkable synthetic accomplishment; elegant, well executed, and concise.                                                             
 
VI. Magnus’ Formal Synthesis of Diazonamide A 
 In late 2007, Magnus and coworkers at the University of Texas at Austin reported 
a formal total synthesis of diazonamide A that intercepted an advanced intermediate in 
the first-generation Nicolaou synthesis.16 The highlights of this work begin with 53, 
which upon treatment with TBAF yields ether 55 via intermediate 54 (Scheme 11). 55 
then undergoes an unusual O–C migration that converts benzhydryl ether to the desired 
                                                
16 Cheung, C.-M.; Goldberg, F. W.; Magnus, P.; Russell, C. J.; Turnbull, R.; Lynch, V. J. Am. Chem. Soc. 
2007, 129, 12320–12327. 
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Scheme 11: Magnus' synthesis of the left-hand macrocycle and the C(10) center
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quaternary center in 56 and 57. The stereoselectivity of this rearrangement step was 
dependent on the stereochemical configuration of the starting ether 55, the nature of 
solvent and the reaction temperature. The best results with regard to stereoselectivity and 
conversion were found to occur in refluxing chloroform, giving 100% yield of the desired 
product as 7:3 mixture of diastereomers (56/57) in favor of the desired isomer. 
Magnus then demonstrated that 56 could be converted in three steps to an 
intermediate in the first Nicolaou synthesis that then requires 13 further steps to furnish 
the natural product 2. As such, if carried to completion this route would be 23 steps in its 
longest linear sequence. This work is remarkable in that it provides exceptionally 
efficient access to the left-hand macrocycle through a highly innovative and original 
transformation, but with poor diastereoselectivity. Interestingly, Nicolaou had reported 
attempting a similar type of cyclization with a nearly identical substrate, albeit under 
different conditions, without any success in his first-generation synthesis. 
 31 
V. Conclusion 
 These summaries provide the context against which the MacMillan studies 
towards diazonamide A were both conceived and executed. The work described above 
acts not only to describe the reactivity of this molecule, but also to point out the 
considerable difficulties inherent in its synthesis.  This in turn gives direction and purpose 
to our own work, to solve these standing problems and to arrive at general solutions that 
will be of interest and use to the synthetic community at large. Our efforts toward these 
ends are described in the remaining chapters of this thesis. 
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Chapter 3 
 
First-Generation MacMillan Synthesis of Diazonamide A: 
Strategy Development and Initial Synthetic Investigations 
 
I. Background 
 In 2001, the MacMillan group described the development of a novel, powerful 
and general platform of asymmetric catalysis based on the reactions of transient α,β-
unsaturated iminium ions, formed from the rapid and reversible condensation of 
secondary amines with enals. This mode of activation was remarkable in that the reaction 
catalysts themselves were simple organic molecules.1 This bucked the conventional 
wisdom that asymmetric catalysis was exclusively the domain of transition metal 
complexes and enzymes, and explicitly conceptualized the both the notion and the value 
of organocatalysis as an undeveloped area of study. Indeed, the disclosure of iminium 
catalysis, along with the work of Barbas and List in the rejuvenation of proline catalysis, 
is widely credited with being a foundational contribution in establishing this active and 
expanding field.2 
O O
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substrate catalyst LUMO–activation
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R
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+•HX
Figure 1:  LUMO-lowering in Lewis acid catalysis and iminium catalysis
 
                                                
1 Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 4243–4244. 
2 List, B.; Lerner, R.; Barbas III, C. F. J. Am. Chem. Soc. 2000, 122, 2395–2396. 
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 Conceptually, the viability of asymmetric iminium catalysis was founded on two 
central assumptions. First, iminium formation should emulate the LUMO-lowering 
electronic activation and equilibrium dynamics attendant to traditional Lewis acid 
catalysis, providing a means for differential substrate activation (Figure 1). Secondly, if 
appropriately chosen, the chiral amine should enable high levels of asymmetric induction 
in bond-forming events by creating a well-defined chiral environment around the reaction 
center. Specifically, an effectively designed amine would have both to control the 
geometry of the iminium with respect to the catalyst framework and to direct the 
approach of nucleophiles to a single enantioface of the aldehyde electrophile. 
Implementation of these design criteria led to the development of a family of chiral 
imidazolidinone catalysts, which have been demonstrated to be efficient and highly 
enantioselective catalysts for a wide range of conjugate addition and cycloaddition 
processes (Figure 2).3  
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Figure 2: Chiral imidazolidinone catalysts in iminium chemistry
 
 In fact more than forty distinct transformations that give enantiomeric excesses in 
upwards of 90% have been developed using imidazolidinone-based iminium catalysis.4 
                                                
3 For a complete recounting of the historical development of the imidazolidinone-based catalysts, see; 
Austin, J. F. Ph.D. Thesis, California Institute of Technology, 2005.  
4 For a recent review of asymmetric iminium chemistry, see: Lelais, G.; MacMillan, D. W. C. Aldrich 
Chimica Acta 2006, 39, 79–87. 
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Importantly, many of these reactions have no traditional analogy in Lewis acid catalysis, 
a testament to the power of iminium activation as not only a practical tool for the 
synthesis of chiral molecules, but also as a platform for the discovery of novel synthetic 
transformations. One particularly successful and important advance in this regard was the 
discovery that iminium catalysis was amenable to the asymmetric Friedel-Crafts addition 
of electron-rich indoles into α,β-unsaturated aldehydes.5 The benzylic indole stereocenter 
is prevalent in both natural products and medicinal agents, and this technology has been 
recognized as a seminal advance in the catalytic, asymmetric construction of this 
particular motif.6  A representative example of this reaction is shown below in equation 1.  
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 Having established the viability and generality of this method, the MacMillan 
group sought to find compelling applications for its use in the construction of structurally 
complex targets. One particularly attractive class of indole-based alkaloids that seemed 
well suited to this end is the pyrroloindoline family (Figure 3). Derived from oxidative 
transformations of the amino acid tryptophan and its derivates, the tricyclic 
pyrroloindoline core is a widely represented structural motif. These molecules have 
received a great deal of attention over the past two decades due to their interesting 
biological properties and unusual structures, and significant advances have been made 
toward their synthesis. Yet, despite all this prior work, no direct, catalytic asymmetric 
                                                
5 Austin, J. F.; MacMillan, D. W. C. J. Am. Chem. Soc. 2002, 124, 1172–1173. 
6 King, H. D.; Meng, Z.; Denhart, D.; Mattson, R.; Kimura, R.; Wu, D.; Gao, Q.; Macor, J. E. Org. Lett. 
2005, 7, 3437–3440. 
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approaches to the pyrroloindoline core from simple tryptamine precursors had been 
reported. Accordingly, the MacMillan group felt that a generic solution to this 
conspicuous gap had the potential to conceptually trivialize future retrosynthetic analysis 
of these targets.  
Figure 3: Representative pyrroloindoline natural products
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 The mechanistic outline for the proposed organocatalytic pyrroloindoline 
synthesis is outlined in contrast to the conventional catalytic cycle for iminium-catalyzed 
Friedel-Crafts additions in Figure 4. While highly analogous, these manifolds are 
differentiated by the fact that in the indole additions, the nucleophilic 3-position of the 
heterocycle which undergoes alkylation bears a proton substituent. Following carbon-
carbon bond formation, this proton is abstracted by the conjugate base of the acid 
cocatalyst, regenerating aromaticity and rendering the alkylation irreversible. However, 
in the pyrroloindoline case, alkylation renders the C(3) position of the tryptamine 
quaternary, precluding the deprotonation pathway. Rather, following alkylation, the 
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amine nucleophile on the end of the two-carbon tether cyclizes onto the pendant indolium 
ion, generating the tricyclic product.  
!  Organocatalytic Indole Alkylation
Figure 4: Organocatalyzed pyrroloindoline construction: catalytic cycle
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When this mechanistic scheme was reduced to practice, this reaction was found to 
be general, efficient, and highly enantioselective.7 A wide variety of sterically and 
electronically diverse enals and tryptamines participated, allowing for the asymmetric 
construction of a wide variety of pyrroloindoline structures in a single step from trivial 
starting materials using an inexpensive amine catalyst (Figure 5). Yet in the context of 
the diazonamides, perhaps the most pertinent discovery to arise from this chemistry was 
the finding that pendant amines are not the only competent terminal nucleophilic traps. 
Specifically, alcohols and phenols were found to cyclize with similarly high levels of 
efficiency and selectivity to form tri- and tetracyclic furanoindoline products (Figure 5). 
                                                
7 Austin, J. F.; Kim, S. G.; Sinz, C. J.; Xiao, W. J.; MacMillan, D. W. C.  Proc. Nat. Acad. Sci. 2004, 101, 
5482–5487. 
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Figure 5: Organocatalytic pyrroloindoline  and furanoindoline formation
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Remarkably, the MacMillan lab’s development of asymmetric access to these 
interesting, but admittedly obscure, furanoindoline heterocycles was concurrent with 
Harran’s disclosure of his synthesis of nominal diazonamide A and its associated 
structural revision described in Chapters 1 and 2.8 Seemingly overnight, the MacMillan 
group found itself in possession of an almost tailor-made and highly original 
retrosynthetic insight into the asymmetric catalytic construction of the tetracyclic core of 
these daunting targets. In particular, this chemistry provided a unique opportunity to 
enable a truly stereoselective synthesis of the C(10) quaternary center, the central 
structural feature of the diazonamides, and the one which had yet to find a suitably 
selective synthetic solution.  
As these opportunities were uniquely enabled by the development of iminium 
catalysis, we felt they exemplified our firm belief that this new technology was 
                                                
8 Li, J.; Burgett, A. W. G.; Esser, L.; Amezcua, C.; Harran, P. G.  Angew. Chem. Int. Ed. 2001, 40, 4770–
4774. 
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generative, and could impact difficult synthetic problems by enabling chemists to design 
and achieve otherwise unprecedented bond constructions. Moreover, we felt such a 
compelling application of our iminium technology would highlight the virtues of its 
chemoselective activation mode and attendant functional orthogonality, testifying to its 
considerable potential for use in late-stage, complex, or highly functionalized settings. 
These ideas guided our thinking, provided our inspiration, and became the conceptual 
cornerstone of our strategy. The remainder of this thesis will detail our considerable 
progress towards these ends.  
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Figure 6: Organocatalytic retrosynthesis of diazonamide A core
 
 
II. Retrosynthetic analysis 
 With the centerpiece of our strategy outlined above, we needed to devise a way to 
advance the product of our organocatalytic process on to the natural product (Figure 6). 
Working retrosynthetically from 1, we planned to install the aryl chlorides at a late stage 
based on the precedent from Harran’s synthesis of nominal diazonamide A (Figure 7).9 
Next we decided to adopt a strategy of building the entire carbon skeleton of the target 
prior to closure of either of the two twelve-membered macrocycles. We felt such a 
                                                
9 Li, J.; Jeong, S.; Esser, L.; Harran, P. G. Angew. Chem. Int. Ed. 2001, 40, 4765–4769. 
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Figure 7: Retrosynthetic outline of MacMillan approach to diazonamide A
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strategy would afford the greatest possible flexibility in addressing issues of endgame 
sequencing. While we recognized that such an approach risks delaying two of the most 
difficult bond formations until a late stage in the synthesis, we felt the risk was well 
justified by the open-ended and adaptable endgame strategy. From such an intermediate, 
we felt that hydrolysis of the tryptamine amide and the central oxazole would furnish an 
amino ketone 2 that should be easily derived from oxidative manipulations of the product 
of our organocatalytic alkylation 3. We envisioned that 3 could arise from biaryl 4, which 
in turn could be accessed readily by the palladium-catalyzed coupling of suitably 
functionalized tyrosine and indole derivatives. 
 
III. First-Generation Synthesis  
 The synthesis commences with the quantitative esterification of 5 to give methyl 
ester 6 (Scheme 1). Though compound 6 is commercially available, this one-step protocol 
proved more economical to generate the large quantities of material necessary to develop 
the synthesis. Amino ester 6 was coupled to (S)-2-triisopropylsiloxy-3-methylbutanoic 
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Scheme 1: Synthesis of Suzuki precursors
11
acid 7 using standard peptide coupling conditions to yield aryl iodide 8 in two steps and 
an overall yield of 70%.10 
 The synthesis of the indole coupling fragment was then undertaken by selectively 
brominating the C(3) position of commercially available 7-benzyloxyindole 9 using Br2 
in DMF according to the procedure of Palla.11 This was followed by PMB protection of 
the indole nitrogen using PMBCl under the action of potassium tert-butoxide in DMF. 
The similarity of the reaction conditions for these two steps allowed them to be carried 
out sequentially in a single reaction flask to give yield of the desired product 10, which 
was subsequently recrystallized to purity in 77% yield. This protection step was followed 
by lithium-halogen exchange on the indole bromide under the action of n-butyllithium in 
THF at –78 °C. The resulting aryl lithium was quenched with pinacol-derived borolane 
11 to provide boronic ester 12 in 82% yield following recrystallization. This scalable 
procedure furnishes the second partner for the Suzuki cross coupling reaction in two steps 
without the need for any chromatographic purification. 
                                                
10 The one-step synthesis of 7 is described in the supporting information. 
11 Bocchi, V.; Palla, G. Synthesis-Stuttgart 1982, 1096–1097. 
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 With these coupling partners in hand, attention turned to their 
palladium-catalyzed union. The proposed Suzuki coupling step is somewhat unorthodox 
given the phenolic oxygen adjacent to the iodide on the tyrosine component 8. Under the 
basic reaction conditions required for successful Suzuki coupling it was postulated that 
the nascent phenoxide would greatly retard the rate of oxidative addition by increasing 
the electron density in the π system of the aromatic ring. However, careful optimization 
of the reaction conditions showed that employing 7.5 mol% Pd(dppf)Cl2 in aqueous 
dioxane at 45 °C using K3PO4 as a base delivered  82% of the desired product 13 (Table 
1, entry 9). 
K3PO4 45 °C
K2CO3 40 °C
KOAc 40 °C
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Me
Me
Me
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Entry Pd Source Base Temp Solvent Conc Yield
Pd(dppf)Cl2
Pd(dppf)Cl2
Pd(dppf)Cl2
Pd(OAc)2
+ dppf
Pd2(dba)3
+ Pd(PtBu3)2
Pd2(dba)3
+ Pd(PtBu3)2
Pd(PPh3)2Cl2
KF
KF
K3PO4
K3PO4
40 °C
40 °C
40 °C
40 °C
THF
Dioxane
DME/H2O
DME/H2O
DME/H2O
DME/H2O
Dioxane/H2O
0.2M
0.2M
0.1M
0.1M
0.1M
0.1M
0.2M
0%
0%
33%
33%
20%
82%
10%
1312 8
K3PO4 40 °C8 Pd(dppf)Cl2 Dioxane/H2O 0.2M 78%
K3PO4 40 °C7 Pd(dppf)Cl2 DME/H2O 0.1M 60%
Table 1: Optimization of Suzuki coupling
 
The success of this cross coupling step provided us with ample material to explore 
the key organocatalytic construction of the C(10) quaternary carbon stereocenter. Several 
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features of this key asymmetric transformation are highly unusual and, as such, are 
worthy of further description. Namely, since acrolein has no nonhydrogen β-substituent, 
the factors controlling stereoinduction for this electrophile are, by necessity, distinct from 
those controlling additions to all other enals. Specifically, although the acrolein-based 
iminium ion is a chiral electrophile, none of its carbons become stereogenic upon 
alkylation. Rather, in the pyrroloindoline case, the C(3) position of the indole nucleophile 
becomes quaternary. As such, to induce asymmetry the catalyst must effectively dictate 
which π-face of the indole nucleophile engages the electrophile in the C-C bond-forming 
event (Figure 8).  
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Figure 8: Asymmetric induction in organocatalytic furanoindoline formation
Catalyst discriminates between reactive faces of indole nucleophile
Si–face Re–face
 
 This is a completely unprecedented mode of asymmetric induction that our 
laboratories have yet to fully investigate. Indeed, studying and understanding the 
undoubtedly subtle factors that enforce enantiocontrol in these reactions would likely 
necessitate intense computational investigations. However, in instances where acrolein is 
used as an electrophile, a heuristic has been devised that correctly predicts the sense of 
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asymmetric induction.12 This model requires a tripartite division of both the iminium ion 
electrophile and the biaryl nucleophile into sectors of increasing steric demand about the 
two carbon atoms undergoing bonding in the transition state (Figure 9). Aligning the 
small, medium, and large sectors on each reactant predicts which face of the 
π-nucleophile adds to the iminium ion. Importantly, this model is not assumed to be an 
accurate representation of the actual transition state, yet it correctly corroborates all of 
Austin’s original results. As such, we determined that the (R,R)-series of the catalyst 
would be required to give the correct absolute stereochemistry for the diazonamide C(10) 
center. 
Figure 9: Heuristic for assessing enantiocontrol in additions to acrolein
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  Model systems pointed to the use of the trifluoroacetic acid salt of catalyst 14 in 
CH2Cl2 and MeOH with excess acrolein as being optimal for maximum stereoselection in 
the alkylation step. However, for 13, while these conditions did prove highly efficient, 
the observed diastereoselectivities were relatively poor, typically being 3:1 (Table 2, 
entry 1). While this provided ample material to explore downstream chemistry, it was felt 
that, since catalyst-controlled C(10) construction was a major goal of this work, more 
                                                
12 Austin, J. F. Ph.D. Thesis, California Institute of Technology, 2005, 48–49. 
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optimization would have to be done to rectify these poor stereoselectivities. With this in 
mind, a variety of catalyst architectures, solvents, and co-catalysts were evaluated. 
Selected results of these studies are summarized in Table 2. 
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Table 2: Optimization studies on organocatalytic pyrroloindoline formation
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 Moving from the mixture of CH2Cl2 and MeOH to a solution of CH2Cl2 and H2O 
provided a moderate boost in stereoselectivity while maintaining high levels of reaction 
efficiency (Table 2, entry 2). This could be further accentuated by use of the t-Bu, indole 
catalyst (Table 2, entry 6). Acid cocatalyst effects are commonly encountered in iminium 
catalysis and this reaction proved no exception. TFA proved to be the most robust 
cocatalyst in terms of reactivity, but several similarly acidic co-catalysts afforded slightly 
higher diastereoselectivities, albeit at the cost of low conversion. Other co-catalysts of 
similar acidity gave little to no conversion at all (Table 2, entries 4 and 5).   
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Following furanoindoline formation, the newly formed aldehyde needed to be 
oxidized to its α,β-unsaturated analogue. Direct oxidation with IBX provided the desired 
product, though in unacceptably low yield.13 Rather a two-step oxidation protocol was 
employed according to the method of Keck (eq 2).14 Aldehyde 15 was first treated with 
freshly prepared PhSeNEt2 in THF to yield the α-selenylated aldehyde in quantitative 
yield. This selenyl functionality was then oxidatively eliminated upon treatment with 
NaIO4 in THF/MeOH/H2O to give the desired unsaturated product 16 in 88% yield over 
two steps. It was also found that this two-step sequence could be carried out in a single 
reaction flask, but with a slightly diminished isolated yield of 80%.  
2. NaIO4, THF/
MeOH/H2O
(88% over two steps)
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 Our initial synthetic plan involved functionalizing α,β-unsaturated aldehyde 16 to 
its corresponding β-hydroxy amino acid. However, all efforts towards these ends met 
with failure (eq 3). Subjection of 16 to osmium-catalyzed aminohydroxylation and 
dihydroxylation conditions only returned starting material. Attempts to perform a 
Weitz-Scheffer-type nucleophilic epoxidation on 16 were also unsuccessful. Presumably, 
nonbonding interactions between the adjacent bulky quaternary center and the employed 
reagents are responsible for this conspicuous lack of reactivity. 
 Faced with this setback we were forced to reexamine our strategy going forward. 
It occurred to us that the product 17 could also be generated by an aldol reaction between 
                                                
13 Nicolaou, K. C.; Montagnon, T.; Baran, P. S.; Zhong, Y.-L. J. Am. Chem. Soc. 2002, 124, 2245–2248. 
14 Keck, G. E.; Cressman, E. N. K.; Enholm, E. J. J. Org. Chem. 1989, 54, 4345–4349. 
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a valine-derived enolate and aldehyde 18, which in turn could come directly from 
ozonolysis of 16 (eq 4). While this required the aesthetically undesirable excision of two 
carbons from the newly installed 3-carbon fragment, this disconnection had the benefit of 
directly installing the entire C(28)-C(35) chain in a single, highly reliable bond 
construction. 
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 Towards this end we attempted the direct ozonolysis of 16 and found that 
oxidation of the electron-rich aminal C-H bond at C(11) was competitive with the desired 
reaction pathway.15 We reasoned that this side product could be avoided by making the 
indoline nitrogen of the aminal core more electron-withdrawn. Accordingly, the indoline 
PMB protecting group was selectively removed by treatment with DDQ in a biphasic 
solution of pH 7 buffer and dichloromethane. This relatively unstable product was then 
immediately reprotected as its trifluoroacetamide after exposure to trifluoroacetic 
anhydride (TFAA) and DMAP in CH2Cl2 to give an 80% yield of 20 over the two steps 
(eq 5). Remarkably, TFAA was the only reagent found out of many surveyed that was 
sufficiently electrophilic to acylate the indoline nitrogen. It is important to note that we 
were prevented from acetylating this nitrogen at an early juncture due to the fact that the 
                                                
15 (a) Deslongchamps, P.; Moreau, C.; Frehel, D.; Atlani, P. Can. J. Chem. 1972, 50, 3402–3404. (b) 
Deslongchamps, P.; Atlani, P.; Malvalal, A.; Frehel, D.; Moreau, C. Can. J. Chem. 1974, 52, 3651–3664. 
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electron-withdrawing trifluoroacetamide would completely diminish the capacity of the 
parent indole compound to participate in the organocatalytic alkylation of acrolein en 
route to furanoindoline formation. However, with this protecting group switch secured 
the ozonolysis of the unsaturated aldehyde 19 was uneventful and gave key aldehyde 20 
in 87% yield after reductive workup and column chromatography (eq 6).   
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 With aldehyde 20 in hand, we were now positioned to investigate our proposed 
aldol reaction. We were initially concerned that the neopentyl aldehyde electrophile 
might be difficult for an enolate to engage, but investigations in the MacMillan lab 
concurrent with this study suggested conditions that might be amenable to use in this 
difficult case. As part of a program in our laboratories aimed at the three-step asymmetric 
production of differentially protected amino-carbohydrates, it was found that titanium 
enolates of valine-derived thioesters were exceptionally effective in reacting with 
hindered and electronically deactivated aldehyde electrophiles.16 In this procedure the 
thioester is complexed at low temperature with titanium tetrachloride, then treated 
                                                
16 Kayano, A.; Saliba, K. R.; MacMillan, D. W. C. Unpublished results. 
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triethylamine to effect a soft enolization.17 Following enolization, acetonitrile is added, 
followed by the aldehyde and the resulting solution is stirred at –30 °C for 16 hours. 
Notably, the addition of acetonitrile was found to be critical to obtaining high conversion, 
presumably by its role of attenuating the Lewis acidity of the titanium center. Application 
of this protocol to thioester 21 and aldehyde 20 was straightforward and we were 
delighted to find that, upon optimization, it provided the desired product 22 in 75% yield 
as a 3:3:1:1 mixture of diastereomers (eq 7). The generation of diastereomers was 
inconsequential, as they were oxidatively annihilated in a subsequent oxidation with 
Dess-Martin periodinane to yield ketone product 23 (eq 8). 
OBn
COSEt
NH
HO
NTFA
BocHN
Me
Me
H
N
O
TIPSO
Me Me
O
CO2Me
O
OBn
O
NTFA
H
N
O
TIPSO
Me Me
O
CO2Me
Me
Me
N
H
O
SEt
ONHBoc
 TiCl4, NEt3
CH2Cl2, MeCN
—40 °C
(75%)
3:3:1:1 dr
21
20 22
(7)
Scheme 2: Titanium aldol and subsequent oxidation
OBn
COSEt
NH
O
NTFA
BocHN
Me
Me
H
N
O
TIPSO
Me Me
O
CO2Me
O
 Dess-Martin
CH2Cl2
 (90%)
23
(8)
22
OBn
COSEt
NH
HO
NTFA
BocHN
Me
Me
H
N
O
TIPSO
Me Me
O
CO2Me
O
 
 This reaction is all the more remarkable for the fact that treatment of this aldehyde 
with heteroatom nucleophiles, such as tryptamine or alkaline solutions of methanol, 
                                                
17 (a) Harrison, C. R.; Tetrahedron Lett. 1987, 28, 4135–4138. (b) Annunziata, R.; Cinquini, M.; Cozzi, F.; 
Borgia, A. L. J. Org. Chem. 1992, 57, 6339–6342. 
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results in Grob fragmentation of the furanoindoline core. As shown in Figure 10, this 
process results in scission of the C(10)-C(30) bond, rearomatization of the indole ring, 
expulsion of the phenol and transfer of the formyl group to the nucleophile. Presumably, 
the stability of the metal aldolate intermediate in this case can be attributed to the strength 
of the titanium(IV)-oxygen bond, which prevents participation in this undesirable and 
destructive process.18 
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 The stage was now set to explore the cyclodehydration of 23 to give the A-ring 
oxazole of diazonamide A. Classical Robinson-Gabriel dehydration reactions using 
strong mineral acids resulted in rapid decomposition of the starting material. While the 
use of POCl3 in pyridine performed admirably in the second Nicolaou synthesis to form 
the analogous A-ring oxazole, that reagent combination failed to produce any of the 
                                                
18 Titanium-oxygen bonds have bond strengths of ~ 100 kcal/mol, while a typical carbon-titanium bond is 
only ~ 45 kcal/mol. Connor, J. A. Top. Curr. Chem. 1977, 71, 71.  
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desired product when applied to substrate 23.19 Similarly, the conditions pioneered by 
Wipf using PPh3 and C2Cl6 also failed to yield any of the desired oxazole product.20,21 
Given the failure of these general and frequently employed oxazole-forming 
technologies, we were forced to devise a solution that would better suit the reactivity 
profile of our particularly fragile substrate (Figure 11). 
Figure 11: Traditional cyclodehydration methods fail to deliver desired oxazole product
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 We recognized a mechanistic opportunity to develop a new oxazole-forming 
protocol based on prior literature involving the nucleophilic fluorinating reagent 
diethylaminosulfurtrifluoride (DAST). DAST is well known to transform ketones into 
gem-difluorides, through a fluoroacetal-type intermediate 33 (Figure 12).22 It is proposed 
that the C-O bond of this intermediate is substantially weakened by coordination by the 
electrophilic sulfur, making it a highly reactive leaving group that, in the absence of other 
nucleophiles, can be displaced by fluoride ion to produce the geminal difluorides, such as 
34. Moreover, in 2000, Wipf and coworkers reported the DAST-mediated cyclization of 
                                                
19 Nicolaou, K. C.; Hao, J.; Reddy, M. V.; Rao, P. B.; Rassias, G.; Snyder, S. A.; Huang, X.; Chen, D. 
Y.-K.; Brenzovich, W. E.; Giuseppone, N.; Giannakakou, P.; O’Brate, A. J. Am. Chem. Soc. 2004, 126, 
12897–12906. 
20 Wipf, P.; Miller, C. P. J. Org. Chem. 1993, 58, 3604–3606. 
21 A regioisomeric oxazole was isolated from this reaction, arising from the amide carbonyl cyclizing onto 
the thioester carbonyl rather than the ketone. 
22 (a) Middleton, W. J. J. Org. Chem. 1975, 40, 575–578. (b) Singh, R. P.; Shreeve, J. M. Synthesis, 2002, 
17, 2561–2578. 
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amidoalcohols, such as 29, to form oxazolines such as 31 (Figure 12).23 In this reaction a 
DAST leaving group is displaced by intramolecular cyclization of the adjacent amide. 
Figure 12: Mechanistic basis for a new oxazole synthesis
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We reasoned that if these two known and established mechanisms could be combined, it 
would form the blueprint of a novel methodology for the synthesis of 4-acyloxazoles, 
such as we required.  
Explicitly, our design plan is illustrated in Figure 13. Treatment of a β-ketoamide 
such as 35 with DAST would first yield the fluoroacetal 36. The pendant amide would 
! Proposed mechanism for DAST-mediated synthesis of oxazoles
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Figure 13: Mechanistic proposal for DAST-mediated oxazole synthesis
35 36 37 38  
                                                
23 Phillips, A. J.; Uto, Y.; Wipf, P.; Reno, M. J.; Williams, D. R. Org. Lett. 2000, 2, 1165–1168. 
 52 
then displace the leaving group in analogy with Wipf’s work, yielding an unstable β-
fluoro acyloxazoline 37 that should undergo β-elimination to yield the desired oxazole 
product, 38.  
Gratifyingly, our insight was richly rewarded when we found that exposure of 22 
to DAST indeed resulted in formation of the desired oxazole 28 (Scheme 3). 
Optimization of the reaction conditions proved that non-polar solvents such as benzene 
and hexanes were superior and yields greater than 65% are routinely observed, even on 
multigram scale. Notably, no desilylation of the TIPS ether has been observed, despite 
the production of stoichiometric fluoride ion byproducts. This is the first known instance 
of DAST being used in the direct construction of oxazoles directly from ketoamides. But 
given the discussion in the literature of the difficulty encountered in creating this A-ring 
oxazole and the failure of the more classical methods in this context, it seems promising 
that these DAST-mediated conditions may prove to be a general method for the creation 
of trisubstituted 4- acyloxazoles.  
Scheme 3: First known use of DAST in the direct synthesis of oxazoles from !-keto amides
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 We felt that the successful installation of this central oxazole was a strategically 
important accomplishment. Firstly, it represented the completion of the intact 
heterocyclic core of diazonamide A. Secondly, once this oxazole was formed the stability 
of the aminal core was greatly increased, allowing for more pressing reaction conditions 
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to be employed than our previous delicate intermediates allowed. Thirdly, this 
intermediate left many options open in regard to the sequence of steps leading to closure 
of the two macrocycles. If one route proved untenable then others could easily be 
assessed from this same point, providing a convenient branch point in exploring 
downstream chemistry.   
 From this point the next goal we aimed to achieve was the installation of the 
B-CD oxazole-indole fragment that constituted the remaining carbons of the diazonamide 
framework. Towards this end, it would first be necessary to transform the ethyl thioester 
of 28 into the corresponding tryptamine-derived amide. Initially, it was found that 
tryptamine displaces the ethyl thioester under DMAP catalysis in toluene at 100 °C to 
give amide 62 in 33% (Table 3, entry 1). However, all our efforts to optimize this result 
did not improve upon this unacceptably low yield, and all attempts to introduce more 
highly functionalized tryptamines met with failure. Fortunately, it was then found that 
addition of AgTFA to a solution of tryptamine in rigorously degassed MeCN allowed 
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Br 100 °C
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Entry Activator Temp Solvent Time Yield
DMAP
DMAP H 100 °C toluene
toluene
dioxane
24 hr
–
–
1 hr
1 hr
33%
15%
88%
70%
<5%
X
DMAP
MeCN
MeCNB(pin)
AgTFA
AgTFA
28
Table 3: Optimization of thioester aminolysis
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displacement of the thioester in 88% yield after 1 hour at 40 °C (Table 3, entry 4).24 The 
mildness of these reaction conditions proved amenable to the incorporation of more 
complex 4-functionalized tryptamines, including a (pinacolato)boronic ester in the 
4-position, which could be envisioned participating in a ring-closing Suzuki reaction to 
close the right-hand macrocycle (Table 3, entry 5). 
 Interestingly, exposure of 28 to these conditions and an excess of water in the 
absence of tryptamine did not produce any of the carboxylic acid but rather returned the 
unreacted thioester starting material. Moreover, none of the labile trifluoroacetate 
protecting group was deprotected under these conditions, though in the absence of silver, 
transamidation of TFA group onto tryptamine in acetonitrile is a rapid and high yielding 
process. Importantly, the success of this reaction represented successful installation of all 
the carbons present in the natural product.  
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Scheme 4: Benzylic oxidation and cyclodehydration towards oxazolyl-indole
(9)
(10)
  
                                                
24 (a) Aggarwal, V. K.; Esquivel-Zamora, B. B. J. Org Chem. 2002, 67, 8618–8621. (b) Ley, S. V.; 
Woodward, P. R. Tetrahedron Lett. 1987, 28, 3019–3020. 
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Next, tryptamide 39 underwent clean and rapid oxidation at the benzylic position 
to the 3’ ketone after treatment with DDQ in aqueous THF (eq 9).25 This oxidized adduct 
40 was then uneventfully cyclized to bisoxazole compound 41 under the PPh3/C2Cl6 
conditions described previously in nearly quantitative yield (eq 10). 
 With 31 in hand, we felt well situated to explore both macrocyclizations 
independently, affording numerous possible endgame sequences. Moreover, we were 
optimistic that successful closure of either of the two twelve-membered rings should aid 
in the closure of the second by limiting rotation around the C(10)-C(30) bond. Yet, we 
speculated that the biaryl juncture would be the more difficult one to form, and given the 
precedence from the Nicolaou and Harran syntheses in successfully closing the right-
hand ring once the left-hand ring was in place, we chose first to focus on the closure of 
the macrolactam. 
  The substrate for macrolactamization was easily obtained in gram quantities 
following a high yielding two-step sequence consisting of methyl ester hydrolysis on 41 
Scheme 5: First attempts at macrolactamization
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25 Oikawa, Y.; Yonemitsu, Y. J. Org. Chem. 1977, 42, 1213–1216. 
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with lithium hydroxide followed by deprotection of the carbamate 42 with TFA (Scheme 
5). However, exposure of the product 43 to a battery of standard peptide coupling 
reagents provided none of the desired product.26 
The uronium-based reagents, such as HATU and TBTU, that proved singularly 
successful in Nicolaou’s investigations of an analogous lactamization were completely 
unsuccessful when applied to 33. Investigation of even more highly activated reagents, 
such as PyBrop and BOPCl, led to the isolation of a new non-polar product with the 
correct molecular mass for the desired product. But, this adduct proved unstable to 
routine characterization protocols and upon further investigation it proved instead to be 
the oxazolone 35 resulting from intramolecular attack of the adjacent valeric amide 
carbonyl onto the activated carboxylate. This oxazolone was characterized in part by the 
diagnostic IR signature of this functionality at 1819 cm-1 and the observation that 
treatment of this adduct with methanol in dichloromethane returned the 
Scheme 6: Undesired oxazolone formation
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26 For reviews on various aspects of macrolactamization and large ring synthesis, see: (a) Li, P.; Roller, P. 
P.; Xu, J. Current Organic Chemistry, 2002, 6, 411–440. (b) Roxburgh, C. Tetrahedron 1995, 51, 9767–
9822. 
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methyl ester 46 in quantitative yield as a 1:1 mixture of epimers at the α-amino 
stereocenter.  
 We were curious if hindered rotation about the C(10)-C(30) and C(3)-C(4) axes 
might be precluding the desired bond-forming event by effectively locking the substrate 
into unreactive rotameric conformations wherein the amine and the activated carboxylate 
are held distal to one another. However, molecular mechanics simulations indicated that 
the activation barrier for rotation around the C(10)-C(30) dihedral was only 8.08 
kcal/mol, meaning the compound was rotating around this axis an average of 13 million 
times a second at room temperature (Figure 14).27 Similarly, the barrier to rotation about 
the C(3)-C(4) bond was only 7.47 kcal/mol, according nearly 40 million rotations per 
second. Thus, the possibility of a rotameric bias in adopting a reactive conformation for 
ring-closure was disregarded. 
Figure 14: Relevant rotational barriers in macrolactamization
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 Thus faced with the failure of our efforts to affect a viable macrolactamization on 
43, we opted instead to begin exploration of chemistry to form the right-hand ring biaryl. 
We hypothesized that a number of different transformations could provide the desired 
                                                
27 These MM3 calculations were carried out using Macromodel. Mohamadi, F.; Richards, N. G. J.; Guida, 
W. C.; Liskcamp, R.; Lipton, M.; Caufield, C.; Chang, G.; Hendrickson, T.; Still, W. C. J. Comput. Chem. 
1990, 11, 440–467. 
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product, such as Suzuki or Stille couplings, aryl Heck-type chemistry, Witkop 
photocoupling, or oxidative biaryl coupling. Yet given the advanced nature of our 
intermediates and the seemingly clear correspondence to prior work in the field, we 
decided to first investigate the use of the Witkop-type chemistry that had previously been 
successfully applied by Harran and Nicolaou.28  
 Yet for all the apparent similarities, it was unclear if such a process would be 
viable in our circumstances. The most worrisome question was whether the aryl triflate 
would be able to accept an electron from the pendant photo-excited indole and undergo 
efficient fragmentation to yield the requisite aryl radical. We could find no literature 
precedent for carrying out Witkop cyclizations employing triflates and all the previous 
examples in the diazonamide field had used aryl bromides.29 Moreover, triflates are 
known to be somewhat photo-labile, and if the rate of electron transfer and subsequent 
ring closure was too slow, then competitive hydrolysis pathways may consume the 
starting material. 
 The substrate was prepared in a straightforward manner by hydrogenolysis of the 
benzyl ether 41, followed by reprotection of the resulting phenol as its corresponding 
triflate 47 (Scheme 7). We then found, after substantial optimization, that when 47 was 
irradiated for one hour with 356 nm light in a solution of aqueous acetonitrile and 
potassium phosphate, the desired product 49 could be obtained in 38% yield with 30% 
recovered 47 (54% based on recovered starting material). Though the yield of the 
reaction was modest, it was in line with that reported with the corresponding bromide in 
                                                
28 For a detailed discussion of this step in these prior syntheses, see Chapter 2. 
29 The use of a 7-oxy substituted indole was necessary to achieve high levels of reactivity in the 
organocatalytic addition/cyclization. The analogous reaction using the 7-bromoindole derivatives was 
nonproductive. 
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the Nicolaou synthesis. Efforts to optimize the reaction efficiency further were hampered 
by the discovery that the product itself was not indefinitely stable to the reaction 
conditions, and to obtain the highest yields the reaction had to be stopped well short of 
full conversion of starting material.30 Notably, however, the phenol resulting from triflate 
hydrolysis was not detected as a component of the reaction mixture. 
Scheme 7: Photocyclization of the right-hand macrocycle
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 With this result in hand, we again turned our attention to the closure of the 
left-hand macrolactam. Notably, if this lactamization could be realized, the only steps 
necessary to complete the total synthesis of diazonamide A would be the known 
chlorination of the B-ring oxazole and D-ring indole and deprotection of the silyl ether. 
Moreover, we were optimistic that the increased structural rigidity of 49 would 
substantially aid the chances of now successfully carrying out the desired amide-forming 
event. The same two-step deprotection sequence was employed again to transform 49 
                                                
30 The efficiency of this reaction suffered when the reactions were run on scales larger than 5 mg. Yet, 
running many scale reactions simultaneously in the photoreactor allowed for sufficient throughput of 
material. 
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into 50 (Scheme 8). However, much to our consternation, all of our efforts to cyclize 50 
met with failure. All reagents surveyed only returned mixtures of starting material, 
oxazolone, dimer, and higher-order oligomers.  
Scheme 8: Failed macrolactamization redux
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 This result was confounding for a number of reasons. DFT calculations indicated 
that the ring closure of the amino-acid chloride with expulsion of HCl was exothermic by 
6.9 kcal/mol.31 Thus the reaction was not failing on thermodynamic grounds. Yet, 
arguments supporting failure of the reaction on kinetic grounds seemed counterintuitive. 
Intermolecular coupling of the carboxylic acid of 50 to tryptamine proceeded efficiently. 
Thus the problem did not reside in the formation of the activated carboxylate. Moreover, 
due to the rigidity of the structure, the reactive ends of the chain are held very close 
together in space, with ample degrees of freedom to align in a bonding-type orientation.  
 The best explanation for the failure of this late-stage that we can posit comes from 
examining the nonbonded interactions introduced into the macrocycle during the initial 
C-N bond forming event. Analysis of the tetrahedral intermediate reveals that upon 
                                                
31 Calculated (B3LYP 3-21G) using the corresponding acid chloride. For details, see supporting 
information. 
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achieving bond C-N formation, three new syn-pentane type interactions are fully 
developed (Figure 15). Each of these nonbonded interactions is worth several kcal/mol in 
the ground state, and likely substantially more in the transition state.32 As such we 
believed that, due to the high energetic penalty associated with assuming a conformation 
containing these new syn-pentane interactions, that the kinetic barrier to form the 
tetrahedral intermediate is simply too high to be overcome.  
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Figure 15: Rationale for failure of macrolactamization
 
 In light of this rationalization, we realized that our synthetic route had a serious 
and irredeemable strategic flaw. We would have to devise a substantially different 
approach to the left-hand macrocycle in order to have any hope of achieving a completed 
total synthesis. Our efforts towards these ends are presented in the subsequent chapters. 
                                                
32 Energetic penalties associated with torsional interactions are much greater in transition states than they 
are in ground states: Caramella, P.; Rondan, N. G.; Paddon-Row, M. N.; Houk, K. N. J. Am. Chem. Soc. 
1981, 103, 2438–2440. 
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Chapter 3 Supporting Information 
 
 
 
General Information: Commercial reagents were purified prior to use following the 
guidelines of Perrin and Armarego.33 All solvents were purified according to the method 
of Grubbs.34 Nonaqueous reagents were transferred under argon via syringe or cannula. 
Organic solutions were concentrated under reduced pressure on a Büchi rotary evaporator 
using a heated water bath. Chromatographic purification of products was accomplished 
using forced-flow chromatography on Silicycle 230–400 mesh silica gel 60 according to 
the method of Still.35 Thin-layer chromatography (TLC) was performed on Silicycle 0.25 
mm silica gel 60-F plates. Visualization of the developed chromatogram was performed 
by fluorescence quenching or by CAM stain. 
 1H and 13C NMR spectra were recorded on a Varian Mercury 300 (300 MHz and 
75 MHz) as noted, and are internally referenced to residual solvent signals. Data for 1H 
NMR are reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant (Hz), and 
assignment. Data for 13C NMR are reported in terms of chemical shift. IR spectra were 
recorded on a Perkin Elmer 1000 spectrometer and are reported in terms of frequency of 
absorption (cm–1). Mass spectra were obtained from the Caltech Mass Spectral Facility. 
                                                
33 Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; 3rd ed., Pergamon Press, Oxford, 
1988. 
34 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J.  Organometallics 1996, 15, 
1518. 
35 Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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Optical rotations were measured on a Jasco P-1010 polarimeter, and [α]D values are 
reported in 10–1 dg cm2 g–1.36 
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Iodophenol 8: Amine 6 (15.4 g, 47.95 mmol), acid 7 (11.96 g, 43.59 mmol), EDC (9.19 
g, 47.95 mmol), and HOBT (6.47 g, 47.95 mmol) are combined in a 500 mL round 
bottom flask and 190 mL of DMF is added. After 12 hours the reaction mixture is diluted 
with 500 mL of ether and washed with 3 x 500 mL of water. The combined organic 
fractions are washed with brine and concentrated. The resulting oil is purified on silica 
gel (30% ethyl acetate in hexanes) to yield the title compound as a colorless oil (21.2 g, 
82% yield). IR (Film): 3402, 2944, 2867, 1746, 1654, 1603, 1505, 1462, 1415, 1347, 
1292, 1215, 1099, 1058, 882, 822, 684 cm–1; 1H NMR: (300 MHz, CDCl3) δ 7.44 (d, 1H, 
J = 2.1 Hz, ArH ortho to iodide), 7.05 (br s, 1H, NH), 6.99 (dd, 1H, J = 2.1, 8.55 Hz, 
ArH para to iodide), 6.87 (d, 1H, J = 8.5 Hz, ArH meta to iodide), 5.82 (s, 1H, OH),  
4.87 (m, 1H, NHCH), 4.15 (d, 1H, J = 3.3 Hz, CHOTIPS), 3.69 (s, 3H, CO2Me), 2.91 
(m, 2H, ArCH2), 1.99 (m, 1H, CH(CH3)2), 1.1–1.0 (m, 21H, TIPS), 0.93 (d, 3H, J = 7.2 
Hz, CH(CH3)2), 0.861 (d, 3H, J = 7.2 Hz, CH(CH3)2), 13C NMR: (75 MHz, CDCl3) δ 
                                                
36 Certain data herein was reproduced from the Caltech thesis of Ian K. Mangion, (2006) with whom this work 
was jointly carried out. 
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172.88, 171.6, 154.5, 139.2, 131.0, 130.0, 115.3, 85.6, 78.3, 52.6, 52.4, 37.4, 34.2, 18.2, 
18.1, 17.9, 17.5, 12.6 HRMS (FAB+) exact mass calculated for [M+H] (C24H41NO5SiI) 
requires m/z 578.1799, found m/z  578.1791; 
! 
["]
D
25  = –5.75 (c = 1.0 CHCl3). 
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TIPS hydroxy valeric acid 7: To (S)-2-hydroxy valeric acid (5.0 g, 42.3 mmol) in a 
stirred solution of DMF (22 mL) was added triisopropylsilyl chloride (22 mL, 102 mmol) 
and imidazole (1.38 g, 204 mmol). After 24 hours, MeOH (210 mL) and 1M aqueous 
K2CO3 (64 mL) were added to this slurry, and after 4 h the resultant solution was diluted 
with 400 mL H2O, acidified to pH 4, and extracted 3 x 300 mL with EtOAc.  The 
combined organic fractions are washed with brine and concentrated. The resulting oil is 
purified of remaining TIPSOH by vacuum distillation of this impurity (85 °C, min. 10 
mTorr) to yield the title compound as a colorless oil (9.7 g, 82% yield). IR (Film): 2963, 
2945, 2869, 1723, 1465, 1388, 1234, 1152, 1068, 997, 882, 825, 681 cm–1; 1H NMR: (300 
MHz, CDCl3) δ 4.26 (d, 1H, J = 3.6 Hz, CHOTIPS), 2.06 (m, 1H, CH(CH3)2), 1.10–0.97 
(m, 27H, TIPS, CH(CH3)2), 13C NMR: (75 MHz, CDCl3) δ 173.2, 65.9, 33.7, 17.9, 17.8, 
17.7, 17.0, 15.3, 12.2; HRMS (FAB+) exact mass calculated for [M+H] (C14H31O3Si) 
requires m/z 275.2043, found m/z  275.2041; 
! 
["]
D
25  = –16.81 (c = 1.0 CHCl3). 
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Bromoindole 10: To a room temperature solution of 7-benzyloxyindole 9 (5.0 g, 22.4 
mmol) in 90 mL of DMF was added bromine (1.18 mL, 22.84 mmol) dropwise over the 
course of ten minutes. After 20 minutes the solution was cooled to 0 °C and KOtBu (5.78 
g, 51.5 mmol) was added in a single portion. 30 minutes later PMBCl (3.65 mL, 26.88 
mmol) was added dropwise over several minutes by syringe, after which the reaction 
mixture was allowed to warm to room temperature. After 6 hours the reaction was judged 
complete by TLC and the reaction mixture was diluted with 300 mL of diethyl ether and 
washed with 100 mL of 1% Na2S2O3. The organic portions were washed three times with 
water and then once with brine before being dried over sodium sulfate. The organic 
portion was then concentrated in vacuo to yield a viscous yellow oil. These crude extracts 
could then be recrystallized from a hot mixture of 10% ethyl acetate in hexanes to afford 
7.27 g (77%) of the title compound as a white crystalline solid. IR (Film): 2931, 1611, 
1574, 1512, 1497, 1453, 1422, 1383, 1322, 1248, 1209, 1175, 1080, 1056, 1033, 988, 
875, 818, 774, 727, 695, 625 cm–1; 1H NMR: (300 MHz, CDCl3) δ 7.38–7.25 (m, 5H, 
ArHs), 7.19 (dd, 1H, J = 0.9, 7.8 Hz, ArH), 7.07 (t, 1H, J = 7.8 Hz, ArH), 7.04 (s, 1H, 
C(2)-H), 6.95–6.88 (m, 2H, ArH), 6.80–6.72 (m, 3H, ArH), 5.51 (s, 2H, PhCH2), 5.12 (s, 
2H, PMBCH2),  3.77 (s, 3H, MeO-Ar) 13C NMR: (300 MHz, CDCl3) δ 158.9, 146.6, 
136.7, 130.9, 129.9, 128.6, 128.1, 127.8, 125.7, 120.8, 114.0, 112.3, 104.6, 90.4, 70.5, 
55.3, 52.2 HRMS (EI+) exact mass calculated for [M+•] (C23H20NO2Br) requires m/z 
421.0677, found m/z  421.0672. 
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Indole Boronic Ester 12: To a solution of n-butyllithium (7.34 mL, 10.65 mmol, 1.2 eq, 
1.45M in hexanes) in 80 mL of THF at –78 °C was added bromoindole 10 (3.75 g, 8.88 
mmol, 1.0 eq) in 10 mL of THF dropwise via syringe over 10 minutes. After 15 minutes, 
freshly distilled 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 11 (3.62 mL, 
17.76 mmol, 2.0 eq) was added via syringe. This reaction mixture was allowed to warm 
to ambient temperature over 3 hours. At this point, 100 mL of a saturated aqueous 
solution of NH4Cl was added to the reaction mixture and the layers were separated. The 
aqueous layer was washed 3 x 100 mL with EtOAc. The combined organic layer was 
washed with 100 mL of brine, dried over sodium sulfate, and concentrated in vacuo. The 
residual oil was then recrystallized from a hot solution of 10% EtOAc in hexanes to give 
the title compound as an off-white crystalline solid (3.40 g, 82% yield). The remaining 
mass was recovered as debrominated 10. IR (Film): 2976, 1613, 1573, 1539, 1513, 1495, 
1454, 1379, 1290, 1267, 1247, 1206, 1144, 1107, 1059, 1009, 783, 735, 696, 681 cm–1; 
1H NMR: (300 MHz, CDCl3) δ 7.66 (dd, 1H, J = 0.6, 8.1 Hz, ArH), 7.48 (s, 1H, C(2)-H), 
7.35–7.22 (m, 5H, ArH), 7.03 (t, 1H, J = 8.1Hz, ArH), 6.91–6.87 (m, 2H, ArH), 6.78–
6.65 (m, 3H, ArH), 5.52 (s, 2H, PhCH2), 5.09 (s, 2H, PMBCH2), 3.75 (s, 3H, MeO-Ar),  
1.35 (s, 12H, 4xMe) 13C NMR: (300 MHz, CDCl3) δ 158.7, 146.6, 138.8, 137.0, 135.3, 
131.3, 128.5, 128.4, 128.1, 127.9, 127.8, 126.9, 120.8, 115.7, 113.8, 104.1, 82.8, 70.3, 
55.3, 52.2, 25.0 HRMS (EI+) exact mass calculated for [M+•] (C29H32BNO4) requires m/z 
469.2424, found m/z  469.2416. 
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Phenol 13: A 100 mL round bottom flask with stirbar is charged with Pd(dppf)Cl2 (0.633 
g, 0.7755 mmol), K3PO4 (8.78 g, 41.36 mmol) and indole boronic ester 12 (8.74 g, 18.62 
mmol) in a glove box. This flask was capped with a rubber septa and brought out of the 
box where in it was placed under a balloon of argon. To the flask is added aryl iodide 8 
(5.976 g, 10.34 mmol) in a 60 mL of degassed 1,4-dioxane. To this solution is then added 
6 mL of degassed water and the resulting solution is stirred at 40 °C for 2 hours. After the 
reaction was judged complete by TLC analysis, the reaction mixture was diluted with 200 
mL of diethyl ether and washed sequentially with 100 mL portions of water, saturated 
NH4Cl solution, and brine. The organic portion is dried over sodium sulfate and 
concentrated in vacuo. These crude extracts were purified by column chromatography 
(4% Et2O/CH2Cl2) to yield the title compound (6.38 g, 78%) as a white amorphous solid. 
IR (Film): 3409, 2945, 2867, 2360, 1747, 1654, 1612, 1570, 1512, 1456, 1385, 1248, 
1209, 1175, 1063, 882, 821 cm–1; 1H NMR: (300 MHz, CDCl3) δ 7.34–6.68 (m, 17H, 
ArH and NH); 5.59 (s, 2H, OCH2Ph), 5.34 (s, 1H, ArOH), 5.15 (s, 2H, OCH2-pMeOPh), 
4.90 (ddd, 1H, J = 6.0, 6.3 and 8.4 Hz, CHCO2Me), 4.14 (d, 1H, J = 3.3 Hz, CHOTIPS); 
3.77 (s, 3H, ArOMe); 3.66 (s, 3H, CO2Me); 3.05 (m, 2H, CH2Ar); 1.93 (ddq, 1H, J = 3.6, 
7.2, and 7.9 Hz, CHMe2); 1.10–0.98 (m, 21H, TIPS); 0.88 (d, 3H, J = 6.9 Hz, 
CH(Me)Me); 0.79 (d, 3H, J = 6.9 Hz, CH(Me)Me) 13C NMR: (300 MHz, CDCl3) δ 
172.4, 171.8, 158.8, 152.5, 146.9, 136.7, 131.0, 129.2, 129.1, 128.6, 128.1, 128.0, 127.8, 
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127.5, 126.5, 121.1, 120.9, 115.4, 113.9, 112.7, 110.9, 104.6, 78.1, 76.6, 70.4, 55.2, 52.5, 
52.2, 52.1, 37.7, 33.9, 18.0, 17.9, 17.7, 17.2, 12.3; HRMS (FAB+) exact mass calculated 
for [M+•] (C47H60N2O7Si) requires m/z 792.4170, found m/z 792.4175; 
! 
["]
D
25 : –9.39 (c = 
1.03, CHCl3). 
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Aldehyde 15: (2R,5R)-2-tert-butyl-5-benzyl-3-methylimidazolidin-4-one•TFA 14 (0.313 
g, 0.87 mmol) and phenol 13 (2.30 g, 2.90 mmol) are dissolved in 13.75 mL of 
dichloromethane and 0.75 mL of MeOH. This mixture is cooled to –78 °C. To this cold 
solution is added freshly distilled acrolein (1.94 mL, 29.0 mmol) at –78 °C. The reaction 
is left at –78 °C for 48 hours before being diluted with 25 mL of pH 7 buffer. The layers 
were separated and the organic portions were washed with brine and dried over sodium 
sulfate. Following concentration in vacuo, the crude reaction extracts were purified by 
flash chromatography in 12:3:1 ratio of dichloromethane, hexanes, and diethyl ether to 
afford the title compound as an amorphous white solid (1.92 g, 85%) in a 3.5:1.0 mixture 
of diastereomers at the C(10) stereocenter. IR (film): 3415, 2944, 2866, 1743, 1677, 
1611, 1511, 1494, 1464, 1365, 1247, 1174, 1098, 882, 821, 734, 684 cm–1; 1H NMR: (300 
MHz, CDCl3) 9.49 (s, 1H, CHO), 7.33–6.68 (m, 12H, ArH and NH); 5.82 (s, 1H, 
OCHN), 5.29 (d, 1H, J = 15.3 Hz, NCH(H)Ar), 5.02 (d, 2H, J = 5.7 Hz, OCH2Ph), 4.88 
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(m, 1H, NHCH),  4.49 (d, 1H, J = 15.3 Hz, NCH(H)Ar), 4.12 (d, 1H, J = 3.6 Hz, 
CHOTIPS); 3.78 (s, 3H, ArOMe); 3.61 (s, 3H, CO2Me); 3.01 (m, 2H, CH2Ar); 2.15–1.80 
(m, 5H, CHOCH2CH2 and CH(CH3)2), 1.10–0.95 (m, 21H, TIPS); 0.88 (d, 3H, J = 7.2 
Hz, CH(Me)Me); 0.79 (d, 3H, J = 7.2 Hz, CH(Me)Me) 13C NMR: (75 MHz, CDCl3) δ 
200.6, 172.3, 171.7, 158.8, 157.8, 144.4, 137.1, 136.8, 133.5, 131.9, 130.9, 129.5, 129.4, 
128.5, 128.4, 127.9, 127.5, 123.7, 120.2, 115.7, 113.9, 113.4, 109.8, 105.8, 78.1, 70.9, 
68.0, 57.9, 55.2, 52.6, 52.1, 50.4, 39.0, 38.1, 33.9, 29.2, 25.6, 18.0, 17.91, 17.87, 17.7, 
17.3, 12.3 HRMS: (FAB+) exact mass calculated for [M+H] (C50H65N2O8Si) requires m/z 
849.4354, found m/z 849.4386. 
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Aldehyde 16: To a solution of aldehyde 15 (6.1 g, 7.184 mmol) in 36 mL of 
dichloromethane at room temperature was added PhSeNEt2 (1.80 mL, 9.34 mmol). After 
stirring for one hour the reaction was judged complete by TLC. The reaction mixture was 
concentrated in vacuo and the crude extracts were purified by flash chromatography 
(33% ethyl acetate in hexanes). The product was thus obtained as a yellow oil in a 3:3:1:1 
mixture of diastereomers as judged by 1H NMR. This product was then taken up in 60 
mL of THF, 30 mL of methanol, and 30 mL of water and cooled to 0 °C. To this cold 
solution was added sodium periodate (7.21 g, 7.184 mmol) in a single portion. After 24 
hours the reaction mixture was concentrated in vacuo to remove the methanol and THF, 
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diluted with ethyl acetate, and washed with water. After separation of the layers the 
organic portions were washed with brine and dried over sodium sulfate. Concentration of 
the resulting solution gave a yellow oil which could be purified by column 
chromatography (20%–35% ethyl acetate in hexanes) to give the title compound as an 
amorphous off-white solid (5.63 g, 88%). IR (Film): 3414, 2945, 2867, 2360, 1743, 1690, 
1611, 1511, 1494, 1464, 1365, 1248, 1176, 1100, 882, 822, 749, 684 cm–1; 1H NMR: (300 
MHz, CDCl3) 9.45 (d, 1H, J = 7.5 Hz, CHO), 7.40–6.68 (m, 17H, ArH, CHOCH=CH 
and NH); 5.97 (s, 1H, OCHN), 5.88 (dd, 1H, J = 7.8 and 15.6 Hz, CHOCH=CH) 5.23 (d, 
1H, J = 15 Hz, NCH(H)Ar), 5.02 (d, 2H, J = 1.5 Hz, OCH2Ph), 4.89 (m, 1H, NHCH),  
4.49 (d, 1H, J = 15 Hz, NCH(H)Ar), 4.12 (d, 1H, J = 3.3 Hz, CHOTIPS); 3.76 (s, 3H, 
ArOMe); 3.61 (s, 3H, CO2Me); 3.02 (m, 2H, CH2Ar); 2.0–1.80 (m, 1H, CH(CH3)2), 
1.10–0.95 (m, 21H, TIPS); 0.88 (d, 3H, J = 7.2 Hz, CH(Me)Me); 0.78 (d, 3H, J = 7.2 Hz, 
CH(Me)Me) 13C NMR: (75 MHz, CDCl3) δ 192.7, 172.3, 171.6, 158.9, 158.1, 154.9, 
145.4, 137.4, 136.6, 133.1, 131.7, 130.3, 130.2, 129.7, 129.6, 129.2, 128.8, 128.5, 128.0, 
127.5, 127.0, 124.8, 121.2, 117.0, 113.9, 113.7, 110.1, 106.8, 78.1, 77.2, 70.8, 61.6, 55.2, 
52.7, 52.4, 52.1, 51.2, 38.0, 33.9, 21.0, 18.0, 17.91, 17.87, 17.7, 17.2, 14.2, 12.3 HRMS: 
(FAB+) exact mass calculated for [M+H] (C50H63N2O8Si) requires m/z 847.4354, found 
m/z 847.4313; 
! 
["]
D
25= –37.11 (c = 1.0 CHCl3). 
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Aldehyde 16a: To a vigorously stirred solution of aldehyde 16 (810 mg, 0.956 mmol) in 
a 1:1 mixture of dichloromethane and pH 7 buffer (16 mL each) at 0 °C was added 
freshly recrystallized DDQ (477 mg, 2.10 mmol). The resulting dark green heterogeneous 
reaction mixture is allowed to warm to ambient temperature over the course of two hours, 
after which time it is diluted with 100 mL of ethyl acetate and washed with 100 mL of a 
saturated solution of sodium bicarbonate. The layers were separated and the aqueous 
layer was washed three times with 50 mL of ethyl acetate. The combined organic layer 
was washed with brine and dried over sodium sulfate. Purification by flash 
chromatography on iatrobeads (25%–35% ethyl acetate in hexanes) gave the desired 
product as an amorphous off-white solid as a 3.5:1 mixture of diastereomers in 89% yield 
(620 mg). IR (film): 3413, 2945, 2867, 1743, 1689, 1620, 1497, 1464, 1348, 1250, 1207, 
1098, 1057, 882, 822, 737, 684 cm–1; 1H NMR: (300 MHz, CDCl3) 9.62 (d, 1H, J = 7.8 
Hz, CHO), 7.40–6.68 (m, 12H, ArH, CHOCH=CH and CONH); 6.27 (s, 1H, OCHN), 
6.18 (dd, 1H, J = 7.8 and 16.2 Hz, CHOCH=CH), 5.13 (br s, 1H, OCHNH) 5.05 (s, 2H, 
OCH2Ph), 4.91 (m, 1H, CONHCH), 4.13 (d, 1H, J = 3.6 Hz, CHOTIPS); 3.62 (s, 3H, 
CO2Me); 3.04 (m, 2H, CH2Ar); 2.00–1.85 (m, 1H, CH(CH3)2), 1.10–0.95 (m, 21H, 
TIPS); 0.89 (d, 3H, J = 6.9 Hz, CH(Me)Me); 0.79 (d, 3H, J = 6.9 Hz, CH(Me)Me) 13C 
NMR: (75 MHz, CDCl3) δ 192.9, 172.3, 171.6, 158.3, 155.0, 152.5, 144.2, 137.2, 136.7, 
133.2, 131.3, 130.3, 129.4, 129.3, 129.1, 128.7, 128.6, 128.33, 128.29, 128.1, 127.9, 
127.6, 124.7, 120.9, 116.5, 112.3, 110.2, 78.1, 77.2, 70.5, 63.7, 52.5, 52.1, 38.1, 33.9, 
18.0, 17.91, 17.88, 17.7, 17.6, 17.3, 17.2, 12.3 HRMS: (FAB+) exact mass calculated for 
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[M+H] (C42H55N2O7Si) requires m/z 727.3779, found m/z 727.3758; 
! 
["]
D
25= –60.33 (c = 
1.0 CHCl3). 
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Aldehyde 19: To a solution of amino aldehyde 16a (354 mg, 0.487 mmol), pyridine (0.1 
mL, 1.2175 mmol), and DMAP (29.7 mg, 0.2435 mmol) in 5 mL of dichloromethane at 0 
°C was added trifluoroacetic anhydride (0.172 mL, 1.22 mmol) dropwise by syringe 
under argon. After 30 minutes the reaction was diluted with 50 mL of ethyl acetate and 
washed with 30 mL of saturated sodium bicarbonate solution. The layers were separated 
and the organic fraction was washed with brine and dried over sodium sulfate. 
Purification by flash chromatography on silica gel (25% ethyl acetate in hexanes) gave 
the title compound product as an amorphous yellow solid in 89% yield (354 mg) in an 
inseparable 3.5:1 mixture of diastereomers. IR (Film): 3415, 2945, 2867, 1731, 1663, 
1610, 1494, 1462, 1203, 1182, 1154, 948, 881, 822, 738 cm–1; 1H NMR: (300 MHz, 
CDCl3) 9.67 (d, 1H, J = 7.2 Hz, CHO), 7.50–6.75 (m, 13H, ArH, CHOCH=CH and 
CONH); 6.57 (d, 1H, J = 1.2 Hz, OCHN), 6.21 (dd, 1H, J = 7.5 and 15.9 Hz, 
CHOCH=CH), 5.20 (app q, 2H, OCH2PH), 4.92 (m, 1H, CONHCH), 4.13 (d, 1H, J = 3.3 
Hz, CHOTIPS), 3.65 (s, 3H, CO2Me), 3.06 (m, 2H, CH2Ar); 2.00–1.85 (m, 1H, 
CH(CH3)2), 1.10–0.95 (m, 21H, TIPS); 0.89 (d, 3H, J = 7.2 Hz, CH(Me)Me), 0.79 (d, 
3H, J = 7.2 Hz, CH(Me)Me) 13C NMR: (75 MHz, CDCl3) δ 192.2, 172.5, 171.7, 157.5, 
151.3, 149.9, 136.5, 135.4, 135.3, 135.1, 131.4, 130.8, 130.7, 129.3, 128.8, 128.5, 128.3, 
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128.2, 127.3, 124.7, 118.1, 116.7, 114.7, 114.3, 110.7, 100.6, 78.3, 71.0, 63.6, 60.6, 52.8, 
52.5, 52.4, 38.3, 34.1, 21.2, 18.2, 18.1, 18.0, 17.7, 17.5, 17.3, 14.4, 12.6, 12.5 HRMS: 
(FAB+) exact mass calculated for [M+H] (C44H54N2O8F3Si) requires m/z 823.3601, found 
m/z 823.3560; 
! 
["]
D
25= –88.69 (c = 1.0 CHCl3).  
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Aldehyde 20: A stream of ozone is passed through a solution of α,β-unsaturated 
aldehyde 19 (2.52 g, 3.06 mmol) in 40 mL of dichloromethane and 4 mL of methanol at  
–78 °C for 45 minutes. The solution was bubbled through with oxygen for ten minutes 
and then quenched by the addition of triphenylphospine (0.96 g, 3.67 mmol). After 
warming to room temperature overnight, the reaction mixture was concentrated in vacuo 
and loaded directly onto a silica gel column. Elution with 35% ethyl acetate in hexanes 
gives 2.10 g of title product (87%) as an amorphous white solid in a 3.5:1 mixture of 
diastereomers. IR (film): 3414, 2945, 2868, 1729, 1666, 1610, 1492, 1462, 1203, 1181, 
1158, 986, 881, 822, 738, 681 cm–1; 1H NMR: (300 MHz, CDCl3) 10.05 (s, 1H, CHO), 
7.50–6.80 (m, 13H, ArH, OCHNTFA and CONH), 5.19 (app q, 2H, OCH2PH), 4.94 (m, 
1H, CONHCH), 4.14 (d, 1H, J = 3.3 Hz, CHOTIPS), 3.65 (s, 3H, CO2Me), 3.07 (m, 2H, 
CH2Ar), 2.0–1.85 (m, 1H, CH(CH3)2), 1.10–0.95 (m, 21H, TIPS), 0.88 (d, 3H, J = 7.2 
Hz, CH(Me)Me), 0.79 (d, 3H, J = 6.6 Hz, CH(Me)Me) 13C NMR: (75 MHz, CDCl3) δ 
191.7, 173.0, 172.7, 171.8, 171.7, 157.0, 149.8, 136.9, 136.5, 135.0, 132.4, 131.7, 131.0, 
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130.9, 130.5, 129.6, 129.5, 129.2, 128.8, 128.7, 128.2, 128.0, 127.3, 125.2, 124.2, 118.0, 
116.0, 115.3, 114.2, 110.9, 109.8, 99.1, 96.1, 78.3, 71.1, 70.8, 60.7, 56.1, 52.7, 52.4, 38.7, 
38.2, 34.1, 33.9, 33.8, 21.3, 18.2, 18.1, 17.8, 17.7, 17.5, 17.4, 17.2, 14.4, 12.55, 12.51 
HRMS: (FAB+) exact mass calculated for [M+H] (C42H52N2O8F3Si) requires m/z 
797.3445, found m/z 797.3420; 
! 
["]
D
25= –112.22 (c = 1.0 CHCl3).  
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Thioester 21: To a 0 °C solution of commercially available N-Boc-valinylglycine (2.96 
g, 10.79 mmol) in 50 mL of CH2Cl2 under argon was added NEt3 (3.91 mL, 28.054 
mmol) followed by isobutyl chloroformate (1.66 mL, 12.95 mL). After 1 hour at 0 °C 
was added ethanethiol (1.67 mL, 2.0 mmol) and the reaction was warmed to room 
temperature and stirred for ten hours. The reaction mixture was then diluted with 
NaHCO3 and extracted 3 x 100 mL of CH2Cl2. The combined organic layer was washed 
with 200 mL of brine and concentrated. The resulting oil was recrystallized from a hot 
solution of 10% ethyl acetate in hexanes to give the title compound as a white crystalline 
solid in 85% yield (2.90 g). IR (Thin Film): 3310, 3077, 2968, 2932, 1688, 1663, 1525, 
1392, 1366, 1298, 1247, 1170, 1094, 1043, 1016, 966 cm–1; 1H NMR: (300 MHz, CDCl3) 
δ 6.66 (br s, 1H, NH), 5.03 (br s, 1H, NHBoc), 4.19 (d, 2H, J = 5.4 Hz, NHCH2), 4.00 
(dd, 1H, J = 6.0, 8.4 Hz, CHNHBoc), 2.91 (q, 2H, J = 7.5 Hz, SCH2), 2.21 (m, 1H, 
CHMe(Me)), 1.44 (s, 9H, OtBu), 1.25 (t, 3H, J = 7.5 Hz, SCH2CH3), 0.98 (d, 3H, J = 6.9 
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Hz,  CHMe(Me)), 0.94 (d, 3H, J = 6.9 Hz,  CHMe(Me)); 13C NMR: (75 MHz, CDCl3) δ 
196.9, 172.2, 156.2, 80.3, 60.1, 49.2, 30.9, 28.5, 23.4, 19.6, 17.9, 14.8; HRMS: (FAB+) 
exact mass calculated for [M+H] (C14H27N2O4S) requires m/z 319.1702, found m/z 
319.1692; 
! 
["]
D
25  = –17.01 (c = 1.0 CHCl3). 
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Ketoamide 23: To a solution of thioester 21 (461 mg, 1.449 mmol) in 6.0 mL of CH2Cl2 
at –78 °C under an argon balloon was added TiCl4 (0.334 mL, 3.029 mmol) and the 
resulting solution turned bright yellow. After 30 minutes triethylamine (0.423 mL, 3.029 
mmol) was added turning the reaction mixture dark purple. After 30 minutes more MeCN 
(0.1375 mL, 2.634 mmol) was added. Ten minutes after aldehyde 20 (1.05 g, 1.317 
mmol) was added dropwise as a solution in 1.5 mL of CH2Cl2. The dark purple reaction 
mixture was stirred at –78 °C for 1 hour then placed in a –30 °C refrigerator for 12 hours. 
At this time the reaction was diluted with CH2Cl2 and quenched with a saturated solution 
of NaHCO3. The layers were separated and the organic layer was washed with 2 x 50 mL 
of water then 50 mL of brine. The organic fractions were concentrated and purified by 
column chromatography (20%–25% ethyl acetate in hexanes) to afford the title 
compound as an amorphous yellow solid. This solid was immediately dissolved in 17.5 
mL of CH2Cl2 and Dess-Martin periodinane (1.11 g, 2.62 mmol) was added. After two 
 
 
76 
hours the solution was diluted with ethyl acetate and washed with a saturated solution of 
NaHCO3. The organic fractions were concentrated and the resulting oil purified by 
column chromatography to afford in 65% yield over the two steps the title compound 
(1.05 g) as an off-yellow solid as a 3.5:3.5:1:1 mixture of inseparable diastereomers by 
1H NMR. This material was carried on without further purification. HRMS: (FAB+) 
exact mass calculated for [M+H] (C56H76N4O12F3SiS) requires m/z 113.490, found m/z 
113.491; 
! 
["]
D
25= –31.69 (c = 1.0 CHCl3) (for ketoamide). 
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Oxazole 28: To a solution of 23 (900 mg, 0.8 mmol) in benzene (15 mL) was added 
DAST (1.5 mL) dropwise by syringe. The solution was stirred at room temperature for 
one hour before being diluted with a saturated solution of NaHCO3. The layers were 
separated and the organic was washed with ethyl acetate 3 x 50 mL. The combined 
organics were washed with brine and concentrated. The resulting oil was purified on 
silica gel (20%–25% ethyl acetate in hexanes) to yield the title compound (500 mg, 55%) 
as pale yellow solid. IR (film): 3415, 2963, 2868, 2360, 2340, 1732, 1674, 1608, 1495, 
1464, 1367, 1290, 1253, 1203, 1159, 1125, 1001, 878, 822, 738, 685, 668 cm–1; 1H NMR: 
(300 MHz, CDCl3): 7.80–6.80 (m, 13H, Ar-H, OCHNTFA and CONH), 5.59 (br d, 1H, J 
= 9.3 Hz, NHBoc), 5.17 (app q, 2H, OCH2Ph), 4.94 (m, 1H, CONHCH), 4.90 (m, 1H, 
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CHNHBOC), 4.08 (d, 1H, J = 3.6 Hz, CHOTIPS), 3.59 (S, 3H, CO2Me), 3.00 (M, 2H, 
CH2Ar), 2.76 (q, 2H, J = 7.5 Hz, CH2CH3), 2.19 (m, 1H, NHCHCH(CH3)2), 1.85 (m, 1H, 
OCHCH(CH3)2), 1.47 (br s, 9H, Boc), 1.20 (t, 3H, J = 7.5 Hz, CH2CH3), 0.99 (m, 27H, 
TIPS and NHCHCH(CH3)2), 0.79 (d, 3H, J = 7.2 Hz, OCHCH(Me)Me); 0.75 (d, 3H, J = 
6.9 Hz, CH(Me)Me); 13C NMR: (75 MHz, CDCl3) δ 186.8, 183.4, 180.6, 174.2, 172.2, 
171.6, 163.5, 162.7, 161.8, 157.5, 155.6, 154.2, 153.7, 149.8, 149.4, 137.0, 136.4, 135.5, 
135.0, 134.0, 133.1, 132.4, 131.0, 129.7, 128.5, 127.9, 127.7, 127.1, 125.1, 116.2, 115.5, 
114.2, 110.1, 99.7, 94.6, 80.0, 78.1, 70.8, 60.1, 59.1, 54.4, 52.1, 47.9, 38.4, 33.7, 32.5, 
28.3, 28.0, 22.9, 18.8, 18.2, 17.9, 17.8, 17.4, 17.1, 16.7, 16.0, 14.2, 13.6, 12.3; 19F NMR: 
(75 MHz, CDCl3) δ –70.4 (s, 3F, CF3); HRMS: (FAB+) exact mass calculated for [M–H] 
(C56H72N4O11F3SiS) requires m/z 1093.464, found m/z 1093.464; 
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25  = –44.62 (c = 1.0 
CHCl3).  
 
 
OBn
COSEt
N
O
NTFA
BocHN
Me Me
H
N
O
TIPSO
Me Me
O
CO2Me
OBn
N
O
NTFA
BocHN
Me Me
H
N
O
TIPSO
Me Me
O
CO2Me
O
HN NH
N
H
NH2
28
AgTFA, CH3CN
39  
Amide 39: To 28 (100 mg, 0.091 mmol), tryptamine (51 mg, 0.318 mmol) and AgTFA 
(46 mg, 0.209 mmol) in a light-protected round-bottom flask was added degassed CH3CN 
(1.8 mL) with stirring. The solution was warmed to 40 °C and held for 45 minutes before 
being diluted with Et2O and passed through celite. After concentration, the resulting oil 
was purified on silica gel (40%–80% Et2O in hexanes) to yield the title compound (87 
mg, 87%) as pale yellow solid. IR (film): 3410, 2961, 2868, 1724, 1672, 1607, 1494, 
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1458, 1367, 1288, 1204, 1159, 1011, 880, 821, 739, 684 cm–1; 1H NMR: (300 MHz, 
CDCl3): 8.14 (s, 1H, C=CNH), 7.78 (d, 1H, Ar-H, 1.2 Hz), 7.58–6.76 (m, 17H, Ar-H, 
OCHNTFA and CONH), 5.49 (br d, 1H, J = 9.3 Hz, NHBoc), 5.16 (m, 2H, OCH2Ph), 
4.95 (m, 1H, CONHCH), 4.75 (m, 1H, CHNHBOC), 4.09 (d, 1H, J = 3.6 Hz, 
CHOTIPS), 3.58 (m, 5H, CO2Me, NHCH2CH2), 3.00 (m, 4H, CH2Ar, NHCH2CH2), 2.14 
(m, 1H, NHCHCH(CH3)2), 1.88 (m, 1H, OCHCH(CH3)2), 1.44 (br s, 9H, Boc),  0.99 (m, 
27H, TIPS and NHCHCH(CH3)2), 0.78 (d, 3H, J = 7.2 Hz, OCHCH(Me)Me); 0.72 (d, 
3H, J = 7.2 Hz, CH(Me)Me); 13C NMR: (75 MHz, CDCl3) δ 172.3, 171.7, 162.0, 160.0, 
157.5, 155.5, 150.0, 149.4, 136.5, 136.3, 135.6, 130.8, 130.3, 129.4, 128.5, 128.4, 128.3, 
127.8, 127.4, 127.3, 127.0, 126.9, 124.8, 122.1, 122.0, 119.3, 118.6, 116.5, 114.0, 112.8, 
111.2, 110.0, 100.1, 80.1, 78.1, 70.7, 60.0, 54.4, 52.2, 52.1, 39.3, 38.4, 33.9, 33.7, 32.3, 
28.4, 25.2, 18.8, 18.2, 18.0, 17.9, 17.8, 17.4, 17.1, 12.3; 19F NMR: (75 MHz, CDCl3) δ 
-70.4 (s, 3F, CF3); HRMS: (FAB+) exact mass calculated for [M+H] (C64H78N6O11F3Si) 
requires m/z 1192.551, found m/z 1192.547; 
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25  = –45.64 (c = 1.0 CHCl3). 
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Ketoindole 40: To a solution of 39 (300 mg, 0.25 mmol) in THF/H2O (10:1, 5 mL) was 
added DDQ (122 mg, 0.75 mmol). The solution was stirred at room temperature for 15 
minutes before being diluted with a saturated solution of NaHCO3. The layers were 
separated and the aqueous was washed with ethyl acetate 3 x 50 mL. The combined 
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organics were washed with brine and concentrated. The resulting oil was purified on 
silica gel (60%–80% Et2O in hexanes) to yield the title compound (228 mg, 75%) as pale 
yellow solid. IR (Film): 3406, 2962, 2868, 1732, 1674, 1608, 1511, 1495, 1455, 1367, 
1288, 1247, 1204, 1159, 1126, 1009, 910, 881, 822, 736, 685, 648 cm–1; 1H NMR: (300 
MHz, CDCl3): 9.63 (d, 1H, C=CNH, 2.1 Hz), 8.21 (d, 1H, Ar-H, 6.9 Hz), 7.98 (t, 1H, Ar-
H, 4.8 Hz), 7.61–6.75 (m, 16H, Ar-H, OCHNTFA and CONH), 5.62 (br d, 1H, J = 9.0 
Hz, NHBoc), 5.09 (m, 2H, OCH2Ph), 4.95 (m, 1H, CONHCH), 4.80 (m, 1H, 
CHNHBOC), 4.45 (t, 2H, J = 5.0 Hz, CH2CO), 4.09 (d, 1H, J = 3.6 Hz, CHOTIPS), 3.59 
(s, 3H, CO2Me), 3.03 (m, 2H, CH2Ar), 2.20 (m, 1H, NHCHCH(CH3)2), 1.87 (m, 1H, 
OCHCH(CH3)2), 1.47 (br s, 9H, Boc),  0.99 (m, 27H, TIPS and NHCHCH(CH3)2), 0.77 
(d, 3H, J = 7.2 Hz, OCHCH(Me)Me); 0.71 (d, 3H, J = 7.2 Hz, CH(Me)Me); 13C NMR: 
(75 MHz, CDCl3) δ 186.5, 172.3, 171.6, 162.4, 160.2, 157.5, 155.6, 155.5, 151.1, 149.3, 
136.4, 136.3, 135.8, 132.0, 130.8, 130.3, 129.5, 128.7, 128.5, 128.2, 127.8, 127.0, 125.5, 
125.3, 125.2, 123.7, 122.7, 121.8, 118.1, 116.2, 114.7, 114.3, 114.0, 111.9, 110.0, 100.3, 
80.2, 78.2, 70.7, 65.9, 60.1, 54.5, 52.5, 52.1, 45.7, 38.3, 34.2, 33.8, 33.7, 32.6, 30.3, 28.4, 
18.8, 18.2, 18.0, 17.9, 17.8, 17.4, 17.1, 15.3, 12.3; 19F NMR: (75 MHz, CDCl3) δ –70.2 
(s, 3F, CF3); HRMS: (FAB+) exact mass calculated for [M–H] (C64H78N6O12F3Si) requires 
m/z 1207.540, found m/z 1207.536; 
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25  = –40.21 (c = 1.0 CHCl3).   
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Bisoxazole 41: To a solution of PPh3 (186 mg, 0.71 mmol) in CH2Cl2 (6.6 mL) was 
added C2Cl6 (168 mg, 0.71 mmol). The solution was stirred at room temperature for 10 
minutes at which time Et3N (0.20 mL, 1.42 mmol) was added dropwise.  The resultant 
solution was stirred for 10 minutes at which time it was added dropwise via cannula to a 
stirred CH2Cl2 (2.8 mL) solution of 40 (171 mg, 0.142 mmol) held at -15 °C.  After 
addition was complete, the reaction was warmed to 0 °C and held at this temperature for 
10 minutes, at which point it was allowed to warm to room temperature and stirred for an 
additional 10 minutes.  The solution was then diluted with a saturated solution of 
NaHCO3. The layers were separated and the aqueous was washed with CH2Cl2 (3 x 20 
mL). The combined organics were washed with brine and concentrated. The resulting oil 
was purified on silica gel (50%–70% Et2O in hexanes) to yield the title compound (157 
mg, 93%) as a pale off-white solid. IR (film): 3406, 2962, 2868, 1733, 1674, 1610, 1495, 
1458, 1367, 1288, 1256, 1203, 1156, 1124, 1057, 997, 882, 741, 668 cm–1; 1H NMR: (300 
MHz, CDCl3): 8.58 (s, 1H, C=CNH), 7.74–6.76 (m, 19H, Ar-H, OCHNTFA and 
CONH), 5.71 (br d, 1H, J = 9.0 Hz, NHBoc), 5.11 (app d, 2H, OCH2Ph, J = 3.6 Hz), 4.92 
(m, 1H, CONHCH), 4.82 (m, 1H, CHNHBOC), 4.09 (d, 1H, J = 3.3 Hz, CHOTIPS), 
3.57 (s, 3H, CO2Me), 2.98 (m, 2H, CH2Ar), 2.20 (m, 1H, NHCHCH(CH3)2), 1.86 (m, 1H, 
OCHCH(CH3)2), 1.46 (br s, 9H, Boc),  0.99 (m, 27H, TIPS and NHCHCH(CH3)2), 0.77 
(d, 3H, J = 6.9 Hz, OCHCH(Me)Me); 0.69 (d, 3H, J = 6.9 Hz, CH(Me)Me); 13C NMR: 
(75 MHz, CDCl3) δ 172.5, 171.8, 164.1, 163.3, 161.6, 161.5, 161.4, 161.3, 161.2, 157.6, 
156.0, 155.8, 155.6, 151.7, 150.8, 149.4, 148.7, 147.5, 136.7, 136.4, 131.2, 130.2, 128.9, 
128.8, 128.2, 128.1, 127.4, 125.8, 125.7, 124.0, 123.2, 123.1, 121.5, 121.1, 119.9, 118.3, 
116.2, 114.3, 111.9, 110.4, 104.9, 100.3, 80.2, 78.4, 70.9, 60.6, 54.8, 52.5, 52.3, 38.6, 
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33.9, 33.1, 30.6, 28.6, 19.0, 18.5, 18.2, 18.1, 18.0, 17.7, 17.3, 12.5; 19F NMR: (75 MHz, 
CDCl3) δ –70.3 (s, 3F, CF3); HRMS: (FAB+) exact mass calculated for [M–H] 
(C64H76N6O11F3Si) requires m/z 1189.529, found m/z 1189.525; 
! 
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D
25  = –21.03 (c = 1.0 
CHCl3).  
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Amino Acid 43: To a solution of 41 (157 mg, 0.132 mmol) in THF/MeOH/H2O (10:2:1, 
4.4 mL) was added LiOH•H2O (56 mg, 1.32 mmol). The solution was stirred at room 
temperature for 1 hour at which time it was acidified with 1% aqueous HCl to pH 2.  The 
aqueous layer was extracted 3x with EtOAc, the organics combined and dried over 
Na2SO4.  Following concentration, the resultant carboxylic acid was redissolved in 
CH2Cl2 (2.4 mL).  To this solution was then added Me2S (0.6 mL) and trifluoroacetic acid 
(1.2 mL) with stirring.  After stirring for 25 minutes, the solvents were removed in vacuo, 
and the resulting solid redissolved in benzene and concentrated three successive times in 
order to remove residual trifluoroacetic acid.  The resulting solid was purified on silica 
gel (5%–10% MeOH in CH2Cl2) to yield the title compound (125 mg, 88%) as a yellow 
solid. IR (film): 3397, 2958, 2929, 2862, 1676, 1622, 1497, 1458, 1387, 1204, 1138, 
1054, 996, 881, 801, 727 cm–1; 1H NMR: (300 MHz, CD3OD): 7.70–6.52 (m, 19H, Ar-H, 
OCHNH and CONH), 4.82 (app d, 2H, OCH2Ph, J = 11.7 Hz), 4.37 (d, 1H, CONHCH, J 
= 5.1 Hz), 4.29 (d, 1H, CHNH2, J = 7.5 Hz), 4.01 (d, 1H, J = 4.2 Hz, CHOTIPS),  2.93 
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(m, 2H, CH2Ar), 2.30 (m, 1H, NHCHCH(CH3)2), 1.78 (m, 1H, OCHCH(CH3)2), 1.04 (m, 
27H, TIPS and NHCHCH(CH3)2), 0.74 (d, 3H, J = 6.9 Hz, OCHCH(Me)Me); 0.68 (d, 
3H, J = 6.9 Hz, CH(Me)Me); 13C NMR: (75 MHz, CD3OD) δ 173.2, 172.6, 158.8, 158.6, 
152.6, 151.5, 149.9, 143.9, 138.2, 137.7, 136.7, 132.4, 132.3, 131.7, 131.6, 130.0, 129.2, 
129.0, 128.8, 128.7, 128.5, 128.2, 128.0, 127.5, 127.4, 127.1, 127.0, 126.9, 126.2, 124.6, 
123.7, 122.1, 120.2, 120.1, 119.3, 118.9, 118.5, 114.6, 112.2, 11.6, 109.5, 103.6, 103.2, 
78.2, 69.6, 67.4, 60.3, 53.9, 53.7, 52.3, 37.0, 33.5, 31.2, 29.5, 25.1, 23.3, 18.9, 17.5, 17.1, 
17.0, 16.9, 16.6, 16.5, 16.3, 12.1; HRMS: (FAB+) exact mass calculated for [M+H] 
(C56H67N6O8Si) requires m/z 979.4790, found m/z 979.4801; 
! 
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25  = –42.16 (c = 1.0 
MeOH).  
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Phenol 41a: To a solution of 41 (192 mg, 0.161 mmol) in THF (10 mL) was added 
Pd(OH)2/C (80 mg). The solution was sparged with H2 for 20 minutes and warmed to 50 
°C under H2 with stirring.  After 18 hours, the solution was then filtered through celite. 
After concentration, the resulting oil was purified on silica gel (70%–90% Et2O in 
hexanes) to yield the title compound (144 mg, 89%) as a pale off-white solid. IR (film): 
3327, 2962, 2868, 1748, 1671, 1633, 1611, 1500, 1463, 1367, 1292, 1250, 1172, 1058, 
1014, 917, 881, 820, 736, 684 cm–1; 1H NMR: (300 MHz, CDCl3): 9.24 (s, 1H, C=CNH), 
7.60–6.52 (m, 14H, Ar-H, OCHNH and CONH), 5.74 (br d, 1H, J = 9.0 Hz, NHBoc), 
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4.85 (m, 2H, CONHCH, CHNHBOC), 4.09 (d, 1H, J = 3.3 Hz, CHOTIPS), 3.50 (s, 3H, 
CO2Me), 2.93 (m, 2H, CH2Ar), 2.16 (m, 1H, NHCHCH(CH3)2), 1.83 (m, 1H, 
OCHCH(CH3)2), 1.39 (br s, 9H, Boc),  0.98 (m, 27H, TIPS and NHCHCH(CH3)2), 0.73 
(d, 3H, J = 7.2 Hz, OCHCH(Me)Me); 0.67 (d, 3H, J = 7.2 Hz, CH(Me)Me); 13C NMR: 
(75 MHz, CDCl3) δ 172.7, 171.6, 163.2, 158.1, 156.0, 152.0, 148.8, 141.7, 136.5, 136.2, 
130.4, 130.0, 129.4, 129.2, 128.9, 125.8, 125.2, 123.8, 123.7, 123.5, 122.6, 121.2, 120.6, 
119.3, 116.0, 115.7, 111.8, 110.0, 104.3, 104.2, 103.3, 80.2, 78.2, 60.6, 54.6, 52.6, 52.1, 
52.0, 38.4, 33.8, 32.6, 31.6, 29.7, 28.3, 18.9, 18.3, 18.1, 17.9, 17.5, 17.4, 12.3; HRMS: 
(FAB+) exact mass calculated for [M+H] (C55H71N6O10Si) requires m/z 1003.500, found 
m/z 1003.503; 
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25  = –12.89 (c = 0.073 CHCl3).  
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Triflate 47: To a solution of 41a (45 mg, 0.045 mmol) in CH2Cl2 (0.9 mL) was added 
PhNTf2 (20 mg, 0.056 mmol) and Et3N (19 µL, 0.134 mmol). The solution was stirred 
under argon for 30 minutes and then diluted with saturated NaHCO3.  The aqueous layer 
was washed with EtOAc, and the combined organics were washed with H2O and dried 
over Na2SO4. After concentration of the solvents in vacuo, the resulting oil was purified 
on silica gel (20% EtOAc in hexanes) to yield the title compound (44 mg, 86%) as a pale 
off-white solid. IR (film): 3307, 2963, 2868, 1672, 1630, 1497, 1424, 1367, 1211, 1140, 
1058, 998, 908, 881, 815, 740, 684 cm–1; 1H NMR: (300 MHz, CDCl3): 8.55 (d, 1H, 
 
 
84 
C=CNH, J = 1.8 Hz), 7.75–6.70 (m, 14H, Ar-H, OCHNH and CONH), 5.68 (br d, 1H, J 
= 9.0 Hz, NHBoc), 4.90, (m, 1H, CONHCH), 4.78 (m, 1H, CHNHBOC), 4.06 (d, 1H, J = 
3.6 Hz, CHOTIPS), 3.52 (s, 3H, CO2Me), 2.95 (m, 2H, CH2Ar), 2.16 (m, 1H, 
NHCHCH(CH3)2), 1.83 (m, 1H, OCHCH(CH3)2), 1.45 (br s, 9H, Boc),  0.98 (m, 27H, 
TIPS and NHCHCH(CH3)2), 0.74 (d, 3H, J = 6.9 Hz, OCHCH(Me)Me); 0.67 (d, 3H, J = 
6.9 Hz, CH(Me)Me); 13C NMR: (75 MHz, CDCl3) δ 172.6, 171.8, 163.6, 158.4, 155.9, 
152.0, 149.4, 148.6, 141.3, 136.5, 133.5, 130.9, 130.0, 129.5, 128.0, 126.6, 125.6, 124.1, 
123.1, 121.8, 121.6, 121.1, 121.0, 119.8, 116.7, 112.0, 110.7, 104.9, 103.1, 80.2, 78.4, 
60.3, 54.8, 52.6, 52.3, 38.6, 33.9, 33.0, 31.8, 29.9, 28.6, 18.9, 18.6, 18.2, 18.1, 17.9, 12.5; 
19F NMR: (75 MHz, CDCl3) δ –73.5 (s, 3F, CF3); HRMS: (FAB+) exact mass calculated 
for [M+H] (C56H70N6O12F3SiS) requires m/z 1135.449, found m/z 1135.449; 
! 
["]
D
25  =           
–10.74 (c = 0.94 CHCl3). 
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Biaryl 49: Triflate 47 (5 mg, 0.0044 mmol) and K3PO4 (0.95 mg, 0.0044 mmol) were 
dissolved in degassed CH3CN/H2O (3:1, 2ml) in a Pyrex flask under argon.  This solution 
was exposed to 356 nm UV light (Hitachi UVA lamps, Luzchem 10 lamp photoreactor) 
with stirring for 1 hour. At this time the solvents were concentrated in vacuo, and the 
resulting oil was purified on silica gel (50% EtOAc in hexanes) to yield the title 
compound (1.9 mg, 38%) as a pale off-white solid. IR (film): 3312, 2961, 2927, 2868, 
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1715, 1673, 1592, 1493, 1456, 1367, 1259, 1210, 1172, 1095, 1016, 914, 882, 803, 739, 
685 cm–1; 1H NMR: (300 MHz, CDCl3): 8.71 (s, 1H, C=CNH), 7.71–6.75 (m, 12H, Ar-H, 
CONH), 6.32 (s, 1H, OCHNH), 5.71 (br d, 1H, J = 9.6 Hz, NHBoc), 5.03, (m, 1H, 
CONHCH), 4.78 (m, 1H, CHNHBOC), 4.11 (d, 1H, J = 3.6 Hz, CHOTIPS), 3.71 (s, 3H, 
CO2Me), 3.15 (m, 2H, CH2Ar), 2.14 (m, 1H, NHCHCH(CH3)2), 1.81 (m, 1H, 
OCHCH(CH3)2), 1.48 (br s, 9H, Boc),  1.06–0.77 (m, 33H, TIPS, NHCHCH(CH3)2, and 
OCHCH(Me)Me); HRMS: (FAB+) exact mass calculated for [M+H] (C55H69N6O9Si) 
requires m/z 985.4895, found m/z 985.4897; 
! 
["]
D
25  = –28.03 (c = 0.1, CHCl3). 
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DFT calculations regarding lactamization thermochemistry: Calculations were 
carried out at using the B3LYP functional at the 3-21G level of theory in the Gaussian 03 
suite of programs. Minimized structures are shown below with their respective energies. 
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 hartrees ΔE (hartree) ΔE (kcal) 
acyl chloride -2772.826609   
lactam -2314.248821   
HCl -458.5887638   
  -0.01097533 -6.887123841 
 
Coordinates, Level of Calculation, and Energies for DFT Structures: 
Acyl Chloride  
E (B3LYP/3-21G) = –2772.82660927 a.u. 
 
0 1 
 C                  0.27336000   -1.68994000    0.44652100 
 C                  1.50501900   -1.74909000    1.07174200 
 C                  2.44471800   -2.70698200    0.66000900 
 C                  2.09625700   -3.62551400   -0.33901800 
 C                  0.84280000   -3.58197300   -0.96128500 
 C                 -0.04971800   -2.58756900   -0.57370700 
 O                 -1.27860400   -2.35114100   -1.16503200 
 C                 -0.41320000    0.72152700    0.48486800 
 C                 -1.60094300   -0.92608500    1.97565000 
 C                 -0.99194000    1.95772200    0.35577300 
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 N                  0.00434200    2.95941100    0.45640300 
 C                  1.13585800    2.33900100    0.64664900 
 O                  0.96600700    0.94327900    0.65833500 
 C                  3.85844700   -2.60972400    1.19888800 
 C                  4.52299200   -1.31829100    0.61612300 
 O                  7.01935900   -1.29770400    0.67024400 
 C                 -2.85749100   -1.50004700    1.71529600 
 C                  2.51809200    2.90180400    0.89819100 
 C                  2.91200200    3.91802100   -0.23357700 
 C                  4.41484100    4.26496600   -0.15130200 
 C                  2.05635300    5.19968100   -0.13496500 
 N                  4.55338000   -1.40095400   -0.83580200 
 C                  4.71202100   -0.31690400   -1.62765700 
 C                  4.53300500   -0.63352200   -3.11575700 
 C                  3.25561000    0.05977200   -3.66122000 
 C                  3.46154500    1.58180600   -3.78967800 
 C                  2.02679500   -0.29319600   -2.79698400 
 O                  4.92901200    0.84510100   -1.21255700 
 C                 -1.93409600   -1.21466600   -0.42489200 
 N                 -3.05313900   -1.65993900    0.34792100 
 C                 -0.86840300   -0.69931200    0.64867900 
 C                 -1.18765800   -0.66042400    3.26833300 
 C                 -2.04477000   -0.97529200    4.33412500 
 C                 -3.29358700   -1.54644700    4.07640500 
 C                 -3.71503700   -1.81614600    2.76904900 
 C                 -2.36551500    2.33922700    0.21410500 
 N                 -2.89948500    3.52985200    0.30375400 
 C                 -4.28073100    3.34538500    0.13074600 
 C                 -4.56477100    2.02279200   -0.05575800 
 O                 -3.32528300    1.33023900   -0.02610100 
 C                 -5.78442300    1.27379300   -0.20721800 
 C                 -6.98471700    1.56145500    0.41391100 
 N                 -7.94091800    0.63214300    0.02562200 
 C                 -7.37026800   -0.28096300   -0.85062700 
 C                 -6.00732700    0.09722100   -1.02669600 
 C                 -5.19688200   -0.63971800   -1.90445900 
 C                 -5.73795700   -1.74595100   -2.55135300 
 C                 -7.08263900   -2.12091600   -2.34729400 
 C                 -7.91313900   -1.39080900   -1.50439700 
 H                  1.77683100   -1.01268000    1.81498000 
 H                  2.81361400   -4.37996600   -0.64638000 
 H                  0.57188700   -4.28336400   -1.73853200 
 H                  4.36754600   -2.27419700   -1.33078600 
 H                 -3.96433200   -1.78258700   -0.07964400 
 H                  3.87344600   -2.53041600    2.28850000 
 H                  4.45254000   -3.48211300    0.90403000 
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 H                  2.45215700    3.47473600    1.83286900 
 H                  2.72138200    3.42729600   -1.19727500 
 H                  4.65056600    5.03905800   -0.89034400 
 H                  4.66323300    4.65961800    0.84234000 
 H                  5.03941200    3.39195700   -0.35806700 
 H                  2.26978600    5.86285100   -0.98080200 
 H                  0.99222500    4.95316800   -0.12360400 
 H                  2.30284300    5.73680400    0.79065700 
 H                  5.41111800   -0.25728700   -3.65708400 
 H                  3.10200000   -0.35181800   -4.67267600 
 H                  2.54328700    2.05608100   -4.15125000 
 H                  3.72910900    1.99600700   -2.81591700 
 H                  4.27013700    1.80979700   -4.49449600 
 H                  2.07476900    0.20102900   -1.82037200 
 H                  1.10901500    0.03212500   -3.29823700 
 H                  1.97124000   -1.37283800   -2.62990900 
 H                 -0.22166600   -0.20452500    3.45355600 
 H                 -1.73878600   -0.77150000    5.35263300 
 H                 -3.95310800   -1.78710400    4.90253300 
 H                  3.95256700   -0.43596900    0.94003400 
 H                 -2.18796500   -0.48441400   -1.18630600 
 H                 -8.89939800    0.61717400    0.34823300 
 H                 -4.96421700    4.17479000    0.13754900 
 H                 -7.21172200    2.34129500    1.12069500 
 H                 -4.17588100   -0.32972600   -2.08513400 
 H                 -5.12343500   -2.32417000   -3.23096700 
 H                 -7.47716400   -2.98768200   -2.86375400 
 H                 -8.94902700   -1.67527000   -1.36306100 
 H                 -4.68526000   -2.25891800    2.58126700 
 O                  4.42751600   -2.09119400   -3.22006000 
 H                  3.99135900   -2.31204100   -4.08314900 
 C                  5.93606000   -1.16986900    1.14508900 
 Cl                 5.75647000   -0.63255800    3.05633600 
 N                  3.47793700    1.79531000    1.10471100 
 H                  3.98514800    1.54527700    0.24700900 
 H                  4.14251000    2.00467400    1.85241400 
 
Lactam  
E (B3LYP/3-21G) = –2314.24882081 a.u. 
 
0,1 
 C                  0.46048600    1.52318400   -1.17304600 
 C                 -0.88393500    1.82309200   -1.27363600 
 C                 -1.62830800    1.30655700   -2.34720200 
 C                 -0.95876900    0.58548700   -3.34824600 
 C                  0.42344100    0.35472700   -3.28770200 
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 C                  1.11481400    0.80773800   -2.16914400 
 O                  2.45997300    0.56289900   -1.87764300 
 C                  0.82333400    0.83585100    1.13728500 
 C                  1.58540000    3.16739200    0.39080900 
 C                  1.04908700   -0.31292000    1.85674400 
 N                 -0.13593600   -0.65667400    2.58104500 
 C                 -1.01581200    0.24984300    2.29238800 
 O                 -0.49559800    1.23919000    1.44171300 
 C                 -3.15214100    1.36931100   -2.27524800 
 C                 -3.64339900    0.37251700   -1.19653000 
 O                 -3.29951800    2.15477800    0.47289800 
 C                  2.79201100    3.60043500   -0.19185000 
 C                 -2.51326000    0.27390300    2.46869900 
 C                 -2.98630700   -0.74951400    3.52269400 
 C                 -4.52626700   -0.87486900    3.50356300 
 C                 -2.48113100   -0.33597800    4.92174700 
 N                 -5.08999300    0.10527000   -1.30148500 
 C                 -5.63925400   -0.94968200   -0.66798600 
 C                 -7.14479500   -1.10442300   -0.91124300 
 C                 -7.47732100   -2.45932300   -1.58280400 
 C                 -7.26475000   -3.63431000   -0.60687800 
 C                 -6.65827600   -2.61641400   -2.87985300 
 O                 -4.98614200   -1.75527000    0.04815500 
 C                  2.77665000    1.27207400   -0.58895800 
 N                  3.44755700    2.53303000   -0.79847700 
 C                  1.39078400    1.69590200    0.04035300 
 C                  0.76458400    4.04422800    1.07641000 
 C                  1.15653500    5.38822600    1.19188300 
 C                  2.35047400    5.81950900    0.61132500 
 C                  3.18277100    4.93427300   -0.08697100 
 C                  2.16860500   -1.20338300    1.99555800 
 N                  2.32597400   -2.15204000    2.88227800 
 C                  3.54597400   -2.77355100    2.57914500 
 C                  4.12804000   -2.17807500    1.49469300 
 O                  3.25028300   -1.14346200    1.08361600 
 C                  5.35345000   -2.37795600    0.77426300 
 C                  6.49015400   -2.97877000    1.28365800 
 N                  7.46216300   -3.03625400    0.29613800 
 C                  6.97127800   -2.46700100   -0.87300400 
 C                  5.63634000   -2.04093300   -0.61223700 
 C                  4.89080400   -1.44347600   -1.64033100 
 C                  5.49219000   -1.26676200   -2.88161700 
 C                  6.81728400   -1.68364900   -3.12223500 
 C                  7.56998100   -2.29141100   -2.12342400 
 H                 -1.38727500    2.37499400   -0.49699600 
 H                 -1.52199300    0.18368100   -4.18416200 
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 H                  0.93554200   -0.19787400   -4.06364600 
 H                 -5.72570200    0.70972800   -1.82024600 
 H                  4.40304500    2.57203300   -1.12845900 
 H                 -3.48869200    2.36987600   -1.98350000 
 H                 -3.59377700    1.09765900   -3.23994600 
 H                 -2.83944600    1.28849100    2.71511800 
 H                 -2.53533500   -1.71576900    3.26467900 
 H                 -4.84472700   -1.59429600    4.26584500 
 H                 -4.98615600    0.09454900    3.73346500 
 H                 -4.89074400   -1.21482200    2.52938500 
 H                 -2.81783600   -1.06171900    5.66960500 
 H                 -1.38826900   -0.30356200    4.94014200 
 H                 -2.87891900    0.64939400    5.19427600 
 H                 -7.64791600   -1.04905600    0.06495900 
 H                 -8.54588100   -2.41312900   -1.84732100 
 H                 -7.45250600   -4.58602400   -1.11486200 
 H                 -6.24060100   -3.60835500   -0.23065300 
 H                 -7.94901400   -3.55887800    0.24699300 
 H                 -5.60381000   -2.79048500   -2.63847700 
 H                 -7.02270400   -3.46517300   -3.46725700 
 H                 -6.74124600   -1.70328300   -3.47735900 
 H                 -0.15678000    3.68863600    1.51905400 
 H                  0.53024400    6.08747700    1.73173900 
 H                  2.64700300    6.85837800    0.70213200 
 H                 -3.12391200   -0.58214300   -1.31334200 
 H                  3.35095000    0.55241200   -0.01906600 
 H                  8.38950300   -3.42120100    0.41702900 
 H                  3.90377400   -3.61387900    3.14538900 
 H                  6.67712400   -3.34737800    2.27797200 
 H                  3.87151800   -1.11890200   -1.48622900 
 H                  4.92563100   -0.79622600   -3.67634000 
 H                  7.25599700   -1.53159200   -4.10149000 
 H                  8.58598200   -2.61805800   -2.31136100 
 H                  4.10872100    5.28108900   -0.52927600 
 O                 -7.52962900    0.01378000   -1.77685500 
 H                 -8.49951000   -0.05772600   -1.97158800 
 C                 -3.33000800    0.93467600    0.22111300 
 N                 -3.05997200   -0.04111000    1.12953400 
 H                 -3.33020500   -0.99888900    0.89235300 
 
HCl 
E (B3LYP/3-21G) = –458.58876379 a.u. 
 
0 1 
 Cl                 0.00000000    0.00000000    0.07166700 
 H                  0.00000000    0.00000000   -1.21833300 
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Chapter 4 
 
Second-Generation MacMillan Synthesis of Diazonamide A: 
Development of a Novel Magnesium-Mediated Macroaldolization 
 
I. Outline of a New Synthetic Strategy 
 In light of our inability to close the left-hand macrocycle of diazonamide A by a 
late stage lactamization in our original synthetic route, we were compelled to devise an 
alternative approach (eq 1). Our foremost concern in doing so was that the strain in this 
particular 12-membered ring would likely preclude the success of any type of ring 
closure if all other structural elements of the ring were already in place. This logic 
suggests first creating a larger and more conformationally flexible ring and subsequently 
contracting it to the desired size in a second, more energetically favorable synthetic 
operation. We recognized that this reasoning could be applied to the cyclodehydration of 
the central A-ring oxazole, prompting us to fully evaluate the risks and benefits of 
attempting to carry out this ring contraction strategy (eq 2).  
Figure 1: Comparison of first- and second-generation strategies toward the left-hand macrocycle
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 In regards to precedence, ring contraction is a classical strategy for the creation of 
strained cyclic systems and thus we were encouraged by the many previous applications 
of this idea to the synthesis of large, strained rings.1 In fact, this concept is still a 
mainstay in contemporary approaches to macrocyclic targets (Figure 2). 
H
Figure 2: Selected recent examples of ring contraction approaches in natural product synthesis
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  In regards to practicality, the application of this strategy to diazonamide A was 
seemingly straightforward. Ketoamide 3 would first be synthesized from an appropriate 
acyclic precursor wherein the A-ring oxazole has yet to be cyclized (Figure 1). We 
postulated that this 13-membered ring would be considerably more flexible and exhibit 
                                                
1 For three recent examples of ring contraction in the synthesis of strained ring systems, see: (a) Rosa, C. 
P.; Kienzler, M. A.; Olson, B. S.; Liang, G.; Trauner, D. Tetrahedron 2007, 63, 6529–6534. (b) Baran, P. 
S.; Shenvi, R. A. J. Am. Chem. Soc. 2006, 128, 14028–14029. (c) Harrowven, D. C.; Woodcock, T.; 
Howes, P. D. Angew. Chem. Int. Ed. 2005, 44, 3899–3901. 
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substantially less ring strain than its ring-contracted analog in the natural product, and 
consequently be more favorable to form. DFT calculations validated this reasoning, 
showing that a simplified ketoamide is 47.4 kcal/mol less strained than its dehydrated 
oxazole form (Table 1).2 Once installed, 3 will be cyclodehydrated to yield the A-ring 
CO2H
N
O
NH
HN
O
Me Me
H
N
O
HO
Me Me
O
NH
O
NH
HN
O
Me Me
H
N
O
HO
Me Me
O
CO2HO
Table 1: Ring contraction thermochemistry
!E° = +47.4 kcal
–H2O
–1973.637342
–1897.607806
–75.97396515
Entry
Ketoamide
Oxazole
Water
E (hartree)
!E°
!E° (kcal) +47.42
0.07557138
oxazole and the left-hand macrocycle of 4 in a single operation.  We were hopeful that 
the generation of aromaticity in this process would mitigate the energetic penalties 
associated with the concomitant increase in ring strain (Figure 1).3  
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2 Calculations carried out using the B3LYP functional at the 3-21G level of theory in Gaussian 03. Energy 
value for the oxazole form takes into account the loss of water. See supporting information for details. 
3 For a recent example of using the generation of aromaticity to form a highly strained macrocyclic ring, 
see: Wipf, P.; Furegati, M. Org. Lett. 2006, 8, 1901–1904. 
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 We envisioned that ketone 3 could be synthesized in analogy to our previous 
work, by oxidation of its corresponding alcohol 9 (eq 4). This alcohol could then 
theoretically be obtained from an intramolecular aldol annulation similar to the 
intermolecular variant realized in our first generation synthesis (eq 3,4).  
 While this aldol disconnection was very straightforward from a tactical and 
retrosynthetic point of view, it was much less obvious whether it would be a synthetically 
viable approach. Specifically, upon searching the relevant literature, we found that 
intramolecular aldolizations to form large rings are inauspiciously rare. The two most 
relevant examples in complex target synthesis were both reported by the Danishefsky 
group; first in the closure of a 30-membered ring in the synthesis of rapamycin (eq 5) and  
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then in the annulation of a 16-membered ring in the synthesis of epothilones A and B (eq 
6).4,5 
 As the aldol reaction is amongst the most reliable and heavily utilized 
carbon-carbon bond constructions in all of synthetic chemistry, we were initially 
surprised to find that its application to macrocyclization was so infrequent. Yet, in order 
to be successful, the intramolecular variants have strict mechanistic requirements that can 
often be difficult to fulfill. Specifically, these transformations require selective 
enolization of the pro-nucleophilic carbonyl in the presence of the electrophilic aldehyde 
carbonyl. Due to the disparity in pKa values between aldehydes and most other carbonyl 
derivatives, this becomes possible only if the nucleophile is pre-activated, as in 
Reformatsky-type processes, or in cases where the aldehyde is nonenolizable. Also, as 
other reasonably acidic sites on the substrate can interfere with productive and selective 
enolate formation, heteroatom-protecting groups are often required to ensure high 
reaction efficiency. Moreover, intermolecular aldol reactions are often kinetically 
competitive, requiring the use of high dilution conditions. 
 Fortunately, the aldehyde electrophile in intermediate 8 (eq 4) is neopentyl and 
nonenolizable, suggesting that its use in intramolecular aldolization may at least be 
possible. However, the desired thioester functionality would still have to be successfully 
and selectively soft-enolized in the presence of the multitude of other strongly Lewis 
basic sites in the substrate. Yet, we deemed that this approach was a sufficiently 
                                                
4 Hayward, C. M.; Yohannes, D.; Danishefsky, S. J. J. Am. Chem. Soc. 1993, 115, 9345–9346. 
5 Meng, D.; Bertinato, P.; Balog, A.; Su, D.; Kamenecka, T.; Sorensen, E. J.; Danishefsky, S. J. J. Am. 
Chem. Soc. 1997, 119, 10073–10074. 
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compelling and original solution to this particular synthetic challenge, and we elected to 
pursue it in earnest. 
     
II. Second-Generation Synthesis 
 In the forward sense, our new approach begins with the hydrolysis of methyl ester 
10, the synthesis of which was described in Chapter 4 (Scheme 1). The product 
carboxylic acid 11 was then appended to valine-glycine thioester 12 under the action of 
EDC and HOBT, to yield 13, the key precursor for our organocatalytic alkylation.  
Scheme 1: Synthesis of a new organocatalytic precursor
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 With 13 in hand, our attention turned to the key iminium-catalyzed alkylation of 
acrolein. We were initially apprehensive that the appendage of the valine-glycine dimer 
to the organocatalytic precursor would affect the efficiency and stereoselectivity of the 
key iminium-catalyzed asymmetric alkylation/furanoindoline formation due to the 
additional steric bulk and the presence of a new, albeit distal, stereogenic center. But we 
were gratified to observe that, upon subjection to our optimized conditions from the 
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original synthetic scheme at –50 °C for 48 hours, we obtained a 94% isolated yield of the 
desired product 15 (Figure 4). The diastereoselectivity of this reaction proved to 
somewhat variable, but the range was typical of what we had observed in our previous 
studies, falling between 3–5:1. Notably, the use of racemic imidazolidinone catalyst 14 
delivered the product as a 1:1 mixture of diastereomers, demonstrating that the 
stereoselectivity in the alkylation step was fully catalyst controlled.  
Figure 4: Alkylation/cyclization on a more complex substrate
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 Notably, during the preparation of this thesis, Joseph Carpenter, a fellow graduate 
student in the MacMillan lab, discovered that treatment of 13 with propynal and the TCA 
salt of imidazolidinone 14 in chloroform at –75 °C results in the direct construction of 
α,β-unsaturated furanoindoline 16 in good yield and with an excellent 12:1 
diastereoselectivity (Figure 5).6 This result is exceptional not only in that it provides such 
amplified levels of stereoselectivity over the acrolein alkylation, but by directly installing 
the unsaturation it also reduces the overall synthetic scheme by two linear steps. The 
factors controlling stereoinduction in iminium ions derived from propynal were expected 
to be analogous to those governing additions to acrolein.7 As such, a rationale for the 
                                                
6 Carpenter, J. E.; MacMillan, D. W. C. Unpublished results. 
7 For a stereochemical rationale for additions to acrolein, see Chapter 4. 
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enhanced stereoselectivity has not yet been formulated, but is an area of active and 
ongoing investigation in the MacMillan lab. 
Figure 5: Propynal alkylation proceeds with exceptional diastereoselectivity
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 Notably, the use of propynal allowed this alkylation reaction to be conducted at 
lower temperatures than were possible in the corresponding acrolein case discussed 
above. As such, it allowed Carpenter to methodically investigate the effect of temperature 
on diastereoselectivity over a much wider range of temperatures (Table 2). Subjecting 
this data to a standard Eyring analysis revealed a highly linear data set, implying that the 
factors the catalyst employs to enforce diastereoselectivity in the transition state are 
invariant over the entire range of temperatures investigated. This is a truly remarkable 
finding in the described circumstance given the strongly reactive electrophile employed  
Table 2: Eyring analysis of temperature effects on diastereoselectivity
–75
–50
–40
–20
Entry
1
2
3
4
Temp °C
12:1
10:1
9:1
7.7:1
dr
!!"
!!S
=  0.798 kcal/mol
=  0.92 cal/mol*K
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and the complex nature of the large, chiral indole nucleophile. This is a strong 
demonstration of the degree of control the imidazolidinone catalyst can exert in transition 
states that engage complex substrates, and we feel confident that this bodes well for 
future uses of asymmetric iminium catalysis in complex and difficult natural product 
applications.  
Prior to this discovery, however, saturated aldehyde 15 was processed through the 
same four-step sequence that had been previously developed in order to reveal the 
requisite aldehyde needed to investigate our aldolization reaction. Sequential, one-pot α-
selenylation of 15 and oxidative elimination with NaIO4 yielded α,β-unsaturated 
aldehyde 16 in 81% yield (Scheme 2). Subsequent treatment of 16 with DDQ in a 
biphasic solution of dichloromethane and pH 7 buffer oxidatively excised the indoline 
Scheme 2: Elaboration of aldehyde organocatalytic adduct
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PMB group to give 17 in 88% yield. The resulting aniline 17 was then reprotected as its 
trifluoroacetamide 18 upon treatment with TFAA and DMAP. Again, this protecting 
group switch was necessary to ensure the stability of the oxidizable aminal functionality 
towards subsequent ozonolysis, which occurred uneventfully to reveal aldehyde 18 for 
our proposed intramolecular aldol reaction. Remarkably, the thioester functionality 
remained untouched by this battery of oxidation events, undergoing no detectable 
oxidative decomposition. 
 With 8 in hand, we were now positioned to begin evaluating our proposed 
intramolecular aldolization reaction. However, preliminary attempts using the 
TiCl4-mediated conditions that had performed well in our previous route resulted only in 
recovered starting material (eq 9). Methodical modulation of all the relevant reaction 
parameters yielded no improvement. Previously in the intermolecular aldol, we had 
observed that addition of the amine base to a solution of substrate and Lewis acid 
produced a highly distinctive inky, blue-black solution that was indicative of the titanium 
enolate. Yet, no such color change was observed upon adding base to a cold solution of 
substrate 8 and TiCl4. In fact, no color change was observed from the initial canary 
yellow solution. Thus, we surmised that no meaningful concentration of enolate was 
being formed and suspected that the titanium salt was irreversibly coordinated to any the 
numerous heteroatoms in the substrate, preventing effective enolization.  
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 Pursuant to this setback, we found a particularly promising new avenue forward 
involving the use of magnesium-based aldol promoters. Evans and coworkers had shown 
that catalytic quantities of magnesium salts were capable of both effecting the soft 
enolization of N-acyloxazolidinones and N-acylthiazolidinethiones and mediating 
subsequent aldol reactions with high levels of efficiency (Figure 6).8,9 
Figure 6: Magnesium-mediated soft enolization aldol sequences
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  Notably, these reactions illustrated two advantageous characteristics that we 
hoped to adapt to our present purpose (Figure 7). First, by virtue of being catalytic these 
examples illustrated that magnesium salts do not form irreversible coordination 
complexes with the stoichiometric amine base. Thus, we were optimistic that the many 
Lewis basic sites present in our substrate would not irreversibly bind the magnesium 
salts. Secondly, while the enolization event itself was both incomplete and reversible in 
these reactions, Evans showed that these aldol reactions still proceeded to full conversion. 
This implies that, so long as the substrate is stable to the reaction conditions, the reaction 
can proceed without its efficiency being predicated on achieving full and complete 
enolate formation. Rather, the electrophile intercepts an equilibrium content of enolate 
until it is fully consumed.  
                                                
8 For Mg-catalyzed aldol reactions with N-acyloxazolidinones, see: Evans, D. A.; Tedrow, J. S.; Shaw, J. 
T.; Downey, C. W. J. Am. Chem. Soc. 2002, 124, 392–392. 
9 For Mg-catalyzed aldol reactions with N-acylthiazolidinethiones, see: Evans, D. A.; Downey, C. W.; 
Shaw, J. T.; Tedrow, J. S. Org. Lett. 2002, 4, 1127–1130. 
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Figure 7: Advantageous equilibria in magnesium-mediated soft enolization
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 However, the use of magnesium also has a notable drawback. Namely, 
magnesium-mediated aldol reactions are often reversible. This could be especially 
problematic in the context of a macrocyclization, as any equilibrium that might be 
established would likely favor the open chain form of the starting material. However, 
Evans has also shown that this issue can be largely avoided by the addition of silyl 
chlorides to the reaction mixture. Silylation of the aldolate renders these reactions 
irreversible, and has the added benefit of assisting in turning over the metal salt, 
effectively increasing its concentration in solution to promote further enolization events.5  
 In light of these arguments, we were ecstatic to find that subjection of substrate 8 
to MgBr•Et2O and triethylamine in EtOAc at room temperature yielded 24% of the 
desired macroaldolization product 9 as a single diastereomer (Table 3, entry 1). This 
yield could be more than doubled to 51% upon addition of TMSCl to the reaction mixture 
(Table 3, entry 2). A small survey of solvents commonly used in soft enolization 
processes revealed THF to be optimal in terms of both rate and efficiency, giving a 67% 
yield of the desired product in under one hour at room temperature. Additionally, we 
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Table 3: Optimization of magneisum-mediated intramoelcular aldol macrocyclization
MgBr2•Et2O
MgBr2•Et2O
MgBr2•Et2O
MgBr2•Et2O
MgBr2•Et2O
MgI2
Mg(ClO4)2
Mg(OTf)2
Entry
1
2
3
4
5
6
7
8
Yield %
24
51
0
67
trace
54
57
0
EtOAc
EtOAc
DCM
THF
THF
THF
THF
THF
SolventLewis acid
3
10
3
3
0.3
3
3
3
Equivalents
--
TMSCl
TMSCl
TMSCl
TMSCl
TMSCl
TMSCl
TMSCl
Additive
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evaluated a variety of common magnesium(II) salts, and while several were comparable, 
MgBr•Et2O still proved optimal (Table 3, entries 6–8). The TMS-protected aldolate could 
be deprotected in the workup by quenching the reactions with a 1.0M HCl solution, 
providing direct access to the desired β-hydroxy thioester product. 
 There are several phenomenological aspects of this reaction that deserve further 
comment. When these reactions are carried out in THF, a white precipitate forms upon 
addition of the triethylamine base. We hypothesize that this precipitate is NEt3•HBr, 
which is known to have limited solubility in THF. By removing these ammonium ions 
from solution, the equilibrium concentration of enolate should be increased, aiding the 
kinetics of the carbon-carbon bond-forming event. We felt this hypothesis was further 
bolstered by the fact that identical reactions carried out in EtOAc remained completely 
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homogenous throughout, but took nearly 24 hours to go to completion. Similarly, using 
Mg(ClO4)2 in THF gave a homogenous reaction mixture and proceeded with similar 
efficiency, but took nearly 12 hours to go to completion (Table 3, entry 7). 
 Secondly, it is notable that these reactions are operationally much less complex to 
carry out than typical Lewis acid-mediated aldol reactions. Specifically, they can be 
carried out at room temperature in solvents that have not been rigorously dried and 
without the use of an inert gas atmosphere, all without substantial detriment to reaction 
efficiency. This, coupled with the fact that MgBr2•Et2O is an easily handled solid, makes 
these reactions both trivial and forgiving from a technical standpoint. The only reaction 
parameter that substantially affected outcomes was the quality of the MgBr2•Et2O. The 
best results were obtained when this reagent had been freshly prepared. 
 Thirdly, and most notably, in all cases examined the aldol product was 
exclusively formed as a single diastereomer. However, the starting material aldehyde was 
typically a 3.5:1 mixture of diastereomers, as the C(10) diastereomers arising from the 
key organocatalytic alkylation event were completely inseparable throughout the entire 
sequence from 15 to 8. Given that yields of the aldol product were observed to approach 
70% and that that the starting material in these reactions is always fully consumed, we 
postulated that the diastereomers of the starting material may be undergoing a parallel 
resolution. The major diastereomer was being converted with high efficiency to the 
desired product 9, while the minor diastereomer was being consumed by a different 
reaction pathway to yield a distinct, and as of yet unidentified, byproduct. Hindered by 
our lack of access to each of the starting material diastereomers in pure form, this 
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possibility remains to be rigorously established, but it remains an active question that will 
be pursued in detail during future investigations. 
 Assigning the stereochemistry of the aldol product was inconsequential to the 
ultimate progress of the project, as the stereocenters in questions would be destroyed in 
an oxidation step immediately following. Yet, in the hopes of better understanding this 
new aldol process and the possible reasons for the aforementioned resolution of starting 
material diastereomers, we were eager to evaluate the possible transition state factors that 
made this reaction so highly diastereoselective.  Yet our initial efforts to determine the 
stereochemistry of 9 were hindered by our inability to convert this hindered alcohol to a 
corresponding pair of diastereomeric Mosher esters. Standard acylation conditions only 
returned starting material, while more forcing conditions resulted in decomposition 
believed to result from β-elimination of the hydroxy group.  
 In light of these failures, we attempted a stereochemical assignment based on 
NOESY analysis. Selected results of these experiments are presented below in Figure 8. 
Both the alcohol- and amine-bearing methines (protons A and B of DFT-9 in Figure 8) 
exhibit cross peaks with the C(11) methine (proton C of DFT-9 in Figure 8) in the 2-D 
NOESY spectrum. Moreover, the vicinal J coupling between the aldehyde and amine 
methines (A and B) is only 0.5 Hz, indicative of a nearly perpendicular orientation of 
these C-H bonds. In light of this data and the conformational constraints inherent to the 
macrocycle, we tentatively propose that the stereochemistry of these two centers is as 
shown in Figure 8.10  
                                                
10 The protecting groups of DFT-9 were omitted for visual clarity and to lessen computational time.  
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 Subsequent theoretical investigations support this view. Minimizing all four 
possible diastereomers of structure 9 using DFT methods provided only one structure that 
displayed a dihedral angle between A and B commensurate with the coupling constant as 
well as the proper proton proximities that could reasonably give rise to the observed NOE 
signals (DFT-9).11 
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 Lastly, the mildness of these reaction conditions and their success in this difficult 
context bodes well for the implementation of this discovery in other similar 
circumstances. We are hopeful that this reaction will serve as further proof that such 
aldolizations can be effective in the formation of large ring systems.  
  Following this, aldol product 9 was oxidized to its corresponding ketone under the 
action of Dess-Martin periodinane in good yield, providing the key intermediate 3 upon 
which our entire strategy hinged (Figure 9). It was entirely unclear whether our 
                                                
11 See supporting information for images of the 3-D structures, and relevant dihedral angles, of the other 
three DFT-minimized diastereomers. 
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DAST-mediated oxazole-forming conditions had any chance of success when coupled to 
an energetically less favorable ring contraction. However, we were extremely gratified to 
find that, upon subjection to our standard conditions of DAST in benzene at room 
temperature, we obtained the desired ring-contracted oxazole and the intact left-hand 
macrocycle of 4 in 81% yield. Notably, this process is markedly more efficient than the 
acyclic case described in Chapter 4. 
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Figure 9: Oxidation and cyclodehydration yield left-hand macrocycle
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 These results were especially pleasing–not only in that our iminium technology, 
magnesium macroaldolization, and novel oxazole-forming reaction had performed so 
well in such difficult circumstances–but also in that analysis of our previous failures on 
mechanistic grounds led to the identification of a pleasingly novel synthetic strategy that 
was successfully reduced to practice. Moreover, the sequence described in this chapter 
thus far represents successful completion of a substantial fraction of our overarching 
project goals. We had created a highly diastereoselective organocatalytic construction of 
the C(10) stereocenter and the furanoindoline core, and had devised a highly novel and 
efficient method to generate the left-hand macrocyclic domain. Moreover, this series of 
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reactions represents by far the most stereoselective access to the C(10) stereocenter, 
furanoindoline core and left-hand macrocycle that have yet been reported in the 
diazonamide literature. Now, all that remained was to affect ring closure of the right-hand 
macrocycle and install the aryl chlorides for our total synthesis to be completed.  
 We were optimistic that this would be accomplished in a straightforward 
manner given our prior success in closing the right-hand macrocycle using a Witkop-type 
arylation.12 So, we next set out to synthesize the requisite photocyclization precursor 24 
PPh3, C2Cl6
NEt3, CH2Cl2
(95%)
Scheme 3: Synthesis of Witkop precursor
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12 For details of our previous efforts using photocyclizations to close this ring, see Chapter 4. 
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(Scheme 3). Thioester 4 was first hydrolyzed to its corresponding carboxylic acid 19 with 
aqueous lithium hydroxide. Notably, Carpenter was able to grow X-ray quality crystals of 
acid 19, proving that our series of intermediates had the correct connectivity and relative 
stereochemistry for the natural product (Figure 10).  
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Figure 10: X-ray structure proves connectivity and relative stereochemistry
 
Acid 19 was then coupled to 3’-oxotryptamine 20 using standard peptide coupling 
protocols, giving amide 21 in an unoptimized 61% yield. This amidoketone 21 was then 
cyclodehydrated according to the procedure of Wipf to yield the B-ring oxazole of 22 in 
95% yield.13 Notably the success of this reaction was dependent on forming the 
phosphonium reagent at room temperature and then adding it portionwise to a solution of 
the substrate. Hydrogenolysis of the benzyl ether with Pearlman’s catalyst yields phenol 
23 in 88% yield. Finally, phenol 23 was treated with NPhTf2 and Hunig’s base in CH2Cl2 
to yield the key aryl triflate 24, with which we would investigate the photo-mediated 
annulation.  
At this point we were very optimistic about our prospects for success. We had 
demonstrated that such reactions were feasible with triflate leaving groups in our first 
generation synthesis (Figure 11). Moreover, Nicolaou had carried out this type of 
                                                
13 Wipf, P.; Miller, C. P. J. Org. Chem. 1993, 58, 3604–3606. 
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cyclization on a structurally similar aryl bromide in his first-generation synthesis of 
diazonamide A. 
Figure 11: Photocyclizations of the right-hand macrocycle
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But these hopes were dashed when we exposed 24 to photolysis and did not 
observe any detectable cyclization (Figure 12). Evaluating a range of wavelengths and 
solvents yielded no improvement. Rather, all that we observed was hydrolysis of the aryl 
triflate to its corresponding free phenol 23. It became apparent that having the left-hand 
macrocycle in place slowed the productive cyclization pathway sufficiently such that this 
competing hydrolysis pathway was able to exclusively consume the starting material. 
This was somewhat surprising, as closing the left-hand ring makes the structure very  
 111 
Witkop cyclization is no longer a viable method for biaryl construction
Figure 12: Major product is the phenol resulting from triflate hydrolysis
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rigid, permanently affixing the electron-rich indole donor in very close proximity to the 
triflate acceptor. Yet, it seemed unlikely that this situation would be easily remedied 
using this photo-annulation technology.  
Needless to say, this was a tremendous setback, as we had again come 
tantalizingly close to completing the synthesis, only to witness another dramatic late-
stage failure. Yet, it also compelled us to recognize that by repeating this cyclization that 
had been used by both Nicolaou and Harran, we were passing on a chance to contribute a 
novel solution to the synthesis of this daunting substructure. As such we resolved to 
pursue an entirely novel approach to synthesizing this challenging substructure. Our 
efforts toward this end are described in detail in the following chapter. 
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Chapter 4 Supporting Information 
 
 
General Information: Commercial reagents were purified prior to use following the 
guidelines of Perrin and Armarego.14 All solvents were purified according to the method 
of Grubbs.15 Nonaqueous reagents were transferred under argon via syringe or cannula. 
Organic solutions were concentrated under reduced pressure on a Büchi rotary evaporator 
using a heated water bath. Chromatographic purification of products was accomplished 
using forced-flow chromatography on Silicycle 230–400 mesh silica gel 60 according to 
the method of Still.16 Thin-layer chromatography (TLC) was performed on Silicycle 0.25 
mm silica gel 60-F plates. Visualization of the developed chromatogram was performed 
by fluorescence quenching or by CAM stain. 
 1H and 13C NMR spectra were recorded on a Varian Mercury 300 (300 MHz and 
75 MHz) as noted, and are internally referenced to residual solvent signals. Data for 1H 
NMR are reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant (Hz) and 
assignment. Data for 13C NMR are reported in terms of chemical shift. IR spectra were 
recorded on a Perkin Elmer 1000 spectrometer and are reported in terms of frequency of 
absorption (cm-1). Mass spectra were obtained from the Caltech Mass Spectral Facility. 
                                                
14 Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; 3rd ed., Pergamon Press, Oxford, 
1988. 
15 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J.  Organometallics 1996, 15, 
1518. 
16 Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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Optical rotations were measured on a Jasco P-1010 polarimeter, and [α]D values are 
reported in 10-1 dg cm2 g-1.17 
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Acid 11: To a solution of 10 (9.50 g, 11.98 mmol) in THF/MeOH/H2O (130 mL, 10:2:1) 
was added LiOH•H2O (2.01 g, 47.9 mmol) with stirring. After the reaction was judged 
complete by TLC analysis (4 h), the reaction mixture was diluted with 300 mL of diethyl 
ether, acidified with 1N HCl to pH 2, and washed with 100 mL of brine. The organic 
portion was dried over sodium sulfate and concentrated in vacuo. These crude extracts 
were purified by column chromatography (40% EtOAc/Hexanes with 1% AcOH) to yield 
the title compound (8.96 g, 96%) as a white amorphous solid. IR (Film): 3402, 2944, 
2867, 1723, 1641, 1613, 1572, 1513, 1454, 1385, 1248, 1209, 1176, 1063, 909, 882, 821, 
732 cm-1; 1H NMR: (300 MHz, CDCl3) δ 7.35–6.73 (m, 17H, ArH and NH); 5.57 (s, 2H, 
OCH2Ph), 5.13 (s, 2H, OCH2-pMeOPh), 4.89 (dd, 1H, J = 7.2, 12.9 Hz, CHCO2H), 4.16 
(d, 1H, J = 3.3 Hz, CHOTIPS); 3.76 (s, 3H, ArOMe); 3.17 (dd, 1H, J = 5.4, 14.7 Hz, 
CH2Ar); 3.05 (dd, 1H, J = 7.2, 14.4 Hz, CH2Ar); 1.92 (m, 1H, CHMe2); 1.04–0.98 (m, 
21H, TIPS); 0.83 (d, 3H, J = 6.9 Hz, CH(Me)Me); 0.74 (d, 3H, J = 6.9 Hz, CH(Me)Me); 
13C NMR: (75 MHz, CDCl3) δ 175.8, 173.5, 158.8, 152.6, 146.9, 136.7, 131.3, 131.1, 
                                                
17 Certain data herein was reproduced from the Caltech thesis of Ian K. Mangion, (2006) with whom this work 
was jointly carried out. 
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129.2, 129.1, 128.6, 128.2, 128.0, 127.8, 127.2, 126.5, 121.3, 120.9, 115.6, 113.9, 112.7, 
110.9, 104.5, 78.0, 70.4, 55.2, 52.6, 52.1, 37.0, 33.9, 18.0, 17.9, 17.6, 17.2, 12.3; HRMS 
(FAB+) exact mass calculated for [M+•] (C46H58N2O7Si) requires m/z 778.4013, found 
m/z 778.4034 
! 
["]
D
25  = –28.48 (c = 0.53, CHCl3) 
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Thioester 12: To a solution of 300 mL of 60:7:2:1 CH2Cl2/TFA/Me2S/H2O under argon 
was added 12a (7.0 g, 22 mmol).  After 12 hours the solution was concentrated. The 
resulting oil was purified by column chromatography (10% MeOH/CH2Cl2) to yield the 
title compound as a white crystalline solid in 90% yield (6.24 g). IR(Thin Film): 2972, 
2941, 1668, 1471, 1202, 1181, 1137, 971, 838, 799, 722 cm-1; 1H NMR: (300 MHz, 
CD3OD) δ 4.28 (d, 1H, J = 17.4 Hz, NHCH2), 4.06 (d, 1H, J = 17.4 Hz, NHCH2), 3.77 
(d, 1H, J = 5.7 Hz, CHNH2), 2.91 (q, 2H, J = 7.5 Hz, SCH2), 2.25 (m, 1H, CHMe(Me)), 
1.23 (t, 3H, J = 7.5 Hz, SCH2CH3), 1.10 (d, 3H, J = 6.9 Hz,  CHMe(Me)), 1.07 (d, 3H, J 
= 6.9 Hz,  CHMe(Me)); 13C NMR: (75 MHz, CD3OD) δ 196.8, 169.0, 156.2, 58.5, 30.3, 
22.7, 17.7, 16.6, 13.9; HRMS: (FAB+) exact mass calculated for [M+H] (C9H19N2O2S) 
requires m/z 219.1167, found m/z 219.1171; 
! 
["]
D
25  = –0.95 (c = 1.0 MeOH) 
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Thioester 13: To a solution of 11 (8.96 g, 11.5 mmol) and 12 (4.71 g, 15.0 mmol) in 
DMF (120 mL) was added HOBt (2.02 g, 15.0 mmol), EDC•HCl (2.87 g, 15.0 mmol), 
and NaHCO3 (3.86 g, 46.0 mmol) with stirring. After the reaction was judged complete 
by TLC analysis (7 hours), the reaction mixture was diluted with 500 mL of diethyl ether 
and washed with 200 mL of saturated NH4Cl, H2O, and brine. The organic portion was 
dried over sodium sulfate and concentrated in vacuo. These crude extracts were purified 
by column chromatography (40% EtOAc/hexanes) to yield the title compound (10.7 g, 
95% yield) as a white amorphous solid. IR (Film): 3288, 2962, 2943, 2868, 1642, 1612, 
1513, 1455, 1385, 1262, 1248, 1209, 1176, 1064, 909, 882, 823, 732 cm-1; 1H NMR: (300 
MHz, CDCl3) δ 7.35–6.49 (m, 19H, ArH and NH); 5.57 (s, 2H, OCH2Ph); 5.15 (s, 2H, 
OCH2-pMeOPh); 4.62 (dd, 1H, J = 7.2, 12.9 Hz, CH2CHCONH); 4.30 (dd, 1H, J = 5.6, 
8.6 Hz, NHCHCHMe2); 4.16 (d, 1H, J = 3.0 Hz, CHOTIPS); 3.98 (t, 2H, J = 4.8 Hz, 
NHCH2); 3.76 (s, 3H, ArOMe); 3.08 (m, 2H, CH2Ar); 2.82 (q, 2H, J = 7.5 Hz, SCH2); 
2.21 (m, 1H, NHCHCHMe2); 1.92 (m, 1H, OCHCHMe2); 1.19 (t, 3H, J = 7.5 Hz, 
SCH2CH3); 1.04–0.98 (m, 21H, TIPS); 0.89–0.83 (m, 9H, OCHCH(Me)Me, 
NHCHCH(Me)Me); 0.74 (d, 3H, J = 6.9 Hz, OCHCH(Me)Me); 13C NMR: (300 MHz, 
CDCl3) δ 196.9, 173.8, 171.0, 170.9, 158.8, 152.5, 146.9, 136.7, 131.2, 131.0, 128.9, 
128.6, 128.3, 128.1, 127.8, 127.7, 126.5, 121.7, 120.9, 115.7, 113.9, 112.7, 110.8, 104.6, 
78.0, 70.4, 58.5, 55.2, 54.8, 52.2, 48.9, 37.2, 34.0, 29.8, 23.0, 19.4, 18.0, 17.5, 17.0, 14.5, 
  116 
12.4; HRMS (FAB+) exact mass calculated for [M+•] (C55H74N4O8SiS) requires m/z 
978.4996, found m/z 978.4966; 
! 
["]
D
25  = –17.13 (c = 2.18, CHCl3). 
 
 
N
N
H
Me O
•TFA
Me
Me
Me
Ph
O
CH2Cl2, MeOH
 –50 °C
H
N
N
HN
O
Me Me
H
N
O
TIPSO
Me Me
O
OBn
O
SEt
O
O
OBn
N
HN
O
H
N
O
TIPSO
Me Me
OH
Me Me
H
N
O
SEt
O
PMB
PMB
14
13 15
 
Aldehyde 15: (2R,5R)-2-tert-butyl-5-benzyl-3-methylimidazolidin-4-one•TFA 14 (1.03 
g, 2.86 mmol) and phenol 13 (8.0 g, 8.17 mmol) are dissolved in 40 mL of 
dichloromethane and 2 mL of MeOH. This mixture is cooled to –50 °C. To this cold 
solution is added freshly distilled acrolein (5.51 mL, 81.7 mmol). The reaction is left for 
48 hours at –50 °C before being diluted with 50 mL of pH 7 buffer. The layers were 
separated and the organic portions were washed with brine and dried over sodium sulfate. 
Following concentration in vacuo, the crude reaction extracts were purified by flash 
chromatography (80% Et2O in pentane) to afford the title compound as an amorphous 
white solid (7.9 g, 93%).  IR (Film): 3408, 3300, 2962, 2942, 2868, 1720, 1648, 1512, 
1495, 1466, 1386, 1247, 1175, 1100, 1065, 915, 882, 822, 733, 683 cm-1; 1H NMR: (300 
MHz, CDCl3) δ 9.45 (s, 1H, CHO); 7.36–6.44 (m, 15H, Ar-H); 5.80 (s, 1H, OCHN); 
5.33 (d, 1H, J = 15.6 Hz, NCH2-pMeOPh); 5.01 (m, 2H, OCH2Ph); 4.60 (m, 2H, 
CHNHCO); 4.47 (d, 1H, J = 15.6 Hz, NCH2-pMeOPh); 4.26–3.94 (m, 3H, CHOTIPS, 
NHCH2); 3.78 (s, 3H, ArOMe); 3.11–2.80 (m, 4H, CH2Ar, SCH2); 2.29–1.84 (m, 6H, 
NHCHCHMe2, OCHCHMe2, CH2CH2CHO); 1.21 (t, 3H, J = 7.5 Hz, SCH2CH3); 1.09–
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0.68 (m, 33H, TIPS, OCHCH(Me)Me, NHCHCH(Me)Me); 13C NMR: (300 MHz, 
CDCl3) δ 201.0, 196.6, 173.9, 173.6, 170.9, 170.8, 170.7, 158.8, 157.8, 152.5, 146.9, 
137.0, 136.7, 133.3, 132.5, 130.1, 130.8, 129.4, 129.3, 129.0, 128.8, 128.6, 128.5, 128.1, 
128.0, 127.9, 127.5, 126.5, 123.6, 121.0, 120.4, 115.6, 114.0, 113.4, 110.7, 109.9, 105.8, 
104.6, 78.0, 70.9, 58.5, 57.8, 55.3, 54.8, 50.4, 49.0, 39.0, 33.9, 29.9, 29.3, 23.1, 19.2, 
18.1, 18.0, 17.6, 17.0, 14.6, 12.4; HRMS (FAB+) exact mass calculated for [M+H] 
(C58H78N4O9SiS) requires m/z 1034.526, found m/z 1034.528; 
! 
["]
D
25  = –35.94 (c = 1.0, 
CHCl3). 
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Aldehyde 16: To a solution of aldehyde 15 (5.73 g, 5.53 mmol) in 70 mL of THF at 
room temperature was added PhSeNEt2 (1.47 mL, 7.65 mmol). After stirring for one hour 
the reaction was judged complete by TLC. The reaction mixture was concentrated in 
vacuo and the crude extracts were purified by flash chromatography (33% EtOAc in 
hexanes). The product was thus obtained as a yellow oil in a 3:3:1:1 mixture of 
diastereomers as judged by 1H-NMR. This product was then taken up in 42 mL of THF, 
21 mL of methanol, and 21 mL of water. To this solution was added sodium periodate 
(2.06 g, 9.62 mmol) in a single portion. After 12 hours the reaction mixture was 
concentrated in vacuo to remove the methanol and THF, diluted with ethyl acetate, and 
washed with water. After separation of the layers the organic portions were washed with 
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brine and dried over sodium sulfate. Concentration of the resulting solution gave a yellow 
oil which could be purified by column chromatography (33% EtOAc in hexanes) to give 
the title compound as an amorphous off-white solid (4.81 g, 84%). IR (Film): 3409, 3300, 
2962, 2942, 2868, 1692, 1648, 1512, 1494, 1466, 1385, 1248, 1175, 1100, 1064, 973, 
911, 882, 822, 733, 683 cm-1; 1H NMR: (300 MHz, CDCl3) δ 9.45 (d, 1H, J = 7.5 Hz, 
CHO); 7.33–6.72 (m, 16H, Ar-H, CH=CHCHO); 6.46 (d, 1H, J = 8.1 Hz, CONH); 5.93 
(s, 1H, OCHN); 5.88 (dd, 1H, J = 15.9, 7.8 Hz, CH=CHCHO); 5.22 (d, 1H, J = 15.3 Hz, 
NCH2-pMeOPh); 5.01 (m, 2H, OCH2Ph); 4.59–4.46 (m, 3H, CHNHCO, NCH2-
pMeOPh); 4.23 (dd, 1H, J = 8.2, 5.8 Hz, NHCH2); 4.15 (d, 1H, J = 3.3 Hz, CHOTIPS); 
4.03 (dd, 1H, J = 5.8, 1.0 Hz, NHCH2); 3.76 (s, 3H, ArOMe); 3.11–2.82 (m, 4H, CH2Ar, 
SCH2); 2.18 (m, 1H, NHCHCHMe2); 1.95 (m, 1H, OCHCHMe2); 1.22 (t, 3H, J = 7.5 Hz, 
SCH2CH3); 1.05 (m, 21H, TIPS); 0.90–0.83 (m, 9H, OCHCH(Me)Me, 
NHCHCH(Me)Me); 0.71 (d, 3H, J = 6.9 Hz, OCHCH(Me)Me); 13C NMR: (300 MHz, 
CDCl3) δ 196.8, 196.6, 193.3, 173.8, 173.4, 171.0, 170.7, 158.9, 158.1, 155.3, 152.5, 
146.9, 145.2, 137.3, 136.6, 136.5, 133.0, 131.8, 131.2, 130.3, 129.9, 129.7, 129.2, 129.0, 
128.3, 128.0, 127.8, 127.5, 126.5, 121.7, 121.3, 121.0, 116.9, 115.7, 114.0, 113.9, 113.6, 
112.7, 110.8, 110.3, 107.0, 104.6, 78.0, 70.8, 70.4, 61.6, 58.5, 55.2, 54.8, 51.1, 49.0, 37.5, 
33.9, 30.3, 23.1, 19.3, 18.1, 17.5, 17.0, 14.6; HRMS (FAB+) exact mass calculated for 
[M+H] (C58H77N4O9SiS) requires m/z 1033.518, found m/z 1033.518; 
! 
["]
D
25  = –46.19 (c = 
1.20, CHCl3). 
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Amine 17: To a vigorously stirred solution of aldehyde 16 (4.8 g, 4.64 mmol) in a 1:1 
mixture of dichloromethane and pH 7 buffer (75 mL each) at 0 °C was added freshly 
recrystallized DDQ (2.10 g, 9.29 mmol). The resulting dark heterogeneous reaction 
mixture is allowed to warm to ambient temperature over the course of two hours, after 
which time it is diluted with ethyl acetate and washed with a saturated solution of 
Na2SO3, followed by a saturated solution of NaHCO3 and brine. The layers were 
separated and the aqueous layer wash washed with three times with 50 mL of ethyl 
acetate. The combined organic layer was washed with brine and dried over sodium 
sulfate. Purification by flash chromatography on silica gel (35%–40% EtOAc in hexanes) 
gave the desired product as an amorphous off-white solid in 84% yield (3.54 g). IR 
(Film): 3301, 2962, 2942, 2868, 1691, 1648, 1498, 1466, 1387, 1206, 1058, 975, 882, 
823, 749, 683 cm-1; 1H NMR: (300 MHz, CDCl3) δ 9.61 (d, 1H, J = 7.5 Hz, CHO); 7.41–
6.67 (m, 12H, Ar-H, CH=CHCHO); 6.56 (d, 1H, J = 8.7 Hz, CONH); 6.24 (d, 1H, J = 
2.4 Hz, OCHN); 6.14 (dd, 1H, J = 15.6, 7.5 Hz, CH=CHCHO); 5.04 (s, 2H, OCH2Ph); 
4.59 (m, 1H, CONHCHCH); 4.24 (dd, 1H, J = 8.6, 5.6 Hz, NHCH2); 4.14 (m, 1H, 
CONHCHCH2); 4.03 (d, 1H, J = 5.7 Hz, CHOTIPS); 3.93 (m, 1H, NHCH2); 3.15–2.80 
(m, 4H, CH2Ar, SCH2); 2.17 (m, 1H, NHCHCHMe2); 1.92 (m, 1H, OCHCHMe2); 1.22 
(t, 3H, J = 7.5 Hz, SCH2CH3); 1.05 (m, 21H, TIPS); 0.90–0.82 (m, 9H, OCHCH(Me)Me, 
NHCHCH(Me)Me); 0.72 (d, 3H, J = 6.9 Hz, OCHCH(Me)Me); 13C NMR: (300 MHz, 
CDCl3) δ 196.6, 193.5, 173.3, 170.7, 170.4, 158.2, 155.4, 137.1, 136.6, 133.1, 130.2, 
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129.7, 129.5, 129.4, 129.3, 129.2, 128.6, 128.1, 127.6, 125.0, 121.0, 116.4, 112.3, 110.4, 
103.0, 78.0, 70.4, 63.7, 58.5, 54.6, 49.0, 37.5, 33.9, 30.3, 23.1, 19.0, 18.1, 18.0, 17.9, 
17.5, 17.0, 14.6, 12.4; HRMS (FAB+) exact mass calculated for [M+H] (C50H69N4O8SiS) 
requires m/z 913.4605, found m/z 913.4632; 
! 
["]
D
25  = –61.30 (c = 3.08, CHCl3). 
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Aldehyde 18: To a solution of amino aldehyde 17 (3.54 g, 3.87 mmol), pyridine (0.78 
mL, 9.68 mmol) and DMAP (165 mg, 1.35 mmol) in 77 mL of dichloromethane at 0 °C 
was added trifluoroacetic anhydride (0.82 mL, 5.81 mmol) dropwise by syringe under 
argon. After 30 minutes the reaction was diluted with 200 mL of ethyl acetate and 
washed with 60 mL of saturated sodium bicarbonate solution. The layers were separated 
and the organic fraction was washed with brine and dried over sodium sulfate. 
Purification by flask chromatography on silica gel (40% ethyl acetate in hexanes) gave 
the title compound product as an amorphous yellow solid in 87% yield (354 mg). IR 
(Film): 3406, 3306, 2962, 2868, 1731, 1695, 1650, 1492, 1463, 1387, 1292, 1204, 1183, 
1154, 1058, 981, 882, 823, 738, 684 cm-1; 1H NMR: (300 MHz, CDCl3) δ 9.65 (d, 1H, J 
= 7.2 Hz, CHO); 7.47–6.54 (m, 13H, Ar-H, CH=CHCHO, OCHN); 6.24 (dd, 1H, J = 
15.9, 7.2 Hz, CH=CHCHO); 5.19 (dd, 2H, J = 18.6, 6.4 Hz, OCH2Ph); 4.59 (m, 1H, 
CONHCHCH); 4.24–4.03 (m, 4H, NHCH2, CHOTIPS, CONHCHCH2); 3.12–2.86 (m, 
4H, CH2Ar, SCH2); 2.13 (m, 1H, NHCHCHMe2); 1.95 (m, 1H, OCHCHMe2); 1.23 (t, 
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3H, J = 7.5 Hz, SCH2CH3); 1.05 (m, 21H, TIPS); 0.90–0.86 (m, 9H, OCHCH(Me)Me, 
NHCHCH(Me)Me); 0.75 (d, 3H, J = 6.6 Hz, OCHCH(Me)Me); 13C NMR: (300 MHz, 
CDCl3) δ 196.2, 192.7, 173.2, 170.5, 170.1, 157.3, 151.6, 149.6, 136.3, 135.2, 131.0, 
130.8, 129.2, 128.6, 128.2, 128.0, 127.0, 124.9, 116.3, 114.4, 110.5, 100.4, 78.0, 70.8, 
63.3, 58.5, 54.4, 49.0, 37.6, 33.9, 30.6, 23.1, 18.9, 18.1, 18.0, 17.5, 17.1, 14.6, 12.4; 19F 
NMR: (75 MHz, CDCl3) δ –70.0 (s, 3F, CF3); HRMS (FAB+) exact mass calculated for 
[M+H] (C52H68N4O9F3SiS) requires m/z 1009.443, found m/z 1009.444; 
! 
["]
D
25  = –133.69 
(c = 0.37, CHCl3). 
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Aldehyde 8: A stream of ozone is passed through a solution of α,β-unsaturated aldehyde 
18 (601 mg, 0.59 mmol) in 14 mL of dichloromethane and 1.4 mL of methanol at –78 °C 
for 45 minutes. The solution was bubbled through with oxygen for ten minutes and then 
quenched by the addition of triphenylphospine (0.44 g, 1.67 mmol). After warming to 
room temperature overnight the reaction mixture was concentrated in vacuo and loaded 
directly onto a silica gel column. Elution with 35% ethyl acetate in hexanes gives 517 mg 
of title product (88%) as an amorphous white solid. IR (Film): 3301, 2963, 2868, 1729, 
1649, 1492, 1464, 1406, 1292, 1252, 1204, 1182, 1159, 985, 882, 823, 738, 684 cm-1; 1H 
NMR: (300 MHz, CDCl3) δ 10.1 (s, 1H, CHO); 7.46–6.42 (m, 12H, Ar-H, OCHN); 5.18 
(dd, 2H, J = 17.7, 12.0 Hz, OCH2Ph); 4.59 (m, 1H, CONHCHCH); 4.24–3.96 (m, 4H, 
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NHCH2, CHOTIPS, CONHCHCH2); 3.14–2.87 (m, 4H, CH2Ar, SCH2); 2.14 (m, 1H, 
NHCHCHMe2); 1.92 (m, 1H, OCHCHMe2); 1.24 (t, 3H, J = 7.5 Hz, SCH2CH3); 1.04 
(m, 21H, TIPS); 0.93–0.84 (m, 9H, OCHCH(Me)Me, NHCHCH(Me)Me); 0.69 (d, 3H, J 
= 6.6 Hz, OCHCH(Me)Me); 13C NMR: (300 MHz, CDCl3) δ 196.4, 191.7, 173.4, 170.6, 
170.4, 156.7, 149.5, 136.2, 132.1, 131.4, 130.7, 129.0, 128.5, 128.0, 127.0, 125.2, 124.0, 
115.7, 115.0, 114.0, 110.8, 100.0, 78.0, 70.8, 58.6, 54.4, 49.0, 37.5, 33.9, 30.4, 23.2, 19.2, 
18.0, 17.9, 17.8, 17.5, 17.0, 14.6, 12.3; 19F NMR: (75 MHz, CDCl3) δ –70.3 (s, 3F, CF3); 
HRMS (FAB+) exact mass calculated for [M+H] (C50H66N4O9F3SiS) requires m/z 
983.4272, found m/z 983.4238; 
! 
["]
D
25  = –93.42 (c = 0.47, CHCl3). 
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Alcohol 9: A flame-dried 1000 mL flask is charged with 8 (2.1 g, 2.14 mmol) and 
MgBr2•Et2O (1.65 g, 6.41 mmol) under Ar.  To this flask is added THF (425 mL) 
followed by Et3N (2.98 mL, 21.4 mmol) and TMSCl (0.68 mL, 5.34 mmol) with stirring.  
After 75 minutes 1N HCl (100 mL) is added and stirred for 10 minutes.  The solution was 
diluted with EtOAc and pH 7 buffer, and washed with brine. The organic fractions were 
concentrated and the resulting oil purified by column chromatography (33% ethyl acetate 
in hexanes) to afford 1.49 g of the title compound (67%) as an off-white solid.  IR (Film): 
3401, 2962, 2868, 1732, 1681, 1644, 1490, 1462, 1288, 1204, 1181, 1160, 1125, 1099, 
1057, 982, 881, 832, 752, 736, 684 cm-1; 1H NMR: (300 MHz, CDCl3) δ 7.50–6.86 (m, 
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10H, Ar-H); 6.77 (d, 1H, J = 8.4 Hz, Ar-H); 6.63 (s, 1H, OCHN); 5.36 (d, 1H, J = 10.2 
Hz, CONH); 5.16 (dd, 2H, J = 17.7, 12.3 Hz, OCH2Ph); 4.89 (d, 1H, J = 9.3 Hz, 
CHC(O)SEt); 4.48 (d, 1H, J = 6.0 Hz, CHOH); 4.36 (m, 1H, CONHCHCH); 4.18–4.10 
(m, 2H, CHOTIPS, CONHCHCH2); 3.04 (dd, 1H, J = 12.3, 4.6 Hz, CH2Ar); 2.85 (q, 2H, 
J = 7.5 Hz, SCH2CH3); 2.65 (t, 1H, J = 12.3 Hz, CH2Ar); 2.05 (m, 1H, NHCHCHMe2); 
1.92 (m, 1H, OCHCHMe2); 1.20 (t, 3H, J = 7.5 Hz, SCH2CH3); 1.06–0.94 (m, 30H, 
TIPS, OCHCH(Me)Me, NHCHCH(Me)Me); 0.84 (d, 3H, J = 6.6 Hz, OCHCH(Me)Me); 
13C NMR: (300 MHz, CDCl3) δ 199.8, 172.3, 170.4, 169.9, 158.6, 149.4, 136.7, 136.4, 
129.8, 129.7, 128.5, 128.4, 128.3, 127.9, 127.3, 127.1, 126.4, 126.2, 117.9, 114.2, 110.9, 
97.8, 77.9, 72.5, 70.8, 64.6, 58.9, 55.8, 40.2, 33.8, 30.1, 23.9, 19.3, 18.2, 18.0, 17.9, 17.8, 
17.6, 17.5, 14.2, 12.2; 19F NMR: (75 MHz, CDCl3) δ –69.7 (s, 3F, CF3); HRMS (FAB+) 
exact mass calculated for [M+H] (C50H66N4O9F3SiS) requires m/z 983.4272, found m/z 
983.4243; 
! 
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D
25  = –129.17 (c = 0.27, CHCl3). 
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Ketone 3: To a solution of 9 (46 mg, 0.047 mmol) in 1.0 mL of CH2Cl2 was added Dess-
Martin periodinane (59 mg, 0.14 mmol). After 30 minutes the solution was diluted with 
EtOAc and washed with a saturated solution of NaHCO3. The organic fractions were 
concentrated and the resulting oil purified by column chromatography to afford 37 mg of 
the title compound (80%) as an off-white solid. IR (Film): 3408, 3272, 2925, 2868, 1735, 
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1651, 1516, 1492, 1465, 1293, 1204, 1184, 1163, 1057, 967, 881, 737, 682 cm-1; 1H 
NMR: (300 MHz, CDCl3) δ 7.56–6.78 (m, 12H, Ar-H, OCHN); 5.76 (m, 2H, CONH, 
CHC(O)SEt); 5.16 (dd, 2H, J = 18.3, 12.3 Hz, OCH2Ph); 4.45 (m, 1H, CONHCHCH); 
4.18 (d, 1H, J = 3.3 Hz, CHOTIPS); 4.02 (m, 1H, CONHCHCH2); 2.95–2.75 (m, 4H, 
CH2Ar, SCH2CH3); 2.05 (m, 1H, NHCHCHMe2); 1.92 (m, 1H, OCHCHMe2); 1.20 (t, 
3H, J = 7.5 Hz, SCH2CH3); 1.06 (m, 24H, TIPS, NHCHCH(Me)Me); 1.01–0.95 (m, 6H, 
OCHCH(Me)Me, NHCHCH(Me)Me); 0.88 (d, 3H, J = 6.3 Hz, OCHCH(Me)Me); 13C 
NMR: (300 MHz, CDCl3) δ 196.3, 195.9, 172.4, 170.9, 169.8, 158.6, 149.0, 136.4, 132.2, 
131.2, 130.3, 128.5, 128.4, 128.3, 128.2, 127.9, 127.0, 125.0, 124.2, 118.0, 114.5, 111.4, 
96.7, 78.0, 73.7, 70.8, 61.8, 59.2, 55.2, 39.2, 33.8, 29.9, 23.8, 19.1, 18.4, 18.1, 18.0, 17.7, 
17.5, 14.1, 12.4; 19F NMR: (75 MHz, CDCl3) δ –70.0 (s, 3F, CF3); HRMS (FAB+) exact 
mass calculated for [M+H] (C50H64N4O9F3SiS) requires m/z 981.4115, found m/z 
981.4107; 
! 
["]
D
25  = –179.9 (c = 0.30, CHCl3). 
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Oxazole 4: To a solution of 3 (125 mg, 0.127 mmol) in benzene (11 mL) was added 
DAST (1.1 mL) dropwise by syringe. The solution was stirred at room temperature for 3 
hours before being diluted with EtOAc and a saturated solution of NaHCO3. The layers 
were separated and the aqueous layer was washed with ethyl acetate 3 x 50 mL. The 
combined organics were washed with brine and concentrated. The resulting oil was 
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purified on silica gel (20% EtOAc in hexanes) to yield the title compound (99 mg, 81%) 
as a pale yellow solid. IR (film): 3405, 3286, 2926, 2868, 1739, 1656, 1494, 1463, 1291, 
1251, 1201, 1157, 990, 879 cm-1; 1H NMR: (300 MHz, CDCl3): δ 7.63 (d, 1H, J = 1.5 
Hz, Ar-H), 7.40–7.26 (m, 5H, Ar-H), 7.18–7.08 (m, 2H, Ar-H), 6.99–6.93 (m, 2H, Ar-
H), 6.84 (s, 1H, OCHN), 6.78 (d, 1H, J = 8.4 Hz, Ar-H), 5.26–5.11 (m, 3H, OCH2Ph, 
CONHCHCH), 4.71 (m, 1H, CONHCHCH2), 3.96 (d, 1H, J = 3.0 Hz, CHOTIPS), 3.42 
(t, 1H, J = 12.3 Hz, CH2Ar), 2.99–2.75 (m, 2H, SCH2CH3), 2.64 (dd, 1H, J = 12.3, 3.3 
Hz, CH2Ar), 2.43 (m, 1H, NHCHCH(CH3)2), 1.72 (m, 1H, OCHCH(CH3)2),  1.18 (t, 3H, 
J = 7.5 Hz, SCH2CH3), 1.07 (m, 24H, TIPS and NHCHCH(CH3)2), 0.91–0.87 (m, 6H, 
NHCHCH(CH3)2, OCHCH(Me)Me), 0.63 (d, 3H, J = 7.2 Hz, OCHCH(Me)Me); 13C 
NMR: (75 MHz, CDCl3) δ 186.2, 172.4, 171.7, 160.8, 156.8, 150.2, 149.7, 136.8, 136.2, 
134.0, 130.4, 130.2, 129.4, 129.2, 128.8, 128.7, 128.6, 128.1, 127.6, 127.4, 115.0, 114.6, 
110.7, 100.3, 77.9, 71.0, 60.9, 55.3, 53.5, 39.0, 34.0, 28.9, 23.0, 19.8, 18.3, 18.2, 18.0, 
17.5, 17.0, 14.4, 12.6; HRMS: (FAB+) exact mass calculated for [M+H] (C50H62 
F3N4O8SiS) requires m/z 963.4010, found m/z 963.3998; 
! 
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25  = –61.01 (c = 0.55, 
CHCl3).   
 
THF, MeOH, H2O
20
CO2H
N
O
NH
HN
O
Me Me
H
N
O
TIPSO
Me Me
O
OBn
4
C(O)SEt
N
O
NTFA
HN
O
Me Me
H
N
O
TIPSO
Me Me
O
OBn
LiOH
 
Acid 20: To a solution of 4 (84 mg, 0.087 mmol) in THF/MeOH/H2O (4.4 mL, 10:2:1) 
was added LiOH•H2O (36.5 mg, 0.87 mmol) with stirring. After the reaction was judged 
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complete by TLC analysis (2 hours), the reaction mixture was diluted with 50 mL of 
diethyl ether, acidified with 1N HCl to pH 2, and washed with 20 mL of brine. The 
organic portion was dried over sodium sulfate and concentrated in vacuo. These crude 
extracts were purified by column chromatography (50% EtOAc/Hexanes to 10% MeOH 
in CH2Cl2) to yield the title compound (71 mg, 99%) as a white amorphous solid. IR 
(Film): 3405, 2917, 2849, 1654, 1498, 1464, 1289, 1251, 1209, 1068, 882, 754, 684 cm-1; 
1H NMR: (300 MHz, CD3OD): δ 7.54–7.26 (m, 6H, Ar-H), 7.18 (dd, 1H, J = 8.2, 1.6 Hz, 
Ar-H), 6.94 (s, 1H, OCHN), 6.87–6.65 (m, 4H, Ar-H), 5.08 (s, 2H, OCH2Ph), 4.93 (m, 
1H, CONHCHCH), 4.53 (m, 1H, CONHCHCH2), 4.16 (d, 1H, J = 3.9 Hz, CHOTIPS), 
3.15 (t, 1H, J = 12.3 Hz, CH2Ar), 2.85 (dd, 1H, J = 12.3, 3.8 Hz, CH2Ar), 2.36 (m, 1H, 
NHCHCH(CH3)2), 2.05 (m, 1H, OCHCH(CH3)2),  1.09 (m, 24H, TIPS and 
NHCHCH(CH3)2), 1.04–1.01 (m, 6H, NHCHCH(CH3)2, OCHCH(Me)Me), 0.87 (d, 3H, 
J = 6.9 Hz, OCHCH(Me)Me); 13C NMR: (75 MHz, CD3OD) δ 172.7, 172.6, 165.9, 
160.0, 157.2, 154.0, 144.0, 138.3, 137.0, 133.0, 130.6, 130.1, 130.0, 128.7, 128.2, 127.9, 
127.6, 127.4, 127.3, 120.3, 114.9, 112.1, 110.2, 103.9, 70.2, 61.5, 55.6, 53.8, 38.6, 33.8, 
28.6, 19.1, 17.6, 17.5, 17.1, 17.0, 16.6, 12.2; HRMS: (FAB+) exact mass calculated for 
[M+Na] (C46H58N4O8SiNa) requires m/z 845.3921, found m/z 845.3914; 
! 
["]
D
25  = –100.66 
(c = 0.493, CHCl3). 
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Ketoindole 21: To a solution of 19 (36.4 mg, 0.044 mmol) in DMF (2.2 mL) was added 
20 (24 mg, 0.088 mmol), EDC•HCl (10.2 mg, 0.052 mmol), HOBt (7.2 mg, 0.052 mmol), 
and NaHCO3 (14.8 mg, 0.18 mmol). The solution was stirred at room temperature for 12 
hours before being diluted with EtOAc and brine. The layers were separated and the 
aqueous was washed with ethyl acetate. The combined organics were washed with brine 
and concentrated. The resulting oil was purified on silica gel (40% EtOAc in hexanes) to 
yield the title compound (28 mg, 68%) as a pale white solid. IR (film): 3404, 3287, 2962, 
2868, 1654, 1500, 1465, 1435, 1289, 1248, 1210, 1119, 1065, 913, 882, 843, 732, 685 
cm-1; 1H NMR: (300 MHz, CDCl3): δ 9.13 (d, 1H, J = 2.4 Hz, C=CNH), 8.24 (m, 1H, Ar-
H), 7.90 (t, 1H, J = 4.6 Hz, Ar-H), 7.73 (d, 1H, J = 3.3 Hz, Ar-H), 7.58 (d, 1H, J = 1.8 
Hz, Ar-H), 7.28–7.22 (m, 9H, Ar-H), 7.08 (dd, 1H, J = 8.2, 1.6 Hz, Ar-H), 6.89 (t, 1H, J 
= 4.4 Hz, Ar-H), 6.70 (m, 2H, Ar-H, OCHN), 6.31 (br d, 1H, J = 8.4 Hz, CONH), 5.62, 
(s, 1H, CONH), 5.16 (dd, 1H, J = 9.0, 5.6, CONHCHCH), 4.87 (dd, 2H, J = 24.6, 11.4 
Hz, OCH2Ph), 4.54 (t, 2H, J = 4.8 Hz, CH2CO), 4.46 (m, 1H, CONHCHCH2), 4.13 (d, 
1H, J = 3.3 Hz, CHOTIPS), 3.36 (t, 1H, J = 12.0 Hz, CH2Ar), 2.74 (dd, 1H, J = 12.0, 3.3 
Hz, CH2Ar), 2.44 (m, 1H, NHCHCH(CH3)2), 1.97 (m, 1H, OCHCH(CH3)2),  1.09 (m, 
24H, TIPS and NHCHCH(CH3)2), 0.98–0.87 (m, 9H, NHCHCH(CH3)2, OCHCH(Me)2); 
13C NMR: (75 MHz, CDCl3) δ 188.4, 171.9, 160.8, 159.5, 157.2, 153.4, 144.0, 138.1, 
136.8, 136.2, 131.4, 130.9, 130.6, 130.1, 129.6, 128.4, 128.2, 128.0, 127.8, 127.4, 125.1, 
123.9, 122.9, 121.9, 120.6, 115.2, 115.1, 112.0, 111.7, 110.6, 103.7, 77.9, 77.2, 70.0, 
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61.4, 56.0, 53.1, 45.9, 38.7, 33.9, 28.5, 19.6, 18.1, 18.0, 17.7, 17.5, 17.2, 12.4; HRMS: 
(FAB+) exact mass calculated for [M+H] (C56H67N6O8Si) requires m/z 979.4789, found 
m/z 979.4765; 
! 
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D
25  = –42.44 (c = 0.147, CHCl3). 
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Bisoxazole 22: To a solution of PPh3 (136 mg, 0.52 mmol) in CH2Cl2 (1.8 mL) was 
added C2Cl6 (123 mg, 0.52 mmol). The solution was stirred at room temperature for 10 
minutes at which time Et3N (0.144 mL, 1.04 mmol) was added dropwise.  The resultant 
solution was stirred for 10 minutes at which time it was added dropwise via cannula to a 
stirred CH2Cl2 (2.8 mL) solution of 21 (51 mg, 0.052 mmol) at 0 °C and held at this 
temperature for 10 minutes, at which point it was allowed to warm to room temperature 
and stirred for an additional 10 minutes.  The solution was then diluted with a saturated 
solution of NaHCO3. The layers were separated and the aqueous was washed with CH-
2Cl2 3 x 5 mL. The combined organics were washed with brine and concentrated. The 
resulting oil was purified on silica gel (40% EtOAc in hexanes) to yield the title 
compound (47.7 mg, 95%) as a pale amorphous solid. IR (film): 3405, 3289, 2961, 2868, 
1655, 1498, 1460, 1288, 1254, 1207, 1116, 1096, 1061, 917, 882, 738, 685 cm-1; 1H 
NMR: (300 MHz, CDCl3): δ 8.12 (s, 1H, C=CNH), 7.68–6.56 (m, 18H, Ar-H, OCHN), 
5.41 (s, 1H, CONH), 5.06–4.86 (m, 3H, CONHCHCH, OCH2Ph), 4.67 (m, 1H, 
CONHCHCH2), 4.09 (d, 1H, J = 3.3 Hz, CHOTIPS), 3.34 (t, 1H, J = 12.0 Hz, CH2Ar), 
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2.77 (dd, 1H, J = 12.0, 3.3 Hz, CH2Ar), 2.38 (m, 1H, NHCHCH(CH3)2), 1.95 (m, 1H, 
OCHCH(CH3)2),  1.07 (m, 24H, TIPS and NHCHCH(CH3)2), 0.96 (d, 3H, J = 6.9 Hz, 
NHCHCH(CH3)2), 0.90 (d, 3H, J = 6.9 Hz, OCHCH(Me)Me), 0.84 (d, 3H, J = 6.9 Hz, 
OCHCH(Me)Me); 13C NMR: (75 MHz, CDCl3) δ 172.1, 172.0, 161.8, 157.5, 152.5, 
149.9, 148.3, 143.7, 137.9, 137.4, 136.3, 130.4, 130.1, 129.7, 129.2, 129.0, 128.8, 128.5, 
128.1, 127.6, 124.0, 123.1, 122.9, 121.6, 121.2, 121.1, 119.8, 115.9, 112.4, 111.8, 110.9, 
105.3, 103.3, 78.1, 70.2, 62.1, 55.8, 54.4, 39.0, 34.1, 29.5, 19.8, 18.3, 18.2, 17.6, 17.5, 
12.5; HRMS: (FAB+) exact mass calculated for [M+H] (C56H65N6O7Si) requires m/z 
961.4687, found m/z 961.4682; 
! 
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25  = –115.47 (c = 0.187, CHCl3). 
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Phenol 23: To a solution of 22 (47.5 mg, 0.049 mmol) in THF (5 mL) was added 
Pd(OH)2/C (120 mg). The solution was sparged with H2 for 20 minutes and kept under a 
H2 atmosphere for 7 hours.  At this time the solution was filtered through a silica plug, 
concentrated, and the resulting oil was purified on silica gel (40%–60% EtOAc in 
hexanes) to yield the title compound (38.0 mg, 88%) as a pale amorphous solid. IR 
(film): 3287, 2962, 2868, 1652, 1496, 1458, 1292, 1254, 1191, 1099, 1061, 917, 882, 
738, 683 cm-1; 1H NMR: (300 MHz, CD3OD): δ 8.67 (d, 1H, J = 7.2 Hz, C=CNH), 7.64 
(m, 1H, Ar-H), 7.49–7.41 (m, 3H, Ar-H), 7.21–7.13 (m, 4H, Ar-H), 7.04 (d, 1H, J = 1.8 
Hz, Ar-H), 6.84–6.80 (m, 2H, Ar-H), 6.57 (dd, 1H, J = 6.0, 2.7 Hz, Ar-H), 6.39 (m, 2H, 
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Ar-H, OCHN), 4.69 (t, 1H, J = 7.2 Hz, CONHCHCH), 4.55 (m, 1H, CONHCHCH2), 
4.15 (d, 1H, J = 3.9 Hz, CHOTIPS), 3.06 (t, 1H, J = 12.0 Hz, CH2Ar), 2.85 (dd, 1H, J = 
12.0, 4.0 Hz, CH2Ar), 2.17–2.00 (m, 2H, NHCHCH(CH3)2, OCHCH(CH3)2),  1.10–0.96 
(m, 33H, TIPS, NHCHCH(CH3)2, OCHCH(Me)2); 13C NMR: (75 MHz, CD3OD) δ 
172.8, 172.3, 162.6, 157.6, 151.7, 151.2, 149.6, 142.0, 137.0, 136.7, 131.2, 129.7, 129.0, 
128.9, 128.4, 127.8, 123.7, 123.6, 121.9, 120.3, 120.0, 119.2, 118.8, 115.0, 113.4, 111.4, 
110.1, 103.7, 103.2, 78.1, 61.9, 55.6, 55.5, 38.1, 33.8, 29.8, 18.4, 18.0, 17.2, 17.1, 16.7, 
12.2; HRMS: (FAB+) exact mass calculated for [M+H] (C49H58N6O7Si) requires m/z 
870.4136, found m/z 870.4132; 
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25  = –102.52 (c = 0.173, CHCl3). 
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Triflate 24: To a solution of 23 (38 mg, 0.044 mmol) in CH2Cl2 (4.3 mL) was added 
PhNTf2 (39 mg, 0.109 mmol) and Et3N (30.4 µL, 0.218 mmol). The solution was stirred 
under argon for 30 minutes and then diluted with brine.  The aqueous layer was washed 
with EtOAc, and the combined organics were dried over Na2SO4. After concentration of 
the solvents in vacuo, the resulting oil was purified on silica gel (30% EtOAc in hexanes) 
to yield the title compound (30 mg, 67%) as a pale yellow-orange amorphous solid. IR 
(film): 3287, 2962, 2869, 1652, 1496, 1471, 1424, 1213, 1139, 1062, 916, 882, 812, 742, 
668 cm-1; 1H NMR: (300 MHz, CD3OD): δ 7.68 (m, 1H, Ar-H), 7.48–7.42 (m, 2H, Ar-
H), 7.26–7.02 (m, 7H, Ar-H), 6.85 (m, 2H, Ar-H, OCHN), 6.52 (dd, 1H, J = 7.5, 6.6 Hz, 
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Ar-H), 4.69 (d, 1H, J = 7.2 Hz, CONHCHCH), 4.56 (dd, 1H, J = 14.2, 3.9 Hz, 
CONHCHCH2), 4.16 (d, 1H, J = 3.9 Hz, CHOTIPS), 3.07 (t, 1H, J = 12.0 Hz, CH2Ar), 
2.87 (dd, 1H, J = 12.0, 3.9 Hz, CH2Ar), 2.19–2.00 (m, 2H, NHCHCH(CH3)2, 
OCHCH(CH3)2),  1.12–0.99 (m, 33H, TIPS, NHCHCH(CH3)2, OCHCH(Me)2); 13C 
NMR: (75 MHz, CD3OD) δ 172.7, 172.2, 162.8, 157.7, 151.4, 150.0, 149.5, 141.5, 136.8, 
133.3, 131.8, 130.3, 129.9, 129.1, 128.8, 128.1, 123.7, 123.0, 122.2, 122.1, 121.2, 120.7, 
120.1, 119.7, 119.2, 118.8, 116.5, 111.5, 110.4, 103.3, 103.2, 78.1, 61.2, 55.4, 38.0, 33.8, 
29.8, 18.4, 18.0, 17.2, 17.1, 16.7, 12.2; 19F NMR: (75 MHz, CD3OD) δ –75.6 (s, 3F, 
CF3); HRMS: (FAB+) exact mass calculated for [M+H] (C50H58N6O9F3SiS) requires m/z 
1003.371, found m/z 1003.369; 
! 
["]
D
25  = –119.34 (c = 0.126 CHCl3). 
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DFT calculation of ring strain: Both structures shown below were minimized using the 
B3LYP density functional and the 3-21G level of theory in the Gaussian 03 suite of 
programs. 
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Table 1: Ring contraction thermochemistry
–1973.637342
–1897.607806
–75.97396515
Entry
Ketoamide
Oxazole
Water
E (hartree)
-0.07557138
ΔE° (hartree) ΔE° (kcal)
-47.42
 
 
 
 
Coordinates, Level of Calculation, and Energies: 
 
Keto-amide 
E (B3LYP/3-21G) = –1973.65734238 a.u. 
 
0 1 
 C                  2.16701900   -1.14812500    0.56846500 
 C                  1.10324700   -1.59966100   -0.19277000 
 C                  0.01293600   -2.21308900    0.44484300 
 C                  0.05850600   -2.40007100    1.83527500 
 C                  1.13290900   -1.94096600    2.60587900 
  133 
 C                  2.17067900   -1.27926300    1.95724300 
 O                  3.23845400   -0.64856400    2.57808000 
 C                  4.40269800   -1.21050700   -0.63712300 
 C                 -0.28336200    2.63891600    0.17571500 
 O                 -0.09304400    3.27418400    1.22576600 
 C                 -1.26500000   -2.48914200   -0.33561200 
 C                 -2.23942600   -1.31395000   -0.11964100 
 C                 -1.66756800   -0.01089700   -0.73659300 
 O                 -0.84014300   -0.00747800   -1.68199800 
 C                  5.51692600   -1.43450600    0.19288900 
 C                 -1.66877200    2.46241400   -0.49649300 
 C                 -2.66777400    3.52471600   -0.00358300 
 C                 -4.09035700    3.25702800   -0.54505400 
 C                 -2.18122200    4.92916300   -0.42509500 
 N                 -2.13397800    1.10225800   -0.13101100 
 N                 -3.57557400   -1.59355400   -0.67647100 
 C                 -4.65732500   -0.91612000   -0.24612600 
 C                 -5.97458000   -1.38794200   -0.87303000 
 C                 -7.00954900   -1.79382700    0.20430300 
 C                 -6.39109900   -2.83421400    1.15912400 
 O                 -4.60481600    0.01355900    0.60438000 
 O                 -5.62292200   -2.53374900   -1.71721800 
 C                  4.11675800   -0.05733200    1.50019100 
 N                  5.37268500   -0.73989700    1.39130900 
 C                  3.39587500   -0.36141100    0.11384000 
 C                  4.35079000   -1.74126500   -1.91425400 
 C                  5.41876000   -2.53310200   -2.36557400 
 C                  6.51299500   -2.77148500   -1.53215200 
 C                  6.57918600   -2.22273900   -0.24484100 
 C                  2.75788900    3.19029700    0.08719700 
 H                  1.05979300   -1.41024600   -1.25656100 
 H                 -0.77449000   -2.88567600    2.33379700 
 H                  1.14840500   -2.06006400    3.68042900 
 H                 -2.91940900    0.99128500    0.51872000 
 H                 -3.74043500   -2.31483000   -1.37799900 
 H                  6.08363600   -0.68314600    2.10717200 
 H                 -1.04702200   -2.57024100   -1.40489800 
 H                 -1.74450000   -3.41258700    0.00771300 
 H                 -1.55699400    2.50642800   -1.58551800 
 H                 -2.66559400    3.47913900    1.09253800 
 H                 -4.76904100    4.04163300   -0.19219200 
 H                 -4.08427800    3.28124700   -1.64233300 
 H                 -4.48503200    2.29053200   -0.21766300 
 H                 -2.89018900    5.68930200   -0.07943800 
 H                 -1.20391000    5.13410600    0.01777300 
 H                 -2.10899300    4.99740800   -1.51772300 
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 H                 -6.37665700   -0.55707500   -1.47157600 
 H                 -7.84171500   -2.26855600   -0.33910700 
 H                 -5.63825500   -2.35407600    1.79380000 
 H                 -7.15920300   -3.27225100    1.80434200 
 H                 -5.91611000   -3.62859200    0.57491600 
 H                  3.51222900   -1.52030900   -2.55996900 
 H                  5.39460600   -2.95221600   -3.36378800 
 H                  7.33354800   -3.38589600   -1.88502600 
 H                 -2.36967000   -1.14138300    0.95280800 
 H                  4.20824600    1.00004500    1.73837500 
 C                 -7.55268100   -0.55916200    0.95154300 
 H                 -8.25530300   -0.86929200    1.73215500 
 H                 -6.71870200   -0.01472600    1.39713900 
 H                 -8.07933800    0.11295600    0.26288300 
 H                 -6.43878300   -2.83904600   -2.19113500 
 O                  2.43319400    4.23182500   -0.44392500 
 C                  2.02112900    1.85735600    0.14619300 
 H                  1.94766800    1.55808500    1.19526700 
 N                  0.71139700    1.96115200   -0.47111900 
 H                  0.47198300    1.35816100   -1.26404900 
 O                  3.96685900    3.01434100    0.76016200 
 H                  4.48649400    3.86422700    0.72475800 
 H                  7.43870400   -2.40480800    0.38873600 
 C                  2.85795900    0.83528000   -0.66103300 
 O                  2.96133400    0.93993000   -1.88095600 
 
 
Oxazole 
E (B3LYP/3-21G) = –1897.60780585 a.u. 
 
0 1 
 C                 -1.76559700   -1.63418300   -0.37382300 
 C                 -0.72066600   -1.79744100    0.51976400 
 C                  0.35952200   -2.62542300    0.17721000 
 C                  0.29096900   -3.37196100   -1.01018900 
 C                 -0.80242200   -3.26904500   -1.87782400 
 C                 -1.80458800   -2.35511700   -1.56359300 
 O                 -2.85932700   -2.00127100   -2.40144700 
 C                 -3.88472500   -0.75972300    0.73350500 
 C                  1.67009000   -2.47481300    0.94363900 
 C                  2.35802200   -1.17459200    0.45669300 
 C                  1.63137000    0.06606700    1.05143800 
 O                  1.04032900    0.04498900    2.14731000 
 C                 -5.04065800   -1.34157900    0.18113600 
 C                  0.93042300    2.37775100    0.53583900 
 C                  1.60948800    3.63575300   -0.06276900 
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 C                  3.09649700    3.69521200    0.35944800 
 C                  0.86962900    4.91400800    0.39280500 
 N                  1.69629000    1.15753900    0.23961100 
 N                  3.78585300   -1.11847600    0.82381300 
 C                  4.62032900   -0.26836700    0.19477600 
 C                  6.07674100   -0.36694300    0.66164600 
 C                  7.02702100   -0.73595100   -0.50402700 
 C                  6.54402700   -2.03227400   -1.18405800 
 O                  4.25490700    0.53100500   -0.70948100 
 O                  6.09620400   -1.40406000    1.69688100 
 C                 -3.66268300   -0.95413600   -1.69937200 
 N                 -4.90811500   -1.47472800   -1.19347000 
 C                 -2.85728600   -0.56139400   -0.37770800 
 C                 -3.78254900   -0.51330100    2.08938500 
 C                 -4.86142400   -0.84888000    2.92434600 
 C                 -6.00764800   -1.42923400    2.37847000 
 C                 -6.11265700   -1.68393100    1.00453800 
 C                 -3.83487100    2.67583200   -1.03559400 
 H                 -0.65544100   -1.20086300    1.41646500 
 H                  1.11770700   -4.02133200   -1.27960700 
 H                 -0.84822600   -3.83425600   -2.79867300 
 H                  2.36796200    1.13594800   -0.53137100 
 H                  4.18959900   -1.69188100    1.56332900 
 H                 -5.64638800   -1.78933500   -1.80780000 
 H                  1.49258200   -2.38059000    2.01978900 
 H                  2.33309000   -3.32464300    0.74950600 
 H                  0.88108300    2.46599800    1.62980500 
 H                  1.54661400    3.55936200   -1.15634100 
 H                  3.55344900    4.60193500   -0.05194700 
 H                  3.17051900    3.74269800    1.45328100 
 H                  3.66280900    2.82802200    0.00753500 
 H                  1.33836600    5.79439000   -0.05980800 
 H                 -0.18172400    4.87512300    0.09898200 
 H                  0.93534000    5.01331000    1.48370900 
 H                  6.36366000    0.61351000    1.06882800 
 H                  8.00948900   -0.92792800   -0.04411500 
 H                  5.63008500   -1.83755000   -1.75621500 
 H                  7.30555400   -2.41688300   -1.86994100 
 H                  6.33307200   -2.78714600   -0.42023900 
 H                 -2.88607300   -0.06331000    2.50089700 
 H                 -4.80129700   -0.65739400    3.98834300 
 H                 -6.83746100   -1.68924500    3.02590000 
 H                  2.30290000   -1.11690500   -0.63334700 
 H                 -3.78471700   -0.14556800   -2.41268800 
 C                  7.17196600    0.43316800   -1.49916800 
 H                  7.81330700    0.13923700   -2.33668300 
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 H                  6.18441800    0.71594000   -1.86776200 
 H                  7.62224500    1.30610000   -1.01071800 
 H                  7.02297300   -1.49092200    2.03911300 
 O                 -4.13024100    3.85391600   -1.17403000 
 O                 -4.74327100    1.64472000   -1.26630400 
 H                 -5.62631400    2.04969800   -1.48466800 
 H                 -7.00869200   -2.13502500    0.59570300 
 C                 -2.56109600    2.11223400   -0.61910500 
 C                 -2.22167600    0.80385500   -0.38233200 
 C                 -0.48471600    2.16734100    0.02896900 
 O                 -0.89460700    0.82328300    0.03410800 
 N                 -1.44794600    2.95441800   -0.35564400 
 
 
Water 
E (B3LYP/3-21G) = –75.97396515 a.u. 
 
0 1 
 O                  0.00000000    0.00000000    0.12275500 
 H                  0.00000000    0.78546200   -0.49102000 
 H                  0.00000000   -0.78546200   -0.49102000 
 
 
 
 
 
 
 
 
Stereochemistry of magnesium aldol product: Each of the four possible aldol 
diastereomers was minimized using the B3LYP density functional and the 3-21G level of 
theory in the Gaussian 03 suite of programs. These four minimized structures are shown 
below, along with the dihedral angles between the alcohol and amine methines, and the 
likelihood of producing the observed NOESY crosspeaks. 
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Coordinates, Level of Calculation, and Energies: 
 
 
9 (S, S) 
E (B3LYP/3-21G) = –2371.04216078 a.u. 
 
0 1 
 C                 -1.61007600   -1.78996300   -0.35573700 
 C                 -0.57843600   -2.00599500    0.54723900 
 C                  0.58945700   -2.65740300    0.12953700 
 C                  0.62237800   -3.23209500   -1.15264700 
 C                 -0.44237300   -3.07720000   -2.04597000 
 C                 -1.52202500   -2.28525200   -1.65453100 
 O                 -2.49899800   -1.80228400   -2.51201800 
 C                 -3.83393500   -0.92758000    0.61880700 
 C                  0.34794900    2.45700300   -0.71839000 
 O                  0.31019200    2.10226900   -1.90804400 
 C                  1.86731000   -2.46125200    0.93459300 
 C                  2.62708900   -1.22154800    0.39099300 
 C                  1.90275800    0.11558600    0.72368100 
 O                  1.05568500    0.21248300    1.64974100 
 C                 -4.93053700   -1.24853600   -0.18574000 
 C                  1.68917100    2.50475600    0.05637800 
 C                  2.61907700    3.54841700   -0.60230900 
 C                  4.05493900    3.49369300   -0.03692500 
 C                  2.01631500    4.95742900   -0.40480700 
 N                  2.27984300    1.14866900   -0.05627800 
 N                  4.00428100   -1.17596000    0.92426600 
 C                  4.97986900   -0.48800900    0.30323900 
 C                  6.36189500   -0.65436700    0.94150500 
 C                  7.36137900   -1.31856400   -0.03933100 
 C                  6.79404500   -2.66179300   -0.54009700 
 O                  4.79456900    0.22086100   -0.72436300 
 O                  6.15603400   -1.49165800    2.12548700 
 C                 -3.27733500   -0.74344600   -1.76083200 
 N                 -4.63673500   -1.11849900   -1.53645800 
 C                 -2.64616400   -0.65463200   -0.29489400 
 C                 -3.94301200   -0.94931600    2.00583500 
 C                 -5.17213800   -1.30481400    2.57261300 
 C                 -6.26520400   -1.63285000    1.76072500 
 C                 -6.15801700   -1.60420700    0.37081500 
 C                 -3.16493900    2.66109200    0.40785100 
 O                 -7.18622400   -1.88968100   -0.52981600 
 H                 -0.61289000   -1.53461700    1.51472100 
 H                  1.51197200   -3.76127100   -1.48037600 
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 H                 -0.39744200   -3.47588400   -3.05037500 
 H                  3.06210900    0.98750000   -0.70345100 
 H                  4.27591600   -1.68107800    1.76797200 
 H                 -5.34047000   -1.18162300   -2.25845800 
 H                  1.63801300   -2.29456800    1.99170500 
 H                  2.53319200   -3.32694800    0.84134900 
 H                  1.53185600    2.72957400    1.11528600 
 H                  2.62914800    3.31063700   -1.67404400 
 H                  4.66059500    4.27983900   -0.50185200 
 H                  4.04010400    3.67076200    1.04598300 
 H                  4.53511400    2.53120100   -0.23339900 
 H                  2.60779800    5.70019000   -0.94959500 
 H                  0.98324500    5.00635400   -0.76548200 
 H                  2.02548600    5.22487800    0.65925700 
 H                  6.72780800    0.34586800    1.21351500 
 H                  8.27107900   -1.52119600    0.54821700 
 H                  5.96281900   -2.48609400   -1.23211800 
 H                  7.56462400   -3.23353100   -1.06664400 
 H                  6.43139800   -3.24701500    0.31057000 
 H                 -3.10056200   -0.64948900    2.60803400 
 H                 -5.28555800   -1.32057400    3.64969100 
 H                 -7.21160500   -1.90622500    2.21776000 
 H                  2.70375200   -1.29145900   -0.69835200 
 H                 -3.16264900    0.15215000   -2.37375500 
 C                  7.72886700   -0.36710200   -1.19564200 
 H                  8.40155000   -0.87058200   -1.89767000 
 H                  6.81966500   -0.05492900   -1.71252200 
 H                  8.23532900    0.52879900   -0.81655400 
 H                  7.03716300   -1.67523600    2.54184000 
 H                 -8.00488100   -2.14376600   -0.03267900 
 O                 -3.05068600    3.20047500    1.49174700 
 C                 -2.04481100    2.06022800   -0.39802900 
 H                 -2.18545000    2.16292200   -1.47285600 
 O                 -1.52570800    0.59724000    1.45407100 
 H                 -0.52659400    0.53619500    1.62452700 
 C                 -1.75087200    0.57669500    0.02075700 
 H                 -0.82629300    0.37691000   -0.53065800 
 S                 -4.81530000    2.46946500   -0.49571800 
 H                 -5.56718100    2.87254300    0.57889400 
 N                 -0.78431400    2.73257200    0.00754500 
 H                 -0.73953700    2.88934800    1.01293200 
 
 
9 (S, R) 
E (B3LYP/3-21G) = –2371.04543883 a.u. 
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0 1 
 C                 -1.80650900   -1.82928500   -0.39265900 
 C                 -0.74068000   -2.17967000    0.42408100 
 C                  0.38807100   -2.80548800   -0.12252900 
 C                  0.34352600   -3.23100600   -1.46034900 
 C                 -0.76533600   -2.96320700   -2.26882500 
 C                 -1.80424900   -2.19639200   -1.73836300 
 O                 -2.82029000   -1.62771300   -2.48203800 
 C                 -3.98012400   -1.02136700    0.76343000 
 C                  0.21500000    2.44837900    0.02011800 
 O                  0.09328000    2.39064900   -1.21428000 
 C                  1.70436800   -2.73802800    0.64142600 
 C                  2.45626200   -1.43130400    0.26680200 
 C                  1.78470700   -0.16390400    0.86946900 
 O                  0.98942100   -0.21738100    1.84531000 
 C                 -5.12241900   -1.18622500   -0.02776700 
 C                  1.59739200    2.30724600    0.69334400 
 C                  2.51389100    3.44961000    0.19825700 
 C                  3.97199600    3.26832000    0.67241000 
 C                  1.94648100    4.80260200    0.68361300 
 N                  2.14022100    0.99157500    0.27180100 
 N                  3.86115000   -1.49310200    0.72285700 
 C                  4.81767000   -0.71232100    0.18878800 
 C                  6.22506600   -1.00319400    0.71917700 
 C                  7.18867100   -1.42160200   -0.41905600 
 C                  6.60049500   -2.61635400   -1.19583400 
 O                  4.59503200    0.17804900   -0.67765800 
 O                  6.06632100   -2.08411000    1.69493400 
 C                 -3.49944900   -0.59164600   -1.60465100 
 N                 -4.87379300   -0.90593600   -1.36150100 
 C                 -2.81233000   -0.68325600   -0.16152900 
 C                 -4.04351600   -1.22024000    2.14052700 
 C                 -5.26804500   -1.58583900    2.70982100 
 C                 -6.40654800   -1.75199400    1.91059300 
 C                 -6.34708900   -1.55099400    0.53318400 
 O                 -7.41913500   -1.67128500   -0.35367900 
 H                 -0.72050100   -1.84679300    1.44602200 
 H                  1.20187200   -3.73624700   -1.89253300 
 H                 -0.78709400   -3.25537900   -3.30999900 
 H                  2.89122900    0.94865700   -0.43005800 
 H                  4.16744900   -2.15717900    1.43438500 
 H                 -5.59925800   -0.88092000   -2.06387200 
 H                  1.52844500   -2.73930200    1.72179600 
 H                  2.35488300   -3.58088800    0.38073600 
 H                  1.51187900    2.31403400    1.78377700 
 H                  2.47012300    3.41976900   -0.89810400 
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 H                  4.57284000    4.12039500    0.33540200 
 H                  4.01176600    3.23631300    1.76868800 
 H                  4.42022300    2.35459200    0.27252400 
 H                  2.55223800    5.62432000    0.28812100 
 H                  0.91277400    4.94938400    0.35199400 
 H                  1.97580600    4.85321000    1.77936700 
 H                  6.59958700   -0.08438900    1.19320200 
 H                  8.11600000   -1.74990100    0.07691900 
 H                  5.74840700   -2.28820200   -1.80151100 
 H                  7.35102100   -3.04922100   -1.86468800 
 H                  6.26434700   -3.38275700   -0.49042900 
 H                 -3.16406800   -1.05170300    2.74010800 
 H                 -5.34225800   -1.73800100    3.77971600 
 H                 -7.34915800   -2.03566800    2.36915100 
 H                  2.46897200   -1.31556300   -0.82131100 
 H                 -3.34366600    0.35187900   -2.11656900 
 C                  7.52248700   -0.22845800   -1.33702800 
 H                  8.17515500   -0.55304200   -2.15396000 
 H                  6.59834600    0.18604800   -1.74337700 
 H                  8.03895000    0.56058900   -0.77683500 
 H                  6.96047600   -2.32774300    2.04764500 
 H                 -8.23266100   -1.94636900    0.14071600 
 C                 -2.15860600    2.01496000    0.30940500 
 O                 -1.58495100    0.22279500    1.70282000 
 H                 -0.58583600    0.09245400    1.82344700 
 C                 -1.87322100    0.48290800    0.28302100 
 H                 -0.97895100    0.37955800   -0.33786400 
 N                 -0.88177000    2.56842600    0.84931900 
 H                 -0.76464100    2.39983200    1.84498400 
 H                 -2.95266300    2.22825200    1.02992500 
 C                 -2.47490200    2.74766300   -0.98265500 
 S                 -2.31201300    4.63675800   -0.69774800 
 H                 -2.86276900    4.92446600   -1.92344200 
 O                 -2.91668500    2.30914200   -2.02725500 
 
 
9 (R, R) 
E (B3LYP/3-21G) = –2371.05397902 a.u. 
 
0 1 
 C                 -1.48884800   -1.54070300   -0.60074000 
 C                 -0.44140400   -1.58377700    0.30434900 
 C                  0.62090200   -2.48839800    0.11764000 
 C                  0.57551900   -3.37200400   -0.96876500 
 C                 -0.50225700   -3.37367000   -1.85911200 
 C                 -1.52492100   -2.45157300   -1.66530200 
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 O                 -2.64058600   -2.34275400   -2.47593500 
 C                 -3.70545900   -1.04817200    0.51163800 
 C                  0.14923100    2.26840800   -0.39261200 
 O                 -0.25689500    2.62509500   -1.51288900 
 C                  1.86909400   -2.38651600    0.98948500 
 C                  2.72102200   -1.21084500    0.47189900 
 C                  2.03836600    0.12679100    0.84070300 
 O                  1.32026300    0.26956300    1.86657500 
 C                 -4.84530800   -1.63093700   -0.04889600 
 C                  1.62124200    2.43005100    0.07006300 
 C                  2.34361700    3.49132800   -0.77767500 
 C                  3.85574000    3.54068800   -0.46172800 
 C                  1.69721800    4.87155100   -0.51237600 
 N                  2.26263200    1.10423100   -0.05836800 
 N                  4.10315500   -1.21019000    0.98406000 
 C                  5.05823700   -0.51219400    0.33603600 
 C                  6.45475100   -0.64979800    0.94844900 
 C                  7.44568600   -1.30926900   -0.04374400 
 C                  6.88986400   -2.66676600   -0.51800400 
 O                  4.83727800    0.17461000   -0.69764500 
 O                  6.28672200   -1.47677600    2.14599400 
 C                 -3.50408700   -1.24263800   -1.91639000 
 N                 -4.75719900   -1.72203000   -1.42617100 
 C                 -2.74366600   -0.67688200   -0.62157900 
 C                 -3.57583200   -0.95129200    1.89527300 
 C                 -4.63173000   -1.38436800    2.70611300 
 C                 -5.78805600   -1.92495600    2.13258200 
 C                 -5.90398800   -2.06466400    0.75079800 
 O                 -6.99588600   -2.61150700    0.07920800 
 H                 -0.39958200   -0.91468800    1.14782000 
 H                  1.39006500   -4.07251000   -1.12226200 
 H                 -0.55144500   -4.06757100   -2.68711200 
 H                  2.99342000    0.94429600   -0.75736900 
 H                  4.38467000   -1.69598100    1.83443300 
 H                 -5.53115900   -2.01114900   -2.00745000 
 H                  1.60555900   -2.18951600    2.03358000 
 H                  2.45391900   -3.31002800    0.92643600 
 H                  1.63238400    2.71252500    1.12839200 
 H                  2.17941400    3.22809100   -1.82922900 
 H                  4.33654500    4.29464600   -1.09494400 
 H                  4.00592200    3.83274600    0.58562700 
 H                  4.35786700    2.58209000   -0.62690300 
 H                  2.12995500    5.62340800   -1.18087900 
 H                  0.61767300    4.83043000   -0.67692900 
 H                  1.88723500    5.18148200    0.52287900 
 H                  6.81026600    0.35921500    1.20160200 
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 H                  8.37031700   -1.49075600    0.52720600 
 H                  6.04174900   -2.51127000   -1.19411000 
 H                  7.65844600   -3.23262200   -1.05392000 
 H                  6.55362500   -3.24690500    0.34684600 
 H                 -2.66542100   -0.58152100    2.35124100 
 H                 -4.55352200   -1.30998800    3.78345100 
 H                 -6.59944100   -2.25602200    2.77326400 
 H                  2.78853600   -1.26542000   -0.61773200 
 H                 -3.60516700   -0.51560400   -2.71675400 
 C                  7.77283300   -0.36461400   -1.21769400 
 H                  8.43519900   -0.86535200   -1.93148800 
 H                  6.84623300   -0.07017700   -1.71367500 
 H                  8.27543800    0.54192500   -0.85920100 
 H                  7.17863400   -1.62820300    2.55242300 
 H                 -7.69357500   -2.87895300    0.73010300 
 C                 -2.10407600    1.68272100    0.39548800 
 C                 -2.58105300    0.85816500   -0.84676300 
 N                 -0.65440700    1.68307000    0.55099300 
 H                 -0.19794600    1.31387900    1.39137100 
 H                 -2.56394800    1.24226500    1.28390700 
 C                 -2.55144900    3.16755000    0.40777100 
 S                 -4.43950800    3.41951100    0.45504500 
 H                 -4.29224300    4.73990800    0.82221100 
 O                 -1.80528000    4.12339800    0.49941700 
 O                 -3.93457600    1.26406200   -1.23959000 
 H                 -3.87913200    2.12030200   -1.74194500 
 H                 -1.86307600    1.04447200   -1.64773100 
 
 
9 (R, S) 
E (B3LYP/3-21G) = –2371.02441932 a.u. 
 
0 1 
 C                 -1.56354300   -1.62916100   -0.52990700 
 C                 -0.47442400   -1.59661300    0.31746000 
 C                  0.60504300   -2.47093700    0.10525300 
 C                  0.49262000   -3.42626500   -0.91697600 
 C                 -0.64382900   -3.50026500   -1.73779900 
 C                 -1.66343700   -2.56756500   -1.55259400 
 O                 -2.78596000   -2.39875400   -2.34993400 
 C                 -3.65842300   -0.76362800    0.51165400 
 C                  0.22718700    2.79012300   -0.64473000 
 O                 -0.04166900    2.92661300   -1.86650500 
 C                  1.91946900   -2.18543300    0.82218300 
 C                  2.56300200   -0.93938100    0.17179900 
 C                  1.86275600    0.38108200    0.54409300 
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 O                  1.16925200    0.56520200    1.56701800 
 C                 -4.85539600   -1.24644800   -0.02804600 
 C                  1.67281500    2.77327100   -0.11828600 
 C                  2.60511400    3.74145600   -0.86719800 
 C                  4.03134900    3.68045300   -0.26741600 
 C                  2.04962400    5.18002500   -0.81414200 
 N                  2.14214300    1.38740600   -0.33202900 
 N                  3.98065800   -0.71266600    0.52798300 
 C                  4.97136700   -1.17393200   -0.28409200 
 C                  6.32915200   -0.52392500    0.00674700 
 C                  7.27628700   -1.48828800    0.76614500 
 C                  6.64788100   -1.92188800    2.10458500 
 O                  4.79646700   -2.02508600   -1.17496300 
 O                  6.04231700    0.68589600    0.79174700 
 C                 -3.47773100   -1.11793100   -1.90328400 
 N                 -4.79821900   -1.35480800   -1.40536700 
 C                 -2.66232500   -0.58730900   -0.64177300 
 C                 -3.49160100   -0.69495000    1.89231300 
 C                 -4.56749000   -1.02029600    2.71985200 
 C                 -5.78581700   -1.44515100    2.16871500 
 C                 -5.93862300   -1.57660400    0.79164100 
 C                 -2.95339700    2.16119900    1.07798700 
 O                 -7.08386400   -2.02629600    0.13531700 
 H                 -0.39278200   -0.84665400    1.09285200 
 H                  1.31589900   -4.10875200   -1.10139200 
 H                 -0.70908000   -4.23051900   -2.53297400 
 H                  2.64951100    1.19324000   -1.19009500 
 H                  4.24505800    0.03157700    1.17088900 
 H                 -5.57142700   -1.69234200   -1.96134900 
 H                  1.77150900   -1.99968900    1.89063400 
 H                  2.62471800   -3.01087800    0.68485700 
 H                  1.68751300    2.96624800    0.95737600 
 H                  2.61801300    3.42302000   -1.91811000 
 H                  4.71631600    4.27870200   -0.87812700 
 H                  4.01912500    4.10885300    0.74292600 
 H                  4.42825500    2.66069900   -0.19546800 
 H                  2.73744700    5.86644600   -1.31901200 
 H                  1.08020800    5.22860600   -1.31783400 
 H                  1.93682400    5.51203200    0.22528300 
 H                  6.77882100   -0.27339400   -0.96319900 
 H                  8.19565800   -0.91977900    0.98077900 
 H                  5.77008600   -2.55330800    1.93214200 
 H                  7.37135600   -2.48749500    2.70058600 
 H                  6.33343700   -1.04098100    2.67279700 
 H                 -2.54940800   -0.37951100    2.31712000 
 H                 -4.46555100   -0.95586700    3.79599100 
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 H                 -6.60936300   -1.69904500    2.82879100 
 H                  2.54159700   -1.09235400   -0.91300500 
 H                 -3.41951700   -0.44562200   -2.75068500 
 C                  7.64119100   -2.69044900   -0.12971400 
 H                  8.22929800   -3.41933600    0.43721100 
 H                  6.72964500   -3.16342600   -0.50339200 
 H                  8.23234900   -2.36572500   -0.99385800 
 H                  6.90299800    1.05928800    1.11714700 
 H                 -7.76952800   -2.29609800    0.79809200 
 O                 -2.55354900    2.04524900    2.22619400 
 C                 -2.07276000    2.14644800   -0.14222600 
 H                 -2.44306800    2.87153400   -0.86957500 
 C                 -1.92167400    0.77978500   -0.97086300 
 S                 -4.73880600    2.43921800    0.59253400 
 H                 -5.25025500    1.97744300    1.77717300 
 N                 -0.71395000    2.51851000    0.29167800 
 H                 -0.44589400    2.22182600    1.23145200 
 H                 -0.87310700    0.54223600   -0.78650500 
 O                 -2.10340400    1.09824200   -2.37422500 
 H                 -1.37321500    1.76937800   -2.56139600 
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Table 1.  Crystal data and structure refinement for k08308. 
 
Identification code  k08308 
Empirical formula  C47 H59 Cl3 N4 O8 Si 
Formula weight  942.42 
Temperature  200(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C 2 
Unit cell dimensions a = 19.546(4) Å a= 90°. 
 b = 17.360(4) Å b= 105.63(3)°. 
 c = 19.889(4) Å g = 90°. 
Volume 6499(2) Å3 
Z 4 
Density (calculated) 0.963 Mg/m3 
Absorption coefficient 0.201 mm-1 
F(000) 1992 
Crystal size 0.40 x 0.30 x 0.20 mm3 
Theta range for data collection 2.58 to 24.38°. 
Index ranges -22<=h<=21, -19<=k<=20, 0<=l<=22 
Reflections collected 8612 
Independent reflections 5228 [R(int) = 0.0623] 
Completeness to theta = 24.38° 94.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.958 and 0.516 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5228 / 22 / 568 
Goodness-of-fit on F2 1.111 
Final R indices [I>2sigma(I)] R1 = 0.1136, wR2 = 0.2908 
R indices (all data) R1 = 0.1515, wR2 = 0.3174 
Largest diff. peak and hole 0.532 and -0.316 e.Å-3 
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Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for k08308.  U(eq) is defined as one third of  the trace of the orthogonalized 
Uij tensor. 
________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________  
Si(1) 1845(2) 3815(2) 3117(2) 86(1) 
O(1) 5341(4) 6479(4) 8038(3) 84(2) 
O(2) 4264(3) 4519(4) 7182(3) 74(2) 
O(3) 4873(4) 3366(4) 9303(4) 95(2) 
O(4) 4828(4) 4640(4) 9345(3) 90(2) 
O(5) 3925(4) 6989(4) 9838(3) 84(2) 
O(6) 3075(4) 4378(4) 5698(3) 89(2) 
O(7) 4400(4) 4544(5) 4089(3) 96(2) 
O(8) 2523(4) 4450(4) 3373(3) 84(2) 
N(1) 4737(4) 6468(5) 8959(4) 77(2) 
N(2) 4535(4) 3426(5) 7809(4) 72(2) 
N(3) 4217(4) 3991(5) 5953(4) 78(2) 
N(4) 3459(4) 4850(6) 4450(4) 82(2) 
C(1) 4347(5) 5596(6) 7972(5) 68(2) 
C(2) 3777(3) 5765(4) 8318(3) 82(3) 
C(3) 3073(4) 5524(4) 8153(3) 84(3) 
C(4) 2631(3) 5770(5) 8553(4) 115(4) 
C(5) 2893(3) 6257(5) 9119(4) 103(4) 
C(6) 3597(3) 6498(4) 9284(3) 83(3) 
C(7) 4039(3) 6252(4) 8883(3) 74(3) 
C(8) 5021(5) 6000(6) 8474(5) 75(3) 
C(9) 4915(3) 6467(4) 7393(3) 80(3) 
C(10) 5075(3) 6780(4) 6811(4) 87(3) 
C(11) 4634(4) 6639(4) 6147(3) 88(3) 
C(12) 4031(3) 6185(4) 6066(2) 86(3) 
C(13) 3871(3) 5872(4) 6649(3) 69(2) 
C(14) 4312(3) 6013(4) 7312(3) 82(3) 
C(15) 4431(5) 4739(5) 7877(4) 68(2) 
C(16) 4599(5) 4081(6) 8251(5) 80(3) 
C(17) 4785(6) 4019(7) 9008(6) 87(3) 
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C(18) 4330(5) 3747(6) 7175(6) 81(3) 
C(19) 4144(6) 3381(6) 6452(5) 78(3) 
C(20) 4505(6) 2632(6) 6395(6) 85(3) 
C(21) 4205(10) 2282(10) 5696(8) 142(6) 
C(22) 5294(7) 2748(7) 6515(6) 100(4) 
C(23) 3676(5) 4452(6) 5644(5) 69(2) 
C(24) 3845(6) 5069(6) 5170(5) 79(3) 
C(25) 3649(7) 5894(7) 5352(5) 91(3) 
C(26) 3766(5) 4603(5) 3983(4) 63(2) 
C(27) 3207(5) 4388(5) 3273(5) 77(3) 
C(28) 3303(6) 4908(7) 2691(5) 79(3) 
C(29) 3230(8) 5764(9) 2859(8) 120(4) 
C(30) 3945(8) 4778(9) 2474(8) 123(4) 
C(31) 1501(6) 3781(5) 2157(5) 100(4) 
C(32) 1296(6) 4541(6) 1791(7) 104(4) 
C(33) 918(8) 3193(10) 1901(8) 145(6) 
C(34) 2145(8) 2839(9) 3485(7) 141(7) 
C(35) 2535(15) 2780(13) 4250(9) 219(13) 
C(36) 2648(15) 2402(11) 3171(17) 227(14) 
C(37) 1160(8) 4262(11) 3478(11) 164(8) 
C(38) 476(10) 3899(14) 3531(14) 208(11) 
C(39) 1327(16) 5070(12) 3745(14) 212(12) 
C(40) 3560(7) 7265(10) 10317(8) 126(5) 
C(41) 3812(5) 7972(4) 10655(4) 95(3) 
C(42) 4089(5) 8546(6) 10317(4) 118(4) 
C(43) 4276(5) 9254(5) 10640(7) 138(6) 
C(44) 4187(5) 9389(5) 11300(7) 142(6) 
C(45) 3910(6) 8815(7) 11638(4) 134(5) 
C(46) 3723(5) 8106(6) 11315(4) 110(4) 
Cl(1) 2755(5) 3628(4) 878(3) 133(3) 
Cl(2) 2424(5) 5208(5) 639(4) 141(3) 
Cl(3) 3492(4) 4592(6) 157(7) 172(4) 
C(1S) 2698(7) 4385(6) 316(8) 125(11) 
Cl(4) 1845(5) 5304(7) 5786(6) 164(4) 
Cl(5) 1064(6) 5554(7) 6790(5) 165(3) 
Cl(6) 346(4) 5406(7) 5310(5) 152(3) 
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C(2S) 1091(6) 5649(15) 5944(6) 174(17) 
 
 
Table 3.   Bond lengths [Å] and angles [°] for  k08308. 
_____________________________________________________  
Si(1)-O(8)  1.694(8) 
Si(1)-C(31)  1.847(10) 
Si(1)-C(37)  1.852(18) 
Si(1)-C(34)  1.875(16) 
O(1)-C(9)  1.328(8) 
O(1)-C(8)  1.458(12) 
O(2)-C(18)  1.347(13) 
O(2)-C(15)  1.387(11) 
O(3)-C(17)  1.266(13) 
O(4)-C(17)  1.260(13) 
O(5)-C(6)  1.404(8) 
O(5)-C(40)  1.419(15) 
O(6)-C(23)  1.215(10) 
O(7)-C(26)  1.205(11) 
O(8)-C(27)  1.407(12) 
N(1)-C(7)  1.383(9) 
N(1)-C(8)  1.479(12) 
N(2)-C(18)  1.336(13) 
N(2)-C(16)  1.423(13) 
N(3)-C(23)  1.337(13) 
N(3)-C(19)  1.485(13) 
N(4)-C(26)  1.306(12) 
N(4)-C(24)  1.477(13) 
C(1)-C(14)  1.485(10) 
C(1)-C(2)  1.488(10) 
C(1)-C(15)  1.515(14) 
C(1)-C(8)  1.585(14) 
C(2)-C(3)  1.3900 
C(2)-C(7)  1.3900 
C(3)-C(4)  1.3900 
  151 
C(4)-C(5)  1.3900 
C(5)-C(6)  1.3900 
C(6)-C(7)  1.3900 
C(9)-C(10)  1.3900 
C(9)-C(14)  1.3900 
C(10)-C(11)  1.3900 
C(11)-C(12)  1.3900 
C(12)-C(13)  1.3900 
C(12)-C(25)  1.503(11) 
C(13)-C(14)  1.3900 
C(15)-C(16)  1.354(14) 
C(16)-C(17)  1.454(14) 
C(18)-C(19)  1.523(15) 
C(19)-C(20)  1.499(15) 
C(20)-C(21)  1.485(17) 
C(20)-C(22)  1.509(17) 
C(23)-C(24)  1.521(14) 
C(24)-C(25)  1.551(16) 
C(26)-C(27)  1.580(13) 
C(27)-C(28)  1.520(13) 
C(28)-C(30)  1.451(17) 
C(28)-C(29)  1.54(2) 
C(31)-C(32)  1.508(10) 
C(31)-C(33)  1.512(10) 
C(34)-C(36)  1.506(11) 
C(34)-C(35)  1.511(11) 
C(37)-C(38)  1.505(11) 
C(37)-C(39)  1.505(11) 
C(40)-C(41)  1.422(17) 
C(41)-C(42)  1.3900 
C(41)-C(46)  1.3900 
C(42)-C(43)  1.3900 
C(43)-C(44)  1.3900 
C(44)-C(45)  1.3900 
C(45)-C(46)  1.3900 
Cl(1)-C(1S)  1.711(9) 
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Cl(2)-C(1S)  1.711(10) 
Cl(3)-C(1S)  1.704(10) 
Cl(4)-C(2S)  1.696(10) 
Cl(5)-C(2S)  1.706(10) 
Cl(6)-Cl(6)#1  1.564(18) 
Cl(6)-C(2S)  1.704(10) 
 
O(8)-Si(1)-C(31)       111.6(4) 
O(8)-Si(1)-C(37) 101.5(5) 
C(31)-Si(1)-C(37) 108.3(7) 
O(8)-Si(1)-C(34) 109.5(5) 
C(31)-Si(1)-C(34) 111.3(6) 
C(37)-Si(1)-C(34) 114.2(8) 
C(9)-O(1)-C(8) 108.0(7) 
C(18)-O(2)-C(15) 106.6(7) 
C(6)-O(5)-C(40) 121.7(8) 
C(27)-O(8)-Si(1) 127.1(6) 
C(7)-N(1)-C(8) 108.2(7) 
C(18)-N(2)-C(16) 101.8(8) 
C(23)-N(3)-C(19) 121.8(8) 
C(26)-N(4)-C(24) 124.2(9) 
C(14)-C(1)-C(2) 116.8(7) 
C(14)-C(1)-C(15) 110.4(7) 
C(2)-C(1)-C(15) 111.7(8) 
C(14)-C(1)-C(8) 100.0(7) 
C(2)-C(1)-C(8) 102.8(7) 
C(15)-C(1)-C(8) 114.4(8) 
C(3)-C(2)-C(7) 120.0 
C(3)-C(2)-C(1) 130.4(6) 
C(7)-C(2)-C(1) 109.5(6) 
C(2)-C(3)-C(4) 120.0 
C(5)-C(4)-C(3) 120.0 
C(4)-C(5)-C(6) 120.0 
C(7)-C(6)-C(5) 120.0 
C(7)-C(6)-O(5) 114.4(5) 
C(5)-C(6)-O(5) 125.6(5) 
  153 
N(1)-C(7)-C(6) 127.0(5) 
N(1)-C(7)-C(2) 113.0(5) 
C(6)-C(7)-C(2) 120.0 
O(1)-C(8)-N(1) 111.8(8) 
O(1)-C(8)-C(1) 107.1(7) 
N(1)-C(8)-C(1) 105.0(7) 
O(1)-C(9)-C(10) 125.1(5) 
O(1)-C(9)-C(14) 114.3(5) 
C(10)-C(9)-C(14) 120.0 
C(9)-C(10)-C(11) 120.0 
C(10)-C(11)-C(12) 120.0 
C(11)-C(12)-C(13) 120.0 
C(11)-C(12)-C(25) 119.3(6) 
C(13)-C(12)-C(25) 119.3(6) 
C(14)-C(13)-C(12) 120.0 
C(13)-C(14)-C(9) 120.0 
C(13)-C(14)-C(1) 128.5(6) 
C(9)-C(14)-C(1) 109.8(5) 
C(16)-C(15)-O(2) 105.8(8) 
C(16)-C(15)-C(1) 141.1(8) 
O(2)-C(15)-C(1) 113.0(8) 
C(15)-C(16)-N(2) 111.5(7) 
C(15)-C(16)-C(17) 126.0(10) 
N(2)-C(16)-C(17) 122.5(9) 
O(4)-C(17)-O(3) 122.5(9) 
O(4)-C(17)-C(16) 116.7(10) 
O(3)-C(17)-C(16) 120.7(10) 
N(2)-C(18)-O(2) 114.2(9) 
N(2)-C(18)-C(19) 130.6(10) 
O(2)-C(18)-C(19) 115.1(9) 
N(3)-C(19)-C(20) 115.8(9) 
N(3)-C(19)-C(18) 107.0(8) 
C(20)-C(19)-C(18) 115.8(9) 
C(21)-C(20)-C(19) 110.5(10) 
C(21)-C(20)-C(22) 109.3(11) 
C(19)-C(20)-C(22) 110.8(10) 
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O(6)-C(23)-N(3) 124.1(10) 
O(6)-C(23)-C(24) 120.4(9) 
N(3)-C(23)-C(24) 115.4(8) 
N(4)-C(24)-C(23) 106.3(8) 
N(4)-C(24)-C(25) 111.7(8) 
C(23)-C(24)-C(25) 113.4(8) 
C(12)-C(25)-C(24) 116.1(9) 
O(7)-C(26)-N(4) 123.5(9) 
O(7)-C(26)-C(27) 124.5(8) 
N(4)-C(26)-C(27) 112.0(9) 
O(8)-C(27)-C(28) 112.3(8) 
O(8)-C(27)-C(26) 108.0(8) 
C(28)-C(27)-C(26) 110.0(7) 
C(30)-C(28)-C(27) 115.4(10) 
C(30)-C(28)-C(29) 110.7(11) 
C(27)-C(28)-C(29) 111.7(9) 
C(32)-C(31)-C(33) 110.4(10) 
C(32)-C(31)-Si(1) 116.5(7) 
C(33)-C(31)-Si(1) 113.6(9) 
C(36)-C(34)-C(35) 100(2) 
C(36)-C(34)-Si(1) 117.7(11) 
C(35)-C(34)-Si(1) 118.3(13) 
C(38)-C(37)-C(39) 118.5(19) 
C(38)-C(37)-Si(1) 126.9(16) 
C(39)-C(37)-Si(1) 114.6(11) 
O(5)-C(40)-C(41) 115.8(13) 
C(42)-C(41)-C(46) 120.0 
C(42)-C(41)-C(40) 121.4(10) 
C(46)-C(41)-C(40) 118.4(10) 
C(43)-C(42)-C(41) 120.0 
C(42)-C(43)-C(44) 120.0 
C(45)-C(44)-C(43) 120.0 
C(44)-C(45)-C(46) 120.0 
C(45)-C(46)-C(41) 120.0 
Cl(3)-C(1S)-Cl(2) 106.7(8) 
Cl(3)-C(1S)-Cl(1) 112.4(9) 
  155 
Cl(2)-C(1S)-Cl(1) 111.6(8) 
Cl(6)#1-Cl(6)-C(2S) 165.6(9) 
Cl(4)-C(2S)-Cl(6) 112.8(9) 
Cl(4)-C(2S)-Cl(5) 114.1(11) 
Cl(6)-C(2S)-Cl(5) 117.3(10) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  #1 -x,y,-z+1       
 
 
Table 4.   Anisotropic displacement parameters  (Å2x 103) for k08308. 
________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
Si(1) 81(2)  86(2) 92(2)  -4(2) 24(1)  -9(2) 
O(1) 90(4)  82(4) 81(4)  -8(4) 22(4)  -6(4) 
O(2) 91(4)  55(4) 74(4)  2(3) 19(3)  6(3) 
O(3) 134(6)  58(4) 94(5)  9(4) 31(4)  4(4) 
O(4) 134(6)  61(4) 70(4)  1(3) 19(4)  9(4) 
O(5) 90(4)  90(5) 80(4)  -22(4) 38(4)  2(4) 
O(6) 101(5)  78(4) 87(4)  0(4) 22(4)  1(4) 
O(7) 81(5)  126(6) 86(4)  -7(4) 31(3)  -2(4) 
O(8) 77(4)  79(4) 96(4)  -18(4) 21(3)  -8(3) 
N(1) 71(5)  80(5) 77(5)  -12(4) 17(4)  -6(4) 
N(2) 78(5)  65(5) 80(5)  -4(4) 32(4)  -6(4) 
N(3) 77(5)  76(5) 84(5)  -2(4) 24(4)  3(4) 
N(4) 79(5)  98(6) 71(5)  8(4) 21(4)  -7(5) 
C(1) 73(5)  70(6) 63(5)  4(4) 21(4)  14(5) 
C(2) 86(7)  77(7) 77(6)  2(5) 11(5)  -4(6) 
C(3) 85(7)  85(7) 87(6)  -3(6) 30(6)  7(6) 
C(4) 73(7)  123(11) 143(10)  -49(9) 16(7)  -28(7) 
C(5) 81(7)  128(10) 96(7)  0(8) 18(6)  -4(7) 
C(6) 69(6)  96(8) 78(6)  -7(6) 10(5)  14(6) 
C(7) 74(6)  70(6) 75(6)  19(5) 16(5)  16(5) 
C(8) 86(6)  76(6) 66(5)  -1(5) 23(5)  -4(5) 
C(9) 99(7)  74(6) 74(6)  -5(5) 32(6)  9(6) 
C(10) 96(7)  53(6) 118(8)  1(5) 40(7)  -15(5) 
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C(11) 96(8)  74(7) 96(8)  9(6) 28(6)  11(6) 
C(12) 83(7)  74(6) 96(7)  -4(6) 18(6)  6(6) 
C(13) 76(6)  68(6) 63(5)  4(4) 21(5)  5(5) 
C(14) 83(7)  87(7) 76(7)  -7(5) 22(5)  9(6) 
C(15) 83(6)  62(6) 63(5)  -13(4) 27(4)  -4(5) 
C(16) 89(7)  78(7) 71(6)  14(6) 18(5)  5(5) 
C(17) 106(8)  73(8) 86(7)  0(6) 33(6)  7(6) 
C(18) 90(7)  62(6) 88(7)  -5(5) 17(5)  3(5) 
C(19) 98(7)  68(6) 63(5)  8(5) 15(5)  0(5) 
C(20) 103(8)  67(6) 87(7)  3(5) 30(6)  15(6) 
C(21) 170(14)  127(12) 109(9)  -48(9) 5(9)  33(10) 
C(22) 117(10)  84(8) 107(8)  4(6) 44(7)  22(7) 
C(23) 42(5)  71(6) 97(6)  -23(5) 24(4)  -11(5) 
C(24) 93(7)  76(7) 66(6)  3(5) 21(5)  -5(5) 
C(25) 117(8)  93(8) 57(5)  5(5) 14(5)  -6(7) 
C(26) 72(6)  61(5) 65(5)  5(4) 34(4)  8(5) 
C(27) 88(7)  47(5) 97(7)  -7(5) 25(5)  -28(5) 
C(28) 90(7)  91(7) 61(5)  17(5) 27(5)  7(5) 
C(29) 132(11)  101(10) 138(11)  38(8) 54(9)  10(8) 
C(30) 142(11)  103(9) 141(11)  8(8) 68(9)  -16(9) 
C(31) 119(9)  84(7) 83(6)  -30(6) 3(6)  16(7) 
C(32) 81(7)  92(8) 127(9)  19(7) 9(6)  2(6) 
C(33) 124(11)  159(15) 128(11)  12(11) -9(9)  -51(11) 
C(34) 115(10)  129(13) 151(13)  47(11) -13(10)  -38(10) 
C(35) 280(30)  132(17) 189(19)  -1(15) -39(19)  -86(18) 
C(36) 230(20)  91(12) 410(40)  46(18) 170(30)  64(14) 
C(37) 93(9)  220(20) 178(14)  -7(15) 40(9)  -56(12) 
C(38) 180(20)  129(15) 280(30)  9(18) 8(18)  -58(15) 
C(39) 290(30)  153(18) 260(20)  -100(18) 190(20)  -51(19) 
C(40) 92(8)  146(13) 128(10)  -45(10) 8(7)  37(8) 
C(41) 96(8)  75(7) 115(9)  -6(7) 32(7)  17(6) 
C(42) 114(9)  131(13) 102(8)  5(9) 16(7)  -24(9) 
C(43) 102(10)  77(10) 226(19)  1(11) 29(11)  -12(7) 
C(44) 126(12)  92(11) 191(17)  -65(12) 13(11)  13(9) 
C(45) 117(10)  158(16) 118(10)  -24(12) 15(8)  23(11) 
C(46) 116(9)  107(10) 105(9)  -14(8) 25(7)  2(8) 
  157 
Cl(1) 193(7)  94(5) 96(4)  2(3) 9(4)  -40(5) 
Cl(2) 173(7)  119(6) 134(5)  1(5) 49(5)  5(5) 
Cl(3) 110(5)  146(8) 286(12)  46(8) 99(7)  26(5) 
C(1S) 101(16)  200(30) 67(11)  -22(16) 14(11)  -80(20) 
Cl(4) 132(6)  144(7) 220(9)  -50(7) 54(6)  -5(6) 
Cl(5) 180(8)  179(9) 137(6)  -20(6) 41(6)  -18(7) 
Cl(6) 107(5)  177(8) 171(7)  11(7) 36(4)  3(5) 
C(2S) 180(30)  130(30) 260(40)  -90(30) 140(30)  -40(20) 
 
 
Table 5.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 
103) for k08308. 
________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________ 
  
H(3) 4976 3425 9738 143 
H(4) 4938 4543 9775 135 
H(1A) 4971 6823 9246 92 
H(3B) 4628 4051 5858 94 
H(4B) 2993 4888 4328 99 
H(3A) 2894 5191 7766 101 
H(4A) 2150 5605 8440 139 
H(5A) 2592 6425 9392 123 
H(8A) 5367 5608 8735 91 
H(10A) 5487 7091 6866 105 
H(11A) 4744 6853 5749 106 
H(13A) 3459 5562 6593 82 
H(19A) 3625 3261 6338 93 
H(20A) 4426 2270 6758 102 
H(21A) 4455 1800 5663 213 
H(21B) 4265 2640 5334 213 
H(21C) 3699 2177 5629 213 
H(22A) 5521 2251 6482 150 
H(22B) 5495 2969 6979 150 
  158 
H(22C) 5379 3100 6160 150 
H(24A) 4366 5053 5212 94 
H(25A) 3745 6254 5002 109 
H(25B) 3132 5910 5306 109 
H(27A) 3287 3842 3153 93 
H(28A) 2898 4791 2275 95 
H(29A) 2791 5841 3000 180 
H(29B) 3214 6075 2444 180 
H(29C) 3638 5921 3241 180 
H(30A) 4014 4223 2427 184 
H(30B) 4354 4992 2823 184 
H(30C) 3902 5030 2023 184 
H(31A) 1908 3591 1987 120 
H(32A) 1133 4456 1286 156 
H(32B) 1708 4885 1897 156 
H(32C) 912 4775 1952 156 
H(33A) 775 3189 1389 218 
H(33B) 509 3328 2073 218 
H(33C) 1093 2682 2074 218 
H(34A) 1708 2516 3413 169 
H(35A) 2650 2239 4371 329 
H(35B) 2233 2980 4531 329 
H(35C) 2974 3081 4344 329 
H(36A) 2753 1899 3401 340 
H(36B) 3090 2695 3237 340 
H(36C) 2429 2326 2671 340 
H(37A) 913 4468 3006 197 
H(38A) 194 4282 3701 312 
H(38B) 583 3465 3857 312 
H(38C) 207 3716 3069 312 
H(39A) 922 5280 3888 318 
H(39B) 1420 5392 3375 318 
H(39C) 1748 5065 4147 318 
H(40A) 3589 6866 10680 152 
H(40B) 3053 7329 10065 152 
H(42A) 4150 8454 9866 142 
  159 
H(43A) 4465 9647 10409 165 
H(44A) 4315 9873 11521 171 
H(45A) 3849 8906 12089 161 
H(46A) 3534 7714 11546 133 
H(1S) 2346 4254 -136 150 
H(2S) 1129 6218 5886 209 
 
 
Table 6.  Hydrogen bonds for k08308  [Å and °]. 
________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________  
 O(3)-H(3)...O(3)#2 0.84 1.85 2.681(15) 168.8 
 O(4)-H(4)...O(4)#2 0.84 1.69 2.507(13) 162.8 
 N(1)-H(1A)...O(5)#2 0.88 2.44 3.164(10) 140.3 
 N(3)-H(3B)...O(7)#3 0.88 2.06 2.891(12) 157.1 
 N(4)-H(4B)...O(8) 0.88 2.02 2.511(10) 113.9 
Symmetry transformations used to generate equivalent atoms:  
#1 -x,y,-z+1    #2 -x+1,y,-z+2    #3 -x+1,y,-z+1       
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Chapter 5 
 
Third-Generation MacMillan Synthesis of Diazonamide A 
 
I. Development of a New Synthetic Strategy 
 As described at the conclusion of the previous chapter, closure of the right-hand 
macrocycle of diazonamide A through a late-stage photocyclization proved unachievable, 
despite several highly analogous precedents (Figure 1). Undaunted, we sought to 
investigate and develop alternative approaches to creating this complicated substructure. 
To take full advantage of our prior success in closing the left-hand portion of the target 
molecule, we chose to begin our new investigations from thioester 3, an intermediate 
from our previous studies. 
Figure 1: Failed Witkop cyclization necessitates new solutions
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 The highly strained nature of the unusual right-hand ring system made us 
circumspect of any disconnection leading to direct annulation of the intact ring. Rather, 
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we chose to revisit our previous strategy of first creating a larger, conformationally 
flexible ring and then subsequently contracting it to the desired size (Figure 2). This 
approach had proven uniquely successful in our efforts to close the left-hand macrocycle 
of diazonamide A, and its use had the additional appeal of providing a pleasing 
conceptual symmetry to our synthesis. 
Figure 2:  Strategies for the synthesis of the right-hand macrocycle
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 Application of this strategy to the system at hand was straightforward. Working 
retrosynthetically from the intact macrocycle 2, we postulated that the ring contraction 
step would be most easily applied to the cyclodehydration of the B-ring oxazole, leading 
to a target structure such as 6 (Figure 2). Amide 6 could then be synthesized by the 
appendage of a suitably substituted tryptamine unit onto an appropriate derivative of 
thioester 3 and closure of the D-E biaryl bond.  
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 Choosing to install the tryptamine unit intact, we were presented with two 
limiting possibilities for accomplishing these two bond constructions in the synthesis of 6 
(Figure 3). The first would be to initially form the D-E biaryl bond in an intermolecular 
process and then attempt a macrolactamization. Alternatively the intermolecular amide 
bond could be created first, followed by intramolecular ring-closing biaryl formation.  
Figure 3: Limiting possibilities for the synthesis of the hydrated right-hand macrocycle
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 Examining both scenarios on the basis of practicality and precedence indicated 
that the macrolactamization approach was unsound. Prior work from the Vedejs group 
illustrated that palladium-catalyzed cross coupling produced the D-E biaryl as a 1:1 
mixture of atropisomers and that the kinetic barrier to their interconversion was roughly 
20 kcal/mol when the indole 3’ benzylic carbon is sp2 hybridized (Figure 4).1 However, 
with an sp3 hybridized methylene group in the benzylic position, such as we required, the 
barrier would likely be substantially higher, if not impossible in a synthetically 
                                                
1 Zajac, M. A.; Vedejs, E. Org. Lett. 2004, 6, 237–240. 
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reasonable temperature regime. This suggested the likelihood that lactamization would 
likely affect a resolution of the atropisomers resulting from intermolecular biaryl 
formation, rendering half of a precious late-stage intermediate unusable.  In light of this 
possibility, we elected to pursue an approach of intermolecular amide formation followed 
by intramolecular biaryl formation as the key ring-closing event. 
Figure 4: Barriers to rotation around D-E biaryl axis
!G = 19 kcal/mol
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 A palladium-catalyzed Suzuki coupling was chosen as the preferred methodology 
to form the desired D-E biaryl bond. This reaction has been used often in the synthesis of 
large rings and the reaction conditions are suitably mild for complex substrates.2 
Secondly, this bond construction could utilize the phenol already present in the benzyl 
ether of 3 as its corresponding triflate. But perhaps most importantly, the 4-indole 
boronic ester 8 was predicted to be synthetically robust. This was deemed an essential 
attribute, as the boron functionality would have to survive intact through several 
                                                
2 For several examples of the use of Suzuki coupling in the synthesis of large ring biaryls, see: (a) Elder, A. 
M.; Rich, D. H. Org. Lett. 1999, 1, 1443–1446. (b) Carbonnelle, A. C.; Zhu, J. Org. Lett. 2000, 2, 3477–
3480. (c) Boi-Choussy, M.; Cristau, P.; Zhu, J. Angew. Chem. Int. Ed. 2003, 42, 4238–4241.  
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transformations prior to its actual use. With this ring contraction strategy and associated 
retrosynthetic analysis in hand, we were ready to evaluate their viability. 
 
 
II. Third-Generation Synthesis  
 In the forward direction our new synthesis begins with the hydrolysis of the ethyl 
thioester and trifluoroacetamide of 3 under the action of aqueous lithium hydroxide (eq 
1). This was followed by hydrogenolysis of the benzyl ether of 9 with Pearlman’s 
catalyst, providing phenol 10 in 99% yield (eq 2). This two-step procedure provides rapid 
and nearly quantitative access to key building block 10, from which we would investigate 
our new annulation strategy. 
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 The synthesis of the 4-boronic ester tryptamine component commences with the 
known reaction of 4-bromoindole 11 and nitroalkene 12 in neat trifluoroacetic acid to 
yield 13 in quantitative yield (Scheme 1). 13 is then reduced to its corresponding 
saturated amine by treatment with excess lithium aluminum hydride in refluxing THF, as 
 165 
had been previously described by Nicolaou.3 The resulting amine product is then 
exhaustively acylated with excess Boc2O in acetonitrile under DMAP catalysis to provide 
triscarbamate 14 in 52% yield over two steps. The resulting aryl bromide of 14 is then 
transformed into its corresponding (pinacolato)boronic ester 15 through a 
palladium-catalyzed Suzuki-Miyaura borylation and the carbamate protecting groups 
were removed with TFA to yield the desired tryptamine 16 in a scalable five-step 
sequence.  
Scheme 1:  Synthesis of 4-boronic ester tryptamine
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 With fragments 10 and 16 in hand, we were able to investigate the amide bond 
formation necessary to join them together.  This was readily accomplished, with the use 
of TBTU and HOBT in DMF proving optimal, providing the desired amide product 17 in 
90% yield (Scheme 2).4 Following intermolecular amide formation, the resulting phenol 
was then transformed into its corresponding aryl triflate in 86% yield using NPhTf2 to 
provide key intermediate 18 for our proposed Suzuki macrocyclization. Gratifyingly, no 
                                                
3 Nicolaou, K. C.; Snyder, S. A.; Huang, X.; Simonsen, K. B.; Koumbis, A. E.; Bigot, A. J. Am. Chem. Soc. 
2004, 126, 10162–10173. 
4 The efficiency of this process was strongly dependent on the quality of the coupling agent and optimal 
results were only obtained using fresh TBTU. 
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protodeborylation of the boronic ester functionality was observed during carbamate 
deprotection, peptide coupling, or triflate formation. 
 Scheme 2: Synthesis of Suzuki macrocyclization precursor
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 With 18 in hand, we were now situated to explore the key intramolecular Suzuki 
reaction to close the right-hand 13-membered ring. While Suzuki couplings are a 
mainstay technology in the synthesis of biaryls, their success is often highly dependent on 
every reaction variable, including the composition of the solvent mixtures, base, 
palladium source, ligand, temperature, and concentration.5 This makes exhaustive 
optimization a time consuming and materially expensive process, which can be especially 
daunting when conducted at an advanced stage of a synthesis with precious 
intermediates. In light of these considerations, we conducted a modest survey of initial 
reaction conditions, with the hope that a promising lead would develop which could be 
optimized further.  
                                                
5 Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457–2483. 
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 Selected results of this initial screening are listed below in Table 1. Pd(PPh3)4 was 
initially found to be an effective catalyst for the desired transformation (Table 1, entry 4). 
Evaluation of the base demonstrated that potassium salts were most effective, and that 
K3PO4 was optimal in terms of yield. A mixed dioxane/water solvent system provided the 
greatest level of conversion, providing the desired adduct 19 in 53% when heated to 70 
°C for one hour. Though modest, this yield was serviceable and allowed subsequent 
downstream chemistry to be examined. Moreover, closure of this macrocycle signaled 
that a substantial fraction of our synthetic strategy had been successfully executed, 
providing a firm footing for both planning and investigating all subsequent approaches to 
this substructure. 
Entry Pd Source Base Temp (°C) Solvent Yield
Table 1: Optimization of intramolecular Suzuki coupling
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  We were now positioned to evaluate our proposed ring-contraction. Toward this 
end, we would need to oxidize the benzylic methylene of our tryptamine fragment of 19 
to its corresponding ketone, followed by cyclodehydration of the resulting ketoamide to 
furnish the desired bisoxazole (Figure 5). 
 Figure 5: Benzylic oxidation route to the keto-amide necessary to form the desired oxazole
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 In our previous work on an analogous acyclic substrate 20, this transformation 
was easily performed with DDQ in aqueous THF (Figure 6). However, when 19 was 
exposed to these conditions, the sole product was oxazoline 22, resulting from the 
intramolecular trapping of the transient cation by the pendant amide carbonyl in a process 
mechanistically related to the well-known Yonemitsu oxidation.6  
OBn
N
O
NH
BocHN
Me Me
H
N
O
TIPSO
Me Me
O
CO2Me
O
HN NH
DDQ
THF/H2O
(70%)
OBn
N
O
NH
BocHN
Me Me
H
N
O
TIPSO
Me Me
O
CO2Me
O
HN NH
O
20 21
Figure 6: Benzylic oxidation of tryptamine
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6 Oikawa, Y.; Yonemitsu, Y. J. Org. Chem. 1977, 42, 1213–1216. 
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 The observation that the amide carbonyl was kinetically able to outcompete the 
water in solution in quenching the carbocation is likely the result of the conformational 
constraints inherent to the large ring that effectively lock this internal nucleophile in close 
proximity to the oxidatively generated cation. This stands in sharp contrast to the high 
yield of aryl ketone 21 observed upon subjection of a highly analogous acyclic substrate 
(20) to identical reaction conditions (eq 3). Yet, though unexpected, this oxazoline 
formation had accomplished our desired ring contraction and this functionality had only 
to be dehydrogenated to yield the intact right-hand macrocycle.  
 Oxidations of dihydroheteroaromatics to their corresponding arenes are well 
known in the literature, and an abundance of conditions have been reported to affect these 
transformations. Thus, we were optimistic that this type of oxidation would also be 
suitable to our purposes and readily accomplished. However, all the known cases of 
oxidizing 4,5 dihydrooxazoles, such as 22, to their corresponding fully aromatic 
congeners required the presence of an electron withdrawing group at the 4-position of the 
ring.7 Yet, being so close to finishing the total synthesis and faced with no other readily 
apparent options, we pushed onward and attempted to apply the most commonly used 
conditions to affect this general type of transformation to 22. Heterogeneous metal 
oxidants, such as MnO2 or Pd/C and O2, were evaluated first, but despite extensive efforts 
these reagents all proved unsuccessful, providing only recovered starting material and 
unidentifiable decomposition products. Furthermore, treatment with oxidants such as 
DDQ or CAN also failed to deliver any of the desired oxazole 23. 
                                                
7 (a) Barrish, J. C.; Singh, J.; Sperel, S. H.; Han, W. C.; Kissick, T. P.; Kronenthal, D. R.; Mueller, R. H. J. 
Org. Chem. 1993, 58, 4494–4496. (b) Tavares, F.; Meyers, A. I. Tet. Lett. 1994, 35, 6803–6806. 
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Figure 7: Attempted dehydrogenation of oxazoline
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III. A Second Approach 
 Thus, faced with the seeming reluctance of substrate 22 to undergo the desired 
oxidation event, we decided to reevaluate our strategy. Being unable to install either the 
aryl ketone functionality necessary for cyclodehydration or to dehydrogenate the 
oxazoline functionality, we chose to synthesize tryptamine 25, where the benzylic carbon 
was already in the desired ketone oxidation state (Figure 8). This could then be coupled 
Figure 8:  New retrosynthesis of the right-hand macrocycle
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to carboxylic acid 24 as described above and subjected to ring-closing Suzuki coupling. 
Following biaryl formation, the ring of 27 could then be contracted through 
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cyclodehydration using any one of a variety of conditions to yield the intact right-hand 
macrocycle 28. 
 In the forward sense, the synthesis of 25 commences with a Vilsmeier-Hack 
acylation between the valine-derived dimethylamide 29 and 4-bromoindole 12 under the 
action of POCl3 in refluxing dioxane, to yield the desired aryl ketone 30 in 76% yield 
following hydrolysis (Scheme 3).8 The N-H bond of this acylindole product was deemed 
too acidic not to interfere in subsequent synthetic steps and was accordingly protected 
with benzyl bromide to yield ketone 31.  The phthalimide group was then removed by a 
two-step protocol involving treatment first with a refluxing solution of aqueous KOH in 
isopropanol followed by refluxing the resulting product in an aqueous solution of HBr 
and AcOH. The resulting free amine 32 was then protected as its Boc-carbamate (33) and 
Scheme 3:  Synthesis of 4-boronic ester 3'-oxotryptamine
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subjected to Suzuki-Miyaura borylation to install the requisite 4-(pinacolato)boronic 
                                                
8 Kreisberg, J. D.; Magnus, P.; McIver, E. G. Tet. Lett. 2001, 42, 627–629. 
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ester. The tert-butyl carbamate of 34 was then removed through protonolysis to yield the 
desired fragment 25 in a straightforward and scalable seven-step sequence.  
 Tryptamine fragment 25 was then coupled to carboxylic acid 10 using EDC and 
HOBT to provide amide 35 in 89% yield (Scheme 4). The phenol was then converted to 
triflate 26 upon treatment with NPhTf2 to yield the precursor for the desired Suzuki 
macrocyclization.  
 Scheme 4: Synthesis of second-generation Suzuki macrocyclization precursor
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 We found that the reaction conditions optimized for the previously described 
Suzuki macrocyclization were also effective for 26, providing the 13-membered ring of 
product 27 in 36% yield. However, with optimization it was discovered that when the 
reaction temperature was raised to 90 °C the product was produced in a more acceptable 
54% yield (Figure 9). Notably, even with this relatively high reaction temperature and the 
presence of a reasonably strong aqueous base, no epimerization of the amino acid-derived 
stereocenters was observed. 
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 We then set out to attempt the proposed cyclodehydration of 27 using the 
chlorophosphonium-mediated conditions reported by Wipf and coworkers that had been 
effective in cyclizing an acyclic analogue (36) (Figure 10).9 However, treatment of 27 
under these conditions only returned the starting material, even when a vast excess of 
reagent was employed. Likewise, treatment with other standard cyclodehydrating 
conditions, such as POCl3 in pyridine or strong mineral acids, produced none of the 
36 37
Figure 10: Failed cyclodehydration using Wipf conditions
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desired oxazole 23. The reasons for the failure of these reagents to act on 27 are not 
                                                
9 Wipf, P.; Miller, C. P. J. Org. Chem. 1993, 58, 3604–3606. 
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clearly apparent, however it seemed that this second approach had reached an 
irresolvable impasse and was subsequently abandoned in favor of a new approach. 
 
 
IV. A Third Approach 
 Having again come within a single transformation of the certain completion of our 
total synthesis of diazonamide A, we were obliged to regroup and devise a new path 
forward. We remained confident that our overarching ring-contraction strategy was 
viable, given our success in forming the ring-contracted oxazoline 22 (Figure 11). 
However, we had found this unfunctionalized form of the heterocycle could not be 
successfully dehydrogenated due to the severe constraints associated with adopting the 
stereoelectronically required coplanar confirmation required to form the requisite 
benzylic oxocarbenium within the oxazoline-containing macrocyclic framework. 
However, we reasoned that this constraint could be bypassed if the homobenzylic 
methylene of the oxazoline was to undergo oxidation instead. This could be most readily 
accomplished if the carbon in question was conjugated to a stabilizing functionality 
external to the macrocyclic framework.  
 There are many known examples of dehydrogenating 4-acyloxazolines under 
oxidizing conditions, presumably through oxidation of the relatively electron-rich enol or 
enolate form of the substrate. This suggests that incorporation of a carbonyl group at the 
homobenzylic position of our tryptamine backbone would provide a secondary avenue by 
which to create the requisite oxazole ring without having to access a highly disfavored 
conformation (Figure 11). We envisioned that the carbonyl functionality could then be 
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Figure 11: Retrosynthetic plan to dehydrogenate  4-acyloxazoline
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excised at a later stage through any one of a variety of standard synthetic protocols. 
While this would necessitate a longer synthetic sequence, we felt the likelihood of 
success more than justified the added steps.  
 For this strategy to be carried out successfully, we would need to access an 
oxazoline substrate such as 38. This was foreseen to arise retrosynthetically from a 
substrate 40, which we reasoned should undergo oxidative ring contraction upon 
treatment with DDQ in a similar fashion to 22, discussed previously (Figure 12). To 
create 40 we planned to utilize the peptide coupling/Suzuki macrocyclization sequence 
that had worked admirably in our earlier efforts. Retrosynthetically this prescribed 
coupling carboxylic acid 10 to a tryptophan derivate similar to 42.  
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Figure 12:  Retrosynthesis with acyloxazoline oxidation as a method to form the B-ring oxazole
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 The synthesis of a functionalized tryptophan 42 was a somewhat more complex 
proposition than the previously described tryptamine syntheses had been, as the necessary 
amino acid stereocenter would have to be produced in a highly enantioenriched form to 
avoid the production of diastereomers when coupled to enantiopure 10. Yet, we felt that 
this problem was solvable and well worth investigating given the potential downstream 
reward. As such we set out with an initial goal to develop a concise, asymmetric 
synthesis of a suitably protected version of 42. 
 Our synthetic investigations began with an attempt to adopt a known enzymatic 
resolution of racemic acyltryptophans to our current purpose. Using a modification of the 
method originally reported by Snyder, we alkylated serine with 4-bromoindole 11 in a 
mixture of AcOH and Ac2O to provide racemic N-acyl tryptophan 45 in 96% yield 
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(Scheme 5).10 This adduct was then subjected to the enzyme Acylase according to the 
procedure of Yokoyama, which effectively resolved the enantiomers of 45, providing 
46% of the (L)-configured, freebased amino acid 46 in 99% ee.11 However, while this 
reaction was highly selective and easily carried out, the purification of the polar amino 
acid products away from the enzyme residue proved untenable on multigram scale, 
despite considerable efforts, and this method of producing 46 was subsequently 
abandoned. However, as an interesting aside, we found that the enzyme tolerated both 
benzyl and PMB protecting groups on the indole nitrogen of the resolution substrates 
without loss of efficiency or selectivity.12  
N
H
Br
HO
NH2
CO2H
Ac2O, 
AcOH
80 °C
N
O
O
Me
N
H
Br
NHAc
CO2H
N
H
Br
NH2
CO2H
N
H
Br
NHAc
CO2H
Acylase
cat. CoCl2
pH = 7.5, 37 °C
(96%)
Scheme 5: Enzymatic resolution route to enantiopure 4-bromotryptphan derivatives
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 Faced with this setback, we next elected to make use of a technology that had 
recently been developed in our laboratories by Dr. Muriel Amatore for the production of 
enantioenriched α-chloroaldehydes.13 This methodology utilizes imidazolidinone catalyst 
                                                
10 Snyder, H. R.; MacDonald, J. A. J. Am. Chem. Soc. 1957, 79, 1257–1259.  
11 Yokoyama, Y.; Hikawa, H.; Mitsuhashi, M.; Uyama, A.; Hiroki, Y., Murakami, Y. Eur. J. Org. Chem. 
2004, 1244–1253. 
12 For use of acylase enzymes in resoling a wide variety of unnatural N-acyl amino acids, see: Chenault, H. 
K.; Dahmer, J.; Whitesides, G. M. J. Am. Chem. Soc. 1989, 111, 6354–6364. 
13 Amatore, M.; MacMillan, D. W. C. Unpublished results. 
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48, which in conjunction with LiCl and a copper(II)trifluoroacetate oxidant, effects a 
highly efficient and uniformly enantioselective α-chlorination across a wide range of 
aldehyde substrates (Scheme 6). Furthermore, prior work in the MacMillan lab had 
shown that the conversion of these chloroaldehydes into their corresponding amino acids 
with net stereochemical retention and without loss of optical purity was easily 
accomplished in a simple three-step, one-pot protocol. We felt that this would be a 
particularly straightforward entry into the catalytic asymmetric synthesis of 
4-bromotryptophans such as 42 and a forceful demonstration of this newly developed and 
valuable technique for the de novo synthesis of unnatural amino acids.14 
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Scheme 6: Asymmetric, organocatalytic synthesis of amino acids from chloroaldehydes
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 Toward this end, we set out to make the β-indolyl aldehyde substrate required for 
the proposed chlorination procedure. This was accomplished first by an iminium-
catalyzed Friedel-Crafts addition of 4-bromoindole 11 into acrolein, giving product 53 in 
78% yield (Scheme 7). The indole nitrogen of 53 was next acylated with CbzCl, yielding 
the substrate for our organocatalytic α-chlorination (54) in a scalable two-step sequence. 
Aldehyde 54 was then treated with trans t-butyl, methyl imidazolidinone catalyst 48, 
                                                
14 Hong, J. B.; Jones, C. M.; Garcia-Garcia, P.; MacMillan, D. W. C. Unpublished results. 
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LiCl, and copper(II)trifluoroacetate in acetonitrile at room temperature to produce the 
desired chloroaldehyde 55, which underwent in situ Pinnick oxidation to yield chloroacid 
56 in 80% yield and 89% ee. Notably, 2-methyl-2-butene, which is frequently used as an 
in situ quench for the electrophilic HOCl byproduct generated during the reaction, was 
not nucleophilic enough to kinetically outcompete an undesired electrophilic chlorination 
of the indole ring. However, using the 1,3-dimethoxybenzene as hypochlorite scavenger 
prevents this undesired reaction pathway and allows the desired chloroacid to be 
produced cleanly and in high yield. 
NaClO2
1,3 dimethoxy benzene
tBuOH, MeCN, H2O
Cu(OTFA)2
LiCl
MeCN
0 °C
 • TFA
N
H
N
MeO
Me CMe3
Scheme 7: Asymmetric, organocatalytic synthesis of enantioenriched !"chloroacid
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 However, when chloroacid 56 was subjected to the standard conditions developed 
for amination, the product was obtained in only 36% ee (Figure 13). We reasoned that 
this was likely due to the involvement of neighboring group participation from the indole 
ring in the displacement of the chloride. The proposed stereoretentive mechanism for 
these reactions is proposed to occur through initial intramolecular SN2 attack of the 
carboxylic acid moiety on the adjacent chloride to yield a stereoinverted epoxylactone 
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intermediate, as shown in Figure 13. This epoxylactone is then opened and inverted again 
by ammonia to yield an amino acid product with the same configuration as the starting 
chloroacid. However, it is well known that electron-rich aromatics such as indoles are 
capable of displacing β-leaving groups, through the intermediacy of phenonium-type 
intermediates.15 If this were to occur at an appreciable rate with substrate 56 it could 
create a possible triple inversion pathway to compete with the desired double inversion 
mechanism. The products of this new pathway would have a configuration opposite to 
that of the starting material, diminishing the enantiomeric purity of the product.  
NH4OH
MeCN
110 °C
Figure 13: Initial attempts at amination of chloroacid
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15 Arumugam, S.; Verkade, J. G.  J. Org. Chem. 1997, 62, 4287–4828. 
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 To bypass this problem we employed an alternate, though less direct, method for 
the conversion of α-chloroaldehydes to amino acids reported by Jørgenson and 
coworkers.16 The antipode of chloroacid 56 was synthesized in the previously described 
manner and was then coupled to trimethylsilylethanol to generate TMSE ester 58 in 77% 
yield (Scheme 8). The chloride was then displaced by sodium azide in DMF to yield the 
TMSEtOH
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Scheme 8: Revised attempt at amination of chloroacid
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stereoinverted α-azidoester 59 in 87% yield. The azide product was then reduced with 
PPh3 in aqueous THF at 50 °C to yield the amine product 60, which was subsequently 
acylated as its benzyl carbamate, 61. Notably, the enantiomeric excess of the starting 
material was retained throughout this sequence, giving fully protected tryptophan 
derivative 61 in a scalable and selective four-step sequence from 56. 
 The aryl bromide was then transformed by a palladium-catalyzed Suzuki-Miyaura 
borylation to boronic ester 62 in 68% yield (Scheme 9). The benzyl carbamates of adduct 
62 were reductively removed to yield the desired 4-boronic ester tryptophan 63. Notably, 
none of the boronic ester functionality was reduced in this hydrogenolysis event. 
                                                
16 Halland, N.; Braunton, A.; Bachmann, S.; Marigo, M.; Jørgensen, K. A. J. Am. Chem. Soc. 2004, 126, 
4790–4791. 
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Scheme 9: Completion of 4-boronic ester tryptophan synthesis
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 Amino ester 63 was next coupled to carboxylic acid 10 using EDC and HOBT in 
DMF to yield the product 64 in 79% yield (Scheme 10). This was followed by triflation 
of the phenol functionality, providing the substrate 65 for our key intramolecular Suzuki 
macrocyclization.  
 Scheme 10: Synthesis of third-generation Suzuki macrocyclization precursor
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 Gratifyingly, subjection of 65 to our standard Suzuki conditions successfully 
forged the desired the biaryl bond and the 13-membered macrocycle 66 in 52% yield 
(Table 2, entry 1). Yet, the yield of this process was still modest and for the sake of 
efficient material throughput we sought to improve upon it further. Given the specific 
dependence of reaction outcome on the catalyst, base, and solvent composition, we felt 
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that modulation of the reaction temperature was the most straightforward variable to 
investigate. However, we were wary that excessive heating under the basic reaction 
conditions presented a significant risk of epimerizing the amino acid-derived 
stereocenters. Fortunately, we observed raising the temperature to 100 °C afforded a 
modest increase in reaction efficiency with no observable epimerization (Table 2, entry 
2). While the boiling point for the dioxane and water solvent system we employed was 
roughly 105 °C, carrying out these reactions under microwave irradiation allowed us to 
access substantially higher reaction temperatures, prompting us to investigate the 
observed dependence of efficiency on reaction temperature more fully.  
Table 2: Third-generation Suzuki macrocyclization
Pd cat, base
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Entry Pd Source Base Temp (°C)Heating Yield
Pd(PPh3)4 K3PO4 thermal 90 52%
Pd(PPh3)4 K3PO4 microwave 120 70%
1
4
Pd(PPh3)4 K3PO4 microwave 110 63%
Pd(PPh3)4 K3PO4 thermal 100 58%
3
2
Pd(PPh3)4 K3PO4 microwave 130 45%5
65 66
 
 Agreeably, we found that running the reactions at 110 °C in the microwave 
reactor provided the desired product 66 in an improved 63% isolated yield (Table 2, entry 
3). Raising the temperature yet again to 120 °C provided the desired adduct in a 
satisfying 70% isolated yield (Table 2, entry 4) with no observable epimerization. 
 184 
Notably, going to yet higher temperatures resulted in a lower overall reaction efficiency 
due to partial decomposition of the starting material (Table 2, entry 5). But we were 
pleased with these results nonetheless, as they represented one of the most efficient 
closures of the right-hand macrocycle in the diazonamide literature and provided material 
to investigate the subsequent ring contraction-oxidation strategy. 
 Biaryl 66 was subjected to DDQ in anhydrous THF in accordance with our 
previously described oxazoline formation. However, the presence of the electron-
withdrawing β-ester required heating the reaction temperature to 80 °C in dioxane to 
effect the desired oxidation. Yet remarkably, along with the expected oxazoline was 
formed a small amount of what initially appeared by NMR and HRMS to be fully 
oxidized acyloxazole product 67 (Figure 14). Our strategy appeared to be even more 
effective than we anticipated as the ester group, while slowing the rate of the first 
oxidation, fully enabled the second in accord with our mechanistic hypothesis. 
Optimization of reaction conditions found that the desired reaction could be carried out 
with an excess of DDQ in CH2Cl2 at 35 °C to provide nominal 67 as the exclusive 
product in 45% isolated yield.  
Figure 14: Presumptive direct oxidative installation of B-ring oxazole
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 However, one feature of the 1H NMR was inconsistent with the structure of 67, 
despite the accordance of the observed mass spectral data. Namely, there was a sharp 
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doublet resonance at 5.03 ppm that possessed a very small J-coupling to the proton at 
C(2) of  C-ring indole and had a 13C NMR resonance at 68.8 ppm. A battery of two-
dimensional correlated NMR experiments finally revealed the true structure of 67 to be 
its corresponding hydrate 68 (Figure 15). Thus, we had indeed affected the desired 
double oxidation. However, the product was sufficiently reactive to irreversibly hydrate 
upon aqueous workup. We had been misled by initial mass spectroscopy of the isolated 
reaction product, as the nascent hydroxyl group eliminated readily upon ionization in the 
spectrometer, suggesting a desiccated form of the molecular ion with the molecular 
formula corresponding to a protonated form of 67. 
Figure 15: Identification of oxidation products
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 Unfortunately, all attempts to advance 68 met with failure. Treatment under even 
mildly basic conditions rapidly decomposed the starting material. Indeed, even attempts 
to deprotect the TMSE ester with TBAF or TASF caused immediate and non-productive 
consumption of the substrate. Notably, 68 was stable to treatment with acidic conditions, 
but still remained always in hydrated form upon isolation   
 Needless to say, given how close we had again come to success, this was easily 
our most disappointing setback. Our synthetic strategy had been effectively and 
succinctly reduced to practice, and our mechanistic insights had led to successful 
installation of the desired functionality in the desired manner. However, the instability of 
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the acyl oxazole moiety was a completely unforeseen, and seemingly unworkable, 
complication.  
 As such, we again set out to formulate an updated tactical approach. One 
particularly promising avenue considered was the oxidative decarboxylation of 
carboxylic acids. First described by J. K. Kochi, this rarely used reaction is a direct 
method of installing an unsaturation from a simple carboxylic acid precursor (Figure 
16).17 In a generalized mechanism, an acid (69) is treated with a metal oxidant, typically 
Pb(IV), Ce(IV), Mn(III), or Ag(I), which induces oxidation of the carboxylate to yield an 
oxygen-bound radical species (71). This intermediate then readily decomposes to expel 
carbon dioxide and yield a new alkyl radical 72. This radical can then abstract a hydrogen 
atom from solvent or, in the presence of copper(II) salts, be oxidized to its corresponding 
carbocation 73.18 This cation can then intercept a solution nucleophile or eliminate to 
yield an olefinic product 74. 
Figure 16: Proposed mechanism of oxidative decarboxylation
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 Application of this mechanistic scheme to our intermediate appeared promising. If 
anoxazoline acid such as 75 was treated under Kochi’s Pb(IV)/Cu(II) conditions, it 
                                                
17 For lead references on oxidative decarboxylation, see: (a) Kochi, J. K.; Bacha, J. D.; Bethea, T. W. J. 
Am. Chem. Soc. 1967, 89, 6538–6547. (b) Bacha, J. D.; Kochi, J. K. Tetrahedron, 1968, 24, 2215–2226 
18 For lead references on the use of copper additives in oxidative decarboxylation see: Bacha, J. D.; Kochi, 
J. K. J. Org. Chem. 1968, 33, 2746–2754. 
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should result in the formation of a carboxyl radical which will fragment to yield radical 
76 and CO2 (Figure 17). This radical would then readily be oxidized by the copper(II) 
salts in solution to generate the carbocation 77. Analysis of the resonance forms of this 
cation (78) reveals that it represents a protonated form of the oxazole, which should 
readily be deprotonated to return the desired aromatic product.19 
Figure 17: Retrosynthetic plan to carry out oxidative decarboxylation
NH
N
O
N
O
NH
HN
O
Me Me
H
N
O
TIPSO
Me Me
O
76
NH
N
O
N
O
NH
HN
O
Me Me
H
N
O
TIPSO
Me Me
O
H
75
NH
N
O
N
O
NH
HN
O
Me Me
H
N
O
TIPSO
Me Me
O
CO2H
Pb(IV) Cu(II)
H
NH
N
O
N
O
NH
HN
O
Me Me
H
N
O
TIPSO
Me Me
O
H
–H+
NH
N
O
N
O
NH
HN
O
Me Me
H
N
O
TIPSO
Me Me
O
7877
23
 
 Toward this end, we set our sights on the synthesis if oxazoline acid 75. We knew 
from our previous investigations that we could generate the oxazoline ester by treating 66 
with DDQ. In fact, the first oxidation was much faster than the second, allowing the 
oxazoline intermediate to be produced selectively. Optimization of the reaction times 
revealed conditions that produced the oxazoline 79 selectively in 56% yield (Figure 18).  
                                                
19 For uses of oxidative decarboxylation in total synthesis, see: (a) Clive, D. J.; Minaruzzaman Org. Lett. 
2007, 9, 5315–5317. (b) Padwa, A.; Brodney, M. A.; Lynch, S. M. J. Org. Chem. 2001, 66, 1716–1724. (c) 
Troast, D. M.; Porco, J. A. Org. Lett. 2002, 4, 991–994. 
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Figure 18: Oxidative installation of B-ring oxazoline
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 79 was then treated with TASF in DMF in an attempt to deprotect the TMSE ester 
(Figure 19). However, this resulted in formation of highly unstable reaction products that 
were much less polar than the expected carboxylic acid should have been. Mass spectral 
analysis of the crude reaction mixture exhibited ions that corresponded to loss of carbon 
Figure 19: Initial failure to deprotect TMSE ester
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dioxide from the starting material, and the crude NMR contained aldehydic methine 
resonances.  
 To account for these results, we surmised that the oxazoline ring was actually in 
equilibrium with an open form that arises from ring opening by attack of the adjacent 
electron-rich indole (Figure 19). With the ester group intact, this equilibrium was benign. 
Yet once the carboxylic acid is liberated, it is readily eliminated to quench the formal 
benzylic cation of the ring-opened isomer.20 This presumably yields an unstable enamide 
product 82 that accounts for the crude reaction’s mass spectral signals, and which, after 
undergoing aqueous workup, would be expected to produce aldehyde byproducts. The 
instability of the presumed adduct prevented this hypothesis from being rigorously 
demonstrated, but nonetheless it required us to alter our plans. 
Figure 20: Successful deprotection of the TMSE ester
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20 For examples of the elimination of carboxylic acids with β-cations, see: (a) Cristol, S. J.; Norris, W. P. J. 
Am. Chem. Soc. 1953, 75, 632–636. (b) Grovenstein, E.; Lee, D. E. J. Am. Chem. Soc. 1952, 74, 2639–
2644. (c) Cristol, S. J.; Norris, W. P. J. Am. Chem. Soc. 1953, 75, 2645–2646. 
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  We reasoned that if this was indeed the source of the products instability, it 
should be possible to tone down the nucleophilicity of the adjacent ring by acylating the 
indole nitrogen. This was readily accomplished by treating ester 79 with CbzCl, DMAP 
and NEt3 in THF to yield the acylated product 83 in 73% yield (Figure 20). This adduct 
was then treated with TASF in DMF, and, as we had predicted, acid 84 was isolated as a 
stable adduct. 
 However, all attempts to oxidatively decarboxylate 84 produced none of the 
desired bisoxazole product. Use of lead(IV) and silver(I) salts, with and without Cu(II) 
additives all met with similar results, with the starting material being consumed but with 
no identifiable products isolated. This approach still has potential due to wide variety of 
conditions known to affect this transformation, and is still an active area of investigation 
in the MacMillan lab. 
 
IV. Conclusion and Future Direction 
 At the time of the writing of this thesis, efforts toward the synthesis of 
diazonamide A are ongoing in the MacMillan group. We feel certain that this strategy 
will ultimately prove successful, and that our current difficulties are primarily tactical in 
nature. Finding successful oxidative decarboxylation conditions should provide an adduct 
that can be easily advanced to the natural product.  As such, investigating further 
oxidative decarboxylation conditions will hopefully yield the desired reaction outcome.  
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Chapter 5 Supporting Information 
 
 
General Information: Commercial reagents were purified prior to use following the 
guidelines of Perrin and Armarego.21 All solvents were purified according to the method 
of Grubbs.22 Nonaqueous reagents were transferred under argon via syringe or cannula. 
Organic solutions were concentrated under reduced pressure on a Büchi rotary evaporator 
using a heated water bath. Chromatographic purification of products was accomplished 
using forced-flow chromatography on Silicycle 230–400 mesh silica gel 60 according to 
the method of Still.23 Thin-layer chromatography (TLC) was performed on Silicycle 0.25 
mm silica gel 60-F plates. Visualization of the developed chromatogram was performed 
by fluorescence quenching or by CAM stain. 
 1H and 13C NMR spectra were recorded on a Bruker AVANCE 500 (500 MHz 
and 125 MHz) as noted, and were internally referenced to residual solvent signals. Data 
for 1H NMR were reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, d 
= doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant (Hz) and 
assignment. Data for 13C NMR were reported in terms of chemical shift. IR spectra were 
recorded on a Perkin Elmer 1000 spectrometer and were reported in terms of frequency 
of absorption (cm-1). Mass spectra were obtained from the Princeton Mass Spectral 
                                                
21 Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; 3rd ed., Pergamon Press, Oxford, 
1988. 
22 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 
1518. 
23 Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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Facility. Optical rotations were measured on a Jasco P-1010 polarimeter, and [a]D values 
were reported in 10-1 dg cm2 g-1. 
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Acid 9: To a solution of 3 (84 mg, 0.087 mmol) in THF/MeOH/H2O (4.4 mL, 10:2:1) 
was added LiOH•H2O (36.5 mg, 0.87 mmol) with stirring. After the reaction was judged 
complete by TLC analysis (2 hours), the reaction mixture was diluted with 50 mL of 
diethyl ether, acidified with 1 N HCl to pH 2, and washed with 20 mL of brine. The 
organic portion was dried over sodium sulfate and concentrated in vacuo. These crude 
extracts were purified by column chromatography (50% EtOAc/Hexanes then 10% 
MeOH in CH2Cl2) to yield the title compound (71 mg, 99%) as a white amorphous solid. 
IR (Film): 3405, 2917, 2849, 1654, 1498, 1464, 1289, 1251, 1209, 1068, 882, 754, 684 
cm-1; 1H NMR: (125 MHz, CD3OD): δ 7.54–7.26 (m, 6H, Ar-H), 7.18 (dd, 1H, J = 8.2, 
1.6 Hz, Ar-H), 6.94 (s, 1H, OCHN), 6.87–6.65 (m, 4H, Ar-H), 5.08 (s, 2H, OCH2Ph), 
4.93 (m, 1H, CONHCHCH), 4.53 (m, 1H, CONHCHCH2), 4.16 (d, 1H, J = 3.9 Hz, 
CHOTIPS), 3.15 (t, 1H, J = 12.3 Hz, CH2Ar), 2.85 (dd, 1H, J = 12.3, 3.8 Hz, CH2Ar), 
2.36 (m, 1H, NHCHCH(CH3)2), 2.05 (m, 1H, OCHCH(CH3)2), 1.09 (m, 24H, TIPS and 
NHCHCH(CH3)2), 1.04–1.01 (m, 6H, NHCHCH(CH3)2, OCHCH(Me)Me), 0.87 (d, 3H, 
J = 6.9 Hz, OCHCH(Me)Me); 13C NMR: (75 MHz, CD3OD) δ 172.7, 172.6, 165.9, 
160.0, 157.2, 154.0, 144.0, 138.3, 137.0, 133.0, 130.6, 130.1, 130.0, 128.7, 128.2, 127.9, 
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127.6, 127.4, 127.3, 120.3, 114.9, 112.1, 110.2, 103.9, 70.2, 61.5, 55.6, 53.8, 38.6, 33.8, 
28.6, 19.1, 17.6, 17.5, 17.1, 17.0, 16.6, 12.2; HRMS: (FAB+) exact mass calculated for 
[M+Na] (C46H58N4O8SiNa) requires m/z 845.3921, found m/z 845.3914; 
! 
["]
D
25  = –100.66 
(c = 0.493, CHCl3). 
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Phenol 10: To a solution of 9 (175 mg, 0.133 mmol) in THF (25 mL) was added 
Pd(OH)2/C (175 mg). The solution was sparged with H2 for 20 minutes, heated to 40 °C 
and kept under a H2 atmosphere for 4 hours.  At this time the solution was filtered 
through a celite plug, concentrated, and the resulting solid was purified on silica gel (10% 
MeOH in CH2Cl2) to yield the title compound (150 mg, 100%) as a pale amorphous 
solid.  IR (Film): 3406, 2962, 2868, 1652, 1601, 1493, 1414, 1295, 1251, 1184, 1097, 
1063, 914, 882, 815, 758, 682 cm-1; 1H NMR: (125 MHz, CD3OD): δ 7.52 (d, 1H, J = 8.7 
Hz, Ar-H), 7.32 (s, 1H, Ar-H), 7.15 (dd, 1H, J = 8.4, 1.5 Hz, Ar-H), 7.02 (s, 1H, Ar-H), 
6.78–6.54 (m, 4H, Ar-H, OCHN), 4.98 (m, 1H, CONHCHCH), 4.56 (m, 1H, 
CONHCHCH2), 4.16 (d, 1H, J = 3.9 Hz, CHOTIPS), 3.15 (t, 1H, J = 12.0 Hz, CH2Ar), 
2.85 (dd, 1H, J = 12.3, 3.2 Hz, CH2Ar), 2.40 (m, 1H, NHCHCH(CH3)2), 2.04 (m, 1H, 
OCHCH(CH3)2),  1.10 (m, 21H, TIPS), 1.02–0.98 (m, 9H, NHCHCH(CH3)2, 
OCHCH(Me)Me), 0.81 (d, 3H, J = 6.3 Hz, OCHCH(Me)Me); 13C NMR: (75 MHz, 
CD3OD) δ 172.8, 172.6, 171.6, 167.0, 159.8, 157.3, 153.2, 142.1, 137.0, 134.0, 131.2, 
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129.9, 129.8, 129.2, 127.8, 120.4, 114.7, 113.4, 110.0, 103.9, 78.0, 61.4, 60.1, 55.6, 53.7, 
38.4, 33.8, 28.5, 18.8, 17.2, 17.1, 16.7, 16.3, 12.2; HRMS: (FAB+) exact mass calculated 
for [M+Na] (C39H52N4O8SiNa) requires m/z 755.3452, found m/z 755.3467; 
! 
["]
D
25  = –
112.44 (c = 0.285, CH3OH). 
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Boc tryptamine 14: To a solution of 6.4 g of 4-bromotryptamine (26.9 mmol) in 64 mL 
of dry MeCN was added 0.3 g of DMAP (2.69 mmol) followed by 18.2 g of Boc2O (83.4 
mmol). The resulting solution was heated to 40 °C and stirred under argon for 24 hours 
until it was judged by TLC that reaction progress had ceased. The solution was diluted 
with 100 mL of diethyl ether and 100 mL of saturated sodium bicarbonate solution. The 
layers were separated and the aqueous was washed with 2 x 100 mL of ether, and the 
combined organic was washed with 200 mL of brine. The solution was dried over sodium 
sulfate and concentrated to yield a black oil. At this point, the reaction was a nearly 
statistical and inseparable mixture of mono-, di-, and tri-Boc protected compound. Thus, 
the crude was resubjected to the reaction conditions described above once more until full 
conversion to the title compound had been achieved. Following workup as described 
above, the crude oil was chromatographed on silica gel (95:5 to 7:3 EtOAc:hexanes) to 
yield 8.6 g of the title compound in 60% yield as a viscous yellow oil. IR (Film): 3419 
(br), 2980, 2934, 1789, 1738, 1698, 1422, 1368, 1282, 1256, 1140, 1112, 1024, 953, 852, 
801, 778, 746 cm-1; 1H NMR: (125 MHz, CDCl3) δ 8.15 (d, 1H, J = 8.4 Hz, C-7 Ar-H), 
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7.36 (dd, 1H, J  = 0.9 Hz, 7.8 Hz, C-5 Ar-H), 7.35 (s, 1H, C-2 Ar-H), 7.093 (dd, 1H, J = 
8.4 Hz, 7.8 Hz, C-6 Ar-H), 3.97 (t, 2H, J = 6.6 Hz, CH2N), 3.22 (t, 2H, J = 6.6 Hz, 
ArCH2), 1.63 (s, 9H, CMe3), 1.36 (s, 18H, 2xCMe3); 13C NMR: (75 MHz, CDCl3) δ 
152.7, 149.3, 128.8, 127.3, 125.7, 125.3, 118.2, 114.7, 114.5, 84.2, 82.2, 46.9, 41.2, 28.3, 
28.2, 28.1, 25.9; HRMS (FAB+) exact mass calc. for [M+•] (C25H35N2O6Br) requires m/z 
538.1678, found m/z  538.1683. 
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Boronic ester-tryptamine 15: Inside a glove box a 100 mL flask was charged with 3.1 g 
14 (5.75 mmol), 0.47 g of Pd(dppf)Cl2 (0.58 mmol), 2.92 g of (Bpin)2 (11.5 mmol), and 
2.26 g of KOAc (23.0 mmol). The flask was sealed with a rubber septa, purged of 
atmosphere, and was charged with 30 mL of DMSO via syringe under argon. The 
resulting solution was heated to 95 °C for 12 hours until judged complete by TLC. After 
cooling to room temperature, the reaction was diluted with 40 mL of diethyl ether and 40 
mL of water, and the resulting black, biphasic solution was filtered through a celite pad to 
remove the insoluble solids. The pad was subsequently rinsed twice with 100 mL of 
ether. The resulting biphasic solution was separated, and the aqueous was washed 3 x 100 
mL with ether, and the combined organic was washed with brine then dried over sodium 
sulfate. Following concentration, the resulting black oil was chromatographed on silica 
gel (95:5 to 9:1 EtOAc:hexanes) to yield 2.06 g the title compound as an off-white solid 
 
 
196 
in 67% yield. IR (Solid): 2979, 2933, 1785, 1732, 1698, 1600, 1455, 1415, 1368, 1282, 
1137, 1047, 965, 898, 852, 765 cm-1; 1H NMR: (125 MHz, CDCl3) δ 8.29 (d, 1H, J = 8.4 
Hz, C-7 Ar-H), 7.68 (dd, 1H, J  = 0.9 Hz, 6.9 Hz, C-5 Ar-H), 7.32 (s, 1H, C-2 Ar-H), 
7.27 (m, 1H, C-6 Ar-H), 3.95 (t, 2H, J = 6.6 Hz, CH2N), 3.21 (t, 2H, J = 6.6 Hz, ArCH2), 
1.63 (s, 9H, CMe3), 1.37 (s, 12H, 4 x Me3), 1.33 (s, 18H, 2 x CMe3); 13C NMR: (75 MHz, 
CDCl3) δ 152.8, 149.8, 135.9, 133.9, 131.1, 124.3, 84.1, 83.7, 83.5, 82.0, 46.1, 28.4, 28.1, 
26.4, 25.2, 25.1; HRMS (FAB+) exact mass calc. for [M+•] (C31H47N2O8B) requires m/z 
586.3425, found m/z  586.3437. 
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Boronic ester 17: A 25 mL flask was charged with 43 mg of 10 (0.0587 mmol), 40 mg of 
16 (0.0881 mmol), and 20.7 mg of TBTU. The flask was sealed with a rubber septa and 
5.9 mL of DMF was added by syringe under argon. To the resulting solution was added 
31 µL of DIPEA (0.176 mmol) via syringe under argon and the reaction was stirred at 
room temperature for 12 hours until judged complete by TLC. The reaction mixture was 
then diluted in 100 mL of EtOAc and washed 2 x 50 mL with water and 2 x 50 mL with 
brine. The combined aqueous fractions were then back extracted with 2 x 50 mL of 
EtOAc. The combined organic layers were then washed once more with 100 mL of brine 
and dried over sodium sulfate. Following concentration, the crude solids were purified by 
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flash chromatography on silica gel (95:5 CH2Cl2:MeOH) to yield 54.4 mg (91%) the title 
compound as an off-white solid. IR (Film): 3402, 2962, 2929, 2868, 2360, 2341, 1652, 
1600, 1506, 1371, 1295, 1143, 1135, 755, 684, 668 cm-1; 1H NMR: (300 MHz, CD3OD) 
δ 7.64 (br m, 1H, NH), 7.55–7.48 (m, 3H, Ar-H and N-H), 7.38 (d, 1H, J = 1.8 Hz, Ar-
H), 7.14 (dd, 1H, J = 1.8 Hz and 8.1 Hz, Ar-H), 7.06 (br s, 1H, N-H), 7.03 (m, 2H, Ar-H), 
6.78 (dd, 1H, J = 3.4 Hz and 4.9 Hz, Ar-H), 6.76 (s, 1H, OCHNH), 6.62 (m, 2H, Ar-H), 
4.93 (d, 1H, J = 6.6 Hz, CHN), 4.47 (m, 1H, CHN), 4.15 (d, 1H, J = 3.9 Hz, CHOTIPS), 
3.45 (m, 2H, CH2N), 3.24 (m, 3H, ArCH2CH2 and ArCH(H)CHN), 2.81 (m, 1H, 
ArCH(H)CHN), 2.23 (m, 1H, CHMe2), 2.06 (m, 1H, CHMe2), 1.34 (s, 12H, 4 x Me), 
1.12 (m, 21H, TIPS), 1.10 (d, 1H, J = 3.4 Hz, CHMe(Me)), 1.07 (d, 1H, J = 6.7 Hz, 
CHMe(Me)), 1.02 (d, 1H, J = 7.0 Hz, CHMe(Me)), 0.91 (d, 1H, J = 6.7 Hz, CHMe(Me)); 
13C NMR: (75 MHz, CD3OD) δ 172.60, 172.56, 161.0, 159.9, 157.2, 153.3, 142.3, 136.9, 
136.7, 131.2, 130.2, 130.0, 128.8, 128.9, 127.9, 124.0, 120.4, 119.8, 114.9, 114.1, 113.3, 
113.1, 110.0, 103.6, 83.4, 78.0, 61.4, 55.7, 53.4, 40.5, 38.3, 33.8, 28.6, 25.7, 23.92, 23.86, 
18.8, 17.21, 17.17, 17.12, 16.7, 12.2; HRMS (FAB+) exact mass calc. for [M+H•] 
(C55H74N6O9BSi) requires m/z 1001.538, found m/z 1001.539; 
! 
["]
D
25  = –38.7 (c = 0.2133, 
CHCl3). Nota bene: Amine starting material 16 was prepared by dissolving protected 
amine 15 in neat TFA for five minutes then concentrating in vacuo. The resulting oil was 
reconcentrated 3 times from toluene to remove residual TFA. 16 was used in the reaction 
described above without further purification. 
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Aryl triflate 18: To a solution of 84 mg of 17 (0.084 mmol) in 8.4 mL of CH2Cl2 was 
added 73 µL of DIPEA (0.42 mmol) via syringe. To the resulting solution was added 90 
mg of NPhTf2 (0.25 mmol). The resulting solution was stirred at room temperature for 10 
hours until judged complete by TLC. The crude reaction was then diluted with 100 mL of 
EtOAc and 100 mL of saturated NaHCO3. The layers were separated and the aqueous 
was washed with 2 x 50 mL of EtOAc. The combined organic fractions were then washed 
with 100 mL of brine and dried over sodium sulfate. Following concentration, the crude 
solid was purified by flash chromatography on silica gel (97.5:2.5 CH2Cl2:MeOH) to 
yield 80 mg (84%) of the title compound as an off-white solid. IR (Film): 3406, 3287, 
2963, 2933, 2360, 1652, 1496, 1423, 1210, 1140, 1062, 912, 882, 812, 755, 684 cm-1; 1H 
NMR: (300 MHz, CDCl3) δ 8.05 (br d, 1H, J = 2.1 Hz Ar-H), 7.65 (dd, 1H, J = 1.2 Hz 
and 7.2 Hz, A-H), 7.51 (d, 1H, J = 2.1 Hz, Ar-H), 7.43 (dd, 1H, J = 1.2 Hz and 8.1 Hz, 
Ar-H), 7.17 (m, 3H, Ar-H), 7.10 (dd, 1H, J = 1.8 Hz and 8.7 Hz, Ar-H), 7.04 (dd, 1H, J = 
0.9 Hz and 8.4 Hz, Ar-H), 7.00 (m, 1H, Ar-H), 6.75 (m, 2H, Ar-H), 5.94 (d, 1H J = 9.3 
Hz, NH), 5.56 (d, 1H J = 4.2 Hz, NH), 5.05 (dd, 1H, J = 5.4 Hz and 9.3 Hz, CHN), 4.31 
(m, 1H, CHN), 4.13 (d, 1H, J = 2.7 Hz, CHOTIPS), 3.55 (dd, 2H, J = 6.6 Hz and 9.9 Hz, 
CH2N), 3.35 (dd, 1H, J = 12 Hz and 12 Hz, ArCH(H)CHN), 3.18 (m, 2H, ArCH2CH2), 
2.73 (dd, 1H, J = 3.3 Hz and 12 Hz, ArCH(H)CHN), 2.29 (m, 1H, CHMe2), 2.01 (m, 1H, 
CHMe2), 1.35 (s, 12H, 4 x Me), 1.07 (m, 21H, TIPS), 1.02 (d, 3H, J = 6.9 Hz, 
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CHMe(Me)), 0.97 (d, 3H, J = 6.9 Hz, CHMe(Me)), 0.93 (d, 3H, J = 7.0 Hz, CHMe(Me)), 
0.85 (d, 3H, J = 6.9 Hz, CHMe(Me)); 13C NMR: (75 MHz, CD3OD) δ 172.62, 172.56, 
160.8, 160.7, 160.0, 157.3, 152.2, 141.3, 136.7, 133.2, 131.79, 131.76, 130.5, 129.84, 
129.78, 129.0, 128.3, 128.0, 127.9, 126.1, 124.0, 122.5, 122.0, 120.9, 120.8, 119.9, 119.1, 
116.5, 114.2, 113.2, 110.3, 103.4, 83.4, 78.0, 60.8, 55.6, 53.6, 40.6, 40.5, 38.3, 33.8, 28.8, 
25.7, 23.93, 23.89, 18.7, 17.2, 17.1, 16.71, 16.69, 12.2; 19F NMR: (75 MHz, CDCl3) -
75.84 (s, 3F, CF3). HRMS (FAB+) exact mass calc. for [M+H•] (C65H75N6O11BSSiF3) 
requires m/z 1135.503, found m/z 1135.502; 
! 
["]
D
25  = –30.3 (c = 0.36, CHCl3). 
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Biaryl 19: A Schlenk vial was charged with 18 (15 mg, 0.013 mmol), K3PO4 (5.5 mg, 
0.0040 mmol) and Pd(PPh3)4 (4.6 mg, 0.0040 mmol).  To this vial was added degassed 
dioxane/H2O (5:1, 3.3 mL). The resulting solution was warmed to 70 °C for 5 hours.  At 
this time the solution was diluted with EtOAc, and Na2SO4 was added to precipitate 
remaining palladium.  This solution was filtered through florisil, concentrated, and the 
resulting oil was purified by prep TLC (100:25:4 CH2Cl2:Hexanes:MeOH) to yield the 
title compound (4.3 mg, 38%) as a pale amorphous solid.  1H NMR: (300 MHz, CD3OD): 
δ 10.56 (s, 1H, C=CNH), 8.66 (d, 1H, J = 7.8 Hz, Ar-H), 7.54 (d, 1H, J = 9.0 Hz, Ar-H), 
7.41 (d, 1H, J = 8.1 Hz, Ar-H), 7.24–7.15 (m, 4H, Ar-H), 6.99 (d, 1H, J = 7.2 Hz, Ar-H), 
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6.90 (t, 1H, J = 7.5 Hz, Ar-H), 6.75 (d, 1H, J = 8.1 Hz, Ar-H), 6.20 (s, 1H, OCHN), 4.73 
(m, 1H, CONHCHCH), 4.59 (m, 1H, CONHCHCH2), 4.16 (d, 1H, J = 3.9 Hz, 
CHOTIPS), 4.04 (m, 1H, CH2CH2NHCO), 3.23 (t, 1H, J = 12.0 Hz, CH2Ar), 2.85 (m, 
2H, CH2Ar, CH2CH2NHCO), 2.68 (m, 1H, NHCHCH(CH3)2), 2.08 (m, 2H, 
OCHCH(CH3)2, CH2CH2NHCO), 1.86 (dd, 1H, J = 15.3, 6.0 Hz, CH2CH2NHCO), 1.11 
(m, 21H, TIPS), 1.05–0.98 (m, 9H, NHCHCH(CH3)2, OCHCH(Me)Me), 0.91 (d, 3H, J = 
6.6 Hz, OCHCH(Me)Me); HRMS: (FAB+) exact mass calc. for [M+Na] (C49H61N6O6Si) 
requires m/z 857.4422, found m/z 857.4397; 
! 
["]
D
25  = –337.6 (c = 0.387, CHCl3). 
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Ketone 30: To an oven-dried 100 mL flask with stirbar was added 4.20 g (18.10 mmol) 
of 29. After being capped with a rubber septa, the flask was charged with 45 mL of 
dioxane introduced via syringe under argon. Next, 1.687 mL (18.10 mmol) of POCl3 was 
added via syringe under argon. The flask was then fitted with a condenser, and heated to 
95 °C under argon for one hour. The reaction mixture was then allowed to cool to room 
temperature. Next, 1.135 mL (9.05 mmol) of 11 was added via syringe through the septa 
on the condenser, and the resulting mixture was heated to reflux at 105 °C for 24 hours. 
After cooling to room temperature, 45 mL of water was added to the reaction mixture, 
followed by the dropwise addition of 1.0 M NaOH solution until the solution was pH 8. 
The resulting solution was heated to 100 °C for 20 minutes, then cooled in an ice bath. 
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The product precipitated as a light brown powder, which was then washed 3 x 100 mL 
with Et2O and dried under vacuum for 24 hours to give 76% (2.65 g) of the title 
compound as a free-flowing tan powder. IR (Solid): 3312, 1769, 1704, 1673, 1657, 1513, 
1426, 1396, 1317, 1314, 1200, 1143, 1100, 1087, 953, 777, 739 cm-1; 1H NMR: (500 
MHz, d6-DMSO) δ 12.49 (br s, 1H, N-H), 8.75 (s, 1H, C-2 Ar-H), 7.85–7.98 (m, 4H, 
phthalimide Ar-H), 7.54 (d, 1H, J  = 8.1 Hz, C7 Ar-H), 7.40 (d, 1H, J  = 8.1 Hz, J = 7.5 
Hz, C-5 Ar-H), 7.15 (app t, 1H, J = 7.9 Hz, C-6 Ar-H) 5.08 (s, 1H, CH2N); 13C NMR: 
(125 MHz, CDCl3) δ 184.6, 167.7, 138.7, 136.1, 134.7, 131.7, 127.1, 124.3, 124.2, 123.3, 
113.7, 111.9, 45.3; HRMS (FAB+) exact mass calc. for [M+•] (C18H12N2O3Br) requires 
m/z 383.0031, found m/z  383.0048. 
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Ketone 31: To –40 °C solution of 1.96 g 30 (5.12 mmol) in 25 mL DMF under argon 
was added 603 mg of KOtBu (5.375 mol) in one portion. The resulting solution was 
stirred for 10 minutes, then 0.64 mL of benzyl bromide (5.21 mmol) was added via 
syringe under argon. The resulting solution was allowed to warm to room temperature 
over 2 hours. The crude mixture was diluted with 200 mL of EtOAc and 200 mL of pH 4 
buffer. The layers were separated and the organic layer was washed with 100 mL of brine 
and dried over sodium sulfate. Following concentration, the crude mixture was purified 
by flash chromatography (2% acetone in CH2Cl2) to yield 1.68 g to title compound as a 
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white solid in 68% yield. IR (Film): 3112, 1766, 1710, 1676, 1604, 1557, 1524, 1419, 
1389, 1317, 1212, 1192, 1105, 1067, 950, 907, 728, 713, 695 cm-1; 1H NMR: (500 MHz, 
CDCl3) δ 7.93 (s, 1H, C-2 ArH), 7.85 (m, 2H, N-Phth ArH), 7.72 (m, 2H, N-Phth ArH), 
7.44 (d, 1H, J = 7.6 Hz, C-7 Ar-H), 7.32 (m, 3H, Bn Ar-H), 7.20 (d, 1H, J = 8.25 Hz, C-5 
Ar-H), 7.12 (d, 1H, J = 6.5 Hz, Bn Ar-H), 7.04 (dd (apt t), 1H, J = 7.6 Hz, 8.25 Hz, C-6 
Ar-H), 5.34 (s, 2H, CH2N), 4.99 (s, 2H, CH2Ar); 13C NMR: (125 MHz, CDCl3) δ 185.0, 
168.1, 138.6, 135.5, 135.1, 134.0, 132.3, 129.3, 129.2, 129.04, 128.99, 128.5, 128.4, 
126.9, 125.6, 124.6, 123.5, 123.4, 115.08, 114.99, 109.6, 51.1, 45.9; HRMS (FAB+) 
exact mass calc. for [M+•] (C25H16N2O3Br) requires m/z 473.0345, found m/z  473.0324. 
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Aryl bromide 33: To a solution of bromide 31 (1.18 g, 2.46 mmol) in 50 mL of 4:1 a 
mixture of water and isopropanol was added 151 mg (2.71 mmol) of KOH pellets. The 
reaction was heated to 100 °C for three hours, then cooled to room temperature. The 
resulting solution was acidified to pH 4 with 10 M HCl and concentrated in vacuo. The 
resulting solids were then dissolved in 10 mL of water and 10 mL of 33% HBr in AcOH 
and the solution was heated to 75 °C for two hours. After cooling to room temperature 
the crude reaction mixture was concentrated and suspended in 100 mL of a 5:1 mixture of 
CH2Cl2 and hexanes. The suspension was filtered through a sintered glass frit, and the 
resulting solids were washed with 2 x 100 mL of a 5:1 mixture of CH2Cl2 and hexanes. 
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The resulting solid was then dissolved in 50 mL of ethanol and 1.24 mL of triethylamine 
(8.93 mmol) was added by syringe. 973 mg of solid Boc2O was then added in a single 
portion and the resulting solution was stirred at room temperature for twelve hours. The 
crude mixture was concentrated, and the resulting oil was dissolved in 300 mL of EtOAc, 
to which was added 300 mL of water. The layers were separated and the organic was 
washed with 100 mL of saturated ammonium chloride and then 100 mL of brine, and 
then dried over sodium sulfate. This solution was then concentrated in vacuo, and 
purified by flash chromatography (1% MeOH in CH2Cl2) to yield 635 mg of the title 
compound as a tan solid, a total of 58% yield over the three-step sequence (unoptimized). 
IR (Film): 3417, 3331, 2976, 1709, 1675, 1555, 1522, 1497, 1454, 1434, 1392, 1365, 
1275, 1259, 1167, 1067, 1024, 1045 cm-1; 1H NMR: (500 MHz, d6-CDCl3) δ 7.85 (s, 1H, 
Ar-H), 7.55 (d, 1H, J = 7.5 Hz, Ar-H), 7.39 (m, 2H, Ar-H), 7.33 (m, 2H, Ar-H), 7.16 (m, 
3H, Ar-H), 5.68 (s, 1H, NH), 5.38 (s, 2H, CH2Ar), 4.53 (d, 2H, J = 4.4 Hz, CH2NH), 1.51 
(s, 9H, CMe3); 13C NMR: (125 MHz, CDCl3) δ 188.9, 155.9, 138.7, 135.0, 134.9 129.7, 
128.6, 128.1, 127.1, 125.6 124.6, 124.5, 115.4, 115.0, 79.6, 51.0, 49.1, 28.4; HRMS 
(FAB+) exact mass calc. for [M+•] (C22H24N2O3Br) requires m/z 433.0970, found m/z  
433.0991. 
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Boronic ester 34: Inside a glove box a 25 mL flask was charged with 300 mg of 33 (0.67 
mmol), 8.76 mg of Pd(MeCN)Cl2 (0.58 mmol), 41 mg of S-Phos (0.10155 mmol), 429 
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mg of (Bpin)2 (1.69 mmol), and 265 mg of KOAc (2.708 mmol). The flask was sealed 
with a rubber septa, removed to atmosphere and charged with 6.8 mL of DMF via syringe 
under argon. The resulting solution was heated to 100 °C for 4 hours until judged 
complete by TLC. After cooling to room temperature, the reaction was poured into 100 
mL of EtOAc and 100 mL of water, and the resulting black, biphasic solution was filtered 
through a celite pad to remove the insoluble solids.  The pad was subsequently rinsed 
twice with 50 mL of EtOAc. The resulting biphasic solution was separated, and the 
aqueous was washed 3 x 50 mL with ethyl acetate, and the combined organic was washed 
with brine then dried over sodium sulfate. Following concentration, the resulting black oil 
was chromatographed on silica gel (35:65 to 1:1 EtOAc:hexanes) to yield 160 mg of the 
title compound as a white solid in 50% yield. IR (Film): 3421 (br), 2975, 2925, 1713, 
1654, 1532, 1497, 1390, 1368, 1308, 1275, 1163, 1087, 852 cm-1; 1H NMR: (500 MHz, 
d6-CDCl3) δ 7.76 (s, 1H, C-2 Ar-H), 7.42 (m, 1H, Ar-H), 7.34–7.26 (m, 6H, Ar-H), 7.33 
(m, 2H, Ar-H),  7.09 (m, 1H, Ar-H), 5.51 (br m, 1H, NH), 5.33 (s, 2H, CH2Ar), 4.45 (d, 
2H, J = 6.0 Hz, CH2N), 1.50 (s, 12H, 4 x Me), 1.47 (s, 9H, CMe3); 13C NMR: (125 MHz, 
CDCl3) δ 188.5, 155.9 136.3, 135.4, 133.8, 129.1, 128.3, 127.8, 127.6, 127.0, 123.4, 
115.0, 111.1, 83.9, 79.6, 50.8, 46.8, 28.4, 25.6; HRMS (FAB+) exact mass calc. for 
[M+H•] (C28H36N2O5B) requires m/z 491.2717, found m/z 491.2742. 
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Phenol 35: A 10 mL flask was charged with 10 (23.85 mg, 0.0325 mmol, 1.0 eq), 25 (16 
mg, 0.0325 mmol, 1.0 eq), EDC•HCl (7.5 mg, 0.039 mmol, 1.2 eq), HOBT (5.27 mg, 
0.039 mmol, 1.2 eq), and NaHCO3 (8.2 mg, 0.0977 mol, 3.0 eq). The flask was sealed 
with a rubber septa and 1.0 mL of DMF was added via syringe under argon. The resulting 
solution was stirred at room temperature for 4.5 hours and then poured into 100 mL of 
EtOAc. The resulting solution was washed with 2 x 100 mL of water and the aqueous 
fraction was back extracted with 100 mL of EtOAc. The resulting organic fraction was 
washed with brine, dried over sodium sulfate, and concentrated in vacuo. The resulting 
solids were purified by silica gel chromatography (1:1 EtOAc/hexanes) to yield the title 
compound (32 mg, 89%) as an off-white solid. IR (Film): 3405, 3291, 2964, 2936, 2865, 
1656, 1600, 1513, 1389, 1297, 1180, 1140, 1092, 1067, 852, 753, 725 cm-1; 1H NMR: 
(400 MHz, CDCl3) δ 8.135 (t, 1H, J = 4 Hz, Ar-H), 7.50 (d, 1H, J = 1.2 Hz, Ar-H), 7.40  
(s, 1H, Ar-H), 7.27 (dd, 1H, J = 4.2 Hz and 9.0 Hz, Ar-H), 7.26 (m, 1H, Ar-H), 7.17 (m, 
1H, Ar-H), 7.07 (m, 1H, Ar-H), 6.92 (s, 1H, C(10) CH), 6.88 (m, 1H, Ar-H), 6.68 (dd, 
1H, J = 7.8 Hz and 13.6 Hz, Ar-H), 6.38 (dd, 1H, J = 8.0 Hz and 8.0 Hz, Ar-H), 6.24 (d, 
1H, J = 8.0 Hz, Ar-H), 5.09 (m, 3H, PhCH2 and CHNH), 4.52 (dd, 1H, J = 16 Hz and 4.4 
Hz, ArCH(H)NH), 4.47 (m, 1H, CHNH), 4.37 (dd, 1H, J = 16 Hz and 4.4 Hz, 
ArCH(H)NH), 4.10 (d, 1H, J = 3.2 Hz, CHOTIPS), 3.34 (dd, 1H, J = 12 Hz and 12 Hz, 
ArCH(H)CHN), 2.74 (m, 1H, ArCH(H)CHN), 2.30 (m, 1H, CHMe2), 1.99 (m, 1H, 
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CHMe2), 1.47 (app d, 12H, J = 3.9 Hz, 4 x Me), 1.08 (br m, 24H, TIPS and CHMe), 0.96 
(d, 3H, J = 6.9 Hz, CHMe), 0.92 (d, 3H, J = 6.9 Hz, CHMe), 0.87 (d, 3H, J = 6.9 Hz, 
CHMe); 13C NMR: (125 MHz, CDCl3) δ 186.8, 172.0, 160.9, 158.9, 157.3, 154.3, 141.8, 
137.3, 135.9, 135.7, 135.1, 130.9, 130.8, 130.0, 128.8, 127.93, 127.90, 127.8, 127.6, 
127.4, 126.5, 123.3, 121.1, 116.0, 113.9, 11.4, 110.6, 104.6, 83.8, 77.8, 61.4, 53.4, 50.75, 
44.8, 38.8, 33.9, 29.1, 25.61, 25.57, 19.4, 18.2, 18.1, 18.0, 17.3, 17.1, 12.3; HRMS 
(FAB+) exact mass calc. for [M+H•] (C62H78N6O10BSi) requires m/z 1105.564, found m/z 
1105.566; 
! 
["]
D
25  = –47.7 (c = 1.225 CHCl3). Nota bene: Amine starting material 25 was 
prepared by dissolving protected amine 34 in neat TFA for five minutes then 
concentrating in vacuo. The resulting oil was then reconcentrated 3 times from toluene to 
remove residual TFA. 25 was used in the reaction described above without further 
purification. 
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Triflate 35: To a solution of 26 (83 mg, 0.0752 mmol, 1.0 eq) in CH2Cl2 (3.76 mL) was 
added PhNTf2 (36.7 mg, 0.0977 mmol, 1.3 eq) and Et3N (31.5 µL, 0.225 mmol, 3.0 eq). 
The solution was stirred under argon for 4 hours and then diluted with saturated 
NaHCO3.  The aqueous layer was washed with EtOAc, and the combined organics were 
washed with H2O and dried over Na2SO4. After concentration of the solvents in vacuo, 
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the resulting oil was purified on silica gel (1:1 EtOAc:hexanes) to yield the title 
compound (71 mg, 76%) as a pale off-white solid. IR (Film): 3402, 3289, 2962, 1657, 
1514, 1496, 1423, 1389, 1211, 1140, 914, 882, 813 cm-1; 1H NMR: (300 MHz, CDCl3) δ 
8.05 (t, 1H, J = 4.2 Hz, Ar-H), 7.70 (s, 1H, Ar-H), 7.59 (d, 1H, J = 1.8 Hz, Ar-H), 7.40 
(dd, 1H, J = 1.8 Hz and 3.0 Hz, Ar-H), 7.23 (m, 4H, Ar-H), 7.20 (d, 1H, J = 0.9 Hz, Ar-
H), 7.10 (d, 1H, J = 4.5 Hz, Ar-H), 7.09 (dd, 1H J = 1.8 Hz and 8.1 Hz, Ar-H), 7.05 (m, 
2H, Ar-H), 6.76 (d, 1H, J = 7.5 Hz, Ar-H), 6.67 (d, 1H, J = 8.1 Hz, Ar-H), 5.21 (app d, 
2H, J = 6.6 Hz, CH2Ph), 5.12 (m, 1H, CHNH), 4.58 (m, 2H, ArCH2N), 4.42 (m, 1H, 
CHNH), 4.12 (d, 1H, J = 3.0 Hz, CHOTIPS), 3.40 (dd, 1H, J = 12 Hz and 12 Hz, 
ArCH(H)NH), 2.75 (dd, 1H, J = 3.3 Hz and 12 Hz, ArCH(H)NH), 2.33 (m, 1H, CHMe2), 
1.99 (m, 1H, CHMe2), 1.50 (s, 12H, 4 x Me), 1.09 (m, 27H, TIPS and 2 x CHMe), 0.97 
(d, 1H, 3.3 Hz, CHMe), 0.97 (d, 1H, 3.3 Hz, CHMe), 0.87 (d, 1H, 3.3 Hz, CHMe). 13C 
NMR: (125 MHz, CDCl3) δ 187.2, 171.9, 160.3, 159.2, 157.4, 152.3, 141.3, 136.2, 135.2, 
134.2, 133.1, 133.0, 131.2, 130.45, 129.0, 128.3, 127.8, 127.6, 127.1, 127.0, 123.5, 122.4, 
121.7, 120.2, 114.5, 111.1, 110.7, 103.5, 83.9, 78.0, 60.8, 53.2. 50.9, 45.3, 38.5, 33.9, 
28.9, 25.6, 25.6, 19.4, 18.13, 18.09, 17.99, 17.4, 17.2, 12.4; HRMS (FAB+) exact mass 
calc. for [M+H•] (C63H77N6O12BF3SSi) requires m/z 1237.513, found m/z 1257.516; 
! 
["]
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= –14.0 (c = 1.0 CHCl3).  
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Aldehyde 53: To a –30 °C solution of 4-bromoindole 11 (5.0 g, 25.50 mmol) and 
imidazolidinone•HCl 52 (883 mg, 2.55 mmol) in 49 mL of CH2Cl2 and 2.55 mL of 
MeOH was added acrolein (0.852 mL, 12.75 mmol) dropwise in one portion. After 24 
hours the reaction mixture was diluted with 300 mL of EtOAc washed with 2 x 100 mL 
saturated ammonium chloride solution. The organic portion was then washed with 200 
mL of brine before being dried over sodium sulfate. The organic portion was 
concentrated in vacuo, and the resulting crude mixture was chromatographed in 15%–
25% EtOAc in hexanes to afford 2.47 g (78%) of the title compound as a white, 
crystalline solid. IR (Film): 3417, 2926, 2830, 2728, 1714(s), 1614, 1548, 1424, 1335, 
1185, 1082, 912, 802, 772, 737; 1H NMR: (500 MHz, d6-acetone) δ 10.38 (br s, 1H, N-
H), 9.83 (s, 1H, CHO), 7.41 (d, 1H, J = 8.1 Hz, C-7 ArH), 7.27 (d, 1H, J = 2.1 C-2 ArH), 
7.20 (app t, 1H, J = 7.85 Hz, C-5 ArH), 6.99 (dd, 1H, J = 7.5. 8.5 Hz, C-6 ArH), 3.32 (t, 
2H, J = 7.4 Hz, Ar-CH2), 2.87 (td, 2H, J = 7.4, 1.35 Hz, CH2-CHO); 13C NMR: (125 
MHz, CDCl3) δ 202.7, 139.3, 126.1, 125.5, 123.9, 123.3, 115.6, 114.2, 112.0, 46.3, 19.7; 
HRMS (ESI-TOF+) exact mass calc. for [M+•] (C11H10NOBr+Na) requires m/z 
273.98435, found m/z  273.9843.  
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Aldehyde 54: To a 0 °C solution of aldehyde 53 (1.90 g, 7.5 mmol), triethylamine (4.2 
mL, 30.1 mmol), and DMAP (924 mg, 7.5 mmol) in 40 mL of DMF was added CbzCl 
(3.22 mL, 22.6 mmol) dropwise over 15 minutes. The solution was allowed to warm to 
room temperature over 1.5 hours and was then diluted with 250 mL of EtOAc and 200 
mL of saturated aqueous ammonium chloride. The layers were separated and the organic 
phase was washed with 2 x 200 mL of brine and then dried over sodium sulfate. 
Following concentration in vacuo, the crude extracts were purified by flash 
chromatography (20% EtOAc in hexanes) to afford the desired product as a colorless oil 
(1.34 g, 54%). IR (Film): 2819, 2722, 1730(s), 1602, 1557, 1424(s), 1391, 1356, 1248, 
1181, 1096, 1053, 772, 758, 742, 698 cm-1; 1H NMR: (500 MHz, d6-acetone) δ 9.82 (s, 
1H, CHO), 8.22 (d, 1H, J = 8.25 Hz, C-7 ArH), 7.62 (s, 1H, C-2 ArH), 7.56 (app d, 2H, J 
= 7.15 Hz, Cbz-ArH), 7.42 (m, 4H, J =  7.15 Hz, C-5 ArH and Cbz-ArH), 7.22 (t, 1H, J =  
8.0 Hz, C-6 ArH), 5.48 (s, 2H, PhCH2), 3.26 (t, 2H, J = 7.4 Hz, C-7 ArCH2), 2.90 (m, 2H, 
J = 7.4 Hz, CH2CHO); 13C NMR: (125 MHz, CDCl3) δ 196.4, 150.9, 138.1, 136.4, 129.6, 
129.51, 129.46, 129.1, 128.3, 126.6, 125.5, 121.5, 115.4, 114.6, 69.6, 44.9, 19.6; HRMS 
(ESI-TOF+) exact mass calc. for [M+•] (C19H16NO3Br+Na) requires m/z 408.0211, found 
m/z 408.021.  
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Chloroacid 55: To a room temperature solution of imidazolidinone•TFA 48 (146 mg, 
0.548 mmol), Cu(OTFA)2 (2.38 g, 8.22 mmol), and LiCl ( 290 mg, 6.85 mmol) in 22 mL 
of MeCN was added the indole aldehyde 54 (1.06 g, 2.74 mmol) in one portion. The 
reaction was stirred at room temperature for 8 hours until judged complete by TLC. The 
reaction was diluted with 22 mL of t-BuOH and 13 mL of H2O and cooled to 0 °C. 
NaH2PO4 (95 mg, 0.685 mmol) and 1,3-dimethoxybenzene (757 mg, 5.48 mmol) were 
added, followed by NaClO2 (1.239 g, 13.7 mmol). The reaction was allowed to warm to 
room temperature over 1.5 hours until judged complete by TLC. The pH of the crude 
reaction was adjusted to 2 by the addition of 1 M HCl. Following extraction with 300 mL 
of EtOAc, the layers were separated and the organic layer was subsequently washed with 
200 mL of brine and dried over sodium sulfate. Following concentration in vacuo, the 
crude extracts were purified by flash chromatography (80:20:1 hexanes:EtOAc:acetic 
acid) to yield the desired product as a white solid (0.954 g, 80%) in 88.5% enantiomeric 
excess. IR (Film): 3036, 1736, 1424, 1392, 1353, 1292, 1281, 1248, 1055, 910, 778, 742, 
697; 1H NMR: (500 MHz, CDCl3) δ 8.20 (br s, 1H, C-7 ArH), 7.58 (br s, 1H, C-2 ArH), 
7.45 (app d, 2H, J = 6.75 Hz, Cbz-ArH), 7.41 (m, 4H, C-5 ArH and Cbz-ArH), 7.15 (t, 
1H, J = 8.1 Hz, C-6 ArH), 5.42 (s, 2H, PhCH2O), 4.75 (dd, 1H, J = 6.6 Hz and 7.9 Hz, 
CHCl), 3.77 (dd, 1H, J = 6.6 Hz and 14.8 Hz, ArCH), 3.40 (dd, 1H, J = 7.9 Hz and 14.8 
Hz, ArCH); 13C NMR: (125 MHz, CDCl3) δ 195.54, 173.92, 134.65, 128.95, 128.87, 
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128.61, 127.75, 127.73, 126.89, 125.88, 115.49, 114.76, 113.68, 69.17, 56.24, 31.45l; 
HRMS (ESI-TOF+) exact mass calc. for [M+•] (C19H15NO4BrCl+Na) requires m/z 
457.9770, found m/z 457.9769; [α]D = –15.14 (c = 1.0, CHCl3) The enantiomeric purity 
of the title compound prepared determined by SFC analysis using a Chiracel ASH 
column (15% MeOH, 4mL/min): R-enantiomer: tr = 5.02 min, S-enantiomer: tr = 5.85 
min. 
 
 
N
Cbz
Br
N
Cbz
Br
CO2H
TMSEtOH
EDC, DMAP
pyr, rt
ClCl
O
O
TMS
56 58  
Chloroester 58: To a room temperature solution of chloroacid 56 (954 mg, 2.188 mmol), 
trimethylsilylethanol (0.936 mL, 6.56 mmol), and DMAP (267 mg, 2.188 mmol) in 22 
mL of pyridine was added EDC•HCl (838 mg, 4.376 mmol) in one portion. The reaction 
was stirred at room temperature for 20 hours until judged complete by TLC. The reaction 
was diluted with 300 mL of EtOAc and the resulting solution was washed with 3 x 150 
mL 0.5 M HCl. The resulting organic layers was washed with 200 mL of brine and dried 
over sodium sulfate. Following concentration in vacuo, the crude extracts were purified 
by flash chromatography (9:1:1 hexanes:EtOAc:CH2Cl2) to yield the desired product as a 
clear oil (0.905 g, 77%). IR (Film): 3034, 2955, 2898, 1739 (s), 1602, 1558, 1424(s), 
1392, 1351, 1248, 1161, 1092, 1054, 932, 858, 838, 777, 743, 697; 1H NMR: (500 MHz, 
CDCl3) δ 8.20 (br s, 1H, C-7 ArH), 7.57 (s, 1H, C-2 ArH), 7.47 (m, 2H, Cbz-ArH), 7.42 
(m, 4H, C-5 ArH and Cbz-ArH), 7.16 (t, 1H, J = 8.1 Hz, C-6 ArH), 5.44 (dd, 2H, J = 12.0 
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Hz and 16.0 Hz, PhCH2O), 4.68 (t, 1H, J = 7.4 Hz, CHCl), 4.23 (m, 2H, CO2CH2), 3.70 
(dd, 1H, J = 7.4 Hz and 14.7 Hz, ArCH), 3.45 (dd, 1H, J = 7.4 Hz and 14.7 Hz, ArCH), 
0.95 (t, 2H, J = 7.5 Hz, CH2TMS), 0.00 (s, 9H, TMS); 13C NMR: (125 MHz, CDCl3) δ 
171.0, 151.7, 136.2, 130.5, 130.4, 129.4,129.3, 128.3, 127.3, 117.5, 116.2, 115.3, 70.6, 
66.1, 58.1, 33.1, 18.6, 0.00. HRMS (ESI-TOF+) exact mass calc. for [M+•] 
(C24H27NO4BrClSi+Na) requires m/z 558.04789, found m/z 558.0478; [α]D = –8.99 (c = 
2.11, CHCl3). 
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Azide 59: To a room temperature solution of chloroester 58 (888 mg, 1.656 mmol) in 33 
mL of DMF was added sodium azide (215 mg, 3.31 mmol) in one portion. The reaction 
was stirred at room temperature for 16 hours until judged complete by TLC. The reaction 
was diluted with 300 mL of EtOAc and the resulting solution was washed with 3 x 150 
mL saturated NH4Cl solution. The resulting organic layer was washed with 200 mL of 
brine and dried over sodium sulfate. Following concentration in vacuo, the crude extracts 
were purified by flash chromatography (10% to 15% EtOAc in hexanes) to yield the 
desired product as a clear oil (0.777 g, 87%). IR (Film): 2956, 2105(s), 1739(s), 1425(s), 
1392, 1355, 1249(s), 1182, 1094, 1054, 859, 838, 777, 744, 697; 1H NMR: (500 MHz, 
CDCl3) δ 8.22 (br s, 1H, C-7 ArH), 7.57 (s, 1H, C-2 ArH), 7.49 (m, 2H, Cbz-ArH), 7.42 
(m, 4H, C-5 ArH and Cbz-ArH), 7.16 (t, 1H, J = 8.1 Hz, C-6 ArH), 5.44 (s, 2H, PhCH-
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2O), 4.33 (dd, 1H, J = 5.7, 8.9 Hz, CHN3), 4.27 (m, 2H, CO2CH2), 3.64 (dd, 1H, J = 5.7 
Hz and 14.8 Hz, ArCH), 3.20 (dd, 1H, J = 8.9 Hz and 14.8 Hz, ArCH), 0.99 (m, 2H, 
CH2TMS), 0.00 (s, 9H, TMS); 13C NMR: (125 MHz, CDCl3) δ 171.7, 151.6, 136.3, 
130.5, 130.4, 130.1, 129.4, 129.3, 127.8, 127.3, 117.6, 116.2, 115.4, 70.6, 66.0, 29.8, 
18.9, 0.0; HRMS (EI +) exact mass calc. for [M+•] (C24H27N4O4BrSi+) requires m/z 
542.0985, found m/z 542.0983; [α]D =  –6.45 (c = 1.0, CHCl3).  
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Amino ester 61: To a room temperature solution of azide 59 (777 mg, 1.418 mmol) in 30 
mL of a 5:1 THF/H2O solution was added triphenylphosphine (450 mg, 1.715 mmol) in 
one portion. The reaction was heated to 50 °C and stirred for 3 hours until judged 
complete by TLC. The reaction was diluted with 300 mL of EtOAc and the resulting 
solution was washed with 150 mL saturated NH4Cl solution. The resulting organic layer 
was washed with 200 mL of brine and dried over sodium sulfate. Following 
concentration in vacuo, the crude extracts were dissolved in 23 mL of THF and NEt3 (1.0 
mL, 7.09 mmol). The resulting solution was stirred and cooled to 0 °C before CbzCl 
(0.608 mL, 4.25 mmol) was added dropwise via syringe over 5 minutes. The reaction was 
stirred and allowed to warm to room temperature over 3 hours at which time it was 
judged complete by TLC. The reaction was diluted with 300 mL of EtOAc and the 
resulting solution was washed with 3 x 150 mL saturated NaHCO3 solution. The resulting 
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organic layer was washed with 200 mL of brine and dried over sodium sulfate. Following 
concentration in vacuo, the crude extracts were purified by flash chromatography (10%–
25% EtOAc in hexanes) to yield the desired product as a white solid (0.720 g, 78% over 
two steps). IR (Film): 3339, 2953, 1736, 1686, 1531, 1453, 1424, 1345, 1324, 1257, 
1188, 1099, 1056, 971, 859, 835, 776, 760, 748, 730, 694 cm-1; 1H NMR: (500 MHz, 
CDCl3) δ 8.21 (br s, 1H, C-7 ArH), 7.53 (s, 1H, C-2 ArH), 7.46 (m, 3H, ArH), 7.42–7.36 
(m, 4H, ArH), 7.32–7.25 (m, 5H, ArH), 7.14 (t, 1H, J = 8.1 Hz, C-6 ArH), 5.41 (s, 2H, 
PhCH2O), 5.03 (s, 2H, PhCH2O), 4.79 (dt, 1H, J = 5.7, 8.9 Hz, CHNH), 4.18 (m, 2H, 
CO2CH2), 3.62 (dd, 1H, J = 5.7 Hz and 14.9 Hz, ArCH), 3.28 (dd, 1H, J = 8.6 Hz and 
14.8 Hz, ArCH), 0.87 (m, 2H, CH2TMS), 0.00 (s, 9H, TMS); 13C NMR: (125 MHz, 
CDCl3) δ 173.7, 157.3, 151.6, 138.5, 137.8, 136.2, 130.42, 130.37, 130.109, 130.03, 
129.8, 129.67, 129.58, 129.4, 127.2, 118.3, 116.1, 115.7, 70.5, 68.4, 65.5, 56.3, 30.7, 
18.7, 0.0; HRMS (ESI-TOF+) exact mass calc. for [M+H•] (C32H36N2O6BrSi+) requires 
m/z 651.1525, found m/z 651.1517; [α]D = –2.3 (c = 0.67, CHCl3). 
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Boronic ester 63: A 25 mL flask was charged with 545 mg 61 (0.836 mmol), 68 mg of 
Pd(dppf)Cl2 (0.0836 mmol),  531 mg of (Bpin)2 (2.091 mmol), and 328 mg of KOAc 
(3.34 mmol) inside a glove box. The flask was sealed with a rubber septa, removed from 
the glove box, and charged with 5.6 mL of DMF via syringe under argon. The resulting 
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mixture was heated to 100 °C for 16 hours until judged complete by TLC. The solution 
was then cooled to room temperature, and then poured into 200 mL of EtOAc and 100 
mL of brine. The layers were separated and the organic portion was washed with 2 x 100 
mL saturated aqueous NH4Cl and then 200 mL of brine. The resulting solution was 
filtered through a pad of florisil, dried over sodium sulfate, and concentrated. The boron 
byproducts and remaining (Bpin)2 were removed by trituration of the resulting crude 
solids with 2 x 100 mL of pentane. Following this, the remaining solids were dissolved in 
25 mL of THF and 325 mg of Pd/C is added in one portion. The solution was degassed 
under argon and then the flask was charged with one atmosphere of hydrogen gas. After 
stirring for 5 hours at room temperature the reaction was judged complete by TLC and 
filtered through a pad of celite. The celite pad was washed with 4 x 50 mL EtOAc and the 
resulting organic solution was concentrated in vacuo. The resulting crude solid was then 
purified by flash chromatography on silica gel (9:1 CH2Cl2:MeOH) to yield the title 
compound as a white solid (200 mg) in 55% yield over the two steps. IR (Film): 3384 
(br), 3250 (br), 3045, 2957, 1731, 1606, 1407, 1372, 1250, 1153, 1074, 1043, 972, 928, 
859, 836, 756, 734 cm-1; 1H NMR: (500 MHz, CDCl3) δ 8.25 (br s, 1H, ArN-H), 7.62 (d, 
1H, J = 7.1 Hz, ArH), 7.41 (d, 1H, J = 8.1 Hz, ArH), 7.15 (app t, 1H, J = 7.6 Hz, C-6 
ArH), 7.06 (br s, 1H, ArH), 4.16 (m, 2H, CO2CH2), 3.82 (dd, 1H, J = 5.4 Hz and 8.4 Hz, 
CHNH), 3.57 (dd, 1H, J = 5.4 Hz and 14.8 Hz, ArCH), 3.22 (dd, 1H, J = 8.4 Hz and 14.8 
Hz, ArCH), 1.37 (s, 12H, 4 x Me), 0.94 (m, 2H, CH2TMS), 0.02 (s, 9H, TMS); 13C NMR: 
(125 MHz, CDCl3) δ 177.0, 137.7, 131.8, 130.1, 125.8, 122.7, 115.6 114.9, 85.1, 64.5, 
57.3, 32.9, 26.46, 26.42, 26.38, 18.9, 0.0; HRMS (ESI-TOF+) exact mass calc. for 
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[M+H•] (C22H35N2O4BSi+) requires m/z 460.2568, found m/z 460.2567; [α]D = –1.56 (c 
= 0.95, CHCl3). 
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Phenol 64: A 25 mL flask was charged with 202 mg of 10 (0.276 mmol), 124 mg of 63 
(0.289 mmol), 44 mg of HOBT•H2O (0.289 mmol), and 55 mg of EDC•HCl (0.289 
mmol). The flask was sealed with a rubber septa and 5.5 mL of DMF was added by 
syringe under argon. The resulting solution was stirred at room temperature for 15 hours 
until judged complete by TLC. The reaction mixture was then diluted 100 mL of EtOAc 
and washed 2 x 50 mL with 0.1 M HCl and 2 x 50 mL with brine. The combined aqueous 
fractions were then back extracted 2 x 50 mL of EtOAc. The combined organic layer was 
then washed once with 100 mL of brine and dried over sodium sulfate. Following 
concentration, the crude solids were purified by flash chromatography on silica gel (40% 
EtOAc in hexanes) to yield 250 mg (79%) the title compound as an off-white solid. IR 
(Film): 3401, 2960, 2868, 1736, 1654, 1599, 1503, 1372, 1297, 1250, 1178, 1136, 1062, 
859, 838, 755 cm-1; 1H NMR: (500 MHz, CD3CN) δ 9.27 (s, 1H, indole N-H), 7.63 (d, 
1H, J = 7.8 Hz, N-H), 7.54 (d, 1H, J = 6.5 Hz, Ar-H), 7.50 (d, 1H, J = 8.0 Hz, Ar-H), 7.34 
(s, 1H, Ar-H), 7.10 (m, 5H, Ar-H and N-H), 7.00 (m, 1H, N-H), 6.84 (br s, 1H), 6.74 (d, 
1H, J = 8.1 H, Ar-H), 6.56 (m, 4H, Ar-H), 5.57 (d, 1H, J = 4.5 Hz, N-H), 4.95 (dd, 1H, J 
= 6.0 Hz and 9.0 Hz, CHNH), 4.64 (dd, 1H, J = 8.0 Hz and 14.5 Hz, CHNH), 4.40 (m, 
1H, CHNH), 4.13 (m, 2H, OCH2CH2TMS), 4.01 (d, 1H, J = 3.0 Hz, CHOTIPS), 3.55 (m, 
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2H, 3’ indole-CH2), 3.13 (dd, 1H, J = 12.0 Hz and 12.0 Hz, tyrosine ArCH(CH)NH), 
2.74 (dd, 1H, J = 2.5 Hz and 12.0 Hz, tyrosine ArCH(CH)NH), 2.19 (m, 1H, CHMe2), 
1.89 (m, 1H, CHMe2), 1.30 (s, 12H, 4 x Me), 1.06 (m, 21H, TIPS), 0.97 (d, 3H, J = 6.6 
Hz, CHMe(Me)), 0.95 (d, 3H, J = 6.6 Hz, CHMe(Me)), 0.90 (m, 2H, CH2TMS), 0.84 (d, 
3H, J = 6.4 Hz, CHMe(Me)), 0.80 (d, 3H, J = 6.7 Hz, CHMe(Me)), 0.00 (s, 9H, TMS); 
13C NMR: (125 MHz, CD3CN) δ 171.7, 170.6, 160.1, 159.8, 156.5, 152.5, 140.8, 136.4, 
135.9, 130.0, 129.94, 129.92, 129.8, 129.6, 128.4, 128.3, 128.1, 124.8, 121.3, 120.2, 
119.9, 114.8, 114.3, 113.7, 111.1, 109.8, 102.6, 83.5, 77.5, 62.7, 55.2, 53.8, 52.3, 38.3, 
33.4, 28.0, 26.9, 23.9, 23.7, 18.9, 17.2, 17.1, 16.6, 16.5, 16.4, 11.8, -2.8. HRMS (ESI+) 
exact mass calc. for [M+H] (C61H85N6O11BSi2) requires m/z 1145.594, found m/z 
1145.589; 
! 
["]
D
25  = –36.3 (c = 2.0, CHCl3). 
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Triflate 65:  To a solution of 200 mg of 64 (0.1746 mmol) in 8.75 mL of CH2Cl2 was 
added 120 µL of DIPEA (0.6984 mmol) via syringe. To the resulting solution was added 
125 mg of NPhTf2 (0.349 mmol). The resulting solution was stirred at room temperature 
for 5 hours until judged complete by TLC. The crude reaction was then diluted with 100 
mL of EtOAc and 100 mL of saturated NaHCO3. The layers were separated and the 
aqueous was washed with 2 x 50 mL of EtOAc. The combined organic fractions were 
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then washed with 100 mL of brine and dried over sodium sulfate. Following 
concentration the crude solid was purified by flash chromatography on silica gel (25% 
EtOAc in hexanes) to yield 183 mg (82%) of the title compound as an off-white solid. IR 
(Film): 3403, 3294, 2961, 2869, 1735, 1655, 1498, 1423, 1372, 1343, 1249, 1211, 1172, 
1137, 1062, 914, 882, 859, 838, 755, 684 cm-1; 1H NMR: (500 MHz, CDCl3) δ 8.03 (s, 
1H, indole N-H), 7.60 (d, 1H, J = 7.1 Hz, Ar-H), 7.50 (d, 1H, J = 8.6 Hz, Ar-H), 7.45 (d, 
1H, J = 1.5 Hz, Ar-H), 7.37 (d, 1H, J = 8.1 Hz, Ar-H), 7.21 (d, 1H, J = 9.4 Hz, Ar-H), 
7.12 (dd, 1H, J = 7.5 Hz and 7.5 Hz, Ar-H), 7.09 (s, 1H, OCHNH), 7.08 (m, 1H, Ar-H), 
7.03 (d, 1H, J = 8.34 Hz, Ar-H), 6.97 (m, 2H, Ar-H and NH), 6.75 (d, 1H, J = 8.1 Hz, Ar-
H), 6.67 (t, 1H, J = 7.5 Hz, Ar-H), 6.07 (br s, 1H, NH), 5.49 (d, 1H, J = 4.5 Hz, NH), 4.98 
(dd, 1H, J = 5.0 Hz and 9.0 Hz, CHNH), 4.81 (m, 1H, CHNH), 4.37 (br m, 1H, CHNH), 
4.10 (m, 3H, OCH2CH2TMS and CHOTIPS), 3.54 (m, indole 3’ Ar-CH2), 3.32 (dd, 1H, J 
= 12.5 Hz and 12.5 Hz, tyrosine ArCH(CH)NH), 2.70 (dd, 1H, J = 3.0 Hz and 12.5 Hz, 
tyrosine ArCH(CH)NH), 2.30 (m, 1H, CHMe2), 1.97 (m, 1H, CHMe2), 1.30 (app d, 12H, 
J = 3.5 Hz, 4 x Me), 1.05 (m, 24H, TIPS and CHMe(Me)), 0.98 (d, 3H, 6.7 Hz, 
CHMe(Me)), 0.96 (d, 3H, 6.7 Hz, CHMe(Me)), 0.85 (m, 2H, CH2TMS), 0.82 (d, 3H, 
CHMe(Me)), 0.00 (s, 9H, TMS); 13C NMR: (125 MHz, CDCl3) δ 173.9, 173.6, 173.5, 
173.3, 173.2, 161.5, 160.8, 158.7, 153.5, 142.3, 137.4, 134.73, 134..63, 134.58, 134.48, 
132.8, 132.0, 131.93, 131.87, 130.7, 129.9, 128.4, 125.6, 123.8, 122.9, 122.6, 121.8, 
121.4, 121.1, 118.8, 113.7, 112.3, 104.4, 85.4, 79.5, 65.1, 62.2, 57.5, 54.8, 54.6, 39.9, 
38.2, 35.4, 31.3, 30.0, 29.9, 26.4, 26.2, 21.2, 19.6, 19.5, 19.0, 13.9. 0.0; HRMS (ESI+) 
exact mass calc. for [M+H] (C62H85N6O13BF3SSi2) requires m/z 1276.5437, found m/z 
1276.5402; 
! 
["]
D
25  = –35.9 (c = 2.0, CHCl3). 
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Macrocycle 66: A microwave reactor vessel was charged with 5.0 mg of 65 (.003915 
mmol), 1.13 mg of Pd(PPh3)4 (0.0009788 mmol), and 1.62 mg of K3PO4 inside a glove 
box. The flask was sealed and charged with 0.83 mL of rigorously degassed dioxane and 
0.16 mL of rigorously degassed water, both via syringe. The reaction was then heated to 
120 °C in a CEM Discover microwave (200W) for 30 minutes. The crude solution was 
cooled to room temperature and diluted with 25 mL of EtOAc and 50 mL of saturated 
NH4Cl solution. The layers were separated and the organic was washed 2 x 25 mL with 
brine and dried over sodium sulfate. Following concentration, the resulting oil was 
purified by flash chromatography on silica gel to provide (1:1 EtOAc:hexanes) to yield 
the title compound as an amorphous tan solid (2.7 mg, 70%). IR (Film): 3402, 3295, 
2957, 2868, 1737, 1653, 1512, 1492, 1456, 1348, 1250, 1171, 1097, 1062, 911, 881, 837, 
731 cm-1; 1H NMR: (500 MHz, CDCl3) δ 8.56 (s, 1H, NH), 7.64 (s, 1H, Ar-H), 7.46 (d, 
1H, J = 7.2 Hz, Ar-H), 7.40 (d, 1H, J = 8.0 Hz, Ar-H), 7.34 (d, 1H, J = 6.6 Hz, Ar-H), 
7.23 (m, 2H, Ar-H), 7.11 (d, 1H, J = 8.3 Hz, Ar-H), 7.05 (d, 1H, J = 6.6 Hz, Ar-H), 7.00 
(t, 1H, J = 7.6 Hz, Ar-H), 6.76 (d, 1H, J = 8.2 Hz, Ar-H), 6.20 (br s, 1H, NH), 6.03 (d, 
1H, J = 3.0 Hz, OCHNH), 5.19 (d, 1H, J = 6.0 Hz, NH), 5.04 (dd, 1H, J = 4.0 Hz and 9.0 
Hz, CHNH), 4.75 (d, 1H, J = 3.0 Hz, OCHNH), 4.46 (m, 1H, CHNH), 4.20 (m, 2H, 
OCH2CH2TMS), 4.12 (d, 1H, J = 3.5 Hz, CHOTIPS), 4.08 (m, 1H, CHNH), 3.44 (dd, 
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1H, J = 12.5 Hz and 12.5 Hz, tyrosine ArCH(CH)NH), 2.91 (dd, 1H, J = 2.0 Hz and 15.5 
Hz, indole 3’ ArCH(CH)NH), 2.75 (dd, 1H, J = 3.0 Hz and 12.5 Hz, tyrosine 
ArCH(CH)NH), 2.55 (m, 1H, CHMe2), 2.01 (m, 2H CHMe2 and indole 3’ 
ArCH(CH)NH), 1.06 (m, 21H, TIPS), 1.00 (d, 3H, J = 6.5 Hz, CHMe), 0.96 (d, 1H, J = 
7.0 Hz, CHMe), 0.89 (d, 1H, J = 7.0 Hz, CHMe), 0.81 (d, 1H, J = 7.0 Hz, CHMe), 0.00 
(s, 9H, TMS); 13C NMR: (125 MHz, CDCl3) δ 173.6, 173.5, 173.4, 163.3, 160.8, 159.1, 
152.3, 149.3, 137.5, 134.3, 132.1, 131.9, 131.4, 130.6, 129.6, 128.8, 128.3, 126.6, 125.9, 
124.6, 124.5, 123.8, 122.4, 121.8, 114.9, 113.0, 112.0, 105.2, 79.4, 65.3, 62.1, 59.7, 57.7, 
55.3, 39.9, 35.2, 29.9, 29.7, 20.9, 19.5, 19.4, 19.0, 18.75, 18.73, 18.6, 13.8, 0.00; HRMS 
(ESI+) exact mass calc. for [M+H] (C55H73N6O8Si2) requires m/z 1001.5023, found m/z 
1001.5008; 
! 
["]
D
25  =  –141.3 (c = 0.40, CHCl3). 
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Alcohol 68: To a room temperature solution of 66 (4.5 mg, 0.0045 mmol) in 0.225 mL of 
CH2Cl2 was added DDQ (3.06 mg, 0.0135 mmol) in one portion. The resulting brown 
solution was stirred at room temperature for 11 hours until judged complete by TLC. The 
reaction was diluted with 5.0 mL of EtOAc and 2.0 mL of saturated sodium thiosulfate 
solution. The solution was agitated until the brown color disappears and the remaining 
solution was bright orange. The layers were separated and the organic layer was washed 
repeatedly with 5.0 mL portions of saturated NaHCO3 until no more orange coloring was 
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extracted into the aqueous phase. The organic fraction was dried over sodium sulfate, 
concentrated, and purified by preparative TLC (1:1 ethyl acetate:hexanes) to yield the 
title compound as a tan solid in 45% yield (2.0 mg). IR (Film): 3402, 2926, 2865, 1729, 
1657, 1519, 1489, 1294, 1251, 1148, 1101, 1063, 912, 840, 68, 680 cm-1; 1H NMR: (500 
MHz, CD3CN) δ 9.45 (s, 1H, NH), 8.10 (d, 1H, J = 1.5 Hz, indole C(2)), 7.80 (d, 1H, J = 
7.5 Hz, Ar-H), 7.50 (d, 1H, J = 7.5 Hz, Ar-H), 7.46 (d, 1H, J = 8.0 Hz, Ar-H), 7.42 (d, 
1H, J = 7.0 Hz, Ar-H), 7.29 (m, 2H, Ar-H), 7.13 (br s, 1H, Ar-H), 7.10 (d, 1H, J = 9.0 Hz, 
N-H), 6.99 (dd, 1H, J = 1.5 Hz and 8.0 Hz, Ar-H), 6.74 (d, 1H, J = 10.0 Hz, N-H), 6.63 
(d, 1H, J = 8.0 Hz, Ar-H, 6.38 (s, 1H, OCHNH), 5.30 (dd, 1H, J = 6.0 Hz and 10.0 Hz, 
CHNH), 5.00 (d, 1H, J = 1.5 Hz, ArCHO), 4.4 (m, 2H, OCH2CH2TMS), 4.13 (m, 1H, 
CHNH), 4.03 (d, 1H, J = 3.5 Hz, CHOTIPS), 3.40 (app t, 1H, J = 12.5 Hz, 
ArCH(H)CHNH), 2.61 (dd, 1H, J = 2.5 Hz and 12.5 Hz, ArCH(H)CHNH), 2.24 (m, 1H, 
CHMe2), 1.94 (m, 1H, CHMe2),  1.05 (d, 3H, J = 7.0 Hz, CHMe), 1.03 (m, 21H, TIPS), 
0.90 (m, 9H, 3 x CHMe), 0.81 (t, 2H, J = 7.5 Hz, CH2TIPS), 0.00 (s, 9H, TMS); 13C 
NMR: (125 MHz, CD3OD) δ 173.74, 173.66, 172.7, 164.3, 163.4, 158.63, 158. 59, 153.7, 
151.9, 138.2, 134.0, 131.6, 131.0, 130.9, 130.74, 130.70, 130.6, 130.1, 129.0, 126.2, 
125.4, 124.5, 120.24, 120.20, 114.2, 112.7, 112.1, 108.8, 79.6, 68.8, 67.6, 59.0, 57.5, 
54.5, 39.5, 35.4, 33.5, 29.3, 21.5, 19.7, 19.6, 19.24, 19.16, 18.9, 0.0; HRMS (ESI+) exact 
mass calc. for [M+H] (C55H71N6O9Si2) requires m/z 1014.4743, found m/z 1014. 4776; 
! 
["]
D
25  = –75.7 (c = 0.147, CHCl3). 
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Oxazoline 79: To a solution of 66 (7.0 mg, 0.007 mmol) in 0.7 mL of CH2Cl2 was added 
DDQ (8.4 mg, 0.037 mmol) in one portion. The resulting brown solution was stirred at 
room temperature for 40 minutes until the reaction was judged complete by TLC. The 
reaction was diluted with 10 mL of EtOAc and 10 mL of saturated sodium thiosulfate 
solution. The layers were separated and the organic was washed 5 x 10 mL with saturated 
NaHCO3 solution until no orange color was extracted into the aqueous phase. The 
organic layer was washed with 20 mL of brine and dried over sodium sulfate. Following 
concentration, the resulting brown solids were purified by silica gel chromatography 
(30% to 100% EtOAc in hexanes) to yield the title compound as an off-white solid (3.9 
mg, 56%). IR (Film): 3404, 3302, 2955, 2870, 1732, 1676, 1656, 1563, 1490, 1466, 
1385, 1238, 1177, 1096, 1062, 839, 765, 747, 682 cm-1; 1H NMR: (500 MHz, CDCl3) * 
In solution, this compound appears to be a hydrolyzed form of the oxazoline, with a 
benzylic alcohol and a secondary amide. This NMR data reflects this isomeric form. δ 
8.04 (br s, 1H, Ar-H), 7.55 (d, 1H, J = 7.0 Hz, Ar-H), 7.45 (d, 1H, J = 8.0 Hz, Ar-H), 7.28 
(m, 2H, Ar-H), 7.17 (M, 2H, Ar-H), 6.86 (dd, 1H, J = 2.0 Hz and 8.0 Hz), 6.46 (d, 1H, J 
= 8.5 Hz, Ar-H), 6.20 (s, 1H, OCHNH), 5.85 (d, J = 10 Hz, NH), 5.75 (d, 1H, J = 8.5 Hz, 
TMSEOC(O)CHNH), 5.30 (app t, J = 10.0 Hz, CHNH), 5.14 (dd, 1H, J = 8.5 Hz and 
12.0 Hz, TMSEOC(O)CHNH), 4.88 (d, 1H, J = 12 Hz, Ar-C(H)OH), 4.22 (m, 2H, 
OCH2CH2TMS), 4.17 (d, 1H, J = 3.5 Hz, CHOTIPS), 4.10 (m, 1H, CHNH), 3.46 (dd, 
1H, J = 12.5 Hz and 12.5 Hz, ArC(H)HNH), 2.55 (dd, 1H, J = 3.0 Hz and 12.5 Hz, 
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ArC(H)HNH), 2.33 (m, 1H, CHMe2), 2.05 (m, 1H, CHMe2), 1.10 (m, 24H, TIPS and 
CH2TMS), 0.98 (m, 12H, 4 x CHMe), 0.00 (s, 9H, TMS); 13C NMR: (125 MHz, CD3CN) 
δ 171.6, 170.6, 168. 9, 164.8, 163.0, 155.8, 155.6, 153.8, 136.7, 134.8, 130.8, 129.4, 
129.2, 129.1, 128.8, 127.4, 127.0, 126.4, 125.4, 122.8, 121.9, 118.7, 166.7, 115.1, 110.8, 
108.9, 105.6, 77.6, 66.0, 64.1, 59.8, 59.6, 55.0, 54.8, 52.4, 38.1, 33.5, 28.0, 19.0, 17.6, 
17.2, 17.1, 16.7, 16.5, 16.3, 13.2, 13.1, 11.9, -3.0; HRMS (ESI+) exact mass calc. for 
[M+H] (C55H71N6O8Si2) requires m/z 999.4794, found m/z 999.4786; 
! 
["]
D
25  = –150.1 (c = 
0.456, CHCl3). 
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Oxazoline 83: To a room temperature solution of 79 (3.9 mg, 0.0039 mmol) in 0.4 mL 
THF was added NEt3 (3.3 µL, 0.0234 mmol), DMAP (0.48 mg, 0.0039 mmol), and 
CbzCl (2.2 µL, 0.0234 mmol). The resulting heterogeneous white solution was stirred for 
five hours at room temperature until judged complete by TLC. It was then diluted with 
5.0 mL of EtOAc and 5.0 mL of 0.5 M HCl. The layers were separated and the aqueous 
layer was washed 2 x 5.0 mL with EtOAc. The combined organics were washed 2 x 10 
mL with brine, dried over sodium sulfate, and concentrated. The resulting solids were 
purified by silica gel chromatography (20%–35% EtOAc in hexanes) to give the title 
compound as an off-white solid in 73% yield (3.2 mg). IR (Film): 3406, 3333, 2960, 
2868, 1733, 1696, 1658, 1491, 1422, 1389, 1357, 1289, 1241, 1179, 11126, 1068, 963, 
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914, 881, 839, 772, 694 cm-1; 1H NMR: (500 MHz, CDCl3) δ 8.162 (br s, 1H, Ar-H), 
8.05 (d, 1H, J = 1.5 Hz, Ar-H), 7.9 (d, 1H, J = 8.0 Hz, Ar-H), 7.63 (br s, 1H, Ar-H), 7.57 
(app t, 1H, J = 6.5 Hz, Ar-H), 7.50–7.25 (m, 5H, Ar-H), 7.22 (d, 1H, J = 9.0 Hz, Ar-H), 
6.88 (dd, 1H, J = 2.0 Hz and 7.0 Hz, Ar-H), 6.48 (d, 1H, J = 8.0 Hz, Ar-H), 6.17 (s, 1H, 
OCHNH), 5.89 (d, 1H, J = 10 Hz, NH), 5.81 (d, 1H, J = 8.5 Hz, NH), 5.55 (d, 1H, J = 12 
Hz, CH(H)OBn), 5.40 (d, 1H, J = 12 Hz, CH(H)OBn), 5.31 (app t, 1H, J = 10.0 Hz, 
CHNH), 5.15 (dd, 1H, J = 10.0 Hz and 6.5 Hz, CHNH), 4.68 (d, 1H, J = 11.5 Hz, 
ArCHOH), 4.22 (m, 2H, OCH2CH2TMS), 4.18 (d, 1H, J = 3.5 Hz, CHOTIPS), 4.11 (m, 
1H, CH2CHNH), 3.47 (dd, 1H, J = 13.0 Hz and 13.0 Hz, CH(H)CHNH), 2.56 (dd, 1H, J 
= 3.0 Hz and 13.0 Hz, CH(H)CHNH), 2.36 (m, 1H, CHMe2), 2.07 (m, 1H, CHMe2), 1.12 
(d, 3H, J = 6.5 Hz, CHMe), 1.10–1.00 (m, 32H, TIPS, 3 x CHMe2, CH2TMS), 0.00 (s, 
9H, TMS); 13C NMR: (125 MHz, CDCl3) δ 173.6, 173.4, 170.5, 167.0, 164.6, 157.88, 
157.85, 155.6, 137.0, 136.5, 131.5, 131.4, 131.2, 130.53, 130.48, 130.45, 130.35, 130.33, 
130.2, 130.0, 129.8, 129.6, 129.5, 128.7, 127.7, 127.6, 124.6, 124.5, 122.1, 116.6, 111.7, 
107.1, 79.7, 70.5, 68.7, 67.0, 57.1, 56.5, 55.0, 39.6, 35.4, 29.5, 21.8, 20.3, 19.7, 19.6, 
19.2, 19.0, 18.7, 14.0, 0.0; HRMS (ESI+) exact mass calc. for [M+H] (C63H76N6O10Si2) 
requires m/z 1132.516, found m/z 1132.517; 
! 
["]
D
25  = –171.5 (c = 0.45, CHCl3). Note: The 
H-NMR spectral data indicate that the oxazoline in product was a ring-opened hydroxy 
amide form in CDCl3. This contradicts the HRMS data and the behavior of the 
compounds by TLC. It was assumed that these species were in equilibria due to acidic 
impurities in the chloroform.  
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Carboxylic Acid 84: To a solution of the 83 (3.2 mg, 0.00282 mmol) in 0.2 mL of DMF 
was added 0.15 mL of a TASF solution (1.72 mg, 0.00622 mmol) in DMF via syringe 
under argon. After stirring for 35 minutes at room temperature the reaction was judged 
complete by TLC and diluted with 2.0 mL EtOAc, 0.5 mL of AcOH, and 1.0 mL of H2O. 
The layers were separated and the aqueous layer was washed 2 x 5 mL with EtOAc, and 
the combined organic was washed twice with 10 mL of brine. The resulting solution was 
dried over sodium sulfate and concentrated in vacuo. The resulting crude solids were 
purified by chromatography on silica gel (99:1 MeCN:AcOH) to yield the title compound 
as a translucent yellow solid in 77% yield (1.9 mg). IR (Film): 3274 (br), 1656, 1423, 
1292, 1246, 1127, 746 cm-1; 1H NMR: (500 MHz, CD3OD) δ 8.05 (br s, 1H, Ar-H), 7.96 
(d, 1H, J = 1.5 Hz, indole C(2) Ar-H), 7.86 (app d, 1H, J = 8.5 Hz, Ar-H), 7.79 (s, 1H, 
Ar-H), 7.55 (dd, 1H, J = 2.5 Hz and 7.5 Hz, Ar-H), 7.50 (d, 1H, J = 7.5 Hz, Ar-H), 7.44–
7.42 (m, 2H, Ar-H), 7.35–7.23 (m, 3H, Ar-H), 7.19 (m, 1H, Ar-H), 6.84 (d, 1H, J = 8.0 
Hz, Ar-H), 6.39 (d, 1H, J = 8.0 Hz, Ar-H), 5.96 (s, 1H, OCHNH), 5.37 (br s, 2H, 
OCH2Ph), 5.12 (d, 1H, J = 10 Hz, CHNH), 4.84 (d, 1H, J = 11.5 Hz, NCHCO2H), 4.71 
(d, 1H, J = 11.5 Hz, ArC(H)OCHCO2H), 4.12 (dd, 1H, J = 3.0 Hz and 11.5 Hz, CHNH), 
3.76 (d, 1H, J = 4.0 Hz, CHOH), 3.31 (app t, 1H, J = 11.5 Hz, ArC(H)HCHN), 2.52 (dd, 
1H, J = 3.0 Hz and 11.5 Hz, ArC(H)HCHN),  2.20 (m, 1H, CHMe2), 1.97 (m, 1H, 
CHMe2), 1.11 (d, 3H, J = 6.5 Hz, CHMe), 0.93 (d, 3H, J = 6.5 Hz, CHMe), 0.90 (d, 3H, J 
= 7.0 Hz, CHMe), 0.78 (d, 3H, J = 7.0 Hz, CHMe); 13C NMR: (125 MHz, CD3OD) δ 
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175.6, 174.5, 166.7, 165.4, 157.9, 157.6, 155.3, 152.3, 137.6, 136.9, 136.6, 132.3, 131.7, 
131.1, 130.9, 130.4, 130.3, 129.8, 129.7, 129.5, 129.3, 128.5, 128.1, 126.7, 126.6, 123.9, 
123.7, 123.3, 76.8, 69.9, 67.6, 61.7, 61.6, 58.1, 56.8, 54.8, 38.9, 33.2, 29.3, 20.6, 19.6, 
19.2, 16.4, 14.5. HRMS (ESI+) exact mass calc. for [M+H] (C49H45N6O10Si2) requires 
m/z 876.3119, found m/z 876.3120; 
! 
["]
D
25  = –116.0 (c = 0.1545, 10:1 CHCl3:MeOH). 
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Chapter 6 
 
Synthetic Investigations of Erythronolide B: 
 Investigations of a Diastereoselective, Late-Stage Aldol Reaction 
 
I. Background 
 The erythrolide antibiotics are metabolites of the fungus Streptomyces erythreus 
that were first isolated in 1952 and structurally elucidated several years later.1 They have 
a prominent history in modern medicine as powerful antibacterial agents, finding 
application in the treatment of human illnesses ranging from acne to pneumonia. In light 
of these interesting biological properties and uniquely complex molecular architectures, 
this family of molecules has also become a classic target set for chemical synthesis.  
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Figure 1: The erythronolides
 
 In particular, the stereochemical relationships along the erythronolide backbone 
have served as both an inspiration and testing ground for chemical methodologies 
                                                
1 (a) McGuire, J. M.; Bunch, R. L.; Anderson, R. C.; Boaz, H. E.; Flynn, E. H.; Powell, H. M.; Smith, J. W. 
Antiobiotics and Chemotherapy 1952, 2, 218–283. (b) Wiley, P. F.; Gerzon, K.; Flynn, E. H.; Sigal, M. V.; 
Quarck, U. C. J. Am. Chem. Soc. 1955, 77, 3677–3678. (c) Wiley, P. F.; Weaver, O. J. Am. Chem. Soc 
1955, 77, 3422–3423. (d) Gerzon, K.; Flynn, E. H.; Sigal, M. V.; Wiley, P. F.; Monahan, R.; Quarck, U. C.  
J. Am. Chem. Soc. 1956, 78, 6396–6408. (e) Wiley, P. F.; Weaver, O. J. Am. Chem. Soc 1956, 78, 808–810. 
(f) Wiley, P. F.; Gale, R.; Pettinga, C. W.; Gerzon, K. J. Am. Chem. Soc. 1957, 79, 6074–6077. (g) Wiley, 
P. F.; Gerzon, K.; Flynn, E. H.; Sigal, M. V.; Weaver, O.; Quarck, U. C.; Chauvette, R. R.; Monahan, R. J. 
Am. Chem. Soc 1957, 79, 6062–6070. (h) Wiley, P. F.; Sigal, M. V.; Weaver, O.; Monahan, R.; Gerzon, K.  
J. Am. Chem. Soc. 1957, 79, 6070–6074. 
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focused upon the production and control of stereogenicity. As strategies and methods for 
the controlled installation of stereochemistry progressed throughout the decades, many 
were applied to challenges posed by the erythronolides, including the use of cyclic 
stereocontrol, chiral pool approaches, and iterative aldol/allylation chemistry.2,3,4 Yet 
these approaches generally require that each stereocenter, or set of stereocenters, be 
installed individually in a distinct reaction, or step. Though this strategic approach is 
effective and easily adaptable to the extant theoretical models of asymmetric induction, it 
is often far from efficient. It often requires extensive protecting group manipulations and 
oxidation state adjustments that can often make up a substantial fraction of the overall 
number of synthetic operations. 
 A promising and distinct approach is one wherein the multiple stereochemical 
elements can be installed directly in a single step through the use of tandem reaction 
sequences. Ideally, in such a process the product of an initial transformation is utilized as 
the starting material for a subsequent one, and so on, with no isolation steps in between. 
This can often bypass the problems of differential reactivity that lead to aforementioned 
inefficiencies, and allow for the installation of more complexity with less expenditure of 
time, effort, and resources. Thus, the MacMillan group realized that the classical 
erythronolide family of targets was an ideal platform from which to highlight the utility 
of their recently developed and highly stereoselective tandem acyl-Claisen 
rearrangement. This methodology could provide diastereoselective access to the entire 
                                                
2 Martin, S. F.; Pacofsky, G. J.; Gist, R. P.; Lee, W. C. J. Am. Chem. Soc. 1989, 111, 7634–7636. 
3 Kochetkov, N. K.; Sviridov, A. F.; Ermolenko, M. S.; Yashunsky, D. V.; Borodkin, V. S. Tetrahedron 
1989, 45, 5109–5136. 
4 Mulzer, J.; Kirstein, H. M.; Buschmann, J.; Lehmann, C.; Luger, P.  J. Am. Chem. Soc. 1991, 113, 910–
923. 
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C(3)-C(9) portion of the erythronolide backbone in a single, elegant synthetic operation 
(vide infra). 
Figure 2: Tandem acyl Claisen route to erythronolide B
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 Yet before discussing the specifics of our synthetic strategy in detail, it would be 
illustrative to discuss two of the completed, prior syntheses of these molecules. Besides 
being landmark accomplishments in the field of total synthesis, these works also provide 
the context for our own work. Specifically, discussion of the Corey group synthesis of 
erythronolide B in 1978 and the Woodward group synthesis of erythromycin A in 1981 
will furnish a pertinent background into the chemistry of these molecules and act to 
provide some perspective into the advantages engendered in our own approach. 
 
II. Corey’s Synthesis of Erythronolide B 
 The synthesis of erythronolide B in the late 1970s by E. J. Corey and his 
coworkers at Harvard is a truly remarkable and historically important chapter in the field 
of complex molecule synthesis.5 This work was not only groundbreaking given the 
                                                
5 Corey, E. J.; Kim, S.; Yoo, S. E.; Nicolaou, K. C.; Melvin, L. S.; Brunelle, D. J.; Falck, J. R.; Trybulski, 
E. J.; Lett, R.; Sheldrake, P. W. J. Am. Chem. Soc 1978, 100, 4620–4622. 
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complexity of the target, but for the profound and deliberate way that it addressed the 
most challenging elements of the molecule by the development of new reagents and 
methods to enable its completion. The Corey synthesis commenced with a para-selective 
allylation of 2,4,6-trimethylphenol 4 with allyl bromide in benzene to furnish dienone 5 
(Scheme 1).  Hydroboration of the newly installed olefin followed by oxidation of the 
resulting alcohol furnished carboxylic acid 6. Subsequent treatment with aqueous 
bromine led to a diastereoselective bromolactonization that gave racemic 7 in high 
chemical yield. Exposure of this product to aqueous base opened the lactone ring and the 
transient alkoxide that was formed displaced the vicinal bromide to form epoxy acid 8. 
Ketone 8 can undergo a second diastereoselective bromolactionization in an iterative 
manner to form 9. 
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Scheme 1: Early steps of Corey's synthesis
 
 Radical dehalogenation of 9 was followed by reductive epoxide opening using 
Al/Hg amalgam in aqueous THF to give 10. Treatment of this adduct with Raney Nickel 
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under a hydrogen atmosphere efficiently and selectively reduced the remaining ketone to 
an 86:14 mixture of diastereomers favoring the correct configuration for the 
erythronolides, 11. Thus, in short order Corey was able to take a simple aromatic 
compound and generate a fully substituted cyclohexane in which all six carbons map 
directly on to the stereochemical framework of erythronolide B.  
 After several straightforward synthetic operations 11 was transformed into 
ketoacid 12 (Scheme 2). Treatment of this unsymmetrical ketone with peroxyacetic acid 
in hot ethyl acetate led to a regiospecific Baeyer-Villiger oxidation furnishing seven-
membered lactone 13 in good yield. This elegant transformation breaks open the 
functionalized cyclohexane to produce a self-protected nine-carbon chain that constitutes 
the entire right side of the molecule, while concurrently installing the hydroxyl center at 
C(6) in a stereospecific manner.  
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Scheme 2: Resolution of racemic intermediate
 
 The free acid of this oxidation product was then transformed into its 2-pyridine 
thiol ester 15. Treatment of this racemic thioester with enantiomerically pure vinyl 
lithium 16 gave ketone 17 with no observable over-addition products. The diastereomers 
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arising from this step could be separated chromatographically, yielding enantioenriched 
material to carry through the rest of the synthesis. Selective reduction of the ketone at 
C(9) under the action of zinc borohydride created an alkoxide which underwent 
transesterification with the lactone carbonyl, expanding the seven-membered ring into the 
ten-membered lactone 18 (Scheme 3). Removal of the silyl ether and saponification of 
this newly formed lactone yielded free carboxylic acid 19, primed for macrolactonization. 
The free acid was transformed into its imidazoyl thioester 20, which, when heated in dry 
toluene, furnished macrolactone 21 which was only a few short transformations from the 
complete natural product.  
Scheme 3: Ring expansion and macrolactonization
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 The key to this macrolactonization strategy is the activation of both reactive 
functionalities by the heterocyclic thioester in 20. The basic nitrogen of the imidazole 
ring facilitates deprotonation of the alcohol nucleophile, and upon protonation activates 
the carbonyl electrophile by means of an intramolecular hydrogen bond. This double 
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activation strategy was key to the successful completion of the molecule and offered a 
general solution to a long-standing problem in the field of large ring synthesis. 
 With all the carbons of the natural product in place, the Corey group pushed 
onward. Oxidation of the free alcohol at C(9) was followed by nucleophilic epoxidation 
under the action of peroxide and base (Scheme 4). Reductive opening of the resulting 
epoxide 23 furnished the C(11) alcohol with the correct requisite stereochemistry, 
however the C(10) methyl group was produced as a mixture of epimers. Treatment with 
mild aqueous base epimerized this center to the thermodynamic conformation found in 
the natural product. A final deprotection of the remaining acetonide gave the natural 
product in a total of 31 steps and overall yield of less than 0.5%.  
Scheme 4: Corey's erythronolide B endgame
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III. Woodward’s Synthesis of Erythromycin A 
 Woodward’s synthesis of the more complicated glycosylated natural product, 
erythromycin A was also a landmark event in synthetic organic chemistry.6,7,8 Completed 
after his death, Woodward’s work took strategic advantage of symmetry elements present 
in the target, allowing asymmetric construction of the C(3)-C(7) as well as the C(8)-
                                                
6  Woodward, R. B., et al. J. Am. Chem. Soc 1981, 103, 3210–3213. 
7  Woodward, R. B., et al. J. Am. Chem. Soc 1981, 103, 3213–3215. 
8  Woodward, R. B., et al. J. Am. Chem. Soc 1981, 103, 3215–3217. 
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C(13) stereocenters from a common precursor. A brief summary of the Woodward route 
to the seco acid of erythronolide A will serve to outline this synthetic strategy and 
simultaneously highlight the burgeoning understanding of diastereoselective aldol 
reactions that occurred in the late 1970s, as this presently remains the dominant strategy 
toward this class of molecules. 
  Exposure of racemic ketoaldehyde 24 to D-proline in a mixture of benzene and 
methanol yielded two optically active aldol products, 25 and 26 as a 1:1 mixture in 36% 
ee (Scheme 5). This remarkable result is believed to arise from a dynamic kinetic 
resolution of the thioether stereocenter via enamine β-elimination, followed by conjugate 
additon into the resulting chiral iminium ion and an intramolecular aldol reaction. 
Scheme 5: Woodward's synthesis of key intermediate
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 Following separation of the diastereomers, the one having the desired 
configuration (26) was dehydrated and then recrystallized to afford the optically pure 
ketone 27. From this stage only a handful of synthetic operations were needed to access 
common building block 28 that was the centerpiece of the Woodward strategy. 
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Scheme 6: Woodward's differentiation of common intermediate
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From this common precursor Woodward and his coworkers were able to construct 
the stereochemical arrays found in the C(4)-C(6) section and the C(10)-C(13) fragment of 
the seco acid. Precursor 28 was readily transformed into 29 and 31, which were then in 
turn joined by a stereoselective aldol condensation. Oxidation of the aldol product gave 
diketone 32 as a single diastereomer in good yield. 
Over the course of nine steps the C(7) ketone of 32 was reduced to its 
corresponding methylene, the sulfur bicycles were cleaved under the action of Raney 
nickel leaving behind the correctly configured methyl groups, and the C(2) oxygen was 
elaborated to aldehyde 33. Subjection of this aldehyde to the (E)-lithium enolate 34 gave 
the expected anti-aldol, Felkin adduct 35 (Scheme 7). Subsequent enolization of the 
resulting product followed by kinetic protonation epimerized the C(2) stereocenter to the 
correct configuration of the natural product, thus completing the entire carbon framework 
and stereochemical array of the natural product aglycone, erythronolide A.  
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 Woodward went on to carry out extensive studies on the macrocyclization step 
and appendage of the sugar moieties, but this work is beyond the scope of this report. 
Taken together the Woodward and Corey syntheses demonstrate two distinctly creative 
and classical approaches towards these molecules. However, there are several aspects of 
these syntheses that are less impressive by modern standards. Firstly both groups relied 
heavily on cyclic stereocontrol to enforce the proper diastereoselection. While this is a 
viable and successful method it often leads to lengthy synthetic sequences. As such it has 
largely been supplanted in recent years by successful models for predicting high levels of 
acyclic stereocontrol. Furthermore asymmetric technologies have negated the necessity 
for classical resolution in synthesis, allowing for greater atom economy.  
Scheme 7: Woodward's completion of the seco acid
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These factors were born in mind at the outset of the MacMillan synthesis towards 
erythronolide B. First and foremost this effort was aimed at illustrating the viability of the 
tandem acyl-Claisen rearrangement as a powerful method for construction of complex 
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acyclic architectures with high levels of stereocontrol.9 This would represent the first use 
of Claisen rearrangement as a key strategy towards the synthesis of an erythrolide 
antibiotic. Were this strategy successful, asymmetric variants of the tandem Claisen 
would be investigated, hopefully leading to a concise asymmetric synthesis of 
erythronolide B. 
 
IV. Preface to MacMillan Retrosynthesis 
 The MacMillan synthesis, as it is reported here, was devised, executed, and 
completed by graduate student Vy M. Dong from 2000–2003.10 The work summarized in 
the forthcoming section came in attempting to replace a late stage auxiliary-based aldol 
condensation in her synthetic route with a substrate-controlled, diastereoselective variant. 
However, to obtain the advanced material needed to investigate this late-stage step, it was 
necessary to repeat her synthetic route up until the point of investigation. Herein, the 
overarching synthetic strategy and forward synthesis will be described along with a 
detailed discussion of the late-stage aldol reaction to install the C(1)-C(2) segment of the 
seco acid. It should be also be noted that there are three other more recent, completed 
syntheses of erythronolide B by Kotchekov, Mulzer, and Martin, but discussion of these 
syntheses are beyond the scope of this report.2,3,4  
 
V. MacMillan Retrosynthetic Analysis of Erythronolide B 
 The MacMillan retrosynthesis begins with the opening of the fourteen-membered 
macrolactone across its ester linkage (Figure 3). This produces the seco-acid of the 
                                                
9 Dong, V. M.; MacMillan, D. W. C. J. Am. Chem. Soc 2001, 123, 2448–2449. 
10 Dong, V. M. Ph.D. Thesis, California Institute of Technology, 2003. 
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natural product that was envisioned to arise from three major bond constructions 
employing propionate 39, known propionaldehyde dimer 38, and ketone 37. The union of 
ketone 37 with fragments 38 and 39 will rely on a series of stereoselective aldol 
reactions. Ketone 37 was envisioned to arise from a tandem acyl-Claisen rearrangement 
developed in the MacMillan lab, retrosynthetically yielding bisallylic amine 40.  
Figure 3: MacMillan Retrosynthesis of erythronolide B
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 The tandem acyl-Claisen rearrangement used in the construction of the C(3)-C(9) 
fragment  is truly the cornerstone of this synthetic strategy (Scheme 8). This variant of 
the Claisen rearrangement involves the use of bisallylic amines that add reversibly to 
electrophilic ketenes in a stereospecific fashion to furnish zwitterionic intermediates that 
rapidly undergo sigmatropic bond reorganization at ambient temperatures (Scheme 8). 
Although the first ketene addition is rapid and reversible, only addition at the amine (E) 
to the olefinic substituent (41) rearranges due to the avoidance of diaxial interactions in 
the transition state. A second equivalent of ketene can then react with the remaining 
allylic amine yielding two possible transition state pathways. Minimization of A(1,2) 
strain in each chair transition state yields the transition state structures 44 and 45 as 
shown in Scheme 8. While 44 has its side chain pointing directly into the center of the 
transition state, 45 undergoes no such unfavorable interactions and productive bond 
reorganization occurs selectively through this manifold to give the bisamide 46 with 
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excellent diastereoselectivity. From the product structure it is easy to see how this 
fragment could be readily elaborated to construct this portion of erythronolide B 
backbone 47. 
Scheme 8: Tandem acyl Claisen route to C(3)-C(9)
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VI. Synthesis 
  The synthesis commences with the benzoylation of the enol ether derived from 
isovaleraldehyde (Scheme 9). The product undergoes radical bromination at each of the 
two allylic methyl positions and these bromides are subsequently displaced by 
morpholine to yield bisamine 40 in an overall yield of 68% over the three steps. 
Treatment of 40 with propionyl chloride, Hünig’s base, and two equivalents of Yb(OTf)3 
yielded 86% of the racemic tandem Claisen product 46 as a 10:1 mixture of 
 240 
diastereomers, the major possessing the desired 2,3-syn and 3,6-anti relative 
stereochemical relationship. 
Scheme 9: Outset of MacMillan synthesis
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Treatment of the Claisen adduct 46 with iodine in a mixture of DME and water 
affects an iodolactonization that differentiates the two morpholine amides with moderate 
regioselectivity (83:17). Reductive opening of the iodolactone with zinc in acetic 
furnishes carboxylic acid 50 in 88% yield over two steps. Following separation of the 
regioisomers, the desired amide 50 was treated with freshly prepared ethyl lithium to 
form ethyl ketone with concomitant removal of benzoate protecting group. The 
morpholine amide acts to stabilize the initial carbanion addition product by keeping it 
tetrahedral until aqueous workup, eliminating problems of over-addition. Reprotection of 
the secondary alcohol followed by basic hydrolysis of the silyl ester gives carboxylic acid 
51 in a yield of 54% over three steps.  
 In order to resolve the enantiomers of ethyl ketone 51, they were subjected to an 
aldol reaction with enantiopure aldehyde 38 (Scheme 10). Treatment of 51 with two 
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equivalents of LiHMDS in cold THF selectively generated the (Z)-enolate that condensed 
with 38 to give the desired syn, anti-Felkin aldol adduct 52 along with an equal amount of 
undesired diastereomer 53. This stereochemical outcome was analogous to that found by 
the Martin group in a similar aldol condensation encountered in their studies on the 
erythronolides.15  
Scheme 10: Resolution of racemic intermediate 51
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 The aldol products were not separable at this stage and were carried on as a 
mixture. Selective reduction to the anti-diol under the action of tetramethylammonnium-
triacetoxtyborohydride, according to the procedure of Evans, followed by protection of 
the newly formed diol as its p-methoxyphenyl acetal 54, furnished separable 
diastereomers in good chemical yield over two steps (Scheme 11).11 Esterification of  
enantiopure carboxylic acid with TMSCHN2, followed by reduction of the newly formed 
methyl ester, gave primary alcohol 55 in 85% yield over the two steps. Oxidation of this 
alcohol furnishes the electrophilic aldehyde required to explore the aforementioned aldol 
reaction.  
 
                                                
11 Evans, D. A.; Chapman, K. T.; Carreira, E. M. J. Am. Chem. Soc 1988, 110, 3560–3578. 
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Scheme 11: Completion of the C(3)-C(15) fragment
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VII. The Second Aldol Disconnection 
 Arguably the most difficult relative stereochemical relationship to form on the 
erythronolide backbone is the all syn stereotetrad from C(2)-C(5). In the synthesis carried 
out by Vy Dong, this sequence of the seco acid was forged by a highly diastereoselective 
aldol reaction that efficiently and selectively gave the desired adduct, but relied on 
Evan’s chiral oxazolidinone technology to enforce the proper stereochemical outcome 
(Figure 4). While this stands as an impressive result and is further testimony to the utility  
Figure 4: Proposed diastereoselective aldol
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of these chiral auxiliaries in complex aldol reactions, we were curious as to whether or 
not we could use the inherent chirality of the aldehyde to give the desired stereochemical 
outcome without the use of chiral controller groups.  
 Analysis of the competing closed transition states illustrates that a simple 
diastereoselective aldol may not be straightforward. In the transition state leading to the 
desired product the methyl group of the nucleophile encounters a highly destabilizing syn 
pentane interaction (+3.7 kcal/mol) with the α-methyl stereocenter of the aldehyde.  This 
Scheme 12: Analysis of closed transition states
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strongly disfavors the syn, Felkin diastereomer required for the erythronolides. Rather, 
this energetically costly interaction is avoided if the enolate attacks the opposite aldehyde 
carbonyl face, which gives rise to the favored syn, anti-Felkin stereochemistry, as was 
observed in the Woodward synthesis (Scheme 7). Thus it seemed likely that traditional 
closed transition state aldol chemistry would not furnish the correctly configured product. 
At this juncture it was speculated that Lewis acid-mediated Mukaiyama aldol 
reactions might provide access to the desired stereochemical relationship. It is widely 
accepted that Lewis acid-promoted additions of silyl ketene acetals to aldehydes occur 
through open transition states. Thus it was postulated that access to diastereomers that are 
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disfavored by Zimmerman-Traxler chair transition states may be possible, such as the 
syn, Felkin adduct required for our synthesis.  
While simple diastereoselection in Mukaiyama aldol processes is often variable, 
stereoselective additions to chiral aldehydes are well precedented.12,13 However, in order 
to ensure successful diastereoselection the impact of each stereocenter proximal to the 
starting aldehyde must be understood. Evans has conducted a systematic study of ketone 
enolsilane additions into α,β-chiral aldehydes with a variety of relative stereochemistries 
and protecting groups.14,15 These results suggest that induction afforded by the syn α-
methyl and β-siloxy group of the aldehyde component are actually nonreinforcing 
Scheme 13: Analysis of  competing induction elements in open transition states
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12 Evans, D. A.; Dart, M. J.; Duffy, J. L.; Yang, M. G. J. Am. Chem. Soc. 1996, 118, 4322–4343. 
13 Heathcock, C. H.; Davidsen, S. K.; Hug, K. T.; Flippin, L. A. J. Org. Chem. 1986, 51, 3027–3037. 
14 Evans, D. A.; Dart, M. J.; Duffy, J. L.; Rieger, D. L. J. Am. Chem. Soc. 1995, 117, 9073–9074 
15 Evans, D. A.; Dart, M. J.; Duffy, J. L.; Yang, M. G.; Livingston, A. B. J. Am. Chem. Soc. 1995,  117, 
6619–6620. 
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(Scheme 13). Additions to α-chiral aldehydes generally adopt transition state structures 
wherein the non-bonding interactions are minimized, giving 1,2-syn products (Felkin 
products). However, it has been found that even under nonchelating conditions β-oxygen 
substituents give mainly the 1,3-anti products due to the minimization of electrostatic 
dipole moments on the aldehyde and steric interactions between aldehyde and the 
nucleophile in the transition state.  
A solution needed to be devised wherein the inherent bias of the β-substituent 
must be overcome and the α-methyl center would dictate the facial bias of the aldehyde 
addition. It has been noted that as the steric bulk of the enolsilane increases, the influence 
of β-oxygen substituent in biasing the transition state toward the 1,3, anti products is 
greatly diminished.16 Thus by employing very bulky silyl ketene acetals we hoped to 
arrive at conditions favoring formation of the syn, Felkin adduct. However, it is crucial to 
note that all the examples Evans employs rely on ketone enolates. To the best of our 
knowledge there are no reports of ester oxidation state enolsilanes adding to syn 
α-methyl, β-siloxy aldehydes with uniformly high levels of stereocontrol. Furthermore, 
Evans proposes no model transition states for propionate nucleophiles.17 Thus we felt that 
rendering this aldol reaction diastereoselective would not only represent a solution to a 
standing problem in the erythronolide literature but also contribute to a better 
understanding of related propionate silyl ketene acetal additions into α, β-chiral 
aldehydes in a more general sense.  
                                                
16 Evans, D. A.; Dart, M. J.; Duffy, J. L.; Yang, M. G. J. Am. Chem. Soc. 1996, 118, 4322–4343. 
17 Evans, D. A.; Yang, M. G.; Dart, M. J.; Duffy, J. L.; Kim, A. S. J. Am. Chem. Soc. 1995, 117, 9598–
9599. 
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 Due to the lengthy preparatory sequence required to access meaningful amounts 
of the actual erythronolide intermediate, a model system was proposed that would allow 
optimization of reaction conditions. The synthesis is straightforward and is described 
below in Scheme 14. 
Scheme 14: Development of model system
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 Methacrolein was condensed with the boron enolate of auxiliary 56. This adduct 
was then protected as its silyl ether and the auxiliary was reductively excised. Oxidation 
of the resulting primary alcohol gives the known model aldehyde 58 for use in our 
studies. It should be noted that this aldehyde is known in the literature to be unstable to 
storage. As a result it was freshly oxidized from the alcohol prior to each usage.  
Figure 5: Four possible diastereomeric products
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 From this aldehyde a range of propionate nucleophiles, solvents, and Lewis acids 
were investigated in the search for conditions that would give the desired stereochemical 
outcome. The stereochemistry of these model aldol products was established by a two-
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part method. By measuring the coupling constant between the protons on the α- and β-
carbons of the chain the relative stereochemistry between these two centers was assigned. 
After a series of steps the aldol products could be converted to their corresponding 
acetonides, allowing the relative 2,4-stereochemical relationship to be determined 
according to the method of Rychnovsky.18 With the relative stereochemistry of the 
starting aldehyde known, these two pieces of NMR evidence enabled complete 
assignment of the relative stereochemistry for the entire chain. 
Figure 6: NMR methods to assign stereochemistry of aldol products
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 Thioester nucleophiles were chosen due to their more selective reactivity 
compared to their ester enolate counterparts. In line with Evans’ observations the first 
nucleophile examined was 1-(tert-butylthio)prop-1-enyloxy)trimethylsilane, in the hope 
                                                
18 Rychnovsky, S. D.; Rogers, B.; Yang, G. J. Org. Chem 1993, 58, 3511–3515. 
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that its bulk would aid in proper diastereoselection. However, much to our surprise, both 
enolate geometries gave a high yields the of the anti, Felkin product as a single 
diastereomer when BF3•Et2O was employed as a Lewis acid in CH2Cl2 at –78 °C. While 
at first puzzling, this result was promising in that the aldehyde α-methyl center was 
properly directing the facial selectivity. However, the newly formed methyl center had 
the wrong configuration. This was later found to fall in line with Gennari’s observation 
that the S-tBu propionate nucleophiles undergo a destabilizing steric interaction between 
the enol methyl group and the Lewis acid in the transition state as a consequence of 
unusually obtuse bond angles found in this class of silyl ketene acetals.19 Despite 
extensive investigations and considerable effort, all other Lewis acids and solvent 
combinations that were evaluated gave non-selective mixtures of diastereomers, 
presumably through the viability of a number of competing transition state structures.  
 At this point focus switched to ethyl thioester nucleophiles in the hope that they 
would retain enough bulk to render 1,2 induction favorable, but not so much as to 
maintain the negative interaction with the Lewis acid experienced by the tert-butyl 
thioester nucleophiles. However, the intermediate steric bulk of this nucleophile produced 
unselective mixtures of diastereomers in all solvents and with all the Lewis acids 
surveyed, presumably due to the intermediacy of a number of competing, viable 
transition states. In the end no conditions employed provided any meaningful amount of 
the syn, Felkin diastereomer. 
 
VIII. Conclusion and Future Directions 
                                                
19 Gennari, C.; Beretta, M. G.; Bernardi, A.; Moro, G.; Scolastico, C.; Todeschini, R. Tetrahedron 1986, 
42, 893–909. 
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 After several months no conditions evaluated appeared to selectively produce the 
desired diastereomer and the focus of my research switched to the synthesis of 
diazonamide A, as is described in the earlier part of this report. As yet the syn, Felkin 
aldol problem still has no general solution. However, as synthetic organic chemistry 
advances and catalytic asymmetric methods capable of overriding intrinsic 
stereochemical preferences are developed, the prospects for the future success of this 
reaction seem undimmed.  
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Chapter 6 Supporting Information 
 
 
General Information: Commercial reagents were purified prior to use following the 
guidelines of Perrin and Armarego.20 All solvents were purified according to the method 
of Grubbs.21 Nonaqueous reagents were transferred under argon via syringe or cannula. 
Organic solutions were concentrated under reduced pressure on a Büchi rotary evaporator 
using a heated water bath. Chromatographic purification of products was accomplished 
using forced-flow chromatography on Silicycle 230–400 mesh silica gel 60 according to 
the method of Still.22 Thin-layer chromatography (TLC) was performed on Silicycle 0.25 
mm silica gel 60-F plates. Visualization of the developed chromatogram was performed 
by fluorescence quenching or by CAM stain. 
 1H and 13C NMR spectra were recorded on a Bruker AVANCE 500 (500 MHz 
and 125 MHz) as noted, and are internally referenced to residual solvent signals. Data for 
1H NMR are reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant (Hz) and 
assignment. Data for 13C NMR are reported in terms of chemical shift. IR spectra were 
recorded on a Perkin Elmer 1000 spectrometer and are reported in terms of frequency of 
absorption (cm-1). Mass spectra were obtained from the Caltech Mass Spectral Facility. 
                                                
20 Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; 3rd ed., Pergamon Press, Oxford, 
1988. 
21 Pangborn, A. B.; Giardello, M. A,; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 
1518. 
22 Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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Optical rotations were measured on a Jasco P-1010 polarimeter, and [a]D values are 
reported in 10-1 dg cm2 g-1. 
 Note: All proton and carbon spectra and optical rotations were identical to those 
reported by Vy Dong in her Ph.D. thesis (Caltech, 2003). The HRMS and IR data for 
erythronolide intermediates presented here were taken from Dong’s Thesis. 
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Benzoic acid-2-(-N-methyl-morpholinyl)-3-(-N-morpholinyl)-propenyl ester 40: To a 
solution of benzoic acid 2-methyl-propenyl ester (1.83 g, 10.37 mmol) and NBS (3.87 g, 
21.77 mmol) in 26 mL of refluxing CCl4 was added benzoyl peroxide (0.05 g, 0.02 
mmol). After two hours the reaction the reaction mixture was filtered through Celite and 
concentrated in vacuo to give the crude dibromide that was used without further 
purification. The crude dibromide was taken up in acetonitrile (270 mL) containing a 
suspension of K2CO3 (4.43 g, 27 mmol). Morpholine (11.76 mL, 135 mmol) was added 
dropwise by syringe over several minutes and the resulting reaction mixture was stirred at 
room temperature for 2 hours until judged complete by TLC. Dilution with 500 mL of 
ether was followed by 3 x 200 mL water washes. The organic fractions were dried over 
MgSO4 and concentrated in vacuo. Purification by chromatography on alumina (100% 
Et2O) furnishes the desired product as a yellow solid (3.59 g, 99%) IR (film): 1729, 1455, 
1293, 1274, 1251, 1116, 1004, 865 cm-1; 1H NMR (300 MHz, CDCl3) δ  8.10 (d, 2H, J = 
7.2 Hz, Ar), 7.63 (app t, 1H, J = 7.4 Hz, Ar), 7.50 (app t, 2H, J = 7.6 Hz, Ar), 7.42 (s, 1H, 
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C=CH), 3.72–3.68 (m, 8H, 2 x O(CH2)2), 3.21 (s, 2H, CH2C=C), 3.02 (s, 2H, CH2C=C), 
2.50–2.45 (m, 8H, 2 x N(CH2)2); 13C NMR (75 MHz, CDCl3) δ 163.4, 135.3, 133.7, 
129.9, 129.0, 128.6, 119.4, 67.1, 58.8, 54.0, 53.8, 53.6; HRMS (FAB+)  exact mass calc. 
for [M+H] (C19H27N2O4) requires m/z 347.1971, found m/z  347.1971. 
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46  
(2R*, 3R*, 6R*)-2,6-dimethyl-4-methylene-1,7-dimorpholino-1,7-dioxoheptan-3yl-
benzoate 46: A round bottom flask containing the bisallylic amine 40 (300 mg, 0.867 
mmol) and a stirbar was charged with Yb(OTf)3 (1.07 g, 1.73 mmol), sealed with a rubber 
septum, and brought out of the box. 17 mL of CH2Cl2 was added by syringe, followed by 
Hünig’s base (0.65 mL, 3.46 mmol), and then propionyl chloride (3.5 mL, 3.46 mmol). 
The resulting solution was stirred under argon at room temperature for 6 hours. After this 
time 10 mL of 1 M NaOH was added, and the resulting solution was washed 3 x 100 mL 
with ethyl acetate and the organic portion was dried over sodium sulfate. Following 
concentration, the resulting oil was purified by silica gel chromatography (100% ethyl 
acetate) to afford the title compound as a white solid (340 mg, 86%) in a 10:1 mix of 
diastereomers syn:anti : syn:syn. IR (film): 2247. 1722, 1637. 1440, 1274, 1116, 1031, 
703 cm-1; 1H NMR (300 MHz, CDCl3) δ 8.06 (d, 2H, J=9.0 Hz, Ar), 7.58 (t, 1H, J = 9.3 
Hz, Ar), 7.45 (t, 2H, J = 9.5 Hz, Ar), 5.69 (d, 1H, J = CHOBz), 5.19 (s, 1H, CH(H)=C), 
4.98 (s, 1H, CH(H)=C), 3.70–3.48 (br m, 16H, 2 x (O(CH2CH2)2N)), 3.25 (dt, 1H, J = 8.5 
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and 17.5 Hz, 1H, CHCHOBz), 3.02 (app t, 1H, J = 8.5 and 20.4 Hz, (CO)CHCH2), 2.55 
(dd, 1H, 18.0 Hz, CH(H)=CH2), 2.14 (dd, 1H, 8.5 and 18.0 Hz, CH(H)=CH2), 1.24 (d, 
3H, J = 8.5 Hz, Me), 1.07 (d, 3H, J=8.5 Hz, Me); 13C NMR (75 MHz, CDCl3) δ 174.6, 
171.7, 165.3, 145.1, 133.0, 130.0, 129.5, 128.4, 114.2, 76.0, 66.8, 46.2, 45.9, 42.1, 38.8, 
37.4, 33.9, 17.7, 13.8; HRMS (FAB+) exact mass calc. for [M+H] (C25H35N2O6) requires 
m/z 459.2495, found m/z  459.2481. 
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46 50  
(2R*,3R*,6R*)-3-benzoate-2,6-dimethyl-4-methylene-7-morpholin-4yl-heptanoic 
acid 50: To a solution of bisamide 46 (420 mg, 0.915 mmol) in 4.6 mol of a DME : water 
solution was added iodine (511 mg, 2.013 mmol). The resulting black solution was stirred 
in the absence of light for three hours at room temperature at which time it was diluted 
with 20 mL of ethyl acetate and quenched with 10 mL of a saturated solution of Na2S2O3. 
The organic phase was washed with 50 mL of brine and dried over sodium sulfate prior 
to concentration in vacuo. The resulting oil was then dissolved in 10 mL of acetic acid 
and zinc metal (4.39 mg, 6.72 mmol) was added. The resulting suspension was heated to 
50 °C under argon for 2 hours, after which time it was cooled to room temperature and 
treated with 1N HCl. The crude mixture was then extracted 3 x 100 mL ethyl acetate and 
the combined organics were washed with brine, dried over sodium sulfate, and 
concentrated. The resulting crude yellow solid was pushed through a pad of silica gel 
with ethyl acetate, and this residue was concentrated to yield the product as a sticky white 
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solid in an 83:17 mixture of regioisomers α,β-disubstituted acid : α,β-disubstituted 
amide. This mixture could be triturated with –78 °C ether to give the title compound in 
isomerically pure form (322 mg). IR (film): 2981, 2935, 2866, 1722, 1637, 1452, 1274, 
1112, 1027, 966, 850 cm-1;  1H NMR (300 MHz, CDCl3) δ 8.06 (d, 2H, J=9.0 Hz, Ar), 
7.58 (app t, 1H, J = 9.3 Hz, Ar), 7.45 (t, 2H, J = 9.5 Hz, Ar), 5.69 (d, 1H, J = CHOBz), 
5.09 (s, 1H, CH(H)=C), 4.98 (s, 1H, CH(H)=C), 3.75–3.48 (br m, 8 H, (O(CH2CH2)2N)), 
3.05–2.99 (m, 2H 2 x CHCH3), 2.61 (dd, 1H, J = 7.0 and 14.5 Hz, CH(H)=CH2), 2.18 
(dd, 1H, 6.5 and 15.0 Hz, CH(H)=CH2), 1.28 (d, 3H, J = 7.0 Hz, Me), 1.13 (d, 3H, J=8.5 
Hz, Me); 13C NMR (75 MHz, CDCl3) δ 176.8, 175.2, 165.3, 143.5, 133.2, 129.6, 128.5, 
128.4, 113.9, 75.6, 66.8, 66.7, 46.1, 42.4, 41.8, 36.9, 34.0, 17.8, 10.9; HRMS (FAB+) 
exact mass calc. for [M+H] (C21H27NO6) requires m/z 389.1838, found m/z 389.1845. 
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(2R*,3R*,6R*)-3-(tert-butyl-dimethyl-silanoxy)-2,6-dimethyl-4-methylene-7-oxo-
nonanoic acid 51: To a solution of acid 50 (910 mg, 2.34 mmol) in 20 mL of THF at –63 
°C was added freshly prepared ethyl lithium (14.73 mmol) by syringe pump over 30 
minutes as 0.6 M solution in diethyl ether. After 1 hour the reaction mixture was 
quenched with 50 mL of NH4Cl and 50 mL of 1 M KHSO4 and allowed to warm to room 
temperature. The aqueous layer was extracted with 3 x 100 mL of ethyl acetate and dried 
over sodium sulfate prior to concentration. The resulting ketone was used without further 
purification. A solution of TBSCl (2.31 g, 15.33 mmol) and imidazole (2.08 g, 30.66 
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mmol) in 8 mL of DMF was added to the ethyl ketone via cannula under an argon 
atmosphere.  After 16 hours at room temperature the reaction mixture was diluted with 50 
mL of KHSO4 and extracted 3 x 50 mL with ethyl acetate. The combined organic layers 
were washed with brine, dried over sodium sulfate and concentrated in vacuo. The 
resulting bis silyl ether was taken up in a 0.25M solution of K2CO3 in MeOH (45 mL) 
and stirred for 30 minutes, after which time the reaction mixture was diluted with 50 mL 
of KHSO4 and the methanol was removed in vacuo. The remaining aqueous suspension 
was extracted 3 x 100 mL with ethyl acetate, dried over sodium sulfate, concentrated, and 
purified by silica gel chromatography (20% ethyl acetate in hexanes) to afford the title 
compound as a clear oil in 54% yield over the three steps. 1H NMR (300 MHz, CDCl3) δ 
5.16 (s, 1H, C=C(H)H), 4.89 (s, 1H, C=C(H)H), 4.46 (d, 1H, J = 4.8 Hz, CHOTBS), 2.9–
2.75 (m, 1H), 2.70–2.60 (m, 1H), 2.60–2.45 (m, 1H), 2.48 (q, 2H, J =7.2 Hz, CH2CH3), 
2.38 (dd, 1H, J = 7.2 and 15.3 Hz, CH(H)C=CH2), 2.01 (dd, 1H, J = 7.4 and 15.8 Hz, 
CH(H)C=CH2), 1.13 (d, 3H, J =7.2 Hz, Me), 1.10 (d, 3H, J =7.8 Hz, Me), 1.07 (t, 3H, J = 
7.2 Hz, CH2CH3), 0.91 (s, 9H, TBS), 0.06 (s, 3H, TBS), 0.00 (s, 3H, TBS); 13C NMR (75 
MHz, CDCl3) δ 214.5, 179, 146.5, 113.1, 76.3, 44.4, 44.0, 34.5, 34.4, 26.1, 18.4, 17.3, 
10.6, 8.1, -4.1, -5.0; HRMS (FAB+) exact mass calc. for [M+H] (C18H35O4Si) requires 
m/z 343.2305, found m/z 343.2301. 
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Carboxylic Acid 52: A 2.1 M solution of n-BuLi in hexanes (1.75 mL, 3.65 mmol) was 
added dropwise to a solution of freshly distilled hexamethyldisilazide (641 mg, 4.38 
mmol) in 5.5 mL of THF under argon at 0 °C. After 30 minutes the reaction mixture was 
cooled to –78 °C and racemic ethyl ketone 51 (500 mg, 1.46 mmol) wass added in 4 mL 
of THF. After 120 minutes the enantiopure aldehyde 38 (780 mg, 3.31 mmol) was added 
dropwise in 4 mL of a  –78 °C solution of THF. After 5 hours the reaction mixture was 
diluted with THF and quenched by the addition of 50 mL of saturated NH4Cl solution. 
The organic fraction was washed with 3 x 75 mL of ethyl acetate, followed by washing 
with brine and drying over sodium sulfate. Concentration yielded the product acid as an 
inseparable mixture of diastereomers in 91% yield (760 mg, 7:7:1:1 syn:syn:anti:anti). 
This material was pushed through a silica plug with ethyl acetate, concentrated, and used 
without further purification.  
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Diol 52a: In a flame-dried 25 mL flask charged with Me4NB(OAc)3H (2.42 g, 9.22 
mmol) was added 10 mL of MeCN. 9 mL of anhydrous acetic acid was added and the 
resulting solution was cooled to –40 °C. The carboxylic acid (760 mg, 1.317 mmol) was 
then added in 10 mL of MeCN and the reaction was stirred at –40 °C for 8 hours. It was 
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then warmed to –20 °C and stirred for 10 hours before being warmed to 0 °C for one 
hour. The reaction mixture was poured into 200 mL of saturated NaHCO3, extracted with 
three 100 mL portions of ethyl acetate, dried over sodium sulfate and concentrated to 
yield the desired anti diols as a 1:1 mixture of diastereomers in 71% yield (538 mg). This 
material was used without further purification.  
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Carboxylic Acid 54: To a solution of the diol diastereomers (649 mg, 0.929 mmol) in 9.5 
mL of dichloromethane under argon was added anisaldehyde dimethylacetal (0.475 mL, 
2.78 mmol) and CSA (10 mg, 0.046 mmol). After 6 hours the reaction was quenched 
with Hünig’s base (0.2 mL) and concentrated in vacuo. The resulting foam was purified 
on silica gel (10%–20 % ethyl acetate in hexanes) to yield two diastereomeric acetals in 
combined yield of 540 mg. Desired Isomer: IR (film): 3500–2600 br, 1710, 1517, 1463, 
1248, 1042, 834 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.36 (d, 2H, J = 8.4 Hz, Ar), 7.30–
7.23 (m, 5H, Ph), 6.85 (d, 2H, J =8.1 Hz, Ar), 5.54 (s, 1H, PMPCH), 5.18 (s, 1H, 
C=CH(H)), 4.93 (s, 1H, C=CH(H)), 4.79 (dd, 2H, J = 6.6 and 11.7 Hz, OCH2O), 4.63 (d, 
2H, J = 2.1 Hz, PhCH2), 4.48 (d, 1H, J = 3.9 Hz, CHOTBS), 4.03–3.95 (m, 2H, 
CHOPMB), 3.78 (s, 3H, ArOMe), 3.37 (d, 1H,  J = 10.5 Hz, CHOBOM), 2.60–2.50 (m, 
2H), 2.07 (d, 1H, J =14.7 Hz ), 1.80–1.70 (m, 4H), 1.48 (dq, 1H, J = 7.3 and 21.5 Hz), 
1.19 (d, 3H, J = 7.2 Hz, Me C(10)), 1.09 (d, 3H, J = 7.2 Hz, Me C(8)), 1.08 (d, 3H, J = 
6.6 Hz, Me C(6)), 0.87 (s, 9H, TBS), 0.90-0.86 (m, 3H,  CH2Me), 0.82 (d, 3H, J = 6.6 
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Hz, Me C(5)), 0.02 (s, 3H, TBS), -0.01 (s, 3H, TBS); 13C NMR (75 MHz, CDCl3) δ 
179.9, 159.7, 146.3, 138.1, 131.9, 128.5, 127.8, 127.6, 127.4, 127.3, 113.7, 95.4, 84.8, 
78.5, 75.5, 75.4, 69.4, 55.5, 44.1, 37.2, 37.0, 29.9, 29.7, 29.6, 26.1, 25.9, 18.4, 16.2, 13.5, 
10.9, 10.4, 7.6, -4.0, -4.8; HRMS (ES) exact mass calc. for [M+H] (C40H62O8SiNa) 
requires m/z 721.4112, found m/z 721.4103; [α]D = –11.1 (c = 1.0, CHCl3); TLC Rf = 
0.15 (20% ethyl acetate in hexanes); Diastereomer: [α]D = –7.0 (c = 1.0, CHCl3); TLC Rf 
= 0.20 (20% ethyl acetate in hexanes). 
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Methyl ester 54a: To a solution of carboxylic acid 54 (170 mg, 0.243 mmol) in 7.0 mL 
of CH2Cl2 and 0.7 mL of MeOH was added TMSCH2N2 (2.0M in ether, 0.85 mL, 1.7 
mmol) at room temperature. After one hour the reaction was cooled to 0 °C and quenched 
by the addition of 1 mL of acetic acid. The reaction mixture was poured into 20 mL of 
saturated NaHCO3 solution and extracted with 3 x 50 mL portions of ethyl acetate. The 
resulting oil was dried over sodium sulfate, concentrated, and flashed on silica gel (20 % 
ethyl acetate in hexanes) to yield 142 mg of the desired methyl ester. IR (film): 2931, 
2361, 2339, 1735, 1616, 1518, 1457, 1250cm-1; 1H NMR (300 MHz, CDCl3) δ 7.36 (d, 
2H, J = 8.1 Hz, Ar), 7.27–7.20 (m, 5H, Ph), 6.85 (d, 2H, J =8.7 Hz, Ar), 5.53 (s, 1H, 
PMPCH), 5.14 (s, 1H, C=CH(H)), 4.90 (s, 1H, C=CH(H)), 4.79 (dd, 2H, J = 6.6 and 18.6 
Hz, OCH2O), 4.63 (dd, 2H, J = 11.9 and 20.0 Hz, PhCH2), 4.42 (d, 1H, J = 5.1 Hz, 
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CHOTBS), 4.02–3.95 (m, 2H), 3.78 (s, 3H, ArOMe), 3.62 (s, 3H, CO2Me), 3.37 (d, 1H,  
J = 10.5 Hz, CHOBOM), 2.50–2.40 (m, 2H), 2.07 (d, 1H, J =14.7 Hz ), 1.85–1.65 (m, 
4H), 1.49 (dq, 1H, J = 7.2 and 21.8 Hz), 1.20 (d, 3H, J = 6.6 Hz, Me), 1.09 (d, 3H, J = 6.6 
Hz, Me), 0.97 (d, 3H, J = 6.6 Hz, Me), 0.87 (s, 9H, TBS), 0.92-0.86 (m, 3H,  CH2Me), 
0.82 (d, 3H, J = 7.2 Hz, Me), -0.01 (s, 3H, TBS), -0.02 (s, 3H, TBS); 13C NMR (75 MHz, 
CDCl3) δ 174.7, 159.7, 146.6, 138.1, 131.9, 128.5, 127.7, 127.3, 113.7, 113.5, 95.4, 95.3, 
84.8, 78.6, 76.0, 75.4, 69.7, 55.5, 51.8, 44.4, 37.2, 36.8, 30.0, 29.6, 26.0, 25.9, 18.4, 16.0, 
13.6, 10.9, 10.8, 7.5, -4.0, -4.9; HRMS (ES) exact mass calc. for [M+] (C41H64O8Si) 
requires m/z 712.4371, found m/z 712.4370; [α]D =  –7.2 (c = 1.0, CHCl3). 
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Alcohol 55: To a solution of ester 54a (60 mg, 0.084 mmol) in 33 mL of THF at 0 °C 
was added LiBEt3H (0.336 mL, 0.336 mmol) as a 1.0 M solution in THF under argon. 
After 1 hour the reaction mixture was diluted with a solution KHSO4 and extracted with 
three portions 20 mL of ethyl acetate. The combined organic layers were washed with 
brine and dried over sodium sulfate prior to concentration. Purification of the crude 
resulting oil on silica gel (25% ethyl acetate in hexanes) provided the title compound as a 
colorless oil in 80% yield. IR (film): 3507, 2960, 2881, 1616, 1517, 1456, 1250, 1103, 
1046, 831, 776cm-1; 1H NMR (300 MHz, CDCl3) δ 7.32 (d, 2H, J = 9.0 Hz, Ar), 7.30–
7.25 (m, 5H, Ph), 6.84 (d, 2H, J = 8.7 Hz, Ar), 5.54 (s, 1H, PMPCH), 5.17 (s, 1H, 
C=CH(H)), 4.93 (s, 1H, C=CH(H)), 4.79 (dd, 2H, J = 6.6 and 19.8 Hz, OCH2O), 4.61 (s, 
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2H, PhCH2), 4.36 (app s, 1H, CHOTBS), 4.06 (d, 1H J = 10.5 Hz), 3.97 (t, 1H, J = 7.2 
Hz), 3.78 (s, 3H, ArOMe), 3.52 (d, 2H, J = 7.2 Hz, CH2OH), 3.36 (d, 1H,  J = 11.1 Hz, 
CHOBOM), 2.60–2.45 (m, 1H), 2.13 (d, 1H, J =14.1 Hz ), 1.85–1.65 (m, 1H), 1.48 (dq, 
1H, J = 7.2 and 21.5 Hz), 1.19 (d, 3H, J = 6.3 Hz, Me), 0.98 (d, 3H, J = 6.0 Hz, Me), 0.87 
(s, 9H, TBS), 0.92–0.88 (m, 3H,  CH2Me), 0.82 (d, 3H, J = 6.6 Hz, Me), 0.75 (d, 3H, J = 
7.2 Hz, Me), 0.07 (s, 3H, TBS), 0.01 (s, 3H, TBS); 13C NMR (75 MHz, CDCl3) δ 159.8, 
147.3, 137.9, 131.9, 128.5, 127.8, 127.7, 127.3, 113.7, 112.7, 95.3, 95.0, 84.9, 78.3, 75.0, 
72.5, 70.0, 65.4, 55.6, 39.6, 38.6, 36.9, 29.3, 29.0, 26.3, 25.5, 18.6, 15.9, 13.3, 10.8, 9.8, 
7.5, -4.0, -4.7; HRMS (ES) exact mass calc. for [M+H] (C40H64O7Si) requires m/z 
684.4421, found m/z 684.4450; [α]D = –16.5 (c = 1.0, CHCl3).  
 
Model System Aldol Product Characterization and Derivatization: 
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General Procedure A: To a solution TMP•HBr (2.1 eq) and 1,10 phenanthroline (trace) 
in THF at 0 °C was added a solution of n-BuLi (2.0 eq) until the solution turned bright 
red, at which point another equal portion of n-BuLi (2.0 eq) was added dropwise. This 
solution was cooled to –78 °C and the thioester was added dropwise (2.0 eq) in a solution 
of THF. After an hour the aldehyde (1.0 eq) was added in a cold solution of THF. The 
resulting mixture was allowed to stir for 2 hours at –78 °C before being quenched by the 
addition of saturated ammonium chloride solution. The resulting heterogeneous solution 
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was allowed to warm to room temperature. It was then diluted with ethyl acetate, washed 
with water and brine, concentrated, and purified on silica gel. 
 
General Procedure B: A 0.1 M solution of silyl ketene thioacetal (1.1 eq) and aldehyde 
(1.0) was cooled to –78 °C and Lewis acid was added dropwise (1.0 eq). After 30 
minutes the resulting mixture was quenched by the addition of saturated ammonium 
chloride. The resulting solution was allowed to warm to room temperature. It was then 
diluted with ethyl acetate and washed with water and brine, concentrated, and purified on 
silica gel. 
 
Diastereomer 1: IR (Film): 3515, 2957, 2928, 2857, 1657, 1472, 1456, 1364, 1252, 
1135, 1042, 1019, 963, 939, 900, 874, 834, 775, 673 cm-1; 1H NMR: (300 MHz, CDCl3) 
δ 4.99 (S, 1H, C=C(H)H), 4.88 (s, 1H, C=C(H)H), 4.48 (app s, 1H, CHOTBS), 3.38 (dt, 
1H, J = 3 and 9 Hz, CHOH), 3.09 (d, 1H, J = 3.3 Hz, OH) 2.81 (dq, 1H, JMe-H = 6.9 Hz 
and JH-H = 3.0 Hz), 1.66 (m, 1H, TBSOCHCH(Me)CHOH), 1.64 (s, 3H, CH2=C(Me)), 
1.45 (s, 9H, St-Bu), 1.32 (d, 1H, J = 6.9 Hz, CH(Me)), 0.90 (s, 9H, TBS), 0.81 (d, 1H, J = 
6.9 Hz, CH(Me)), 0.09 (s, 3H, TBS), 0.00 (s, 3H, TBS); 13C NMR: (75 MHz, CDCl3) δ 
204.2, 146.4, 111.4 76.6, 74.5, 49.9, 48.7, 41.3, 29.9, 26.2, 20.1, 18.5, 16.9, 10.0, -4.2, 
-5.0 HRMS (FAB+) exact mass calc. for [M+H] (C20H41O5SiS) requires m/z 389.2546, 
found m/z  389.2555; [α]D = –34.51 (c = 0.68, CHCl3). 
 
Diastereomer 2: 1H NMR: (300 MHz, CDCl3) δ 5.06 (S, 1H, C=C(H)H), 4.91 (s, 1H, 
C=C(H)H), 4.48 (app s, 1H, CHOTBS), 3.38 (dt, 1H, J = 3 and 8.4 Hz, CHOH), 2.99 (d, 
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1H, J = 3 Hz, OH) 2.71 (dq, 1H, JMe-H = 6.9 Hz and JH-H = 3.0 Hz), 1.67 (s, 3H, 
CH2=C(Me)), 1.60 (m, 1H, TBSOCHCH(Me)CHOH),  1.47 (s, 9H, St-Bu), 1.32 (d, 1H, 
J = 6.9 Hz, CH(Me)), 0.92 (s, 9H, TBS), 0.73 (d, 1H, J = 6.9 Hz, CH(Me)), 0.09 (s, 3H, 
TBS), 0.00 (s, 3H, TBS); 13C NMR: (75 MHz, CDCl3) δ 206.1, 146.2, 111.6 74.5, 73.2, 
50.9, 48.3, 38.8, 30.0, 26.2, 20.3, 18.5, 10.5, 9.5, -4.2, -5.0. 
 
 Diastereomer 3: IR (Film): 3532, 3072, 2958, 2928, 2885, 2857, 1769, 1678, 1472, 
1461, 1455, 1364, 1251, 1217, 1161, 1117, 1067, 1005, 958, 902, 876, 837, 775; 1H 
NMR: (300 MHz, CDCl3) δ 4.93 (S, 1H, C=C(H)H), 4.88 (s, 1H, C=C(H)H), 4.04 (d, 
1H, J = 7.5 Hz, CHOTBS), 3.72 (m, 1H, CHOH), 2.70 (dq, 1H, JMe-H = 6.9 Hz and JH-H = 
8.7 Hz), 2.28 (d, 1H, J = 5.7 Hz, OH), 1.70–1.60 (m, 1H, TBSOCHCH(Me)CHOH), 1.65 
(s, 3H, CH2=C(Me)), 1.45 (s, 9H, St-Bu), 1.09 (d, 1H, J = 7.2 Hz, CH(Me)), 0.91 (d, 1H, 
J = 6.9 Hz, CH(Me)), 0.89 (s, 9H, TBS), 0.052 (s, 3H, TBS), -0.007 (s, 3H, TBS); 13C 
NMR: (75 MHz, CDCl3) δ 205.0, 146.1, 113.5, 79.8, 74.0, 52.4, 48.4, 38.6, 30.0, 26.2, 
26.1, 26.0, 18.4, 17.6, 15.4, 8.3, -4.3, -4.9; HRMS (FAB+)  exact mass calc. for [M+H] 
(C20H41O5SiS) requires m/z 389.2546, found m/z  389.2562; [α]D = 31.48 (c = 1.0, 
CHCl3). 
 
Diastereomer 4: IR (Film): 3527, 2958, 2929, 2858, 1678, 1456, 1364, 1256, 1067, 958, 
902, 876, 836, 774, 674 cm-1; 1H NMR: (300 MHz, CDCl3) δ 4.92 (S, 1H, C=C(H)H), 
4.89 (s, 1H, C=C(H)H), 4.04 (d, 1H, J = 5.1 Hz, CHOTBS), 3.76 (m, 1H, CHOH), 2.71 
(dq, 1H, JMe-H = 6.9 Hz and JH-H = 9.0 Hz), 2.40 (d, 1H, J = 3.3 Hz, OH), 1.72 (m, 1H, 
TBSOCHCH(Me)CHOH), 1.61 (s, 3H, CH2=C(Me)), 1.45 (s, 9H, St-Bu), 1.23 (d, 1H, J 
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= 6.9 Hz, CH(Me)), 0.91 (d, 1H, J = 6.0 Hz, CH(Me)), 0.90 (s, 9H, TBS), 0.09 (s, 3H, 
TBS), 0.00 (s, 3H, TBS); 13C NMR: (75 MHz, CDCl3) δ 203.7, 145.9, 112.6, 80.5, 75.4, 
52.8, 48.2, 38.6, 29.9, 26.1, 18.5, 18.3, 15.3, 7.2, -4.2, -4.9;  HRMS (FAB+)  exact mass 
calc. for [M+H] (C20H41O5SiS) requires m/z 389.2546, found m/z  389.2556; [α]D = –4.36 
(c = 1.0, CHCl3). 
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General Procedure: To a solution of thioester (1.0 eq) at 0 °C in ether (0.15 M) was 
added LiBH4 as a 2.0 M solution in THF. After 3 hours the reaction mixture was 
quenched by the addition of aqueous Rochelle’s salt, extracted with ether and dried over 
sodium sulfate. Following concentration, the resulting oil could be purified on silica gel.  
 
Diastereomer 1 diol: 1H NMR: (300 MHz, CDCl3) δ 4.95 (app s, 2H), 4.38 (d, 1H, J = 
2.4 Hz), 3.85 (dd, 1H, J = 3.6 and 10.8 Hz), 3.60 (m, 2H), 3.41 (br m, 2H), 1.95–1.80 (m, 
2H), 1.72 (s, 3H), 1.02 (d, 3H, J = 7.2 Hz), 0.90 (s, 9H), 0.86 (d, 1H, J = 7.2 Hz), 0.11 (s, 
3H), 0.02 (s, 3H); 13C NMR: (75 MHz, CDCl3) δ 145.1, 113.0, 80.8, 77.9, 66.5, 39.4, 
36.6, 26.1, 26.0, 20.3, 18.3, 15.0, 12.0, -4.1, -4.8; HRMS (FAB+) exact mass calc. for 
[M+H] (C20H41O5SiS) requires m/z 303.2536, found m/z 303.2359; [α]D = –23.6 (c = 
4.76, CHCl3). 
 
Diastereomer 2 diol: 1H NMR: (300 MHz, CDCl3) δ 4.95 (app s, 2H), 4.30 (d, 1H, J = 
3.3 Hz), 3.90–3.60 (m, 4H), 1.55–1.60 (m, 2H), 1.77 (s, 3H), 0.95 (d, 3H, J = 6.9 Hz), 
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0.91 (s, 9H), 0.90 (d, 1H, J = 6.9 Hz), 0.09 (s, 3H), 0.02 (s, 3H); 13C NMR: (75 MHz, 
CDCl3) δ 145.5, 113.0, 79.1, 75.9, 68.5, 40.6, 36.4, 26.0, 20.3, 18.4, 12.0, 8.6, -4.6, -5.2. 
 
 Diastereomer 3 diol: IR (Film): 3368, 3073, 2957, 2929, 2857, 2884, 2359, 2342, 1652, 
1472, 1462, 1251, 1071, 1053, 971, 901, 875, 836, 774, 675 cm-1; 1H NMR: (300 MHz, 
CDCl3) δ 4.96 (S, 1H, C=C(H)H), 4.91 (s, 1H, C=C(H)H), 4.08 (d, 1H, J = 7.5 Hz, 
CHOTBS), 3.65 (br d, 2H, J = 5.4 Hz), 3.55 (d, 1H, J = 9.6 Hz), 3.33 (br s, 1H), 1.90–
1.70 (m, 3H), 1.66 (s, 3H, CH2=C(Me)),0.90 (s, 9H, TBS), 0.89 (d, 1H, J = 6.6 Hz, 
CH(Me)), 0.75 (d, 1H, J = 6.9 Hz, CH(Me)), 0.087 (s, 3H, TBS), 0.005 (s, 3H, TBS); 13C 
NMR: (75 MHz, CDCl3) δ 146.0, 112.8, 81.0, 80.2, 69.2, 38.3, 37.8, 26.1, 18.6, 18.3, 
13.8, 7.0, -4.3, -5.0; HRMS (FAB+) exact mass calc. for [M+H] (C16H35O5Si) requires 
m/z 303.2356, found m/z  303.2341; [α]D = 7.41 (c = 3.36, CHCl3). 
 
Diastereomer 4 diol: IR (Film): 3363, 3069, 2927, 2955, 2885, 2857, 1471, 1461, 1377, 
1249, 1140, 1067, 1051, 1034, 968, 895, 877, 836, 775, 679, 550 cm-1; 1H NMR: (300 
MHz, CDCl3) δ 4.96 (S, 1H, C=C(H)H), 4.90 (s, 1H, C=C(H)H), 4.04 (d, 1H, J = 5.1 Hz, 
CHOTBS), 3.70–3.60 (m, 3H), 2.04 (br s, 2H), 1.86 (m, 1H), 1.78 (m, 1H) 1.67 (s, 3H, 
CH2=C(Me)), 1.03 (d, 1H, J = 6.9 Hz, CH(Me)), 0.92 (d, 1H, J = 6.9 Hz, CH(Me)),  0.91 
(s, 9H, TBS), 0.06 (s, 3H, TBS), 0.00 (s, 3H, TBS); 13C NMR: (75 MHz, CDCl3) δ 146.0, 
112.5, 79.7, 76.0, 66.9, 38.8, 38.5, 26.1, 18.9, 18,4, 12.5, 8.2, -4.2, -4.9; HRMS (FAB+) 
exact mass calc. for [M+H] (C16H35O5Si) requires m/z 303.2356, found m/z  303.2367; 
[α]D = 15.83 (c = 1.43, CHCl3). 
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General Procedure: To a solution of diol (1.0 eq) in pyridine (0.1 M) is added PivCl 
(2.0 eq). After 1 hour the resulting solution was diluted with toluene and concentrated. 
The crude reaction mixture was loaded directly onto silica gel and chromatographed to 
yield the product alcohol. 
 
Diastereomer 2 Pivoate: 1H NMR: (300 MHz, CDCl3) 4.96 (s, 1H), 4.93 (s, 1H), 4.37 
(d, 1H, J = 2.4 Hz), 4.16 (dd, 1H, J = 8.4 and 10.8 Hz), 3.96 (dd, 1H, J = 6.0 and 10.8 
Hz), 3.59 (d, 1H, J = 9.9 Hz), 3.03 (br s, 1H), 2.00–1.88 (m, 1H), 1.80–1.70 (m, 1H), 1.73 
(s, 3H), 1.20 (s, 9H), 0.87 (d, 3H J = 6.9 Hz), 0.71 (d, 3H, J = 7.2 Hz), 0.06 (s, 3H), 0.003 
(s, 3H); 13C NMR: (75 MHz, CDCl3) δ 179.1, 145.9, 112.4, 71.7, 67.4, 39.9, 39.0, 35.1, 
27.4, 26.7, 26.1, 20.3, 18.4, 11.0, 8.8, -4.5, -5.0. 
 
 Diastereomer 3 Piovate: IR (Film): 3523, 3072, 2959, 2930, 2883, 2857, 2359, 2340, 
1730, 1712, 1480, 1472, 1462, 1286, 1251, 1168, 1070, 975, 877, 836, 774, 679 cm-1; 1H 
NMR: (300 MHz, CDCl3) δ 4.93 (s, 1H), 4.85 (s, 1H), 4.39 (dd, 1H, J = 4.8 and 10.8 Hz), 
4.03 (m, 1H), 3.47 (app q, 1H, J = 7.2 Hz), 3.26 (m, 1H), 2.63 (d, 1H, J = 3.9 Hz), 1.90-
1.80 (m, 1H), 1.75–1.65 (m, 1H), 1.64 (s, 3H), 1.19 (s, 9H), 0.91 (d, 3H, J = 3.0 Hz), 0.89 
(s, 9H), 0.87 (d, 3H, J = 6.6 Hz), 0.067 (s, 3H), 0.00 (s, 3H); 13C NMR: (75 MHz, CDCl3) 
δ 184.3, 151.2, 118.0, 85.7, 77.7, 71.8, 44.0, 42.7, 41.9, 32.3, 31.6, 31.0, 23.3, 22.5, 18.9, 
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12.5, 0.55, 0.00; HRMS (FAB+)  exact mass calc. for [M+H] (C21H43O4Si) requires m/z 
387.2931, found m/z  387.2927; [α]D = 7.01 (c = 3.36, CHCl3). 
  
Diasteromer 4 Pivoate: IR (Film): 3533, 2958, 2930, 2884, 2857, 2360, 1731, 1713, 
1481, 1473, 1462, 1398, 1388, 1369, 1285, 1251, 1161, 1069, 974, 939, 900, 876, 836, 
774, 676 cm-1; 1H NMR: (300 MHz, CDCl3) δ 4.95 (S, 1H, C=C(H)H), 4.89 (s, 1H, 
C=C(H)H), 4.10–4.00 (m, 2H),  3.92–3.84 (m, 1H), 3.49 (m, 1H), 2.2 (d, 1H, J = 3.9 Hz), 
1.96 (m, 1H), 1.76 (m, 1H), 1.65 (s, 3H, CH2=C(Me)), 1.19 (s, 9H, Piv), 1.04 (d, 1H, J = 
6.9 Hz, Me), 0.91 (d, 1H, J = 5.4 Hz, Me), 0.90 (s, 9H, TBS), 0.07 (s, 3H, TBS), 0.00 (s, 
3H, TBS); 13C NMR: (75 MHz, CDCl3) 183.7, 151.0, 117.6, 85.4, 80.0, 71.9, 44.0, 43.6, 
41.5, 32.4, 31.7, 31.0, 23.5, 23.3, 18.9, 12.7, 0.7, 0.0; HRMS (FAB+) exact mass calc. for 
[M+H] (C21H43O4Si) requires m/z 387.2931, found m/z  387.2931; [α]D = 12.83 (c = 1.0, 
CHCl3). 
 
 
TBAF, THF
OH
Me
Me
OTBS
Me
OPiv OH
Me
Me
OH
Me
OPiv
 
General Procedure: To a solution of alcohol (1.0 eq) in THF (0.1 M) was added TBAF 
(2.0 eq) as a 1.0 M solution in THF. After ten minutes the reaction was judged complete 
and the reaction was concentrated and pushed through a silica plug. The product was 
used without further purification. 
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General Procedure: To a solution of diol (1.0 eq) in 2,2-DMP (0.1 M) was added CSA 
(trace). After ten minutes the reaction was judged complete and the reaction was 
concentrated and purified on silica gel.  
 
Diastereomer 2 Acetonide: 1H NMR: (300 MHz, CDCl3) δ 4.99 (S, 1H, C=C(H)H), 
4.86 (s, 1H, C=C(H)H), 4.16 (app d, 1H, J = 1.8 Hz, C=CCHOC(Me)2), 4.00 (m, 2H, 
CH2OPiv), 3.51 (dd, 2H, J = 2.7 and 8.4 Hz, CHOC(Me)2), 2.00–1.85 (m, 2H), 1.66 (s, 
3H, C=CMe), 1.32 (s, 3H, acetonides Me), 1.30 (s, 3H, acetonides Me), 1.20 (s, 9H, Piv), 
0.97 (d, 3H, J = 6.9 Hz, Me), 0.69 (d, 3H, J = 6.9 Hz, Me); 13C NMR: (75 MHz, CDCl3) 
δ 145.5, 110.3, 100.9, 74.0, 71.9, 66.5, 36.0, 35.5, 27.4, 25.2, 23.7, 20.2, 12.5, 11.1. 
 
Diastereomer 3 Acetonide:  IR (Film): 2972, 2938, 2876, 1729, 1480, 1459, 1380, 1284, 
1259, 1202, 1159, 1104, 1018, 998, 976, 935, 901, 869, 770 cm-1; 1H NMR: (300 MHz, 
CDCl3) δ 5.04 (S, 1H, C=C(H)H), 4.90 (s, 1H, C=C(H)H), 4.26 (app s, 1H, 
C=CCHOC(Me)2), 4.11 (m, 2H, CH2OPiv), 3.70 (dd, 2H, J = 2.4 and 9.6 Hz, 
CHOC(Me)2), 2.00–1.85 (m, 1H), 1.67 (s, 3H, C=CMe), 1.70–1.60 (m, 1H), 1.41 (s, 3H, 
acetonides Me), 1.39 (s, 3H, acetonides Me), 1.21 (s, 9H, Piv), 0.90 (d, 3H, J = 6.9 Hz, 
Me), 0.73 (d, 3H, J = 6.9 Hz, Me); 13C NMR: (75 MHz, CDCl3) δ 178.8, 142.9, 110.6, 
99.1, 75.6, 73.6, 66.3, 39.2, 34.8, 31.1, 30.1, 27.5, 27.4, 19.6, 19.57, 12.5, 4.8; HRMS 
(FAB+)  exact mass calc. for [M+H] (C15H27O4) requires m/z 271.1909, found m/z  
271.1914; [α]D = 22.64 (c = 3.36, CHCl3). 
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Diastereomer 4 acetonide: IR (Film): 2971, 2937, 2875, 2359, 2341, 1730, 1480, 1457, 
1379, 1283, 1259, 1201, 1160, 1109, 1018, 991, 938, 901, 870 cm-1; 1H NMR: (300 
MHz, CDCl3) δ 5.03 (S, 1H), 4.90 (s, 1H), 4.21 (s, 1H), 3.97 (ddd, 2H), 3.67 (dd, 1H), 
1.95 (m, 1H), 1.63 (s, 3H), 1.44 (s, 3H), 1.43 (s, 3H), 1.21 (s, 9H), 1.04 (d, 3H), 0.77 (d, 
3H); 13C NMR: (75 MHz, CDCl3) δ 178.8, 142.7, 110.6, 99.2, 75.8, 75.6, 66.0, 39.1, 
34.6, 32.0, 30.1, 27.4, 19.6, 19.5, 14.8, 5.5; HRMS (FAB+) exact mass calc. for [M+H] 
(C15H27O4) requires m/z 271.1909, found m/z  271.1891; [α]D = 3.22 (c = 1.0, CHCl3). 
 
